<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006462.pub4" GROUP_ID="PREG" ID="996805082219381579" MERGED_FROM="" MODIFIED="2016-08-30 13:35:41 +0100" MODIFIED_BY="Leanne Jones" REVIEW_NO="0693" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2016-08-30 13:35:39 +0100" MODIFIED_BY="Leanne Jones">
<TITLE>Early additional food and fluids for healthy breastfed full-term infants</TITLE>
<CONTACT MODIFIED="2016-08-30 13:35:39 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="85726689980777333546101112131056" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Hazel</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Smith</LAST_NAME><POSITION>Research Coordinator</POSITION><EMAIL_1>smith.hazelann@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Paediatric Intensive Care Unit</DEPARTMENT><ORGANISATION>Our Lady's Children's Hospital</ORGANISATION><ADDRESS_1>Crumlin</ADDRESS_1><CITY>Dublin 12</CITY><COUNTRY CODE="IE">Ireland</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-08-30 13:35:39 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="85726689980777333546101112131056" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Hazel</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Smith</LAST_NAME><POSITION>Research Coordinator</POSITION><EMAIL_1>smith.hazelann@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Paediatric Intensive Care Unit</DEPARTMENT><ORGANISATION>Our Lady's Children's Hospital</ORGANISATION><ADDRESS_1>Crumlin</ADDRESS_1><CITY>Dublin 12</CITY><COUNTRY CODE="IE">Ireland</COUNTRY></ADDRESS></PERSON><PERSON ID="EE5D21D682E26AA201CF22BBD5EB6D97" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Genevieve</FIRST_NAME><MIDDLE_INITIALS>E</MIDDLE_INITIALS><LAST_NAME>Becker</LAST_NAME><EMAIL_1>gbecker@bestservices.ie</EMAIL_1><URL>www.bestservices.ie</URL><ADDRESS><ORGANISATION>BEST Services</ORGANISATION><ADDRESS_1>2 Kylemore Park</ADDRESS_1><CITY>Galway</CITY><COUNTRY CODE="IE">Ireland</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-06-22 10:12:43 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="3" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="3" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="3" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="12" YEAR="2011"/>
<LAST_CITATION_ISSUE ISSUE="8" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-08-09 11:59:20 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-08-09 11:59:20 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>Conclusions unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="3" YEAR="2016"/>
<DESCRIPTION>
<P>Search updated and two additional trials (<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) included. One trial previously listed as ongoing, now published, has also been included (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
<P>Two new ongoing trials were identified (<LINK REF="STD-Flaherman-2014" TYPE="STUDY">Flaherman 2014</LINK>; <LINK REF="STD-Kair-2014" TYPE="STUDY">Kair 2014</LINK>).</P>
<P>Seven more studies have been added to 'Excluded studies' (<LINK REF="STD-Cameron-2015" TYPE="STUDY">Cameron 2015</LINK>; <LINK REF="STD-de-Jong-1998" TYPE="STUDY">de Jong 1998</LINK>; <LINK REF="STD-Du-Toit-2015" TYPE="STUDY">Du Toit 2015</LINK>; <LINK REF="STD-Juvonen-1996" TYPE="STUDY">Juvonen 1996</LINK>; <LINK REF="STD-Kimani_x002d_Murage-2013" TYPE="STUDY">Kimani-Murage 2013</LINK>; <LINK REF="STD-Flaherman-2011" TYPE="STUDY">Flaherman 2011</LINK>; <LINK REF="STD-Saarinen-1999" TYPE="STUDY">Saarinen 1999</LINK>).</P>
<P>Three 'Summary of findings' tables have been incorporated in this update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-02-08 12:00:15 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-02-08 12:00:12 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>There have been no major changes made to the conclusions of the review since the last update. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-08 12:00:15 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="3" YEAR="2014"/>
<DESCRIPTION>
<P>Two additional trials have been included (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>).</P>
<P>One additional paper to an already included trial has also been added (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>).</P>
<P>Six more studies have been added to 'Excluded studies' (<LINK REF="STD-de-Oliveira-2012" TYPE="STUDY">de Oliveira 2012</LINK>; <LINK REF="STD-French-2012" TYPE="STUDY">French 2012</LINK>; <LINK REF="STD-Krebs-2013" TYPE="STUDY">Krebs 2013</LINK>; <LINK REF="STD-Olaya-2013" TYPE="STUDY">Olaya 2013</LINK>; <LINK REF="STD-Schiess-2010" TYPE="STUDY">Schiess 2010</LINK>; <LINK REF="STD-Ziegler-2011" TYPE="STUDY">Ziegler 2011</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-08-30 12:57:37 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2016-08-30 12:56:42 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-08-30 12:56:42 +0100" MODIFIED_BY="[Empty name]">
<NAME>G Becker and HA Smith undertook the update of this review as volunteers with no funding or protected time support</NAME>
<COUNTRY CODE="IE">Ireland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2016-08-30 12:57:37 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2016-08-30 12:57:09 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Pregnancy and Childbirth received a grant from the Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development, World Health Organization</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-08-30 12:56:17 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-08-29 18:37:01 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2016-06-11 17:00:44 +0100" MODIFIED_BY="[Empty name]">Early additional food and fluids for healthy breastfed full-term infants</TITLE>
<SUMMARY_BODY MODIFIED="2016-08-29 18:37:01 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>What is the issue?</B>
</P>
<P>Internationally, exclusive breastfeeding for the first six months of life is recommended but the practice of giving breastfeeding infants other fluids and/or foods before six months is common in many countries and communities.</P>
<P>
<B>Why is this important?</B>
</P>
<P>Given that many infants are not exclusively breastfeeding for six months it is important to examine the possible benefits or risks associated with giving breastfeeding infants liquids other than breastmilk or complementary food in the first six months after birth.</P>
<P>
<B>What evidence did we find?</B>
</P>
<P>This review includes 11 randomised controlled trials involving 2542 infants.</P>
<P>Giving babies small amounts of artificial milk for a few days after birth in addition to breastfeeding did not effect the number of infants with any breastfeeding at hospital discharge though did slightly increase the likelihood of any breastfeeding at three months of age. There was no difference in the level of maternal confidence between the groups. The use of artificial milk before breastfeeding had a slight protective effect against allergy symptoms at 18 months of age compared to exclusive breastfeeding, however the trial did not perform diagnostic challenges or other tests to confirm the allergy symptoms noticed and thus requires caution in interpretation.</P>
<P>The likelihood of infants continuing to breastfeed was higher in the exclusive breastfeeding group than the group provided with additional water or glucose water in the first few days after birth. There was no evidence of benefit related to glucose levels, temperature, weight loss to breastfeeding newborn infants who were given additional water or glucose water.</P>
<P>Breastfeeding infants receiving complementary foods at four to six months did not show reduced risk of food allergy, eczema, or food protein-induced enterocolitis syndrome reactions. There was no difference between the early complementary foods and the exclusive breastfeeding groups for the percentage of days of cough, congestion, nasal discharge and hoarseness, fever, iron deficiency or weight gain.</P>
<P>
<B>What does this mean?</B>
</P>
<P>This review did not find sufficient evidence for disagreement with the recommendation of the World Health Organization and other international health organisations that as a general policy exclusive breastfeeding, without additional foods or fluids, should be recommended for the first six months after birth.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-08-28 13:25:21 +0100" MODIFIED_BY="Genevieve Becker">
<ABS_BACKGROUND MODIFIED="2016-06-23 22:26:24 +0100" MODIFIED_BY="[Empty name]">
<P>Health organisations recommend exclusive breastfeeding for six months. However, the addition of other fluids or foods before six months is common in many countries. Recently, research has suggested that introducing solid food at around four months of age while the baby continues to breastfeed is more protective against developing food allergies compared to exclusive breastfeeding for six months. Other studies have shown that the risks associated with non-exclusive breastfeeding are dependent on the type of additional food or fluid given. Given this background we felt it was important to update the previous version of this review to incorporate the latest findings from studies examining exclusive compared to non-exclusive breastfeeding.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-06-23 17:42:38 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the benefits and harms of additional food or fluid for full-term healthy breastfeeding infants and to examine the timing and type of additional food or fluid.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-06-16 14:47:57 +0100" MODIFIED_BY="Genevieve Becker">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (1 March 2016) and reference lists of all relevant retrieved papers.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-11-10 21:26:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials in infants under six months of age comparing exclusive breastfeeding versus breastfeeding with any additional food or fluids.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-07-19 10:53:28 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. Two review authors assessed the quality of the evidence using the GRADE approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-08-28 13:25:02 +0100" MODIFIED_BY="Genevieve Becker">
<P>We included 11 trials (2542 randomised infants/mothers). Nine trials (2226 analysed) provided data on outcomes of interest to this review. The variation in outcome measures and time points made it difficult to pool results from trials. Data could only be combined in a meta-analysis for one primary (breastfeeding duration) and one secondary (weight change) outcome. None of the trials reported on physiological jaundice. Infant mortality was only reported in one trial.</P>
<P>For the majority of older trials, the description of study methods was inadequate to assess the risk of bias. Most studies that we could assess showed a high risk of other biases and over half were at high risk of selection bias.</P>
<P>Providing breastfeeding infants with artifical milk, compared to exclusive breastfeeding, did not affect rates of breastfeeding at hospital discharge (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.97 to 1.08; one trial, 100 infants; <I>low-quality evidence</I>). At three months, breastfeeding infants who were provided with artificial milk had higher rates of any breastfeeding compared to exclusively breastfeeding infants (RR 1.21, 95% CI 1.05 to 1.41; two trials, 137 infants; <I>low-quality evidence</I>). Infants who were given artifical milk in the first few days after birth before breastfeeding, had less "obvious or probable symptoms" of allergy compared to exclusively breastfeeding infants (RR 0.56, 95% CI 0.35 to 0.91; one trial, 207 infants; <I>very low-quality evidence</I>). No difference was found in maternal confidence when comparing non-exclusive breastfeeding infants who were provided with artificial milk with exclusive breastfeeding infants (mean difference (MD) 0.10, 95% CI -0.34 to 0.54; one study, 39 infants; <I>low-quality evidence</I>). Rates of breastfeeding were lower in the non-exclusive breastfeeding group compared to the exclusive breastfeeding group at four, eight, 12 (RR 0.68, 95% CI 0.53 to 0.87; one trial, 170 infants; <I>low-quality evidence)</I>, 16 and 20 weeks.</P>
<P>The addition of glucose water resulted in fewer episodes of hypoglycaemia (below 2.2 mmol/L) compared to the exclusive breastfeeding group, reported at 12 hours (RR 0.07, 95% CI 0.00 to 1.20; one trial, 170 infants; <I>very low-quality evidence</I>), but no significant difference at 24 hours (RR 1.57, 95% CI 0.27 to 9.17; one trial, 170 infants; <I>very low-quality evidence</I>). Weight loss was lower for infants who received additional glucose water (one trial, 170 infants) at six, 12, 24 and 48 hours of life (MD -32.50 g, 95% CI -52.09 to -12.91; <I>low-quality evidence) </I>compared to the exclusively breastfeeding infants but no difference between groups was observed at 72 hours of life (MD 3.00 g, 95% CI -20.83 to 26.83; <I>very low-quality evidence). </I>In another trial with the water and glucose water arms combined (one trial, 47 infants), we found no significant difference in weight loss between the additional fluid group and the exclusively breastfeeding group on either day three or day five (MD -1.03%, 95% CI -2.24 to 0.18; <I>very low-quality evidence</I>) and (MD -0.20%, 95% CI -0.86 to 0.46; <I>very low-quality evidence</I>).</P>
<P>Infant mortality was reported in one trial with no deaths occurring in either group (1162 infants). The early introduction of potentially allergenic foods, compared to exclusively breastfeeding, did not reduce the risk of "food allergy" to one or more of these foods between one to three years of age (RR 0.80, 95% CI 0.51 to 1.25; 1162 children), visible eczema at 12 months stratified by visible eczema at enrolment (RR 0.86, 95% CI 0.51 to 1.44; 284 children), or food protein-induced enterocolitis syndrome reactions (RR 2.00, 95% CI 0.18 to 22.04; 1303 children) (<I>all moderate-quality evidence). </I>Breastfeeding infants receiving additional foods from four months showed no difference in infant weight gain (g) from 16 to 26 weeks compared to exclusive breastfeeding to six months (MD -39.48, 95% CI -128.43 to 49.48; two trials, 260 children; <I>low-quality evidence</I>) or weight z-scores (MD -0.01, 95% CI -0.15 to 0.13; one trial, 100 children; <I>moderate-quality evidence</I>).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-08-28 13:25:21 +0100" MODIFIED_BY="Genevieve Becker">
<P>We found no evidence of benefit to newborn infants on the duration of breastfeeding from the brief use of additional water or glucose water. The quality of the evidence on formula supplementation was insufficient to suggest a change in practice away from exclusive breastfeeding. For infants at four to six months, we found no evidence of benefit from additional foods nor any risks related to morbidity or weight change. The majority of studies showed high risk of other bias and most outcomes were based on low-quality evidence which meant that we were unable to fully assess the benefits or harms of supplementation or to determine the impact from timing and type of supplementation<I>. </I>
</P>
<P>We found no evidence to disagree with the current international recommendation that healthy infants exclusively breastfeed for the first six months.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-08-29 18:37:33 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2016-08-29 18:37:12 +0100" MODIFIED_BY="[Empty name]">
<P>Human milk for human babies is the biological norm. It has long been recognised as both the unequalled way of providing all the nutritional, immunological and psychological requirements that a healthy, term infant needs to thrive, and important to the health and well-being of the mother. Reviews of studies in both economically advantaged and disadvantaged settings have shown short-term and long-term risks to the child and to the mother from not breastfeeding (<LINK REF="REF-Chen-2004" TYPE="REFERENCE">Chen 2004</LINK>; <LINK REF="REF-Horta-2013a" TYPE="REFERENCE">Horta 2013a</LINK>; <LINK REF="REF-Ip-2007" TYPE="REFERENCE">Ip 2007</LINK>; <LINK REF="REF-Kramer-2012" TYPE="REFERENCE">Kramer 2012</LINK>; <LINK REF="REF-Leon_x002d_Cava-2002" TYPE="REFERENCE">Leon-Cava 2002</LINK>; <LINK REF="REF-Victora-2016" TYPE="REFERENCE">Victora 2016</LINK>).</P>
<CONDITION MODIFIED="2016-08-29 18:37:05 +0100" MODIFIED_BY="[Empty name]">
<P>Exclusive breastfeeding is defined as an infant's consumption of human milk with no supplementation of any type, including no water, juice, non-human milk or foods, although medicines, vitamins and minerals are allowed (<LINK REF="REF-WHO-2008" TYPE="REFERENCE">WHO 2008</LINK>). A review of interventions in 42 developing countries estimated that exclusive breastfeeding for six months and continued breastfeeding for the first year of life could prevent 13% of the over 10 million deaths per annum of children less than five years old. Breastfeeding is identified as the single most important preventative intervention in saving such lives (<LINK REF="REF-Black-2013" TYPE="REFERENCE">Black 2013</LINK>; <LINK REF="REF-Jones-2003" TYPE="REFERENCE">Jones 2003</LINK>). Compared to exclusive breastfeeding, the risks from partial or non-exclusive breastfeeding have been recognised for many years, including a higher rate of infant morbidity and mortality from diarrhoea and respiratory illness (<LINK REF="REF-Arifeen-2001" TYPE="REFERENCE">Arifeen 2001</LINK>; <LINK REF="REF-Brown-1989" TYPE="REFERENCE">Brown 1989</LINK>; <LINK REF="REF-Chantry-2006" TYPE="REFERENCE">Chantry 2006</LINK>; <LINK REF="REF-Feachem-1984" TYPE="REFERENCE">Feachem 1984</LINK>; <LINK REF="REF-Horta-2013b" TYPE="REFERENCE">Horta 2013b</LINK>; <LINK REF="REF-Kramer-2003" TYPE="REFERENCE">Kramer 2003</LINK>; <LINK REF="REF-Quigley-2007" TYPE="REFERENCE">Quigley 2007</LINK>; <LINK REF="REF-Talayero-2006" TYPE="REFERENCE">Talayero 2006</LINK>; <LINK REF="REF-Victora-2016" TYPE="REFERENCE">Victora 2016</LINK>; <LINK REF="REF-Wilson-1998" TYPE="REFERENCE">Wilson 1998</LINK>). Non-exclusive breastfeeding may result in an earlier return of the mother's fertility and a shorter inter-birth interval (<LINK REF="REF-WHO-1999" TYPE="REFERENCE">WHO 1999</LINK>).</P>
<P>International actions work to improve the health of children and their mothers through the promotion of exclusive breastfeeding. The Baby Friendly Hospital Initiative (BFHI) is a global programme started in 1989 to protect and support exclusive breastfeeding through improvement of healthcare practices that affect infant feeding. It has an assessment criterion of 'Give newborn infants no food or drink other than breast milk unless medically indicated' (<LINK REF="REF-UNICEF_x002f_WHO-2009" TYPE="REFERENCE">UNICEF/WHO 2009</LINK>). In 2002, the World Health Assembly, supported by many national and international health associations, reiterated the importance of exclusive breastfeeding in the Global Strategy for Infant and Young Child Feeding. Their previous recommendation for exclusive breastfeeding for "four to six months" was amended to state that as a global public health recommendation, infants should be exclusively breastfeeding for the first six months of life and thereafter breastfeeding continued up to two years of age or beyond with the addition of adequate and safe complementary foods (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>).</P>
<P>From the data in the World Health Organization (WHO) Global Data Bank on Infant and Young Child Feeding 2009, it is estimated that only 38% of infants are exclusively breastfeeding for the first six months. There are indications that in many countries exclusive breastfeeding, though still low, has increased in the last decade (<LINK REF="REF-WHO-2014" TYPE="REFERENCE">WHO 2014</LINK>).</P>
<P>Supplementary feedings are classified as feeds provided in place of breastfeeding. These may include artificial baby milk, glucose water, teas, water or complementary semi-solid or solid) foods. Thus, any foods or fluids given before six months, the recommended duration of exclusive breastfeeding, are therefore defined as supplementary (<LINK REF="REF-AAP-2012" TYPE="REFERENCE">AAP 2012</LINK>; <LINK REF="REF-ABM-2009" TYPE="REFERENCE">ABM 2009</LINK>).</P>
<P>Studies on early additional fluids or foods tend to involve either additional fluids in the early weeks or the addition of foods at four to six months of age. Numerous health services, personal, socioeconomic and cultural factors influence the decision to supplement human milk. These factors include:</P>
<OL>
<LI>pre-lacteal feeds may be given in the belief that colostrum is harmful, or to clean the infant's gut (<LINK REF="REF-Davies_x002d_Adetugbo-1997" TYPE="REFERENCE">Davies-Adetugbo 1997</LINK>);</LI>
<LI>early additional fluids are more likely following caesarean section (<LINK REF="REF-Ladomenou-2007" TYPE="REFERENCE">Ladomenou 2007</LINK>), if hospital practices separate mother and infant at birth (<LINK REF="REF-Gagnon-2005" TYPE="REFERENCE">Gagnon 2005</LINK>; <LINK REF="REF-Kurinij-1991" TYPE="REFERENCE">Kurinij 1991</LINK>), or if the hospital does not follow practices in accordance with the WHO/UNICEF Baby Friendly Hospital Initiative (<LINK REF="REF-AAP-2012" TYPE="REFERENCE">AAP 2012</LINK>; <LINK REF="REF-Biro-2011" TYPE="REFERENCE">Biro 2011</LINK>);</LI>
<LI>additional fluids or foods may be given in the belief they will reduce maternal fatigue, by health workers (<LINK REF="REF-Cloherty-2004" TYPE="REFERENCE">Cloherty 2004</LINK>; <LINK REF="REF-Gagnon-2005" TYPE="REFERENCE">Gagnon 2005</LINK>), and by family members (<LINK REF="REF-Cohen-1999" TYPE="REFERENCE">Cohen 1999</LINK>);</LI>
<LI>lack of health worker time to assist breastfeeding (<LINK REF="REF-Furber-2006" TYPE="REFERENCE">Furber 2006</LINK>; <LINK REF="REF-Gagnon-2005" TYPE="REFERENCE">Gagnon 2005</LINK>);</LI>
<LI>additional fluids or foods as the solution to the perception that the baby is unsettled due to low milk supply (<LINK REF="REF-Akuse-2002" TYPE="REFERENCE">Akuse 2002</LINK>; <LINK REF="REF-Blomquist-1994" TYPE="REFERENCE">Blomquist 1994</LINK>; <LINK REF="REF-Gagnon-2005" TYPE="REFERENCE">Gagnon 2005</LINK>; <LINK REF="REF-Graffy-1992" TYPE="REFERENCE">Graffy 1992</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>), or to make the baby sleep longer;</LI>
<LI>maternal unrealistic expectations of newborn behaviour, difficulty in caring for a newborn, or other maternal concerns, and fluids other than mother's milk is seen as the solution to difficulties (<LINK REF="REF-DaMota-2012" TYPE="REFERENCE">DaMota 2012</LINK>; <LINK REF="REF-Wagner-2013" TYPE="REFERENCE">Wagner 2013</LINK>);</LI>
<LI>weight charts that are based on formula-fed infants or cultural beliefs about infant growth may imply that breastfeeding infants are underweight and additional fluids or foods are given in the belief they will result in higher weight gain that is thought to be beneficial (<LINK REF="REF-Sachs-2006" TYPE="REFERENCE">Sachs 2006</LINK>; <LINK REF="REF-Vail-2015" TYPE="REFERENCE">Vail 2015</LINK>);</LI>
<LI>additional fluids are given in a belief that they will prevent dehydration, hypoglycaemia and neonatal jaundice (<LINK REF="REF-Akuse-2002" TYPE="REFERENCE">Akuse 2002</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="REF-Stewart-2015" TYPE="REFERENCE">Stewart 2015</LINK>);</LI>
<LI>early introduction of allergenic foods in the belief this may reduce the incidence of later food allergy (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>);</LI>
<LI>early maternal return to employment and lack of facilities in the workplace to breastfeed (<LINK REF="REF-Gielen-1991" TYPE="REFERENCE">Gielen 1991</LINK>; <LINK REF="REF-Ladomenou-2007" TYPE="REFERENCE">Ladomenou 2007</LINK>), and mothers perceive disapproval from society of breastfeeding outside her home (<LINK REF="REF-Bai-2009" TYPE="REFERENCE">Bai 2009</LINK>);</LI>
<LI>marketing of formula that suggests mother's milk is insufficient (<LINK REF="REF-Chezem-1998" TYPE="REFERENCE">Chezem 1998</LINK>; <LINK REF="REF-Yee-2007" TYPE="REFERENCE">Yee 2007</LINK>);</LI>
<LI>translation of research into practice, even with the provision of information and development of professional guidelines (<LINK REF="REF-ABM-2011" TYPE="REFERENCE">ABM 2011</LINK>), is sometimes met with barriers and delays (<LINK REF="REF-Brodribb-2008" TYPE="REFERENCE">Brodribb 2008</LINK>; <LINK REF="REF-Brodribb-2011" TYPE="REFERENCE">Brodribb 2011</LINK>).</LI>
</OL>
<P>Additional foods or fluids may be needed for medical reasons in specific situations related to the infant or mother. This review deals with the healthy, term infant and does not address individual needs or treatment in medical conditions. This review does not examine the use of oral sucrose solution for pain management in infants, oral probiotics, or interventions that provide promotion, education or support for increasing exclusive breastfeeding prevalence or duration.</P>
</CONDITION>
<THEORY MODIFIED="2016-08-29 18:37:12 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Effects of early additional foods or fluids</HEADING>
<P>It is difficult to obtain robust evidence about the effect of early additional foods and fluids (supplementation) on full-term, healthy, babies due in part to problems in the consistency of breastfeeding definitions (<LINK REF="REF-Labbok-2012" TYPE="REFERENCE">Labbok 2012</LINK>), and of normal early neonatal weight change (<LINK REF="REF-Thulier-2016" TYPE="REFERENCE">Thulier 2016</LINK>), poor research design (<LINK REF="REF-McNiel-2010" TYPE="REFERENCE">McNiel 2010</LINK>; <LINK REF="REF-Renfrew-2007" TYPE="REFERENCE">Renfrew 2007</LINK>), publication bias (<LINK REF="REF-Boyle-2016" TYPE="REFERENCE">Boyle 2016</LINK>), changes in composition of artificial milks over time,and the belief that supplementation is a routine acceptable practice, not an intervention, and thus does not need to be noted (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="REF-Mulford-1995" TYPE="REFERENCE">Mulford 1995</LINK>). Early additional foods and fluids or exclusive breastfeeding may potentially affect the duration of breastfeeding, the infant immune system, infant morbidity and mortality, maternal infant bonding, as well as infant growth and development, length of postnatal hospital stay, physiological jaundice, maternal self-confidence and confidence in breastfeeding of those who influence the mother. Healthcare economics, family poverty, environmental burden and human development potential are also affected by the value put on exclusive breastfeeding (<LINK REF="REF-Rollins-2016" TYPE="REFERENCE">Rollins 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect on duration of breastfeeding</HEADING>
<P>Observational studies and surveys have found associations between early additional foods and fluids and shorter duration of breastfeeding (<LINK REF="REF-Blomquist-1994" TYPE="REFERENCE">Blomquist 1994</LINK>; <LINK REF="REF-Chantry-2014" TYPE="REFERENCE">Chantry 2014</LINK>; <LINK REF="REF-Giovannini-2005" TYPE="REFERENCE">Giovannini 2005</LINK>; <LINK REF="REF-Hornell-2001" TYPE="REFERENCE">Hornell 2001</LINK>; <LINK REF="REF-Kurinij-1991" TYPE="REFERENCE">Kurinij 1991</LINK>). The effect of early additional foods and fluids on reducing breastfeeding duration may include decreased milk production due to reduced removal of milk from the breast; difficulties in developing effective breastfeeding skills when the newborn infant is also feeding from a bottle and artificial teat which may result in low infant weight gain; or maternal sore nipples and breasts; all of which may result in early cessation of breastfeeding, as well as reduced maternal confidence in the ability to successfully breastfeed and the reinforcement of a negative belief that human milk is insufficient for an infant. Qualitative studies in the UK (<LINK REF="REF-Cloherty-2004" TYPE="REFERENCE">Cloherty 2004</LINK>; <LINK REF="REF-Furber-2006" TYPE="REFERENCE">Furber 2006</LINK>) have indicated that, despite their awareness of policies supporting exclusive breastfeeding, some midwives think that providing an occasional formula supplement in hospital may give the mother an opportunity to rest and be more likely to continue to breastfeed, thus an aid to longer duration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect on infant morbidity and mortality</HEADING>
<P>As mentioned earlier, infant mortality and morbidity may be affected by the addition of other fluids or foods to the infant in the first six months. The effect of early additional foods and fluids on infant morbidity and mortality may be related to a single factor or a combination of factors, including incorrectly prepared early additional foods and fluids, contamination of the fluid or food or the device used to give it (<LINK REF="REF-Horman-2010" TYPE="REFERENCE">Horman 2010</LINK>; <LINK REF="REF-Renfrew-2008" TYPE="REFERENCE">Renfrew 2008</LINK>; <LINK REF="REF-WHO-2007" TYPE="REFERENCE">WHO 2007</LINK>); receiving a reduced amount of the anti-infective nutrients in human milk (<LINK REF="REF-Ballard-2013" TYPE="REFERENCE">Ballard 2013</LINK>); the effect of the non-human milk on the infant's developing immune and digestive systems; or other reasons (<LINK REF="REF-Turin-2014" TYPE="REFERENCE">Turin 2014</LINK>). Longer-term indications of morbidity related to immune reactions may include eczema and other skin conditions, asthma and digestive-related conditions (<LINK REF="REF-Horta-2013a" TYPE="REFERENCE">Horta 2013a</LINK>; <LINK REF="REF-Ip-2007" TYPE="REFERENCE">Ip 2007</LINK>). Short-term indications of possible morbidity include hypo- or hyperthermia, hypo- or hyperglycaemia, diarrhoea, respiratory symptoms and otitis media (<LINK REF="REF-Horta-2013b" TYPE="REFERENCE">Horta 2013b</LINK>; <LINK REF="REF-Kramer-2012" TYPE="REFERENCE">Kramer 2012</LINK>; <LINK REF="REF-Victora-2016" TYPE="REFERENCE">Victora 2016</LINK>). An increased or reduced temperature may indicate an infection or other immune reaction. Normal temperature range is considered 36 to 38 degrees Celsius (97 to 100.4 degrees Fahrenheit). The advent of cot-side testing of blood glucose in the early 1970s led to attempts to define a level of asymptomatic hypoglycaemia that could be classified as a risk level, in the belief that treating at this level would reduce the risk of symptomatic hypoglycaemia occurring (<LINK REF="REF-Williams_x002f_WHO-1997" TYPE="REFERENCE">Williams/WHO 1997</LINK>). These older studies and textbooks were likely to use formula-fed infants as the norm and consider the values found in healthy breastfeeding infants as low. Transient hypoglycaemia is now understood as a normal adaptive response to the establishment of ex-utero feeding (<LINK REF="REF-ABM-2014" TYPE="REFERENCE">ABM 2014</LINK>), though extended hypoglycaemia may be an indication of illness. There is no agreed definition of hypoglycaemia as the value varies with the infant's maturity, pathology, clinical signs and method of testing. A suggested range of values considered as hypoglycaemia are between 30 and 50 mg/dL (1.7 to 2.8 mmol/L) (<LINK REF="REF-Wright-2006" TYPE="REFERENCE">Wright 2006</LINK>); however, older studies may use different values. Feeding healthy infants cow's milk formula in an attempt to raise their blood glucose levels to an unphysiological high level introduces non-human milk proteins, which may result in immunological reactions, possible bacterial contaminants and reduce the appetite of the infant to feed at the breast. Glucose water has additional risks from providing fewer calories than a similar volume of milk, thus filling the infant's stomach while providing insufficient nutrients. This increases the risks of hypoglycaemia and poor weight gain. There is no evidence that high blood glucose levels are of benefit to the infant, and high levels may affect the metabolic response, with later effects on risks of obesity and diabetes. Diarrhoea may indicate an infection or an intolerance to foreign proteins or carbohydrates in non-milk feeds. As normal stools of a breastfeeding infant are much looser than the stools of a cow's milk formula-fed infant this makes the definition of diarrhoea open to interpretation. Breastfeeding provides for optimal immune system functioning and thus the level of respiratory infections and otitis media occurrences can indicate if there is an effect on the immune system.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect on physiological jaundice</HEADING>
<P>Babies are born with fetal red blood cells which are no longer needed and must be metabolised and excreted. Bilirubin is a product of this breakdown, released in the blood stream and ultimately excreted in the baby's stool. A newborn&#8217;s serum bilirubin level normally rises from birth until the third or fourth day postpartum and a significant proportion will have total serum bilirubin concentrations greater than 5.0 mg/dL (86 umol/L) while remaining healthy. This is termed physiological jaundice (<LINK REF="REF-ABM-2009" TYPE="REFERENCE">ABM 2009</LINK>). Ineffective feeding and thus reduced calorie intake can increase bilirubin levels (<LINK REF="STD-De-Carvalho-1981" TYPE="STUDY">De Carvalho 1981</LINK>; <LINK REF="REF-Yamauchi-1990" TYPE="REFERENCE">Yamauchi 1990</LINK>). The normal initial fluid loss in newborn infants and situations of ineffective feeding leading to dehydration may lead to a belief that fluid supplements will prevent dehydration and jaundice, though the replacement of milk with water will further reduce the infant's calorie intake and has not been shown to reduce bilirubin levels (<LINK REF="STD-De-Carvalho-1981" TYPE="STUDY">De Carvalho 1981</LINK>; <LINK REF="REF-Houston-1984" TYPE="REFERENCE">Houston 1984</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>). The replacement of breastfeeding with formula has been tested as a treatment to reduce high levels of serum bilirubin (<LINK REF="REF-Amato-1985" TYPE="REFERENCE">Amato 1985</LINK>; <LINK REF="REF-Osborn-1985" TYPE="REFERENCE">Osborn 1985</LINK>), which may have led some health workers to use supplements to prevent high levels of bilirubin occurring (<LINK REF="REF-Akuse-2002" TYPE="REFERENCE">Akuse 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Effect on infant growth and development</HEADING>
<P>Weight loss in the newborn represents mainly fluid loss but may also involve loss of fat stores during the establishment of feeding (<LINK REF="REF-Wright-2004" TYPE="REFERENCE">Wright 2004</LINK>). A breastfeeding baby will commonly lose up to 5% to 7% in the first few days with no adverse effects (<LINK REF="REF-Thulier-2016" TYPE="REFERENCE">Thulier 2016</LINK>). There may be a fear that the baby will become dehydrated until breastfeeding is established, and such babies are supplemented with water, glucose or artificial milk. Water, and glucose in particular, have no or little calorific value and may cause a baby to be full but remain deficient in calorific intake. Supplementation in such instances, as well as interfering with breastfeeding, will in fact contribute to further weight loss in the early postpartum period (<LINK REF="REF-Glover-1990" TYPE="REFERENCE">Glover 1990</LINK>). Evidence from studies in tropical climates demonstrate that breastfeeding babies will not become dehydrated if allowed to fully breastfeed on demand (<LINK REF="REF-Almroth-1990" TYPE="REFERENCE">Almroth 1990</LINK>).</P>
<P>The WHO published comprehensive infant growth charts developed from data on breastfeeding infants (<LINK REF="REF-De-Onis-2004" TYPE="REFERENCE">De Onis 2004</LINK>). This long-term multi-centre study indicated that previous charts were likely to have categorised healthy breastfeeding infants as underweight, which may have contributed to the addition of foods and fluids before six months of age. Additional foods and fluids above the nutritional needs of the infant may result in the infant becoming overweight. Early introduction of complementary foods to breastfeeding infants is likely to result in less breast milk consumed, which may affect nutritional and immune status (<LINK REF="REF-Heinig-1993" TYPE="REFERENCE">Heinig 1993</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Confidence in breastfeeding</HEADING>
<P>Antenatal or early postnatal breastfeeding self-efficacy of the mother is associated with more exclusive breastfeeding and longer duration of breastfeeding (<LINK REF="REF-Blyth-2004" TYPE="REFERENCE">Blyth 2004</LINK>; <LINK REF="REF-Noel_x002d_Weiss-2006" TYPE="REFERENCE">Noel-Weiss 2006</LINK>). If the mother or family members, health workers or others with influence on the mother have low confidence in the ability to breastfeed or the adequacy of mother's milk, this may lead to artificial formula supplementation and maternal feelings of failure (<LINK REF="REF-Hoddinott-1999" TYPE="REFERENCE">Hoddinott 1999</LINK>; <LINK REF="REF-Wagner-2013" TYPE="REFERENCE">Wagner 2013</LINK>). For the older infant, the decision to add formula or complementary foods may affect the duration of breastfeeding. Hornell suggests that formula given by bottle, because the mother perceived that she did not have sufficient milk, may reduce the duration of breastfeeding more so than complementary foods that are added because the mother thought the infant had reached an appropriate age (<LINK REF="REF-Hornell-2001" TYPE="REFERENCE">Hornell 2001</LINK>).</P>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2016-06-01 09:21:07 +0100" MODIFIED_BY="[Empty name]">
<P>Despite many years of widespread recommendations to support exclusive breastfeeding for four and more recently six months, common practice does not appear to reflect these recommendations suggesting there are perceived benefits from early additional fluids or foods. Given the potential risks from additional fluids or foods, this review aims to summarise the existing evidence on the effects of early additional food and fluids for breastfeeding full-term infants.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-07-25 13:57:55 +0100" MODIFIED_BY="Heather Maxwell">
<P>The main objective of the review was to assess the benefits and harms of additional foods and fluids for full-term healthy breastfeeding infants. We also aimed to determine what impact the timing (during early phase of initiation of breastfeeding versus later on for maintenance) and type (water, artificial milk, foods) of additional foods and fluids had on these infants.<BR/>
</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-08-24 16:03:22 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2016-07-25 15:46:26 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_STUDIES MODIFIED="2011-09-29 02:12:42 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials (RCTs).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-07-25 14:35:23 +0100" MODIFIED_BY="Heather Maxwell">
<P>Full-term (that is 37 to 42 completed weeks' gestation (singleton or multiple births)) breastfeeding infants up to the age of six months (the currently recommended age after which complementary foods should commence), or the mothers of these infants.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-07-11 11:55:27 +0100" MODIFIED_BY="[Empty name]">
<P>Breastfeeding with any additional food or fluids (once or more) in the first six months versus exclusive breastfeeding (as defined in the trial).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-07-25 15:46:26 +0100" MODIFIED_BY="Heather Maxwell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-07-25 15:46:26 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Duration of breastfeeding</LI>
<LI>Incidence of infant morbidity, for example, hypo- or hyperthermia, hypo- or hyperglycaemia, gastro-intestinal infection, ear infection, asthma, eczema or other allergy (depending on how defined in individual trials)</LI>
<LI>Infant mortality (at discharge, 28 days, or one year)</LI>
<LI>Physiological jaundice, absence or presence, and if present, duration (days) (as defined in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK>)</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-06-01 22:45:26 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Measures of weight, growth and development (as defined by trial authors)</LI>
<LI>Duration of hospital stay (days)</LI>
<LI>Confidence in breastfeeding, for example of mothers, fathers, health workers or others with significant influence on the feeding of the infant (however assessed in individual trials)</LI>
<LI>Maximum serum bilirubin levels</LI>
<LI>Phototherapy in hospital or home setting if required, absence or presence, and if present, duration (days)</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-07-19 10:50:09 +0100" MODIFIED_BY="[Empty name]">
<P>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-07-19 10:50:09 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting their Information Specialist (1 March 2016).</P>
<P>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate the Pregnancy and Childbirth Group&#8217;s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A> in the<I> Cochrane Library</I> and select the &#8216;<B>
<I>Specialized Register</I>
</B>
 &#8217; section from the options on the left side of the screen.</P>
<P>Briefly, the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by their Information Specialist and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE (Ovid);</LI>
<LI>weekly searches of Embase (Ovid);</LI>
<LI>monthly searches of CINAHL (EBSCO);</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<LINK TAG="INCLUDED_STUDIES" TYPE="SECTION">Included studies</LINK>; <LINK TAG="EXCLUDED_STUDIES" TYPE="SECTION">Excluded studies</LINK>; <LINK TAG="ONGOING_STUDIES" TYPE="SECTION">Ongoing studies</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-06-16 12:31:13 +0100" MODIFIED_BY="Genevieve Becker">
<P>We examined reference lists of all relevant retrieved papers to identify further studies.</P>
<P>We did not apply any language, geographic or date restrictions. For non-English articles, we reviewed the abstract and if RCT and the intervention or outcome was mentioned in the abstract we arranged further translation. </P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-08-24 16:03:22 +0100" MODIFIED_BY="[Empty name]">
<P>For methods used in the previous versions of this review, <I>see </I>
<LINK REF="REF-Becker-2011" TYPE="REFERENCE">Becker 2011</LINK> and <LINK REF="REF-Becker-2014" TYPE="REFERENCE">Becker 2014</LINK>.</P>
<P>For this update, the following methods were used for assessing the reports that were identified as a result of the updated search.</P>
<P>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group.</P>
<STUDY_SELECTION MODIFIED="2016-07-25 15:47:08 +0100" MODIFIED_BY="Heather Maxwell">
<P>Both review authors independently applied the inclusion criteria to all potential trials. We performed this without blinding. Two trials were discussed with a member of the Cochrane Pregnancy and Childbirth Group editorial office to assist in reaching agreement.<B>
<BR/>
</B>
</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-09-21 11:48:41 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors independently extracted the data (using a customised data extraction form) and assessed the risk of bias of the selected trials. We resolved any disagreements through discussion. Both authors entered data into Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-08-24 16:03:22 +0100" MODIFIED_BY="[Empty name]">
<P>Both review authors assessed each trial using a simple form and followed the domain-based evaluation as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We also reported on whether the investigators had performed a sample-size calculation.</P>
<P>We compared assessments and resolved any inconsistencies by discussion.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>Given the nature of the interventions, blinding was generally not possible for participants and caregivers and so this was graded as an unclear risk of bias in this review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it was clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review were reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes were reported; one or more reported primary outcomes were not pre-specified; outcomes of interest were reported incompletely and so could not be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Handbook</I> (<A HREF="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716&amp;format=REVMAN_GRAPHS#REF-Higgins-2011">Higgins 2011</A>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses - <I>see</I> <A HREF="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716&amp;format=REVMAN_GRAPHS#SENSITIVITY_ANALYSIS">Sensitivity analysis</A>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of the quality of the evidence using the GRADE approach</HEADING>
<P>For this update, the quality of the evidence was assessed using the GRADE approach as outlined in the GRADE handbook. We produced separate GRADE 'Summary of findings' tables summarising evidence for our three comparisons of: 1. non-exclusive breastfeeding (with artificial milk) versus exclusive breastfeeding; 2. non-exclusive breastfeeding (with water or glucose water) versus exclusive breastfeeding; and 3. non-exclusive breastfeeding (with additional foods) versus exclusive breastfeeding. Due to few trials with limited outcome data for the primary and secondary outcomes specified in this review, our 'Summary of findings' tables report different outcomes for different comparisons. We have not downgraded any evidence for lack of blinding (performance bias) and assessed the quality of the body of evidence relating to the following outcomes listed below:</P>
<OL>
<LI>duration of breastfeeding (at different time points);</LI>
<LI>infant morbidity (including: allergy related, hypoglycaemia, fever);</LI>
<LI>weight change (at different time points);</LI>
<LI>confidence in breastfeeding (maternal or of those influencing the mother).</LI>
</OL>
<P>We used the <A HREF="http://www.guidelinedevelopment.org/">GRADEpro</A> Guideline Development Tool to import data from Review Manager 5.3 (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>) in order to create 'Summary of findings&#8217; tables. A summary of the intervention effect and a measure of quality for each of the above outcomes were produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-07-25 15:49:20 +0100" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we present results as summary risk ratio (RR) with 95% confidence intervals, where appropriate. </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous outcomes, we recorded either the mean relative change from baseline for each group or mean post-treatment or post-intervention values and standard deviation. When standard errors were reported we converted these to standard deviations (as with <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>). We calculated a pooled estimate of treatment effect by calculating the mean difference (MD).</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-07-11 11:59:00 +0100" MODIFIED_BY="[Empty name]">
<P>The protocol for this review does not include cross-over trials or cluster-randomised trials. For studies that had multi-intervention arms, we first assessed which groups were relevant to this review and the appropriate method of analysis. If groups were similar, e.g. water and glucose water, then we combined the groups. If we found that more than two comparison groups were applicable, then we entered data as a single pair-wise comparison into <LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>. In instances in which there were more than two groups to be compared, we took measures to avoid double counting or inappropriate totaling.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2014-11-17 18:19:48 +0000" MODIFIED_BY="Heather Maxwell">
<P>We planned to enter the data on the number of participants by allocated treated group, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow-up in order to allow an intention-to-treat analysis. However, this was not always possible, as for example, within some included trials, mothers who ceased to comply during the trial were excluded from the analysis (these trial authors did not provide outcome data on the full allocated group).</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-07-11 11:56:42 +0100" MODIFIED_BY="[Empty name]">
<P>In future updates, when a sufficient number of trials are included in a meta-analysis, we plan to assess statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We will regard heterogeneity as substantial if an I² is greater than 30% and either a Tau² is greater than zero, or there is a low P value (less than 0.10) in the Chi² test for heterogeneity. </P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-07-25 15:49:38 +0100" MODIFIED_BY="Heather Maxwell">
<P>In future updates of this review, if there are 10 or more studies in a meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-07-25 15:49:49 +0100" MODIFIED_BY="Heather Maxwell">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and we judged the trials&#8217; populations and methods to be sufficiently similar. In future updates, if there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if we detect substantial statistical heterogeneity, we will use random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials is considered clinically meaningful. We will treat the random-effects summary as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials.</P>
<P>Where multiple time points have been reported within the included trial reports we have clearly reported when measurements were taken by the primary investigators during the trial, what measurements were reported within the published paper and what data we are reporting in the review.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-07-25 15:50:11 +0100" MODIFIED_BY="Heather Maxwell">
<P>When more data are included in the review, if we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses.</P>
<P>In future updates of this review we plan to carry out the following subgroup analysis:</P>
<OL>
<LI>timing of supplementation: given at early phase of initiation of breastfeeding (neonatal period - up to and including the first four weeks of life) compared with later on; for maintenance (after neonatal period) - (relating to primary outcomes (1), (2) and (3);</LI>
<LI>type of supplementation: water/ formula/glucose/food compared with each other - (relating to primary outcomes (1), (2) and (3);</LI>
<LI>geographical location: trials conducted in disadvantaged populations versus trials in advantaged populations - (relating to primary outcomes (2) and (3)).</LI>
</OL>
<P>We will assess subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). We will report the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-08-07 21:04:22 +0100" MODIFIED_BY="[Empty name]">
<P>When sufficient trials are included in the review, for primary outcomes only, we plan to perform a sensitivity analysis based on the risk of bias of the trials, including and excluding quasi-randomised trials.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-08-29 18:37:32 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2016-08-29 18:37:24 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]">
<P>See: <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>An updated search in March 2016 retrieved 14 reports. We included two new trials (three reports) (<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>). We also included another trial (four reports) previously listed as an ongoing study (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
<P>We identified two new ongoing trials (<LINK REF="STD-Flaherman-2014" TYPE="STUDY">Flaherman 2014</LINK>; <LINK REF="STD-Kair-2014" TYPE="STUDY">Kair 2014</LINK>).</P>
<P>We excluded six newly identified studies (<LINK REF="STD-Cameron-2015" TYPE="STUDY">Cameron 2015</LINK>; <LINK REF="STD-de-Jong-1998" TYPE="STUDY">de Jong 1998</LINK>; <LINK REF="STD-Du-Toit-2015" TYPE="STUDY">Du Toit 2015</LINK>; <LINK REF="STD-Juvonen-1996" TYPE="STUDY">Juvonen 1996</LINK>; <LINK REF="STD-Kimani_x002d_Murage-2013" TYPE="STUDY">Kimani-Murage 2013</LINK>; <LINK REF="STD-Saarinen-1999" TYPE="STUDY">Saarinen 1999</LINK>), plus one previously ongoing study (<LINK REF="STD-Flaherman-2011" TYPE="STUDY">Flaherman 2011</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-08-29 18:37:24 +0100" MODIFIED_BY="[Empty name]">
<P>This review now includes 11 trials, in which a total of 2542 breastfeeding infants or their mothers were randomised (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). Four of the trials have multiple references; the Cohen trial has been reported in five individual papers, the Dewey trial in four, and the Jonsdottir in five plus a PhD thesis, Perkin (EAT trial) has published three papers at time of this review (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>), and two papers for <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>. For each of the remaining six trials there is one paper published on each (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Setting</HEADING>
<P>Two trials were carried out in San Pedro Sula, Honduras (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>) (these were associated trials); one in each of Teruel, Spain (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>); Ile-Ife, Nigeria (<LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>); Philadelphia, USA (<LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>); London, UK (<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>); San Francisco, USA (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>); Danderyd, Sweden (<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>); Czech Republic (<LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>); one across seven centres in Iceland (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>), and one trial including children across England and Wales (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>Seven trials were carried out in the first few days after birth and compared exclusive breastfeeding versus additional water and/or glucose water in four trials (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>), and the addition of formula in three trials (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>). One two-arm trial compared a 'glucose water' group (who received 5% glucose <I>ad libitum </I>from a bottle for the first three days of life in addition to breastfeeding), to a 'non-glucose water' group (who did not receive any alternative fluid to human milk) (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>). In a further two-arm trial, one group received glucose water feedings and the other colostrum (<LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>). Another two-arm trial compared exclusive on-demand breastfeeding versus on-demand breastfeeding plus additional water where the choice of sterile water or 5% glucose water was left to the mother (<LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). A three-arm trial compared an additional water group versus a non-supplement group versus a glucose supplement group (<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>). One two-armed trial compared formula use before commencing breastfeeding with exclusive breastfeeding from birth (<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>), and two similar trials compared exclusive breastfeeding versus breastfeeding plus a specific amount of formula added at specific intervals (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>).</P>
<P>Four trials compared continued exclusive breastfeeding to six months versus complementary feeding plus breastfeeding from three to six months (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>). One three-arm trial included an exclusive breastfeeding group versus a complementary foods group, with the introduction of complementary foods at 16 weeks, with <I>ad libitum</I> breastfeeding; or complementary foods and maintenance (SF-M), with the introduction of complementary foods at 16 weeks with maintenance of pre-intervention breastfeeding frequency (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>). Two two-armed trials compared a group of continued exclusive breastfeeding to six months versus complementary feeding ( plus breastfeeding from four to six months (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>). In the Dewey trial it was stated that mothers were encouraged to maintain baseline (16-week) breastfeeding frequency (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>). The EAT Study (Enquiring About Tolerance) examined whether the early introduction of specific foods from three months of age plus continued breastfeeding in previously exclusively breastfeeding infants would prevent food allergies compared to levels in infants who were exclusively breastfeeding for approximately six months (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>Outcomes (unless otherwise indicated) were to be measured at hospital discharge, three months and six months. We stated in the protocol that if outcome data were recorded at other time periods, we would consider examining these as well. Therefore, we have presented data for these other time periods that were reported.</P>
<P>Both of the included three-arm trials reported data for secondary outcomes 'weight change'; Nicoll also reported on 'maximum serum bilirubin levels' (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>). For each trial, we decided to combine the data for both of the supplemented interventions (water and glucose groups for the Nicoll trial; complementary foods and complementary foods with maintenance for the Cohen trial) into single intervention groups (supplemented group) to enable us to present these data within the analyses. In order to convert the sample sizes, means and standard deviations, we used the formulae as presented in the <I>Handbook </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>For the Martin-Calama trial and the outcome 'duration of breastfeeding' we estimated from the graph the percentage of mothers breastfeeding at each time period (<I>see</I> <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>), and calculated the number of women breastfeeding at each time period from these estimates, which enabled us to enter data on this outcome into the analysis.</P>
<P>The primary outcome 'incidence of morbidity' was considered to include trial outcomes related to any allergic symptoms including symptoms of food protein intolerances, as well as hypoglycaemia, fever, upper respiratory illness, anaemia. The secondary outcome of 'weight change' was broadened in this update to include measures of weight, growth and development, and 'maternal confidence' was broadened to include confidence in breastfeeding of mothers, fathers, health workers or others with significant influence on the feeding of the infant.</P>
<P>The nine included trials which provided data for analysis (n = 2226) reported on one (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>) or two of the four primary outcomes (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>), and/or one (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>) or two of the five secondary outcomes (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>).</P>
<P>Two of the included trials did not report any data that were eligible for inclusion in the review (<LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). In the Ojofeitimi trial, bacterial counts in fluids (colostrum and glucose water) and stools were reported, but no actual data on morbidity were reported (<LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>). The outcome in the Schutzman trial was "arrival of true milk" (<LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). As it is over 20 years since these two studies were published, we concluded that it was not feasible to seek further data from the trial authors.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded 30 trials from the review (see the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). We excluded 18 because, on closer inspection, we identified that there was no exclusively breastfeeding group (<LINK REF="STD-Bannert-1995" TYPE="STUDY">Bannert 1995</LINK>; <LINK REF="STD-Corchia-1985" TYPE="STUDY">Corchia 1985</LINK>; <LINK REF="STD-Cronenwett-1992" TYPE="STUDY">Cronenwett 1992</LINK>; <LINK REF="STD-de-Jong-1998" TYPE="STUDY">de Jong 1998</LINK>; <LINK REF="STD-Du-Toit-2015" TYPE="STUDY">Du Toit 2015</LINK>; <LINK REF="STD-French-2012" TYPE="STUDY">French 2012</LINK>; <LINK REF="STD-Gray_x002d_Donald-1985" TYPE="STUDY">Gray-Donald 1985</LINK>; <LINK REF="STD-Juvonen-1996" TYPE="STUDY">Juvonen 1996</LINK>; <LINK REF="STD-Kearney-1990" TYPE="STUDY">Kearney 1990</LINK>; <LINK REF="STD-Ly-2006" TYPE="STUDY">Ly 2006</LINK>; <LINK REF="STD-Rosegger-1985" TYPE="STUDY">Rosegger 1985</LINK>; <LINK REF="STD-Rosegger-1986" TYPE="STUDY">Rosegger 1986</LINK>; <LINK REF="STD-Sachdev-1991" TYPE="STUDY">Sachdev 1991</LINK>; <LINK REF="STD-Schiess-2010" TYPE="STUDY">Schiess 2010</LINK>; <LINK REF="STD-Schmitz-1992" TYPE="STUDY">Schmitz 1992</LINK>; <LINK REF="STD-Schubiger-1997" TYPE="STUDY">Schubiger 1997</LINK>; <LINK REF="STD-Simondon-1996" TYPE="STUDY">Simondon 1996</LINK>; <LINK REF="STD-Ziegler-2011" TYPE="STUDY">Ziegler 2011</LINK>). We excluded four trials that included only preterm infants (<LINK REF="STD-Collins-2004" TYPE="STUDY">Collins 2004</LINK>; <LINK REF="STD-Howard-2003" TYPE="STUDY">Howard 2003</LINK>; <LINK REF="STD-Marinelli-2001" TYPE="STUDY">Marinelli 2001</LINK>; <LINK REF="STD-Mosley-2001" TYPE="STUDY">Mosley 2001</LINK>), two trials that compared regimens of the iron-containing foods used (<LINK REF="STD-Krebs-2013" TYPE="STUDY">Krebs 2013</LINK>; <LINK REF="STD-Olaya-2013" TYPE="STUDY">Olaya 2013</LINK>), and one trial protocol that was to examine treatment of a condition (<LINK REF="STD-Flaherman-2011" TYPE="STUDY">Flaherman 2011</LINK>). We assessed two trials, which on closer inspection, we considered as not being randomised or quasi-randomised (<LINK REF="STD-De-Carvalho-1981" TYPE="STUDY">De Carvalho 1981</LINK>; <LINK REF="STD-Saarinen-1999" TYPE="STUDY">Saarinen 1999</LINK>). Three trials related to effects of counselling in preventing the introduction of other foods or fluids before six months (<LINK REF="STD-de-Oliveira-2012" TYPE="STUDY">de Oliveira 2012</LINK>: <LINK REF="STD-Cameron-2015" TYPE="STUDY">Cameron 2015</LINK>; <LINK REF="STD-Kimani_x002d_Murage-2013" TYPE="STUDY">Kimani-Murage 2013</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-07-25 15:53:00 +0100" MODIFIED_BY="Heather Maxwell">
<P>We assessed each trial for risk of bias as outlined in the <LINK TAG="METHODS" TYPE="SECTION">Methods</LINK> section. We have presented summary descriptions of the assessments on the risk of bias in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>, and provided details of the assessment for each trial in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<ALLOCATION MODIFIED="2016-07-19 11:18:26 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed sequence generation and concealment of allocation as low risk in three trials (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>); high risk in three trials (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>); and of unclear risk in four trials (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK> was assessed as low risk for sequence generation and unclear risk for concealment of allocation.</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-07-25 15:52:21 +0100" MODIFIED_BY="Heather Maxwell">
<P>Given the nature of the interventions blinding was not possible for participants and caregivers. As a result we graded all studies as having an unclear risk for performance bias. There was no information provided by six of the included trials with regards to whether outcome assessors were blinded or not (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). Therefore, we assessed these six trials as having an unclear risk of detection bias. For the Jonsdottir trial, while nurses who collected data on complementary food intakes and anthropometric outcomes were not blinded to participant group status, those who undertook all mass spectrometric analyses and isotopic modelling were blinded, therefore we considered this study as having a low risk of detection bias (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>). A blinded research assistant assessed outcome data for the Stra&#328;ák and Flaherman trials, which we assessed as having a low risk (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>). <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK> replied to our query that the outcome assessors were not blinded however that outcome was based on strict set objectivity measures of allergic sensitivity, thus this was rated at low risk of detection bias.</P>
<P>
<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK> reported that all paediatricians who assessed for allergy symptoms when infants were 18 months old "were unaware of the feeding regimen" however they &#8220;scrutinized the history, and then filled in a detailed form concerning feeding&#8221; and this may have resulted in the group allocation being disclosed; therefore the study was graded as high risk.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-07-25 15:52:38 +0100" MODIFIED_BY="Heather Maxwell">
<P>Five studies clearly documented reasons for any incomplete outcome data and therefore, we assessed these as having a low risk of bias for this domain (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>). Three of these trials ((<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) reported similar dropout rates between treatment groups. Lindfors reported numbers lost to follow-up at each stage with low loss over five years and similar loss in both groups.</P>
<P>We assessed five trials as having an unclear risk of bias (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). The published data from the Cohen and Dewey trials report analyses based on compliance with allocation, not intention-to-treat (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>). For the Cohen trial, the dropout rate differed significantly between treatment groups, for the randomised controlled part of the Dewey trial, dropout rates between treatment groups were not balanced and there were significant differences in some patient characteristics, for this domain we therefore assessed these two trials as having an unclear risk of bias. A further trial reported that a high percentage of mother/baby pairs defaulted and were replaced by further randomised pairs in one of the three arms of the trial, we therefore also assessed this as having an unclear risk of bias (<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>). No reference to dropouts was reported in <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>, while in <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> information on missing data was not clearly reported.</P>
<P>In the Ojofeitimi trial, participation was voluntary, and those mothers who failed to adhere were excluded from the trial (42%); we therefore assessed this trial as having a high risk of bias for this domain (<LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-07-11 13:06:53 +0100" MODIFIED_BY="[Empty name]">
<P>Seven studies reported data on all the outcomes mentioned in the 'Methods' section of their articles (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>
<I>; </I>
<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>), though not at all the time periods were mentioned. We did not retrieve any of the protocols or raw data of these trials and thus did not identify whether outcomes other than those reported within the papers were collected but not reported on. We have therefore assessed this domain as having an unclear risk of bias for these trials.</P>
<P>One study (<LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) measured and recorded clinical outcomes that were not pre-determined as study outcomes in the registered protocol and we marked this study as having an unclear risk of bias.</P>
<P>The Flaherman and Jonsdottir trials were registered trials with protocols available (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>). The protocol for the Flaherman trial referred to outcomes of weight nadir and maternal satisfaction, which are not referred to in the published trial report, and the introduction to the report refers to effect on infant weight, however only loss is reported, not any weight gain. The protocol for the Jonsdottir trial referred to secondary outcomes of upper respiratory infections and diarrhoeal episodes, although in one of the published references to this study (<LINK REF="REF-Wells-2012" TYPE="REFERENCE">Wells 2012</LINK>) it states "Finally, our study was designed to evaluate growth and energy intake and not other issues such as development of dietary preferences, mineral status, or effects on health such as diarrhoea and allergy". We therefore assessed these two trials as having a high risk of bias for this domain. For <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK> there was a protocol published, very extensive appendices on-line with additional data and additional publications are planned to report further on outcomes, thus we assessed this study as low risk of reporting bias.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-07-25 15:53:00 +0100" MODIFIED_BY="Heather Maxwell">
<P>Two studies (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>) were assessed as being low risk for other sources of potential biases. Two studies were graded as having a unclear risk. In one trial, telephone follow-up at five months was used to collect data on the exclusiveness and duration of breastfeeding during the previous 20 weeks, which could be a possible source of recall bias and lack of consensus to what is considered a risk level of low serum glucose in the first few days after birth (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>); there was low adherence to the study protocol in the intervention group in the other study (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
<P>The remaining seven studies were all graded as high risk for other sources of potential biases. <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> and <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK> were graded as high risk due to their inclusion criteria of weight loss of &#8805; 5% in the first few days after birth, though this is well within the range of normality. This may have influenced those involved to consider there was a problem with exclusive breastfeeding when there was not and result in overuse of formula supplementation. The publications from both studies reported no direction given as to how often to give the supplement beyond "after each breastfeed". Further communication with the Stra&#328;ák team provided the information that the supplement was given on a three-hourly schedule; feeding to a schedule could conflict with the protocol of feeding in response to baby signs (demand feeding) and this might limit the number of breastfeeds. With both studies, the supplement was given by oral syringe and the infant was not able to refuse the supplement if already content with the amount of breast milk consumed. Additional information also clarified that definitions used for exclusive breastfeeding at a time point related to the previous 24 hours only and thus giving a different result than if the definition used was the time since birth as per WHO definitions. In <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> at the start of the intervention, of those replying (15% did not reply), 47% of the formula supplementation group and 32% of the exclusive breastfeeding group had previously planned to use infant formula in addition to breastfeeding, which may have affected their motivation to comply with the allocation. Compliance with allocation is not reported. Other variables known to effect exclusive breastfeeding and weight change, such as birth practices, information and support, feeding in response to infant cues ("demand feeding") and skilled assistance, were not included. Though the effect on weight is an outcome of the Flaherman trial, the trial did not include a weighing protocol and relied on weights routinely collected, which varied as to what time points these were collected (additional information from trialist). <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK> referred to infants being breastfeed &#8220;when the mother's breast milk production started&#8221; with no information if this meant colostrum or Lactogenesis II and if the infants in the breastfeeding group might have received water/glucose water if mother's milk was not expected to be present for a few days. There was a high number of outcome assessors working independently and diagnosis of allergy was based on clinical criteria with no laboratory testing at 18 months. For these reasons <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK> was graded as high risk for other bias.</P>
<P>Most older studies (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>) did not demonstrate any evidence of undertaking a power calculation to determine their sample size and were rated as high risk for bias. <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> states: "The sample size was chosen as a pilot to demonstrate feasibility".</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-08-29 18:37:32 +0100" MODIFIED_BY="[Empty name]">
<P>We included 11 trials (n = 2542 randomised infants or their mothers). The variation in use of outcome measures and time points in different trials made it difficult to pool results from trials. Nine trials (n = 2226) provided data on outcomes of interest to this review. Data could only be combined in a meta-analysis for one primary outcome (breastfeeding duration) (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) and one secondary outcome (weight change) for two studies (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>). None of the included studies reported on physiological jaundice, absence or presence, and if present, duration (days) (as defined in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK>). Only one trial reported on infant mortality (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>). The trials that provided outcome data compared exclusively breastfeeding infants with breastfeeding infants who were provided with additional artificial milk (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>), glucose water/water (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>) or complementary foods (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
<P>See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK> for the quality of evidence for each of the three main comparisons.</P>
<SUBSECTION>
<HEADING LEVEL="3">Non-exclusive breastfeeding infants (artificial milk) versus exclusive breastfeeding infant (comparison 1)</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Duration of breastfeeding</HEADING>
<P>This outcome was reported in two trials (139 pairs analysed) (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>).The Flaherman and Stra&#328;ák trials used a similar protocol to compare non-exclusively breastfeeding infants who were provided with artificial milk in the first few days after birth with exclusively breastfeeding infants. The intervention of additional artificial milk did not effect the number of infants with any breastfeeding at hospital discharge (risk ratio (RR) 1.02, 95% confidence interval (CI) 0.97 to 1.08; participants = 100; <I>low-quality evidence</I>) and the intervention resulted in a marginally higher number with exclusive breastfeeding in the 24 hours prior to discharge (RR 1.11, 95% CI 1.00 to 1.24; participants = 100) <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>. The results from a similar intervention by <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> indicated the additional artificial milk intervention resulted in a marginally higher number with exclusive breastfeeding in the 24 hours prior to data collection at one week (RR 1.71, 95% CI 1.09 to 2.68; participants = 39). Both trials (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) measured the method of feeding at three months which combined results indicated the group fed additional artificial milk in hospital were more likely to be exclusive breastfeeding in the previous 24 hours (RR 1.43, 95% CI 1.15 to 1.77; participants = 138), and more likely at three months to have any breastfeeding in the previous 24 hours (RR 1.21, 95% CI 1.05 to 1.41; participants = 137; <I>low-quality evidence</I>) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>Adherence to protocol was low among the exclusive breastfeeding group. <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> reported that during the first week after birth, newborn infants assigned to additional artificial milk intervention received 116 <U>
<I>+</I>
</U> 110 mL artificial milk, and controls (exclusive breastfeeding) received 262 <U>
<I>+</I>
</U> 411 mL; intervention period began at 24 to 48 hours until 72 to 106 hours of age. <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK> reported that &#8220;Only 11 out of 50 (22%) infants in the control group were exclusively breastfeeding during hospitalisation&#8221;; the total control group (exclusively breastfeeding) received 475 mL of artificial milk feeds and the study group received 400 mL of artificial milk additional feeds.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Incidence of infant morbidity</HEADING>
<P>
<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK> and <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK> examined the effect of non-exclusive breastfeeding with artificial milk to exclusive breastfeeding in the first few days after birth on the incidence of fever (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>) and allergy symptoms (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>), respectively.</P>
<P>The use of additional artificial milk had no effect on the incidence of fever (RR 1.06, 95% CI 0.83 to 1.36; participants = 28), but did show a protective effect against "obvious or probable symptoms" of allergy at 18 months of age (RR 0.56, 95% 0.35 to 0.91; participants = 207; <I>very low-quality evidence</I>) compared to exclusive breastfeeding. It should be noted that the trialists reported that no diagnostic challenges or other tests were performed to confirm the allergy symptoms (<LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Confidence in breastfeeding</HEADING>
<P>The intervention of supplementation with artificial milk in the first few days after birth showed no difference in maternal confidence measured by a modified breastfeeding self-efficacy score at week one (mean difference (MD) 0.10, 95% CI -0.34 to 0.54; participants = 39; <I>low-quality evidence</I>) (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). The modified breastfeeding self-efficacy score consists of Items rated on a scale from 1 (&#8220;Strongly Disagree&#8221;) to 5 (&#8220;Strongly Agree&#8221;), with higher scores associated with increased breastfeeding self-efficacy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Phototherapy in hospital or home setting if required, absence or presence, and if present, duration (days)</HEADING>
<P>The intervention of additional artificial milk in the first few days after birth did not show an effect on the incidence of requiring phototherapy; one incidence of phototherapy in the control group was reported as lasting 48 hours and none reported in the intervention group (RR 0.33, 95% CI 0.01 to 7.99; participants = 100) (<LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>The following secondary outcomes were not reported in the trials: measures of weight, growth and development, duration of hospital stay and maximum serum bilirubin levels.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Non-exclusive breastfeeding (water or glucose water) versus exclusive breastfeeding infants (comparison 2)</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Duration of breastfeeding</HEADING>
<P>
<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK> (n = 170) compared breastfeeding infants who were provided with additional glucose water versus exclusively breastfeeding infants. Breastfeeding duration was evaluated at four, eight, 12, 16 and 20 weeks (and presented as a graph). We have estimated from the graph the percentage of mothers breastfeeding at each time period (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and calculated the number breastfeeding at each time period from these estimates. The additional glucose water did not improve the number of infants breastfeeding. The likelihood of infants continuing to breastfeed was lower in the non-exclusive breastfeeding (additional glucose water) group across all five time periods (participants = 170): at four weeks (RR 0.83, 95% CI 0.73 to 0.94); at eight weeks (RR 0.79, 95% CI 0.65 to 0.96); at 12 weeks (RR 0.68, 95% CI 0.53 to 0.87; <I>low-quality evidence</I>); at 16 weeks (RR 0.65, 95% CI 0.49 to 0.87); and at 20 weeks (RR 0.69, 95% CI 0.50 to 0.95) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). We do note that the trial authors report that this difference had disappeared at the end of 20 weeks, which is not the case in our analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Incidence of infant morbidity</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Hypothermia or hyperthermia</HEADING>
<P>The addition of glucose water to breastfeeding babies did not show any clinically significant difference in infants' mean maximum temperature and mean minimum rectal temperatures measured at 72 hours of age by <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK> (170 infants analysed); mean difference in the maximum temperature (degrees Celcius) (MD -0.10, 95% CI -0.19 to -0.01) and minimum temperature (MD -0.10, 95% CI -0.18 to -0.02), respectively (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). The trial author states that three infants (1%, all in the exclusively breastfeeding group) had a temperature exceeding 38 degrees C (the level generally accepted as fever) and does not report any occurrences of hypothermia of clinical concern.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Hypoglycaemia or hyperglycaemia</HEADING>
<P>The addition of glucose water resulted in a lower number of episodes of hypoglycaemia in the glucose water group compared to the exclusive breastfeeding group. The difference was originally lower at 12 hours (RR 0.07, 95% CI 0.00 to 1.20; participants = 170; <I>very low-quality evidence</I>) with no significant difference reported at six hours (RR 0.42, 95% CI 0.08 to 2.10; participants = 170), at 24 hours (RR 1.57, 95% CI 0.27 to 9.17; participants = 170; <I>very low-quality evidence</I>), or at 48 hours (RR 0.35, 95% CI 0.04 to 3.29; participants = 170) <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK> (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). Trialists used a cut-off point as serum glucose less than 2.2 mmol/L and they point out that there is no consensus on the risk level and some researchers define a lower cut-off level (1.7 mmol/L). Overall, the number of episodes was low and trialists report there was no case of serum glucose levels under 1.7 mmol/L in either of the two groups and no cases presented hypoglycaemic symptoms.</P>
<P>The addition of glucose water to healthy full-term breastfeeding infants marginally increased the mean serum (capillary) glucose level (mmol/L) in the glucose water group compared to the exclusive breastfeeding group, measured at six hours after birth (MD 0.29, 95% CI 0.02 to 0.56; participants = 170), 12 hours (MD 0.47, 95% CI 0.24 to 0.70) and 24 hours (MD 0.34, 95% CI 0.08 to 0.60) though the difference was no longer evident at 48 hours (MD 0.24, 95% CI -0.03 to 0.51) <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK> (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Measures of weight, growth and development</HEADING>
<P>It is common for infants to lose some weight in the first 48 hours after birth as excess fluid is shed. The addition of glucose water to breastfeeding babies showed a reduced weight loss (grams (g)) in the intervention group compared to exclusively breastfeeding babies, measured at six hours (MD -7.00 g, 95% CI -13.24 to -0.76; participants = 170); 12 hours (MD -11.50 g, 95% CI -21.29 to -1.71; participants = 170); 24 hours (MD -13.40 g, 95% CI -26.37 to -0.43; participants = 170); and at 48 hours (MD -32.50 g, 95% CI -52.09 to -12.91; participants = 170; <I>low-quality evidence</I>), respectively. However, at 72 hours, there was no significant difference between the groups in infant weight loss (MD 3.00 g, 95% CI -20.83 to 26.83; participants = 170; <I>very low-quality evidence</I>) (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). The trialists report that "weight loss did not exceed 7% in either group" (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>).</P>
<P>The percentage weight loss was reported on day three and five for each of the three groups. The authors state that the percentage weight loss on day three was significantly lower in the additional glucose water group compared to the exclusive breastfeeding group and the water supplemented group (presumed by trial authors to be due to marginally greater hydration), the authors also state that this difference was not apparent by day five. When we analysed the data from the glucose water and the water groups as one intervention arm, and compared this to the exclusive breastfeeding group, we found no significant difference in weight loss between the combined supplemented group and the exclusive breastfeeding group on either day three or day five (MD -1.03%, 95% CI -2.24 to 0.18; participants = 47; <I>very low-quality evidence</I>) and (MD -0.20%, 95% CI -0.86 to 0.46; <I>very low-quality evidence</I>), respectively (<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>) (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Maximum serum bilirubin levels</HEADING>
<P>One three-arm trial (<LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>) compared additional water or additional glucose water with exclusive breastfeeding in the first few days after birth and we have presented data for the additional fluids groups combined. The mean plasma bilirubin levels on day six (µmol/L) was higher in the additional water and the glucose water groups combined compared to the exclusively breastfeeding group (MD 18.84, 95% CI -1.35 to 39.03; participants = 47) (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>). A table in the published trial report shows the plasma bilirubin levels across the three groups as mean (SE) additional water 93.5 µmol/L (13.8), glucose water 80.8(8.8), and exclusive breastfeeding 67.7(6.7), all well within the clinical low-risk zone that extends to 222 µmol/L at 144 hours (six days) (American Academy of Pediatrics).</P>
<P>The following secondary outcomes were not reported in the trials: duration of hospital stay, confidence in breastfeeding and phototherapy in hospital or home setting.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Non-exclusive breastfeeding infants (foods) versus exclusive breastfeeding infants (comparison 3)</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Duration of breastfeeding</HEADING>
<P>Among these older infants, <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK> (participants = 1162) reports in their published appendix that the median duration of any breastfeeding was similar in both groups, 50.2 weeks in the standard group (exclusive breastfeeding) and 49 weeks in the early introduction of potential allergenic foods intervention group.</P>
<P>
<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK> (participants = 100) retrospectively collected information on total duration of breastfeeding for all infants. However, we are unable to present these data as they were combined with data from an additional cohort of infants from a separate national prospective study.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Incidence of infant morbidity</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Fever</HEADING>
<P>The addition of complementary foods to infants at four months versus six months showed no evidence of difference in the reported prevalence (percentage of days) of fever in infants aged from 16 to 26 weeks (MD -0.70 day, 95% CI -3.40 to 2.00; participants = 119; <I>low-quality evidence</I>) (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>) (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Upper respiratory illness</HEADING>
<P>The prevalence (percentage of days) of cough, congestion, nasal discharge and hoarseness in breastfeeding infants receiving additional foods from four months versus exclusive breastfeeding to six months was reported from 16 to 26 weeks (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>). There was no difference between groups in the percentage of days with cough (MD 3.10, 95% CI -4.52 to 10.72; participants = 119) (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>); with congestion (MD 3.60, 95% CI -3.41 to 10.61; participants = 119) (<LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>); with nasal discharge (MD 4.20, 95% CI -1.13 to 9.53; participants = 119) (<LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>); with hoarseness (MD 0.10, 95% CI -1.84 to 2.04; participants = 119) (<LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>).</P>
<P>In one trial, Cohen (participants = 141) reported narratively (no data provided) that upper respiratory illness was relatively uncommon; the prevalence was approximately 4% of days between 16 and 26 weeks. The trial authors reported that the additional food group had a lower prevalence of respiratory illness than the exclusively breastfeeding group which reflected a difference in coughs. When fever accompanied a respiratory illness (less than 1% of days), there was no difference in prevalence among groups (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Diarrhoea</HEADING>
<P>Breastfeeding infants receiving additional foods from four months versus exclusive breastfeeding to six months was reported from 16 to 26 weeks, participants = 119 (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>). The trial authors used a nonparametric test for non-normally distributed data when analysing this outcome, therefore we have not entered it into the RevMan analysis. They report that the prevalence of diarrhoea (defined by the researchers as more than three liquid stools per day) was less common in the additional foods group (percentage of days, mean (SD), 2.8% (5.4%) versus 5.4% (8.5%) in the complementary food group). The report states: "The difference was marginally significant (1.4% +/- 3.0% in the additional foods group compared with 2.9% +/- 5.0% in the exclusive breastfeeding group) when diarrhoea was defined as more than five liquid stools per day. The difference in proportion of days with diarrhoea was due to a difference in the number of episodes (no data provided), not to the duration of episodes" (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>).</P>
<P>Cohen (participants = 141 pairs) did not report any morbidity data but narratively reported that diarrhoea was relatively uncommon, with a prevalence of approximately 4% of days between 16 and 26 weeks and that morbidity from diarrhoeal disease was similar among groups (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Allergies</HEADING>
<P>Early introduction of potentially allergenic foods was not found to reduce the risk of "food allergy" to one or more of these foods between one to three years of age compared to the group exclusively breastfeeding to about six months (RR 0.80, 95% CI 0.51 to 1.25; participants = 1162; <I>moderate-quality evidence</I>) (<LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>). Nor was the early introduction of these foods found to reduce the risk of visible eczema at 12 months stratified by visible eczema at enrolment (at three months of age) (RR 0.86, 95% CI 0.51 to 1.44; participants = 284; <I>moderate-quality evidence</I>) (<LINK REF="CMP-003.07" TYPE="ANALYSIS">Analysis 3.7</LINK>). Food protein-induced enterocolitis syndrome reactions were reported by families for 10 children and on food challenge, three children were reported with positive reactions, one in the early allergen foods and two in the control group (RR 2.00, 95% CI 0.18 to 22.04; participants = 1303; <I>moderate-quality evidence</I>) (<LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK>) (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>) (Tables S6 and S9 in study appendix).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Anaemia</HEADING>
<P>Jonsdottir measured iron deficiency anaemia (the criteria for iron-deficiency anaemia (IDA) required that all three indicators met the following cut-off points: haemoglobin (Hb), 105 g/L, mean cell volume (MCV), 74 fl, and complementary food (CF), 12 mg/L) (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>). Two infants had iron deficiency anaemia (one in the exclusive breastfeeding group, one in the early complementary foods group). No significant differences were reported between groups in iron deficiency with or without anaemia.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Infant mortality (at discharge, 28 days or one year)</HEADING>
<P>One of the included studies reported on this outcome with no deaths occurring in either group (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">1. Measures of weight, growth and development</HEADING>
<P>Breastfeeding infants receiving additional foods from four months showed no clinically meaningful difference in infant weight gain (g) from 16 to 26 weeks compared to exclusive breastfeeding to six months (MD -39.48 g, 95% CI -128.43 to 49.48; participants = 260; <I>low-quality evidence</I>) (<LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK>) (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>), or using infant weights calculated as z scores (<LINK REF="REF-World-Health-Organization" TYPE="REFERENCE">World Health Organization</LINK>), (MD -0.01 SD, 95% CI -0.15 to 0.13; participants = 100; <I>moderate-quality evidence</I>) (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>) (<LINK REF="CMP-003.10" TYPE="ANALYSIS">Analysis 3.10</LINK>). Furthermore, <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK> reported that the introduction of complementary foods at four months did not affect the prevalence of overweight children at 18 months (P = 0.74) or 29 to 38 months of age (P = 0.36).</P>
<SUBSECTION>
<HEADING LEVEL="4">2. Confidence in breastfeeding</HEADING>
<P>As part of the larger study of mothers of low birthweight infants in Honduras (<LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>), the mothers' reactions to attempting to breastfeed exclusively for four or six months and the obstacles they encountered were explored using interviews, focus groups and views of the field workers (<LINK REF="REF-Cohen-1999" TYPE="REFERENCE">Cohen 1999</LINK>). The study authors narratively reported that at two weeks 87% of the mothers said that they were confident in their ability/desire to breastfeed exclusively, rising to 96% to 97% at eight to 12 weeks, with those who did not maintain exclusive breastfeeding being less confident. Confidence is not reported by the groups of exclusive breastfeeding to six months and additional foods from four months.</P>
<P>There may be a lack of confidence in exclusive breastfeeding for six months and later outcomes. A higher number of parents in the exclusive breastfeeding group expressed concerns about their child's development or behavioural status at 18 months (44% exclusive breastfeeding group versus 17% complementary foods group), though the difference was not significant when adjusted for baseline differences (P = 0.08); and at 30 to 35 months (19% exclusive breastfeeding group versus 2% complementary foods group), which remained significant after adjustment (P = 0.03), however no significant inter-group differences in the children's developmental measures were found (<LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>).</P>
<P>The following secondary outcomes were not reported in the trials: duration of hospital stay,maximum serum bilirubin levels and phototherapy in hospital or home setting.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-08-29 18:37:33 +0100" MODIFIED_BY="[Empty name]">
<P>This review now includes 11 trials in which a total of 2542 healthy breastfeeding infants or their mothers were randomised. There are two time periods in this review. Seven trials related to the first few days after birth and the intervention of additional water, glucose or artificial formula compared with exclusive breastfeeding, with two taking place in the USA and one in each of Spain, Nigeria, Sweden, the UK and the Czech Republic. Four trials focused on three- to six-month-old infants and the intervention of additional foods from three or four months compared with exclusive breastfeeding until six months, with two related trials carried out in Honduras, and one in each of Iceland and the UK, two in the USA, two in the UK and one in each of Spain, Nigeria, Sweden and the Czech Republic.</P>
<P>The trials were very variable in size and showed high heterogeneity, as would be expected due to differences among the trials' interventions and measures of outcomes. The trials extend over a long time span and practices considered normal care in the past, such as additional water in the first few days or additional foods before six months, have been shown not to be best practice. They are included in this review as these older practices still are seen in some places or these beliefs affect information given by those advising new mothers. Care needs to be taken with interpretation of studies where definitions of exclusive breastfeeding were unclear, varied within the trial report, and differed from WHO definitions. Except for the two trials related to allergy, trials were short term and this may mask effects of the interventions on later health.</P>
<P>The control group is healthy infants exclusively breastfeeding to six months of age.</P>
<SUMMARY_OF_RESULTS MODIFIED="2016-08-29 18:37:33 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Additional artifical milk formula to breastfeeding babies in the first few days after birth</HEADING>
<P>In two trials with a similar protocol, giving infants 10 mL of hydrolysed formula via feeding syringe according to a schedule after feeding at the breast in the first few days did not effect the number of infants with any breastfeeding at hospital discharge. although it did show a marginally higher number with exclusive breastfeeding in the 24 hours prior to discharge and in the 24 hours prior to data collection at one week and at three months. Some of the main quality concerns of these two trials include the apparent willingness of the women to be assigned to either exclusive breastfeeding or to supplement breastfeeding, which calls into question what information they had on the value of exclusive breastfeeding and potential increased risks of ill health associated with not exclusively breastfeeding; the use of 5% weight loss as a risk and the entry criteria for the trial, which is within the normal limits of neonatal weight loss; that the control group of exclusively breastfeeding infants were reported as receiving higher amounts of artifical milk during the trial period than the intervention group arising from maternal request and raises questions about what support was available for mothers to achieve exclusive breastfeeding; as well as varying definitions of exclusive breastfeeding. There was no difference in maternal perception of their breastfeeding self-efficacy between the exclusive breastfeeding and the additional artificial formula groups when assessed at one week, which does not appear to support one trial investigators' statement that the intervention of scheduled supplementation would reduce maternal concerns. The intervention of additional artificial milk in the first few days after birth did not show an effect on the incidence of requiring phototherapy. In another study, the finding that cows' milk artificial formula in the first few days before commencing exclusive breastfeeding showed results that indicated these children were less likely to show "obvious or probable symptoms" of allergy (atopic eczema, wheezing, urticaria, gastrointestinal (GI) allergy or multiple allergies) at 18 months should be interpreted cautiously as artificial formula composition changes frequently and formula used in a trial in 1988 may differ considerably from those currently available. The intervention was only for two to three days immediately after birth and many other variables could affect later allergic signs, as well as the lack of diagnostic challenges or other tests performed to confirm that the reported signs of allergy were clinically confirmed.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Additional water or glucose water to breastfeeding babies in the first few days after birth</HEADING>
<P>Trials giving additional water or glucose water to breastfeeding babies in the first few days after birth did not provide evidence that the practice was of benefit to the newborn infant as regards the incidence of fever (the difference of 0.1 degree is likely not to be at a clinically significant level) or effect the risk of bilirubin levels reaching a level needing clinical treatment. Newborn weight change showed, by day three, no significant differences between groups. As might be expected, serum glucose levels were marginally higher in the infants who received glucose supplements in the first 24 hours, though there was no significant difference at 48 hours and there was no evidence of beneficial difference shown in the number of episodes of hypoglycaemia in the first 48 hours. In interpreting the results, there may be the assumption that higher glucose levels are better and thus the exclusively breastfeeding infant is possibly at risk; similarly that higher weight gain is beneficial. However, it could be interpreted that non-exclusively breastfeeding infants with higher glucose levels and weight gains are the infants at possible risk, particularly in relation to longer-term health outcomes related to obesity and diabetes. One trial showed possible risk in that the additional fluids may contribute to a reduction in the duration of breastfeeding as well as highlighting the cost to the hospital involved in giving additional fluids to infants who will not benefit from these fluids. This trial highlighted concerns about the quantity of glucose water used, up to 70 mL/kg/day, when given based on the mother's or staff perception of the need for the supplement as giving large amounts of water/glucose water may displace nutrients that would be provided by milk resulting in increased weight loss/low weight increase.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Additional foods started at three to four months of age</HEADING>
<P>Starting additional foods early did not show significant difference from the exclusively breastfeeding as regards weight gain; incidence of fever; upper respiratory symptoms of cough, congestion, nasal discharge or hoarseness; or iron deficiency with or without anaemia, during the trial period (up to six months of age). The percentage of days that infants 16 to 26 weeks old had diarrhoea (reported by mother and defined as more than three liquid stools/day) was higher in the exclusive breastfeeding than the additional foods groups in one trial though not in the other trial by the same group. The trialists highlight that the infants in the additional foods groups received commercially prepared jars of food and that the more normal situation of using home-prepared foods from the local culture, with a potentially higher bacterial load, might have shown a higher prevalence of diarrhoea. The trialists also discuss how differences in definitions of diarrhoea may affect their conclusions. Breastfeeding infants normally have stools that are more frequent and softer than infants who are fed on cow's milk feeds or complementary foods. The definition of what is considered abnormal can affect the interpretation of the findings. Relying on maternal diagnosis of infant illness and maternal recall of any illness over the previous three weeks may result in recall bias.</P>
<P>In one trial, parents in the group exclusively breastfeeding for six months had significantly more concerns about their child's development or behavioural status at 18 months and at 30 to 35 months, despite developmental tests showing no differences between groups. Reasons for the parental concern are not discussed and mention is made by the trial investigator of low iron levels contributing to developmental delay, though neither iron deficiency anaemia or developmental delay was found among the children. Expressing this link in the research raises a question: are parents and health workers as well as researchers receiving information from commercial marketing that implies exclusively breastfeeding for six months could result in lack of iron and later developmental concerns?</P>
<P>A recent large trial included in this review examined the effect of early addition to breastfeeding infants of six potentially allergenic foods (from three months of age) on the incidence of food allergy, eczema and food protein enterocolitis syndrome, among many other outcomes. The results, analysed as intention-to-treat, showed no difference between the groups in the duration of any breastfeeding or for any of the allergy outcomes. Only 43% adhered to the complex intervention protocol and a per-protocol analysis indicated the intervention reduced the incidence of allergy. Debate within the allergy research community is continuing including, if there are previous family experiences of allergy, do parents attribute minor behaviours of the infant to allergic reactions and avoid giving the foods, are some of the foods too difficult for immature oral-motor skills, and how much can the protocol vary and still be effective (<LINK REF="REF-Wong-2016" TYPE="REFERENCE">Wong 2016</LINK>)?</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-08-24 16:06:38 +0100" MODIFIED_BY="[Empty name]">
<P>We applied standard Cochrane methods for our searches, examined references cited in trials, searched for additional publication by previously included trialists, and contacted authors of recent trials for further information and unpublished data to include. Both review authors are employed in areas related to this topic and likely to be aware of research so we are confident this review is a comprehensive representation of the existing body of literature. This topic experiences widespread debate currently, and over past decades and more trials might be expected, however ethical concerns about reducing an infant's acces to their mother's milk or adding a non-human milk protein into a newborn baby's system make these trials difficult to undertake. Past research findings resulted in internationally recognised guidelines for practice clearly supporting exclusive breastfeeding for the first six months and thus funders, parents and research review boards may be hesitant about involvement in trials contrary to these guidelines.</P>
<P>One included study from 1982 (no data for inclusion) examined the effect on intestinal bacteria of the newborn infant of additional glucose water versus exclusive colostrum. It is surprising that more recent trials were not found on the effect of additional fluids and foods versus exclusive breastfeeding on the infant microbiota and effects on later health.</P>
<P>The studies reviewed came from a wide range of countries and are published in English. Breastmilk is readily available and does not involve additional resources such as electricity or technology, or the costs associated with purchasing alternative fluids and food. Evidence not part of the topic of this review indicates there may be negative effects of early additional of non-human fluids which may have illness-associated costs. One older study in this review mentioned the cost of the early fluids additional to mother's milk and one study referred to possible concerns from contamination of the intervention fluids and foods. The costs and safety of interventions are important to include in determining the suitability of an intervention.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-07-25 15:56:52 +0100" MODIFIED_BY="Heather Maxwell">
<P>The evidence for the comparison of additional early artificial milk versus exclusive breastfeeding was graded as a having a low quality of evidence for any breastfeeding at discharge and three months, maternal self-confidence and very low quality of evidence for allergy symptoms for reasons including unclear definitions of supplement feeds, uncertainty of the impact of recruiting infants with a 5% or greater weight loss and small sample size.</P>
<P>The evidence for the comparison of additional early water or glucose water versus exclusive breastfeeding had low quality of evidence for any breastfeeding at 12 months and weight change at 48 hours of life because of lack of information on sequence generation or allocation concealment and small sample size. The evidence for the comparison of additional early water or glucose water versus exclusive breastfeeding had very low quality of evidence for hypoglycaemia at 12 and 24 hours of life, weight change at 72 hours of life and weight loss (%) at three and five days of age because of one trial with no information on sequence generation or allocation concealment and wide confidence intervals or confidence intervals meeting the line of no effect.</P>
<P>The evidence for the comparison of early additional foods versus exclusive breastfeeding had a low quality of evidence for fever and mean weight change at four to six months due to quasi-random sequence generation, small sample size and wide confidence interval crossing the line of no effect. The remaining outcomes (weight change expressed as a z-score at four to six months, food allergy at one to three years, visible eczema at 12 months (stratified by visible eczema at enrolment) and food protein enterocolitis syndrome) were graded as having moderate quality of evidence because of wide confidence interval crossing the line of no effect and small sample size.</P>
<P>We did not downgrade any of studies for performance bias as due to the nature of the interventions blinding would not have been possible. See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK> for further details.</P>
<P>We assessed each of the 11 studies for risk of bias and found that over half of the studies (n = 7) had a high risk of other biases. We were unable to assess eight studies for selection bias. All but one study (<LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>) achieved the same grade for both random sequence generation and allocation concealment, which are both markers for selection bias. Three studies each were assessed as being low (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) and high (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>) risk for selection bias, and we could not evaluate four trials (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>) for selection bias. Further details are listed in the 'Risk of bias' tables (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>) and summary graphs of methodological quality (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>Three of the 11 included studies provided no information on funding sources in their published papers <I>(</I>
<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>; <LINK REF="STD-Ojofeitimi-1982" TYPE="STUDY">Ojofeitimi 1982</LINK>; <LINK REF="STD-Schutzman-1986" TYPE="STUDY">Schutzman 1986</LINK>). Support from, or a financial relationship with an infant food manufacturer, or their marketing body, was declared in five trials (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>). The non-standard intervention artifical milk was supplied in pre-filled syringes though it is not stated if these were provided by the manufacturers (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>). Sources of non-commercial support were declared by seven trials (<LINK REF="STD-Cohen-1994" TYPE="STUDY">Cohen 1994</LINK>; <LINK REF="STD-Dewey-1999" TYPE="STUDY">Dewey 1999</LINK>; <LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013</LINK>; <LINK REF="STD-Jonsdottir-2012" TYPE="STUDY">Jonsdottir 2012</LINK>; <LINK REF="STD-Lindfors-1988" TYPE="STUDY">Lindfors 1988</LINK>; <LINK REF="STD-Perkin-2016" TYPE="STUDY">Perkin 2016</LINK>; <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-07-25 16:18:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>We applied a search strategy to identify all potential trials. However, although we identified 11 trials, we were unable to extract several relevant outcome data pre-specified in our protocol. Some of these outcome measures were most likely not ascertained during the trial; however, others could have been collected but not reported. For the studies over 10 years since publication we did not contact the primary investigators to obtain any additional data.</P>
<P>Otherwise, to minimise bias, we followed the methodology for systematic reviews outlined in the<I> Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) and customised to this review as described in <LINK TAG="METHODS" TYPE="SECTION">Methods</LINK>.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-07-19 11:48:48 +0100" MODIFIED_BY="[Empty name]">
<P>This review did not find any disagreements with the Cochrane review by Kramer which included both observational studies and randomised controlled trials examining exclusive breastfeeding versus earlier introduction of complementary foods (<LINK REF="REF-Kramer-2012" TYPE="REFERENCE">Kramer 2012</LINK>). This Kramer review formed the basis for the World Health Organization recommendations, and thus numerous other recommendations, that exclusive breastfeeding is recommended for the first six months after birth. A review to systematically evaluate the effect of additional fluids or feedings during the first days of life on the overall breastfeeding duration and rate of exclusive breastfeeding among healthy infants was conducted in 2006 (<LINK REF="REF-Szajewska-2006" TYPE="REFERENCE">Szajewska 2006</LINK>). The <LINK REF="REF-Szajewska-2006" TYPE="REFERENCE">Szajewska 2006</LINK> review only included one of the trials (<LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK>) eligible for inclusion in this Cochrane review and concluded that there is insufficient evidence to form conclusions about the effect of brief exposure to additional food or fluids or both on infant health and the duration of breastfeeding.</P>
<P>This review found potential disagreement with the World Health Organization recommendations, and thus numerous other recommendations, in respect of early additional artifical milks versus exclusive breastfeeding. The findings from two trials with the same protocol (<LINK REF="STD-Flaherman-2013" TYPE="STUDY">Flaherman 2013;</LINK> <LINK REF="STD-Stra_x0148__x00e1_k-2016" TYPE="STUDY">Stra&#328;ák 2016</LINK>) present data that would be in disagreement with findings of many other studies (such as those cited in the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK>). We found quality concerns in these two trials, as outlined in the review, and we could not recommend that guidance or practice be altered based on their findings.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-07-25 15:57:22 +0100" MODIFIED_BY="Heather Maxwell">
<IMPLICATIONS_PRACTICE MODIFIED="2016-07-25 15:57:12 +0100" MODIFIED_BY="Heather Maxwell">
<P>This review did not find any evidence for disagreement with the recommendation of the World Health Organization and other international health associations (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>) that, as a general policy exclusive breastfeeding, without additional foods or fluids, should be recommended for the first six months after birth.</P>
<P>Additional fluids and foods may have short- and long-term risks to the infant and parents and health workers should be aware of these risks in order to make an informed decision about the use of additional fluids and foods for the breastfeeding baby.</P>
<P>Care should be taken to provide skilled support from birth to establish milk production and effective milk transfer so as to reduce the risk of weight loss exceeding an established clinical risk level and additional fluids and foods seen as the routine treatment. Pratices and attitudes in hospitals should facilitate evidence-based international recommendations implemented as standard practice to enable exclusive breastfeeding and to protect infants from additional fluids or foods if these are not clinically indicated (<LINK REF="REF-UNICEF_x002f_WHO-2009" TYPE="REFERENCE">UNICEF/WHO 2009</LINK>).</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-07-25 15:57:22 +0100" MODIFIED_BY="Heather Maxwell">
<P>In the previous version of this review we stated that older trials and "more recent observational studies and theoretical constructs indicate possible negative effects from supplementation of the breastfeeding infant in the first few months, and combined with recommendations from international health authorities to avoid supplementation unless for a clear medical need, it may now be considered unethical to conduct a trial in which an infant is randomised to receive supplements solely for the purpose of the trial (<LINK REF="REF-Becker-2011" TYPE="REFERENCE">Becker 2011</LINK>)". There was one trial in the 2011 version and a second trial in this updated review that did provide additional feeds to breastfeeding infants for the purpose of their trial, both using greater than 5% weight loss as the indicator of need for additional feeds, despite this level being within accepted normal weight patterns. The negative reaction to the first trial from professional associations and individual health professionals (<LINK REF="REF-Furman-2013" TYPE="REFERENCE">Furman 2013</LINK>; <LINK REF="REF-Merewood-2013" TYPE="REFERENCE">Merewood 2013</LINK>; <LINK REF="REF-Smith-2013" TYPE="REFERENCE">Smith 2013</LINK>; <LINK REF="REF-Stuebe-2013" TYPE="REFERENCE">Stuebe 2013</LINK>) did not appear to affect further associated research conducted on routine scheduled formula supplementation of healthy babies in the first few days after birth without a clinical need and with imprecise definitions of exclusive breastfeeding. It is of concern that this protocol appears to be used in two associated ongoing trials listed in this review thus increasing the risk that these routine supplementation practices and the 5% loss regarded as a clinical risk will come into common use without regard for major limitations of these trials.</P>
<P>Use of precise and internationally accepted definitions of exclusive breastfeeding would improve the quality and comparability of trials, as would information on birth method including maternal intravenous (IV) fluid load and time from birth to initiation of breastfeeding. These variables have been shown to affect infant weight in the first week.</P>
<P>Though not an outcome included in this review, supplementing the breastfeeding infant may have effects on the mother that could include engorgement, mastitis, earlier return of fertility, nutritional status, and maternal use of time as well as maternal mental health and financial effects related to duration of breastfeeding. These maternal aspects could be examined in any future research on this topic. This review did not examine an effect of the method by which any supplement was given, though the use of an artifical teat may affect infant sucking skills, contributing to breastfeeding difficulties as well as introducing a potential source of infection and a potential confounder related to morbidity. This review looked at studies up to the infant age of six months. The addition of non-human milk, other fluids and foods into the infant's immature system may have long-term effects on the gastrointestinal development, metabolic and immunological status of the child (<LINK REF="REF-Horta-2007" TYPE="REFERENCE">Horta 2007</LINK>). It would be valuable if in future studies the longer-term effects were also considered.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-08-30 12:56:17 +0100" MODIFIED_BY="[Empty name]">
<P>We are grateful to Sharon Remmington for her contribution to the protocol (<LINK REF="REF-Remmington-2007" TYPE="REFERENCE">Remmington 2007</LINK>) and the initial version of this review (<LINK REF="REF-Becker-2011" TYPE="REFERENCE">Becker 2011</LINK>) and to Tracey Remmington for her contribution to all previous versions (<LINK REF="REF-Remmington-2007" TYPE="REFERENCE">Remmington 2007</LINK>; <LINK REF="REF-Becker-2011" TYPE="REFERENCE">Becker 2011</LINK>; <LINK REF="REF-Becker-2014" TYPE="REFERENCE">Becker 2014</LINK>).</P>
<P>We are grateful to the study authors and their colleagues who provided further information, and to those people who noticed the requests and directed us to additional studies and ways of contacting authors.</P>
<P>Thanks are also due to Sonja Henderson (previous Managing Editor), Frances Kellie (Managing Editor), and Leanne Jones (Associate Editor), over the years of this review and their colleagues in the Review Group office of Cochrane Pregnancy and Childbirth.</P>
<P>Cochrane Pregnancy and Childbirth received a grant from the Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development, World Health Organization (WHO). The findings, interpretations and conclusions expressed in this paper are entirely those of the authors and should not be attributed in any manner whatsoever to WHO.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-08-29 18:46:42 +0100" MODIFIED_BY="[Empty name]">
<P>In October 2012 Hazel A Smith registered as a PhD student to study the effects of infant's milk diet at two months of age on their body composition, growth and neurodevelopment in the first 2 years of life. Hazel is the Research Coordinator for the Paediatric Intensive Care Unit in Our Lady's Children's Hospital, Ireland. Hazel is not in receipt of any financial relationship with any commercial entity.</P>
<P>Genevieve Becker works in the general area of infant and young child feeding but not specifically connected with the topic of this review. Genevieve is not in receipt of any financial relationship with any commercial entity.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-07-19 11:51:42 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Previous version of the review</HEADING>
<P>Genevieve Becker co-ordinated the review update. Genevieve Becker and Tracey Remmington assessed study eligibility independently extracted data and entered data. Genevieve Becker wrote the first draft with input from Tracey Remmington (<LINK REF="REF-Becker-2014" TYPE="REFERENCE">Becker 2014</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Current version of the review</HEADING>
<P>Hazel A Smith co-ordinated the review update. Hazel A Smith and Genevieve Becker assessed study eligibility independently extracted data and entered data. Hazel A Smith lead on the analysis aspects and Genevieve Becker lead on the text; both authors agreed the final draft.</P>
</SUBSECTION>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-07-25 15:58:02 +0100" MODIFIED_BY="Heather Maxwell">
<P>We updated the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> section and refocused to reflect exclusive breastfeeding as the norm and supplementation as an intervention, as well as more justification for the outcomes selected for examination.</P>
<P>Outcomes as listed in the protocol amended to (primary) physiological jaundice, absence or presence, and if present, duration (days), and (secondary) phototherapy in hospital or home setting if required, absence or presence, and if present, duration (days). This was changed in recognition that some participants are likely not to be jaundiced or to need phototherapy.</P>
<P>In the 2016 update, the outcomes "Weight change" was changed to "Measures of weight, growth and development" so as to include measures such as height, head circumference, and developmental aspects that may be included in trials, and "Maternal self-confidence in breastfeeding" was changed to "Confidence in breastfeeding" in order to include trials that examined confidence of fathers and other family members, health workers or those with significant influence on the mother. Infant morbidity examples were expanded to include hypoglycaemia and symptoms of allergy.</P>
<P>We have updated the methods in accordance with the updated <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). In the 2016 update, we have assessed the evidence using the GRADE approach and added 'Summary of findings' tables.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2016-07-25 15:58:10 +0100" MODIFIED_BY="Heather Maxwell">
<P>In the next update, we will review the outcomes listed for their relevance in the future, and combine/reduce outcomes related to jaundice and hyperbilirubinaemia.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-08-30 13:35:41 +0100" MODIFIED_BY="Leanne Jones">
<STUDIES MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-08-08 13:47:56 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cohen-1994" MODIFIED="2016-08-08 11:53:06 +0100" MODIFIED_BY="[Empty name]" NAME="Cohen 1994" YEAR="1995">
<REFERENCE MODIFIED="2016-08-08 11:52:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen RJ, Brown KH, Canahuati J, Rivera LL, Dewey KG</AU>
<TI>Determinants of growth from birth to 12 months among breast-fed Honduran infants in relation to age of introduction of complementary foods</TI>
<SO>Pediatrics</SO>
<YR>1995</YR>
<VL>96</VL>
<NO>3 Pt 1</NO>
<PG>504-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971741"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-24 11:12:54 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cohen RJ, Brown KH, Canahuati J, Rivera LL, Dewey KG</AU>
<TI>Effects of age of introduction of complementary foods on infant breast milk intake, total energy intake, and growth: a randomised intervention study in Honduras</TI>
<SO>Lancet</SO>
<YR>1994</YR>
<VL>344</VL>
<NO>8918</NO>
<PG>288-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971740"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-02-24 20:19:30 +0000" MODIFIED_BY="Genevieve E Becker" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen RJ, Rivera LL, Canahuati J, Brown KH, Dewey KG</AU>
<TI>Delaying the introduction of complementary food until 6 months does not affect appetite or mother's report of food acceptance of breast-fed infants from 6 to 12 months in a low income, Honduran population</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>11</NO>
<PG>2787-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971742"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-01-15 12:27:26 +0000" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dewey KG, Cohen RJ, Brown KH, Rivera LL</AU>
<TI>Effects of exclusive breastfeeding for four versus six months on maternal nutritional status and infant motor development: results of two randomized trials in Honduras</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<NO>2</NO>
<PG>262-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971743"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-08 11:53:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Escamilla R, Cohen RJ, Brown KH, Rivera LL, Canahuati J, Dewey KG</AU>
<TI>Maternal anthropometric status and lactation performance in a low-income Honduran population: evidence for the role of infants</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>528-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971744"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971739"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dewey-1999" MODIFIED="2016-08-08 11:53:23 +0100" MODIFIED_BY="[Empty name]" NAME="Dewey 1999" YEAR="2004">
<REFERENCE MODIFIED="2010-01-15 13:54:25 +0000" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cohen RJ, Brown KH, Rivera LL, Dewey KG</AU>
<TI>Promoting exclusive breastfeeding for 4-6 months in Honduras: attitudes of mothers and barriers to compliance</TI>
<SO>Journal of Human Lactation</SO>
<YR>1999</YR>
<VL>15</VL>
<PG>9-18</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971746"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-08 11:53:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dewey KG, Cohen RJ, Brown KH, Rivera LL</AU>
<TI>Age of introduction of complementary foods and growth of term, low-birth-weight, breast-fed infants: a randomized intervention study in Honduras</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<PG>679-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971747"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-22 21:12:36 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dewey KG, Cohen RJ, Brown KH, Rivera LL</AU>
<TI>Effects of exclusive breastfeeding for four versus six months on maternal nutritional status and infant motor development: results of two randomised trials in Honduras</TI>
<SO>Journal of Nutrition</SO>
<YR>2001</YR>
<VL>131</VL>
<PG>262-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971748"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-08 11:53:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dewey KG, Cohen RJ, Brown KH</AU>
<TI>Exclusive breast-feeding for 6 months, with iron supplementation, maintains adequate micronutrient status among term, low-birthweight, breast-fed infants in Honduras</TI>
<SO>Journal of Nutrition</SO>
<YR>2004</YR>
<VL>134</VL>
<NO>5</NO>
<PG>1091-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971749"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971745"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flaherman-2013" MODIFIED="2014-03-31 21:30:36 +0100" MODIFIED_BY="[Empty name]" NAME="Flaherman 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-31 21:30:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flaherman VJ, Aby J, Burgos AE, Lee KA, Cabana MD, Newman TB</AU>
<TI>Effect of early limited formula on duration and exclusivity of breastfeeding in at-risk infants: an RCT</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>131</VL>
<NO>6</NO>
<PG>1059-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971751"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971750"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jonsdottir-2012" MODIFIED="2016-07-24 11:16:41 +0100" MODIFIED_BY="Heather Maxwell" NAME="Jonsdottir 2012" YEAR="2012">
<REFERENCE MODIFIED="2016-07-24 11:16:41 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jonsdottir OH, Fewtrell MS, Gunnlaugsson G, Kleinman RE, Hibberd PL, Jonsdottir JM, et al</AU>
<TI>Initiation of complementary feeding and duration of total breastfeeding: unlimited access to lactation consultants versus routine care at the well-baby clinics</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>4</NO>
<PG>196-202</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971753"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-27 10:18:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jonsdottir OH, Kleinman RE, Wells JC, Fewtrell MS, Hibberd PL, Gunnlaugsson G, et al</AU>
<TI>Exclusive breastfeeding for 4 versus 6 months and growth in early childhood</TI>
<SO>Acta Paediatrica</SO>
<YR>2014</YR>
<VL>103</VL>
<NO>1</NO>
<PG>105-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971754"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-27 10:18:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jonsdottir OH, Thorsdottir I, Gunnlaugsson G, Fewtrell MS, Hibberd PL, Kleinman RE</AU>
<TI>Exclusive breastfeeding and developmental and behavioral status in early childhood</TI>
<SO>Nutrients</SO>
<YR>2013</YR>
<VL>5</VL>
<NO>11</NO>
<PG>4414-28</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971755"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-03 22:25:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jonsdottir OH, Thorsdottir I, Hibberd PL, Fewtrell MS, Wells JC, Palsson GI, et al</AU>
<TI>Timing of the introduction of complementary foods in infancy: A randomized controlled trial</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>6</NO>
<PG>1038-45</PG>
<EN>ISRCTN41946519</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971756"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-04-29 23:01:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jonsdottir OH</AU>
<TI>The effects of diet during the first six months of life on health outcomes in infancy and early childhood</TI>
<SO>[thesis]</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971757"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-03 22:17:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wells JCK, Jonsdottir OH, Hibberd PL, Fewtrell MS, Thorsdottir I, Eaton S, et al</AU>
<TI>Randomized controlled trial of 4 compared with 6 mo of exclusive breastfeeding in Iceland: Differences in breast-milk intake by stable-isotope probe</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>96</VL>
<NO>1</NO>
<PG>73-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971758"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971752"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindfors-1988" MODIFIED="2016-07-19 12:32:10 +0100" MODIFIED_BY="[Empty name]" NAME="Lindfors 1988" YEAR="1988">
<REFERENCE MODIFIED="2016-07-14 23:29:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lindfors A, Enocksson E</AU>
<TI>Development of atopic disease after early administration of cow milk formula</TI>
<SO>Allergy</SO>
<YR>1988</YR>
<VL>43</VL>
<PG>11-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971836"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-19 12:32:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindfors ATB, Danielsson L, Enocksson E, Johansson SGO, Westin S</AU>
<TI>Allergic symptoms up to 4-6 years of age in children given cow milk neonatally</TI>
<SO>Allergy</SO>
<YR>1992</YR>
<VL>47</VL>
<PG>207-11</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4359205"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971835"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martin_x002d_Calama-1997" MODIFIED="2008-10-22 21:23:04 +0100" MODIFIED_BY="Tracey Remmington" NAME="Martin-Calama 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-10-22 21:23:04 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martin-Calama J, Bunuel J, Valero MT, Labay M, Lasarte JJ, Valle F, et al</AU>
<TI>The effect of feeding glucose water to breastfeeding newborns on weight, body temperature, blood glucose, and breastfeeding duration</TI>
<SO>Journal of Human Lactation</SO>
<YR>1997</YR>
<VL>13</VL>
<PG>209-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971760"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971759"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nicoll-1982" MODIFIED="2008-10-22 20:52:55 +0100" MODIFIED_BY="Tracey Remmington" NAME="Nicoll 1982" YEAR="1982">
<REFERENCE MODIFIED="2008-07-07 14:27:46 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nicoll A, Ginsburg R, Tripp JH</AU>
<TI>Supplementary feeding and jaundice in newborns</TI>
<SO>Acta Paediatrica Scandinavica</SO>
<YR>1982</YR>
<VL>71</VL>
<PG>759-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971762"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971761"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ojofeitimi-1982" MODIFIED="2016-08-08 11:54:19 +0100" MODIFIED_BY="[Empty name]" NAME="Ojofeitimi 1982" YEAR="1982">
<REFERENCE MODIFIED="2016-08-08 11:54:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ojofeitimi EO, Elegbe IA</AU>
<TI>The effect of early initiation of colostrum feeding on proliferation of intestinal bacteria in neonates</TI>
<SO>Clinical Pediatrics</SO>
<YR>1982</YR>
<VL>21</VL>
<PG>39-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971764"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971763"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perkin-2016" MODIFIED="2016-08-08 13:47:56 +0100" MODIFIED_BY="[Empty name]" NAME="Perkin 2016" YEAR="2016">
<REFERENCE MODIFIED="2016-08-08 13:47:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN14254740</AU>
<TI>Early introduction of allergenic foods to induce tolerance in infants</TI>
<TO>Randomised controlled trial of early introduction of allergenic foods to induce tolerance in infants</TO>
<SO>controlled-trials.com/ISRCTN14254740</SO>
<YR>Date first received: 31 March 2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971769"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-14 23:35:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perkin MR, Logan K, Craven J, Marrs T, Radulovic S, Flohr C, et al</AU>
<TI>Enquiring About Tolerance (EAT) study: feasibility of an early allergenic food and impact on breastfeeding</TI>
<SO>Clinical and Translational Allergy</SO>
<YR>2015</YR>
<VL>5</VL>
<NO>Suppl 3</NO>
<PG>O6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971768"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-14 23:33:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perkin MR, Logan K, Marrs T, Radulovic S, Craven J, Flohr C, et al</AU>
<TI>Enquiring About Tolerance (EAT) study: feasibility of an early allergenic food introduction regimen</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>2016</YR>
<VL>137</VL>
<NO>5</NO>
<PG>1477&#8211;1486.e8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971767"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-14 23:39:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al</AU>
<TI>Randomized trial of introduction of allergenic foods in breast-fed infants</TI>
<SO>New England Journal of Medicine</SO>
<YR>2016</YR>
<VL>374</VL>
<PG>1733-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971766"/><IDENTIFIER TYPE="DOI" VALUE="10.1056/NEJMoa1514210"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-08-08 12:22:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971765"/><IDENTIFIER MODIFIED="2016-08-08 12:22:39 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="14254740"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schutzman-1986" MODIFIED="2009-12-15 20:41:52 +0000" MODIFIED_BY="Tracey Remmington" NAME="Schutzman 1986" YEAR="1986">
<REFERENCE MODIFIED="2009-12-15 20:41:49 +0000" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schutzman DL, Hervada AR, Branca PA</AU>
<TI>Effect of water supplementation of full-term newborns on arrival of milk in the nursing mother</TI>
<SO>Clinical Pediatrics</SO>
<YR>1986</YR>
<VL>25</VL>
<NO>2</NO>
<PG>78-80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971771"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971770"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Stra_x0148__x00e1_k-2016" MODIFIED="2016-08-08 12:23:07 +0100" MODIFIED_BY="[Empty name]" NAME="Stra&#328;ák 2016" YEAR="2016">
<REFERENCE MODIFIED="2016-08-08 12:23:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stra&#328;ák Z, Feyereislova S, &#268;erná M, Kollárová J, Feyereisl J</AU>
<TI>Limited amount of formula may facilitate breastfeeding: randomized, controlled trial to compare standard clinical practice versus limited supplemental feeding</TI>
<SO>PLoS One</SO>
<YR>2016</YR>
<VL>11</VL>
<NO>2</NO>
<PG>e0150053</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971773"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971772"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bannert-1995" MODIFIED="2010-11-16 15:07:30 +0000" MODIFIED_BY="Jill Hampson" NAME="Bannert 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-01-15 11:54:48 +0000" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bannert N, Lamme W</AU>
<TI>Influence of supplementary feeding on the breast feeding of newborns</TI>
<SO>Sozialpadiatrie und Kinderartzliche</SO>
<YR>1995</YR>
<VL>17</VL>
<PG>502-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971775"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-11-16 15:07:30 +0000" MODIFIED_BY="Jill Hampson"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971774"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cameron-2015" MODIFIED="2016-03-18 18:29:00 +0000" MODIFIED_BY="[Empty name]" NAME="Cameron 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-03-18 18:29:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cameron SL, Heath AM, Gray AR, Churcher B, Davies RS, Newlands A, et al</AU>
<TI>Lactation consultant support from late pregnancy with an educational intervention at 4 months of age delays the introduction of complementary foods in a randomized controlled trial</TI>
<SO>Journal of Nutrition</SO>
<YR>2015</YR>
<VL>145</VL>
<PG>1481-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971777"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971776"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Collins-2004" MODIFIED="2016-08-08 12:23:20 +0100" MODIFIED_BY="[Empty name]" NAME="Collins 2004" YEAR="2004">
<REFERENCE MODIFIED="2016-08-08 12:23:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Collins CT, Ryan P, Crowther CA, McPhee AJ, Paterson S, Hiller JE</AU>
<TI>Effect of bottles, cups, and dummies on breast feeding in preterm infants: a randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>329</VL>
<NO>7459</NO>
<PG>193-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971779"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971778"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corchia-1985" MODIFIED="2016-08-08 12:23:26 +0100" MODIFIED_BY="[Empty name]" NAME="Corchia 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-08-08 12:23:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corchia C, Ruiu M, Orzalesi M</AU>
<TI>Breast-feeding and hyperbilirubinemia in full-term newborn infants</TI>
<SO>Pediatrics</SO>
<YR>1985</YR>
<VL>75</VL>
<PG>617-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971781"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971780"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cronenwett-1992" MODIFIED="2008-07-07 14:14:25 +0100" MODIFIED_BY="Tracey Remmington" NAME="Cronenwett 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-07 14:14:25 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cronenwett L, Stukel T, Kearney M, Barrett J, Covington C, Del Monte K, et al</AU>
<TI>Single daily bottle use in the early weeks postpartum and breastfeeding outcomes</TI>
<SO>Pediatrics</SO>
<YR>1992</YR>
<VL>90</VL>
<NO>5</NO>
<PG>760-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971783"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971782"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Carvalho-1981" MODIFIED="2009-04-16 09:11:40 +0100" MODIFIED_BY="Tracey Remmington" NAME="De Carvalho 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-04-16 09:11:40 +0100" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Carvalho M, Hall M, Harvey DR</AU>
<TI>Effects of water supplementation on physiological jaundice in breast-fed babies</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1981</YR>
<VL>56</VL>
<PG>568-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971785"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971784"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Jong-1998" MODIFIED="2016-07-14 23:44:02 +0100" MODIFIED_BY="[Empty name]" NAME="de Jong 1998" YEAR="1998">
<REFERENCE MODIFIED="2016-07-14 23:44:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>deJong MH, Scharp-van der Linden VTM, Aalberse RC, Oosting J, Tijssen JGP, de Groot CJ</AU>
<TI>Randomised controlled trial of brief neonatal exposure to cows&#8217; milk on the development of atopy</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1998</YR>
<VL>79</VL>
<NO>2</NO>
<PG>126-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971787"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971786"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Oliveira-2012" MODIFIED="2014-11-14 11:32:06 +0000" MODIFIED_BY="Heather Maxwell" NAME="de Oliveira 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-02-24 20:23:32 +0000" MODIFIED_BY="Genevieve E Becker" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nunes LM, Giugliani ER, Santo LC, de Oliveira LD</AU>
<TI>Reduction of unnecessary intake of water and herbal teas on breast-fed infants: a randomized clinical trial with adolescent mothers and grandmothers</TI>
<SO>Journal of Adolescent Health</SO>
<YR>2011</YR>
<VL>49</VL>
<NO>3</NO>
<PG>258-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971789"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-14 11:32:06 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Oliveira LD, Giugliani ERJ, Santo LCDE, Nunes LM</AU>
<TI>Impact of a strategy to prevent the introduction of non-breast milk and complementary foods during the first 6 months of life: a randomized clinical trial with adolescent mothers and grandmothers</TI>
<SO>Early Human Development</SO>
<YR>2012</YR>
<VL>88</VL>
<NO>6</NO>
<PG>357-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971790"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971788"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Du-Toit-2015" MODIFIED="2016-07-14 23:44:22 +0100" MODIFIED_BY="[Empty name]" NAME="Du Toit 2015" YEAR="2015">
<REFERENCE MODIFIED="2016-07-14 23:44:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Du Toit G</AU>
<TI>Randomized trial of peanut consumption in infants at risk for peanut allergy, the LEAP Study</TI>
<SO>New England Journal of Medicine</SO>
<YR>2015</YR>
<VL>372</VL>
<PG>803-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971792"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971791"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flaherman-2011" MODIFIED="2016-08-08 14:42:25 +0100" MODIFIED_BY="[Empty name]" NAME="Flaherman 2011" YEAR="2014">
<REFERENCE MODIFIED="2016-08-08 14:26:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01330667</AU>
<TI>Effect of early limited formula on total serum bilirubin among newborns with hyperbilirubinemia</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01330667</SO>
<YR>Date first recieved: 23 February 2011</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971813"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-07-14 23:45:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971812"/><IDENTIFIER MODIFIED="2016-07-14 23:45:05 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01330667"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-French-2012" MODIFIED="2014-04-29 23:07:23 +0100" MODIFIED_BY="[Empty name]" NAME="French 2012" YEAR="2012">
<REFERENCE MODIFIED="2014-04-29 23:07:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>French GM, Nicholson L, Skybo T, Klein EG, Schwirian PM, Murray-Johnson L, et al</AU>
<TI>An evaluation of mother-centered anticipatory guidance to reduce obesogenic infant feeding behaviors</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>3</NO>
<PG>e507-e517</PG>
<EN>NCT01565525</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971794"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971793"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gray_x002d_Donald-1985" MODIFIED="2016-08-08 12:24:20 +0100" MODIFIED_BY="[Empty name]" NAME="Gray-Donald 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-08-08 12:24:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gray-Donald K, Kramer MS, Munday S, Leduc DG</AU>
<TI>Effect of formula supplementation in the hospital on the duration of breast-feeding: a controlled clinical trial</TI>
<SO>Pediatrics</SO>
<YR>1985</YR>
<VL>75</VL>
<PG>514-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971796"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971795"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Howard-2003" MODIFIED="2016-08-08 12:24:27 +0100" MODIFIED_BY="[Empty name]" NAME="Howard 2003" YEAR="2003">
<REFERENCE MODIFIED="2016-08-08 12:24:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Howard CR, Howard FM, Lanphear B, Eberly S, DeBlieck EA, Oakes D, et al</AU>
<TI>Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeeding</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>111</VL>
<NO>3</NO>
<PG>511-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971798"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-08 12:24:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Howard CR, Howard FM, Lanphear BP, Eberly S, Oakes D, Lawrence RA</AU>
<TI>Complementary feeding methods for breastfed babies. A randomized trial of cup versus bottle and the effect on breastfeeding success</TI>
<SO>Pediatric Research</SO>
<YR>2001</YR>
<VL>49</VL>
<NO>4</NO>
<PG>161A</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971799"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971797"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Juvonen-1996" MODIFIED="2016-07-24 11:24:56 +0100" MODIFIED_BY="Heather Maxwell" NAME="Juvonen 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-07-24 11:24:56 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Juvonen P, Mansson M, Andersson C, Jakobsson I</AU>
<TI>Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three-year prospective follow-up</TI>
<SO>Acta Paediatrica</SO>
<YR>1996</YR>
<VL>85</VL>
<NO>9</NO>
<PG>1047-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4359207"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4359206"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kearney-1990" MODIFIED="2016-08-08 12:24:32 +0100" MODIFIED_BY="[Empty name]" NAME="Kearney 1990" YEAR="1990">
<REFERENCE MODIFIED="2016-08-08 12:24:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kearney MH, Cronenwett LR, Barrett JA</AU>
<TI>Breast-feeding problems in the first week postpartum</TI>
<SO>Nursing Research</SO>
<YR>1990</YR>
<VL>39</VL>
<PG>90-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971801"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971800"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kimani_x002d_Murage-2013" MODIFIED="2016-03-18 18:29:07 +0000" MODIFIED_BY="[Empty name]" NAME="Kimani-Murage 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-03-18 18:29:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kimani-Murage EW, Kyobutungi C, Ezeh AC, Wekesah F, Wanjohi M, Muriuki P, et al</AU>
<TI>Effectiveness of personalised, home-based nutritional counselling on infant feeding practices, morbidity and nutritional outcomes among infants in Nairobi slums: study protocol for a cluster randomised controlled trial</TI>
<SO>Trials [Electronic Resource]</SO>
<YR>2013</YR>
<VL>14</VL>
<PG>445</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971803"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971802"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krebs-2013" MODIFIED="2014-03-27 18:07:09 +0000" MODIFIED_BY="Genevieve E Becker" NAME="Krebs 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-27 18:07:09 +0000" MODIFIED_BY="Genevieve E Becker" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krebs NF, Sherlock LG, Westcott J, Culbertson D, Hambidge KM, Feazel LM, et al</AU>
<TI>Effects of different complementary feeding regimens on iron status and enteric microbiota in breastfed infants</TI>
<SO>Journal of Pediatrics</SO>
<YR>2013</YR>
<VL>163</VL>
<NO>2</NO>
<PG>416-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971805"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971804"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ly-2006" MODIFIED="2016-08-08 12:24:45 +0100" MODIFIED_BY="[Empty name]" NAME="Ly 2006" YEAR="2006">
<REFERENCE MODIFIED="2016-08-08 12:24:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ly CT, Diallo A, Simondon F, Simondon KB</AU>
<TI>Early short-term infant food supplementation, maternal weight loss and duration of breast-feeding: a randomised controlled trial in rural Senegal</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>60</VL>
<NO>2</NO>
<PG>265-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971807"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971806"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marinelli-2001" MODIFIED="2016-08-08 12:24:49 +0100" MODIFIED_BY="[Empty name]" NAME="Marinelli 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-08-08 12:24:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marinelli KA, Burke GS, Dodd VL</AU>
<TI>A comparison of the safety of cup feedings and bottle feedings in premature infants whose mothers intend to breastfeed</TI>
<SO>Journal of Perinatology</SO>
<YR>2001</YR>
<VL>21</VL>
<PG>350-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971809"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971808"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mosley-2001" MODIFIED="2016-08-08 12:24:52 +0100" MODIFIED_BY="[Empty name]" NAME="Mosley 2001" YEAR="2001">
<REFERENCE MODIFIED="2016-08-08 12:24:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mosley C, Whittle C, Hicks C</AU>
<TI>A pilot study to assess the viability of a randomised controlled trial of methods of supplementary feeding of breast-fed pre-term babies</TI>
<SO>Midwifery</SO>
<YR>2001</YR>
<VL>17</VL>
<PG>150-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971811"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971810"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olaya-2013" MODIFIED="2014-03-27 18:10:36 +0000" MODIFIED_BY="Genevieve E Becker" NAME="Olaya 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-27 18:10:36 +0000" MODIFIED_BY="Genevieve E Becker" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olaya A, Lawson M, Fewtrell S</AU>
<TI>Efficacy and safety of new complementary feeding guidelines with an emphasis on red meat consumption: a randomized trial in Bogota, Colombia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2013</YR>
<VL>98</VL>
<NO>4</NO>
<PG>983-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971815"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971814"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosegger-1985" MODIFIED="2016-08-08 12:27:41 +0100" MODIFIED_BY="[Empty name]" NAME="Rosegger 1985" YEAR="1985">
<REFERENCE MODIFIED="2016-08-08 12:27:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosegger H, Purstner P</AU>
<TI>Supplementation with fully adapted milk substitute or calorie-free tea in the first days of life. Effect on drinking behavior and some measurements in mature healthy newborns</TI>
<TO>Zufutterung von volladaptierter Kunstmilch oder kalorienlosem Tee in den ersten Lebenstagen. Effekt auf das Trinkverhalten und einige Messwerte beim reifen gesunden Neugeborenen.</TO>
<SO>Wiener Klinische Wochenschrift</SO>
<YR>1985</YR>
<VL>97</VL>
<PG>411-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971817"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971816"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosegger-1986" MODIFIED="2016-08-08 12:27:45 +0100" MODIFIED_BY="[Empty name]" NAME="Rosegger 1986" YEAR="1986">
<REFERENCE MODIFIED="2016-08-08 12:27:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosegger H</AU>
<TI>Supplementation of 13% maltodextrine-solution vs fully adapted formula during the first four days of life: influence on some characteristics observed and measured in mature breast fed infants</TI>
<SO>Wiener Klinische Wochenschrift</SO>
<YR>1986</YR>
<VL>98</VL>
<PG>310-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971819"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971818"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saarinen-1999" MODIFIED="2016-07-24 11:29:47 +0100" MODIFIED_BY="Heather Maxwell" NAME="Saarinen 1999" YEAR="1999">
<REFERENCE MODIFIED="2016-07-24 11:29:47 +0100" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saarinen KM, Juntunen-Backman K, Järvenpää AL, Kuitunen P, Lope L, Renlund M, et al</AU>
<TI>Supplementary feeding in maternity hospitals and the risk of cow&#8217;s milk allergy: A prospective study of 6209 infants</TI>
<SO>Journal of Allergy and Clinical Immunology</SO>
<YR>1999</YR>
<VL>104</VL>
<NO>2 Pt 1</NO>
<PG>457-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971821"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971820"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sachdev-1991" MODIFIED="2016-08-08 12:27:51 +0100" MODIFIED_BY="[Empty name]" NAME="Sachdev 1991" YEAR="1991">
<REFERENCE MODIFIED="2016-08-08 12:27:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sachdev HPS, Krishna J, Puri RK, Satyanarayana L, Kumar S</AU>
<TI>Water supplementation in exclusively breastfed infants during summer in the tropics</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>337</VL>
<PG>929-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971823"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971822"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schiess-2010" MODIFIED="2014-04-29 23:09:30 +0100" MODIFIED_BY="[Empty name]" NAME="Schiess 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-04-29 23:09:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schiess SA, Grote V, Scaglioni S, Luque V, Martin F, Stolarczyk A, et al</AU>
<TI>Intake of energy providing liquids during the first year of life in five European countries</TI>
<SO>Clinical Nutrition</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>726-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971825"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971824"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmitz-1992" MODIFIED="2016-08-08 12:27:56 +0100" MODIFIED_BY="[Empty name]" NAME="Schmitz 1992" YEAR="1992">
<REFERENCE MODIFIED="2016-08-08 12:27:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmitz J, Digeon B, Chastang C, Dupouy D, Leroux B, Robillard P, et al</AU>
<TI>Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins</TI>
<SO>Journal of Pediatrics</SO>
<YR>1992</YR>
<VL>121</VL>
<PG>s85-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971827"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971826"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schubiger-1997" MODIFIED="2016-08-08 12:28:06 +0100" MODIFIED_BY="[Empty name]" NAME="Schubiger 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-01-04 22:27:38 +0000" MODIFIED_BY="Tracey Remmington" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kind C, Schubiger G, Schwarz U, Tonz O</AU>
<TI>Provision of supplementary fluids to breast fed infants and later breast feeding success</TI>
<SO>Advances in Experimental Medicine &amp; Biology</SO>
<YR>2000</YR>
<VL>478</VL>
<PG>347-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971829"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-08 12:28:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schubiger G, Schwarz U, Tonz O</AU>
<TI>UNICEF/WHO baby-friendly hospital initiative: Does the use of bottles and pacifiers in the neonatal nursery prevent successful breastfeeding?</TI>
<SO>European Journal of Pediatrics</SO>
<YR>1997</YR>
<VL>156</VL>
<PG>874-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971830"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971828"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simondon-1996" MODIFIED="2016-08-08 12:28:10 +0100" MODIFIED_BY="[Empty name]" NAME="Simondon 1996" YEAR="1996">
<REFERENCE MODIFIED="2016-08-08 12:28:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simondon KB, Gartner A, Berger J, Cornu A, Massamba JP, San Miguel JL, et al</AU>
<TI>Effect of early, short-term supplementation on weight and linear growth of 4-7-mo-old infants in developing countries: a four-country randomized trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1996</YR>
<VL>64</VL>
<NO>4</NO>
<PG>537-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971832"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971831"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ziegler-2011" MODIFIED="2014-02-24 20:24:42 +0000" MODIFIED_BY="Genevieve E Becker" NAME="Ziegler 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-02-24 20:24:42 +0000" MODIFIED_BY="Genevieve E Becker" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ziegler EE, Fomon SJ, Nelson SE, Jeter JM, Theuer RC</AU>
<TI>Dry cereals fortified with electrolytic iron or ferrous fumarate are equally effective in breast-fed infants</TI>
<SO>Journal of Nutrition</SO>
<YR>2011</YR>
<VL>141</VL>
<NO>2</NO>
<PG>243-8</PG>
<EN>NCT00841061</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2971834"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2971833"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-05-14 19:00:57 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2016-08-08 14:36:57 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Flaherman-2014" MODIFIED="2016-08-08 14:36:57 +0100" MODIFIED_BY="[Empty name]" NAME="Flaherman 2014" YEAR="2015">
<REFERENCE MODIFIED="2016-08-08 14:36:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02313181</AU>
<TI>Early limited formula for treating lactation concerns</TI>
<SO>clinicaltrials.gov/ct2/show/NCT02313181</SO>
<YR>Date first received: 5 December 2014</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4359209"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-07-14 23:45:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4359208"/><IDENTIFIER MODIFIED="2016-07-14 23:45:53 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT02313181"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kair-2014" MODIFIED="2016-08-08 14:36:38 +0100" MODIFIED_BY="[Empty name]" NAME="Kair 2014" YEAR="1167">
<REFERENCE MODIFIED="2016-08-08 14:10:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02221167</AU>
<TI>Rx Milk study of donor milk supplementation to improve breastfeeding outcomes</TI>
<SO>clinicaltrials.gov/ct2/show/NCT02221167</SO>
<YR>Date first received: 18 August 2014</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4359211"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-07-14 23:46:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4359210"/><IDENTIFIER MODIFIED="2016-07-14 23:46:10 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT02221167"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-08-30 13:00:42 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2016-08-30 13:00:42 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-2012" MODIFIED="2014-02-24 21:34:19 +0000" MODIFIED_BY="Genevieve E Becker" NAME="AAP 2012" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics</AU>
<TI>Policy Statement: breastfeeding and the use of human milk</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>129</VL>
<PG>e827-e841</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ABM-2009" MODIFIED="2011-10-14 11:46:32 +0100" MODIFIED_BY="Jill Hampson" NAME="ABM 2009" TYPE="OTHER">
<AU>Academy of Breastfeeding Medicine Protocol Committee</AU>
<TI>Clinical Protocol Number 3: hospital guidelines for the use of supplementary feedings in the healthy, term breastfed neonate</TI>
<SO>www.bfmed.org/Resources/Protocols.aspx</SO>
<YR>(accessed 2011)</YR>
<IDENTIFIERS MODIFIED="2010-11-16 15:07:56 +0000" MODIFIED_BY="Jill Hampson"/>
</REFERENCE>
<REFERENCE ID="REF-ABM-2011" MODIFIED="2014-11-05 10:45:13 +0000" MODIFIED_BY="[Empty name]" NAME="ABM 2011" TYPE="JOURNAL_ARTICLE">
<AU>Academy of Breastfeeding Medicine Protocol Committee</AU>
<TI>Educational objectives and skills for the physician with respect to breastfeeding</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>2</NO>
<PG>99-105</PG>
<IDENTIFIERS MODIFIED="2014-08-05 17:17:21 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-ABM-2014" MODIFIED="2014-11-05 10:46:35 +0000" MODIFIED_BY="[Empty name]" NAME="ABM 2014" TYPE="JOURNAL_ARTICLE">
<AU>Wight N, Marinelli KA, and The Academy of Breastfeeding Medicine</AU>
<TI>ABM clinical protocol #1: guidelines for blood glucose monitoring and treatment of hypoglycemia in term and late-preterm neonates, revised 2014</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2014</YR>
<VL>9</VL>
<NO>4</NO>
<PG>173-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Akuse-2002" MODIFIED="2010-08-29 20:47:37 +0100" MODIFIED_BY="[Empty name]" NAME="Akuse 2002" TYPE="JOURNAL_ARTICLE">
<AU>Akuse RM, Obinya EA</AU>
<TI>Why healthcare workers give prelacteal feeds</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>56</VL>
<NO>8</NO>
<PG>729-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Almroth-1990" MODIFIED="2010-11-17 10:34:31 +0000" MODIFIED_BY="Jill Hampson" NAME="Almroth 1990" TYPE="JOURNAL_ARTICLE">
<AU>Almroth S, Bidinger PD</AU>
<TI>No need for water supplementation for exclusively breast-fed infants under hot and arid conditions</TI>
<SO>Transactions of the Royal Society of Tropical Medicine and Hygiene</SO>
<YR>1990</YR>
<VL>84</VL>
<NO>4</NO>
<PG>602-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Amato-1985" MODIFIED="2011-09-29 22:29:31 +0100" MODIFIED_BY="Jill Hampson" NAME="Amato 1985" TYPE="JOURNAL_ARTICLE">
<AU>Amato M, Howald H, Von Muralt G</AU>
<TI>Interruption of breast-feeding versus phototherapy as treatment of hyperbilirubinemia in full term infants</TI>
<SO>Helvetica Paediatrica Acta</SO>
<YR>1985</YR>
<VL>40</VL>
<NO>2-3</NO>
<PG>127-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arifeen-2001" MODIFIED="2014-11-14 11:41:00 +0000" MODIFIED_BY="Heather Maxwell" NAME="Arifeen 2001" TYPE="JOURNAL_ARTICLE">
<AU>Arifeen S, Black RE, Antelman G, Gaqui A, Caulfield L, Becker S</AU>
<TI>Exclusive breastfeeding reduces acute respiratory disease and diarrhoea deaths among infants in Dhaka slums</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>108</VL>
<NO>4</NO>
<PG>E67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bai-2009" MODIFIED="2014-11-14 11:42:36 +0000" MODIFIED_BY="Heather Maxwell" NAME="Bai 2009" TYPE="JOURNAL_ARTICLE">
<AU>Bai YK, Middlestadt SE, Joanne Peng CY, Fly AD</AU>
<TI>Psychosocial factors underlying the mothers decision to continue exclusive breastfeeding for 6 months: an elicitation study</TI>
<SO>Journal of Human Nutrition and Dietetics</SO>
<YR>2009</YR>
<VL>22</VL>
<NO>2</NO>
<PG>134-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ballard-2013" MODIFIED="2014-11-05 10:47:05 +0000" MODIFIED_BY="[Empty name]" NAME="Ballard 2013" TYPE="JOURNAL_ARTICLE">
<AU>Ballard O, Morrow AL</AU>
<TI>Human milk composition: nutrients and bioactive factors</TI>
<SO>Pediatric Clinics of North America</SO>
<YR>2013</YR>
<VL>60</VL>
<PG>49-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Biro-2011" MODIFIED="2014-03-27 10:18:49 +0000" MODIFIED_BY="[Empty name]" NAME="Biro 2011" TYPE="JOURNAL_ARTICLE">
<AU>Biro MA, Sutherland GA, Yelland JS, Hardy P, Brown SJ</AU>
<TI>In-hospital formula supplementation of breastfed babies: a population based study</TI>
<SO>Birth</SO>
<YR>2011</YR>
<VL>38</VL>
<NO>4</NO>
<PG>302-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Black-2013" MODIFIED="2014-04-30 21:56:33 +0100" MODIFIED_BY="[Empty name]" NAME="Black 2013" TYPE="JOURNAL_ARTICLE">
<AU>Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis P, et al</AU>
<TI>Maternal and child under nutrition and overweight in low-income and middle-income countries</TI>
<SO>Lancet</SO>
<YR>2013</YR>
<VL>382</VL>
<PG>427-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blomquist-1994" MODIFIED="2010-08-24 21:59:52 +0100" MODIFIED_BY="[Empty name]" NAME="Blomquist 1994" TYPE="JOURNAL_ARTICLE">
<AU>Blomquist HK, Jonsbo F, Serenius F, Persson LA</AU>
<TI>Supplementary feeding in the maternity ward shortens the duration of breastfeeding</TI>
<SO>Acta Paediatrica</SO>
<YR>1994</YR>
<VL>83</VL>
<NO>11</NO>
<PG>1122-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blyth-2004" MODIFIED="2011-09-29 22:29:53 +0100" MODIFIED_BY="Jill Hampson" NAME="Blyth 2004" TYPE="JOURNAL_ARTICLE">
<AU>Blyth R, Creedy D, Dennis CL, Moyle W, Pratt J, DeVries S</AU>
<TI>Effect of maternal confidence on breastfeeding duration: an application of breastfeeding self-efficacy theory</TI>
<SO>Birth</SO>
<YR>2004</YR>
<VL>29</VL>
<NO>4</NO>
<PG>278-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boyle-2016" MODIFIED="2016-07-24 11:37:53 +0100" MODIFIED_BY="Heather Maxwell" NAME="Boyle 2016" TYPE="JOURNAL_ARTICLE">
<AU>Boyle RJ, Ierodiakonou D, Khan T, Chivinge J, Robinson Z, Geoghegan N, et al</AU>
<TI>Hydrolysed formula and risk of allergic or autoimmune disease:systematic review and meta-analysis</TI>
<SO>BMJ</SO>
<YR>2016</YR>
<VL>352</VL>
<PG>i974</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brodribb-2008" MODIFIED="2014-11-05 10:47:27 +0000" MODIFIED_BY="[Empty name]" NAME="Brodribb 2008" TYPE="JOURNAL_ARTICLE">
<AU>Brodribb W</AU>
<TI>Breastfeeding and Australian GP registrars &#8211; their knowledge and attitudes</TI>
<SO>Journal of Human Lactation</SO>
<YR>2008</YR>
<VL>24</VL>
<PG>422-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brodribb-2011" MODIFIED="2014-11-05 10:47:45 +0000" MODIFIED_BY="[Empty name]" NAME="Brodribb 2011" TYPE="JOURNAL_ARTICLE">
<AU>Brodribb W</AU>
<TI>Barriers to translating evidence-based breastfeeding information into practice</TI>
<SO>Acta Paediatrica</SO>
<YR>2011</YR>
<VL>100</VL>
<PG>486-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-1989" MODIFIED="2011-09-29 22:30:06 +0100" MODIFIED_BY="[Empty name]" NAME="Brown 1989" TYPE="JOURNAL_ARTICLE">
<AU>Brown K, Black R, DeRomana GL, DeKanashiro HC</AU>
<TI>Infant feeding practices and their relationship with diarrhoeal and other diseases in Huascar (Lima) Peru</TI>
<SO>Pediatrics</SO>
<YR>1989</YR>
<VL>83</VL>
<NO>1</NO>
<PG>31-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chantry-2006" MODIFIED="2010-08-29 20:58:40 +0100" MODIFIED_BY="[Empty name]" NAME="Chantry 2006" TYPE="JOURNAL_ARTICLE">
<AU>Chantry C, Howard C, Auinger P</AU>
<TI>Full breastfeeding duration and associated decrease in respiratory tract infection in US children</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>117</VL>
<NO>2</NO>
<PG>425-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chantry-2014" MODIFIED="2014-04-04 14:27:02 +0100" MODIFIED_BY="[Empty name]" NAME="Chantry 2014" TYPE="OTHER">
<AU>Chantry CJ, Dewey KG, Peerson MS, Wagner EA, Nommsen-Rivers LA</AU>
<TI>In-hospital formula use increases early breastfeeding cessation among first-time mothers intending to exclusively breastfeed</TI>
<SO>Journal of Pediatrics</SO>
<YR>2014 [online ahead of print]</YR>
<IDENTIFIERS MODIFIED="2014-03-09 11:51:56 +0000" MODIFIED_BY="Genevieve E Becker"/>
</REFERENCE>
<REFERENCE ID="REF-Chen-2004" MODIFIED="2010-08-29 20:58:48 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Chen A, Rogan WJ</AU>
<TI>Breastfeeding and the risk of postneonatal death in the United States</TI>
<SO>Pediatrics</SO>
<YR>2004</YR>
<VL>113</VL>
<NO>5</NO>
<PG>e435-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chezem-1998" MODIFIED="2010-11-17 10:33:54 +0000" MODIFIED_BY="Jill Hampson" NAME="Chezem 1998" TYPE="JOURNAL_ARTICLE">
<AU>Chezem J, Friesen C, Montgomery P, Fortman T, Clark H</AU>
<TI>Lactation duration: influences of human milk replacements and formula samples on women planning postpartum employment</TI>
<SO>Journal of Obstetric, Gynecologic, &amp; Neonatal Nursing</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>6</NO>
<PG>646-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cloherty-2004" NAME="Cloherty 2004" TYPE="JOURNAL_ARTICLE">
<AU>Cloherty M, Alexander J, Holloway I</AU>
<TI>Supplementing breast fed babies in the UK to protect their mothers from tiredness or distress</TI>
<SO>Midwifery</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>2</NO>
<PG>194-204</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1999" MODIFIED="2014-11-14 11:45:48 +0000" MODIFIED_BY="Heather Maxwell" NAME="Cohen 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cohen RJ, Brown KH, Rivera LL, Dewey KG</AU>
<TI>Promoting exclusive breastfeeding for 4-6 months in Honduras: attitudes of mothers and barriers to compliance</TI>
<SO>Journal of Human Lactation</SO>
<YR>1999</YR>
<VL>15</VL>
<PG>9-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DaMota-2012" MODIFIED="2014-03-27 10:19:47 +0000" MODIFIED_BY="[Empty name]" NAME="DaMota 2012" TYPE="JOURNAL_ARTICLE">
<AU>DaMota K, Bañuelos J, Goldbronn J, Vera-Beccera LE, Heinig MJ</AU>
<TI>Maternal for in-hospital supplementation of healthy breastfed infants among low-income women</TI>
<SO>Journal of Human Lactation</SO>
<YR>2012</YR>
<VL>28</VL>
<PG>476-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davies_x002d_Adetugbo-1997" MODIFIED="2010-11-17 10:36:29 +0000" MODIFIED_BY="Jill Hampson" NAME="Davies-Adetugbo 1997" TYPE="JOURNAL_ARTICLE">
<AU>Davies-Adetugbo AA, Adetugbo K, Orewole Y, Fabiyi AK</AU>
<TI>Breast-feeding promotion in a diarrhoea programme in rural communities</TI>
<SO>Journal of Diarrhoeal Disease Research</SO>
<YR>1997</YR>
<VL>15</VL>
<NO>3</NO>
<PG>161-6</PG>
<IDENTIFIERS MODIFIED="2010-11-17 10:36:29 +0000" MODIFIED_BY="Jill Hampson"/>
</REFERENCE>
<REFERENCE ID="REF-De-Onis-2004" MODIFIED="2014-04-30 21:56:02 +0100" MODIFIED_BY="[Empty name]" NAME="De Onis 2004" TYPE="JOURNAL_ARTICLE">
<AU>De Onis M, Garza C, Victora CG, Onyango AW, Frongillo EA, Martines J, et al</AU>
<TI>The WHO Multicentre Growth Reference Study: planning, study design and methodology</TI>
<SO>Food and Nutrition Bulletin</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>Suppl 1</NO>
<PG>S15-S26</PG>
<IDENTIFIERS MODIFIED="2010-11-17 10:36:38 +0000" MODIFIED_BY="Jill Hampson"/>
</REFERENCE>
<REFERENCE ID="REF-Feachem-1984" MODIFIED="2010-08-29 21:02:39 +0100" MODIFIED_BY="[Empty name]" NAME="Feachem 1984" TYPE="JOURNAL_ARTICLE">
<AU>Feachem R, Koblinsky M</AU>
<TI>Interventions for the control of diarrhoeal disease among young children: promotion of breastfeeding</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>1984</YR>
<VL>62</VL>
<NO>2</NO>
<PG>271-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furber-2006" MODIFIED="2010-08-29 21:04:20 +0100" MODIFIED_BY="[Empty name]" NAME="Furber 2006" TYPE="JOURNAL_ARTICLE">
<AU>Furber C, Thompson A</AU>
<TI>'Breaking the rules' in baby-feeding practice in the UK: deviance and good practice?</TI>
<SO>Midwifery</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>4</NO>
<PG>365-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Furman-2013" MODIFIED="2014-04-04 14:27:41 +0100" MODIFIED_BY="[Empty name]" NAME="Furman 2013" TYPE="JOURNAL_ARTICLE">
<AU>Furman L</AU>
<TI>Early limited formula Is not ready for prime time</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>131</VL>
<NO>6</NO>
<PG>1182-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gagnon-2005" MODIFIED="2010-11-17 10:32:10 +0000" MODIFIED_BY="Jill Hampson" NAME="Gagnon 2005" TYPE="JOURNAL_ARTICLE">
<AU>Gagnon A, Leduc G, Waghorn K, Yang H, Platt R</AU>
<TI>In-hospital formula supplementation of healthy breastfeeding newborns</TI>
<SO>Journal of Human Lactation</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>4</NO>
<PG>397-405</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gielen-1991" MODIFIED="2010-11-17 10:32:37 +0000" MODIFIED_BY="Jill Hampson" NAME="Gielen 1991" TYPE="JOURNAL_ARTICLE">
<AU>Gielen A, Faden R, O'Campo P, Brown C, Paige D</AU>
<TI>Maternal employment during the early postpartum period: effects on initiation and continuation of breast-feeding</TI>
<SO>Pediatrics</SO>
<YR>1991</YR>
<VL>87</VL>
<NO>3</NO>
<PG>298-305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giovannini-2005" MODIFIED="2010-11-16 12:43:34 +0000" MODIFIED_BY="Genevieve E Becker" NAME="Giovannini 2005" TYPE="JOURNAL_ARTICLE">
<AU>Giovannini M, Riva E, Banderali G, Salvioni M, Radaelli G, Agostoni C</AU>
<TI>Exclusive versus predominant breastfeeding in Italian maternity wards and feeding practices through the first year of life</TI>
<SO>Journal of Human Lactation</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>3</NO>
<PG>259-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glover-1990" NAME="Glover 1990" TYPE="JOURNAL_ARTICLE">
<AU>Glover J, Sandilands M</AU>
<TI>Supplementation of breastfeeding infants and weight loss in hospital</TI>
<SO>Journal of Human Lactation</SO>
<YR>1990</YR>
<VL>6</VL>
<NO>4</NO>
<PG>163-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Graffy-1992" MODIFIED="2010-08-24 21:47:18 +0100" MODIFIED_BY="[Empty name]" NAME="Graffy 1992" TYPE="JOURNAL_ARTICLE">
<AU>Graffy J</AU>
<TI>Mothers' attitudes to and experience of breast feeding: a primary care study</TI>
<SO>British Journal of General Practice</SO>
<YR>1992</YR>
<VL>42</VL>
<NO>355</NO>
<PG>61-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heinig-1993" MODIFIED="2010-08-29 21:06:55 +0100" MODIFIED_BY="[Empty name]" NAME="Heinig 1993" TYPE="JOURNAL_ARTICLE">
<AU>Heinig MJ, Nommsen LA, Peerson JM, Lonnerdal B, Dewey KG</AU>
<TI>Intake and growth of breast-fed and formula-fed infants in relation to the timing of introduction of complementary foods: the DARLING study</TI>
<SO>Acta Paediatrica</SO>
<YR>1993</YR>
<VL>82</VL>
<NO>12</NO>
<PG>999-1006</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-04-01 13:43:07 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hoddinott-1999" MODIFIED="2010-08-24 22:52:49 +0100" MODIFIED_BY="[Empty name]" NAME="Hoddinott 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hoddinott P, Pill R</AU>
<TI>Nobody actually tells you: a study of infant feeding</TI>
<SO>British Journal of Midwifery</SO>
<YR>1999</YR>
<VL>7</VL>
<NO>9</NO>
<PG>558-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horman-2010" MODIFIED="2014-09-05 13:53:16 +0100" MODIFIED_BY="[Empty name]" NAME="Horman 2010" TYPE="JOURNAL_ARTICLE">
<AU>Hormann E</AU>
<TI>Reducing the risk for formula-fed infants: examining the guidelines</TI>
<SO>Birth</SO>
<YR>2010</YR>
<VL>37</VL>
<NO>1</NO>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hornell-2001" MODIFIED="2010-11-17 10:53:22 +0000" MODIFIED_BY="Jill Hampson" NAME="Hornell 2001" TYPE="JOURNAL_ARTICLE">
<AU>Hornell A, Hofvander Y, Kylberg E</AU>
<TI>Solids and formula: association with pattern and duration of breastfeeding</TI>
<SO>Pediatrics</SO>
<YR>2001</YR>
<VL>107</VL>
<NO>3</NO>
<PG>e38</PG>
<IDENTIFIERS MODIFIED="2010-11-17 10:53:22 +0000" MODIFIED_BY="Jill Hampson"/>
</REFERENCE>
<REFERENCE ID="REF-Horta-2007" MODIFIED="2010-11-17 10:58:17 +0000" MODIFIED_BY="Jill Hampson" NAME="Horta 2007" TYPE="OTHER">
<AU>Horta BL, Bahl R, Martines JC, Victora CG</AU>
<TI>Evidence on the long-term effects of breastfeeding: systematic reviews and meta-analysis</TI>
<SO>World Health Organization</SO>
<YR>2007</YR>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horta-2013a" MODIFIED="2016-07-24 11:46:25 +0100" MODIFIED_BY="Heather Maxwell" NAME="Horta 2013a" TYPE="OTHER">
<AU>Horta BL, Victora CG</AU>
<TI>Long-term effects of breastfeeding: a systematic review</TI>
<SO>Department of Maternal Newborn Child and Adolescent Health, World Health Organization, Geneva</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Horta-2013b" MODIFIED="2016-07-24 11:46:49 +0100" MODIFIED_BY="Heather Maxwell" NAME="Horta 2013b" TYPE="OTHER">
<AU>Horta BL, Victora CG</AU>
<TI>Short-term effects of breastfeeding: a systematic review on the benefits of breastfeeding on diarrhoea and pneumonia mortality</TI>
<SO>Department of Maternal Newborn Child and Adolescent Health, World Health Organization, Geneva</SO>
<YR>2013</YR>
<IDENTIFIERS MODIFIED="2014-04-29 23:25:33 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Houston-1984" MODIFIED="2010-08-29 21:14:19 +0100" MODIFIED_BY="[Empty name]" NAME="Houston 1984" TYPE="JOURNAL_ARTICLE">
<AU>Houston MJ, Howie PW, McNeilly AS</AU>
<TI>The effect of extra fluid intake by breast fed babies in hospital on the duration of breastfeeding</TI>
<SO>Journal of Reproductive and Infant Psychology</SO>
<YR>1984</YR>
<VL>2</VL>
<NO>1</NO>
<PG>42-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ip-2007" MODIFIED="2010-12-03 10:22:53 +0000" MODIFIED_BY="Lynn Hampson" NAME="Ip 2007" TYPE="BOOK_SECTION">
<AU>Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al</AU>
<TI>Breastfeeding and maternal and infant health outcomes in developed countries</TI>
<SO>Evidence Report/Technology Assessment No. 153 (Prepared by Tufts-New England Medical Center Evidence-based Practice Center, under Contract No. 290-02-0022)</SO>
<YR>2007</YR>
<VL>AHRQ Publication No. 07-E007</VL>
<PB>Agency for Healthcare Research and Quality</PB>
<CY>Rockville, MD</CY>
<IDENTIFIERS MODIFIED="2010-08-24 17:30:20 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Jones-2003" MODIFIED="2014-04-30 22:00:27 +0100" MODIFIED_BY="[Empty name]" NAME="Jones 2003" TYPE="JOURNAL_ARTICLE">
<AU>Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, Bellagio Child Survival Study Group</AU>
<TI>How many child deaths can we prevent this year?</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>362</VL>
<NO>9377</NO>
<PG>65-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kramer-2003" MODIFIED="2010-08-29 21:17:20 +0100" MODIFIED_BY="[Empty name]" NAME="Kramer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Kramer M, Guo T, Platt R, Sevkovskaya Z, Dzikovich I, Collet JP, et al</AU>
<TI>Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>78</VL>
<NO>2</NO>
<PG>291-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kramer-2012" MODIFIED="2016-06-27 21:06:45 +0100" MODIFIED_BY="[Empty name]" NAME="Kramer 2012" TYPE="COCHRANE_REVIEW">
<AU>Kramer M, Kakuma R</AU>
<TI>Optimal duration of exclusive breastfeeding</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>8</NO>
<IDENTIFIERS MODIFIED="2010-11-17 10:47:27 +0000" MODIFIED_BY="Jill Hampson"><IDENTIFIER MODIFIED="2010-11-17 10:47:27 +0000" MODIFIED_BY="Jill Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD003517"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kurinij-1991" NAME="Kurinij 1991" TYPE="JOURNAL_ARTICLE">
<AU>Kurinij N, Shiono PH</AU>
<TI>Early formula supplementation of breast-feeding</TI>
<SO>Pediatrics</SO>
<YR>1991</YR>
<VL>88</VL>
<NO>4</NO>
<PG>745-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Labbok-2012" MODIFIED="2014-09-05 13:53:52 +0100" MODIFIED_BY="[Empty name]" NAME="Labbok 2012" TYPE="JOURNAL_ARTICLE">
<AU>Labbok M, Starling A</AU>
<TI>Definitions of breastfeeding: call for the development and use of consistent definitions in research and peer-reviewed literature</TI>
<SO>Breastfeeding Medicine</SO>
<YR>2012</YR>
<VL>7</VL>
<NO>6</NO>
<PG>397-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ladomenou-2007" MODIFIED="2010-11-17 10:56:26 +0000" MODIFIED_BY="Jill Hampson" NAME="Ladomenou 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ladomenou F, Kafatos A, Galanakis E</AU>
<TI>Risk factors related to intention to breastfeed, early weaning and suboptimal duration of breastfeeding</TI>
<SO>Acta Paediatrica</SO>
<YR>2007</YR>
<VL>96</VL>
<NO>10</NO>
<PG>1441-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leon_x002d_Cava-2002" MODIFIED="2014-11-14 11:52:03 +0000" MODIFIED_BY="Heather Maxwell" NAME="Leon-Cava 2002" TYPE="OTHER">
<AU>Leon-Cava N, Lutter C, Ross J, Martin L</AU>
<TI>Quantifying the benefits of breastfeeding: a summary of the evidence</TI>
<SO>Pan American Health Organization, Washington DC</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McNiel-2010" MODIFIED="2014-09-05 13:54:04 +0100" MODIFIED_BY="[Empty name]" NAME="McNiel 2010" TYPE="JOURNAL_ARTICLE">
<AU>McNiel ME, Labbok MH, Abrahams SW</AU>
<TI>What are the risks associated with formula feeding? A re-analysis and review</TI>
<SO>Birth</SO>
<YR>2010</YR>
<VL>37</VL>
<NO>1</NO>
<PG>50-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Merewood-2013" MODIFIED="2014-04-30 21:51:04 +0100" MODIFIED_BY="[Empty name]" NAME="Merewood 2013" TYPE="JOURNAL_ARTICLE">
<AU>Merewood A</AU>
<TI>Of elves and ethics: first, do no harm</TI>
<SO>Journal of Human Lactation</SO>
<YR>2013</YR>
<VL>29</VL>
<NO>4</NO>
<PG>443</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mulford-1995" MODIFIED="2014-09-05 13:56:10 +0100" MODIFIED_BY="[Empty name]" NAME="Mulford 1995" TYPE="JOURNAL_ARTICLE">
<AU>Mulford C</AU>
<TI>Swimming upstream: breastfeeding care in a non-breastfeedtng culture</TI>
<SO>Journal of Obstetric, Gynecologic, and Neonatal Nursing</SO>
<YR>1995</YR>
<VL>24</VL>
<PG>464-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Noel_x002d_Weiss-2006" MODIFIED="2010-11-17 10:54:00 +0000" MODIFIED_BY="Jill Hampson" NAME="Noel-Weiss 2006" TYPE="JOURNAL_ARTICLE">
<AU>Noel-Weiss J, Rupp A, Cragg B, Bassett V, Woodend K</AU>
<TI>Randomized controlled trial to determine effects of prenatal breastfeeding workshop on maternal breastfeeding self-efficacy and breastfeeding duration</TI>
<SO>Journal of Obstetric, Gynecologic, &amp; Neonatal Nursing</SO>
<YR>2006</YR>
<VL>35</VL>
<NO>5</NO>
<PG>616-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Osborn-1985" MODIFIED="2010-08-29 21:19:02 +0100" MODIFIED_BY="[Empty name]" NAME="Osborn 1985" TYPE="JOURNAL_ARTICLE">
<AU>Osborn LM, Bolus R</AU>
<TI>Breast feeding and jaundice in the first week of life</TI>
<SO>Journal of Family Practice</SO>
<YR>1985</YR>
<VL>20</VL>
<NO>5</NO>
<PG>475-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Quigley-2007" MODIFIED="2014-04-30 21:51:19 +0100" MODIFIED_BY="[Empty name]" NAME="Quigley 2007" TYPE="JOURNAL_ARTICLE">
<AU>Quigley MA, Kelly YJ, Sacker A</AU>
<TI>Breastfeeding and hospitalisation for diarrheal and respiratory infection in the United Kingdom Millenium Cohort Study</TI>
<SO>Pediatrics</SO>
<YR>2007</YR>
<VL>119</VL>
<NO>4</NO>
<PG>E837-E842</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Renfrew-2007" MODIFIED="2014-09-05 13:56:24 +0100" MODIFIED_BY="[Empty name]" NAME="Renfrew 2007" TYPE="JOURNAL_ARTICLE">
<AU>Renfrew MJ, Spiby H, D'Souza L, Wallace LM, Dyson L, McCormick F</AU>
<TI>Rethinking research in breast-feeding: a critique of the evidence base identified in a systematic review of interventions to promote and support breast-feeding</TI>
<SO>Public Health Nutrition</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>7</NO>
<PG>726-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Renfrew-2008" MODIFIED="2014-09-05 13:56:38 +0100" MODIFIED_BY="[Empty name]" NAME="Renfrew 2008" TYPE="JOURNAL_ARTICLE">
<AU>Renfrew MJ, McLoughlin M, McFadden A</AU>
<TI>Cleaning and sterilisation of infant feeding equipment: a systematic review</TI>
<SO>Public Health Nutrition</SO>
<YR>2008</YR>
<VL>11</VL>
<PG>1188-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2014-09-21 11:48:48 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rollins-2016" MODIFIED="2016-07-24 11:52:27 +0100" MODIFIED_BY="Heather Maxwell" NAME="Rollins 2016" TYPE="JOURNAL_ARTICLE">
<AU>Rollins NC, Bhandari N, Hajeebhoy N, Horton S, Lutter CK, Martines JC, et al; Lancet Breastfeeding Series Group</AU>
<TI>Why invest, and what it will take to improve breastfeeding practices?</TI>
<SO>Lancet</SO>
<YR>2016</YR>
<VL>387</VL>
<PG>491&#8211;504</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sachs-2006" MODIFIED="2010-08-29 21:20:30 +0100" MODIFIED_BY="[Empty name]" NAME="Sachs 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sachs M, Dykes F, Carter B</AU>
<TI>Weight monitoring of breastfed babies in the United Kingdom - interpreting, explaining and intervening</TI>
<SO>Maternal and Child Nutrition</SO>
<YR>2006</YR>
<VL>2</VL>
<NO>1</NO>
<PG>3-18</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2013" MODIFIED="2014-05-02 14:12:36 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2013" TYPE="JOURNAL_ARTICLE">
<AU>Smith H, Murphy M</AU>
<TI>The dangers of only telling half the story</TI>
<SO>MIDIRS Midwifery Digest</SO>
<YR>2013</YR>
<VL>23</VL>
<NO>3</NO>
<PG>379-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stewart-2015" MODIFIED="2016-07-24 11:56:46 +0100" MODIFIED_BY="Heather Maxwell" NAME="Stewart 2015" TYPE="JOURNAL_ARTICLE">
<AU>Stewart CE,Sage ELM, Reynolds P</AU>
<TI>Supporting 'Baby Friendly': a quality improvement initiative for the management of transitional neonatal hypoglycaemia</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2015</YR>
<VL>Epub ahead of print</VL>
<PG>0-0</PG>
<IDENTIFIERS MODIFIED="2016-05-07 18:41:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-05-07 18:41:21 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/archdischild-2015-308950"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stuebe-2013" MODIFIED="2014-03-27 23:01:30 +0000" MODIFIED_BY="Genevieve E Becker" NAME="Stuebe 2013" TYPE="OTHER">
<AU>Steube A</AU>
<TI>Early, limited data for early, limited formula use</TI>
<SO>Academy of Breastfeeding Medicine blog</SO>
<YR>2013</YR>
<IDENTIFIERS MODIFIED="2014-03-27 23:01:30 +0000" MODIFIED_BY="Genevieve E Becker"><IDENTIFIER MODIFIED="2014-03-27 23:01:30 +0000" MODIFIED_BY="Genevieve E Becker" TYPE="OTHER" VALUE="http://bfmed.wordpress.com/2013/05/13/early-limited-data-for-early-limited-formula-use/"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Szajewska-2006" NAME="Szajewska 2006" TYPE="JOURNAL_ARTICLE">
<AU>Szajewska H, Horvath A, Koletzko B, Kalisz M</AU>
<TI>Effects of brief exposure to water, breast-milk substitutes, or other liquids on the success and duration of breastfeeding: a systematic review</TI>
<SO>Acta Paediatrica</SO>
<YR>2006</YR>
<VL>95</VL>
<NO>2</NO>
<PG>145-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Talayero-2006" MODIFIED="2014-11-14 11:56:06 +0000" MODIFIED_BY="Heather Maxwell" NAME="Talayero 2006" TYPE="JOURNAL_ARTICLE">
<AU>Talayero JMP, Lizan-Garcia M, Otero Puime A, Muncharaz MJB, Soto BB, Sanchez-Palomares M, et al</AU>
<TI>Full breastfeeding and hospitalization as a result of infections in the first year of life</TI>
<SO>Pediatrics</SO>
<YR>2006</YR>
<VL>188</VL>
<NO>1</NO>
<PG>e92-e99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thulier-2016" MODIFIED="2016-07-24 11:59:22 +0100" MODIFIED_BY="Heather Maxwell" NAME="Thulier 2016" TYPE="JOURNAL_ARTICLE">
<AU>Thulier D</AU>
<TI>Weighing the facts: a systematic review of expected patterns of weight loss in full-term, breastfed infants</TI>
<SO>Journal of Human Lactation</SO>
<YR>2016</YR>
<VL>32</VL>
<NO>1</NO>
<PG>28-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turin-2014" MODIFIED="2014-09-05 13:59:26 +0100" MODIFIED_BY="[Empty name]" NAME="Turin 2014" TYPE="JOURNAL_ARTICLE">
<AU>Turin CG, Ochoa TJ</AU>
<TI>The role of maternal breast milk in preventing infantile diarrhea in the developing world</TI>
<SO>Current Tropical Medicine Reports</SO>
<YR>2014</YR>
<VL>1</VL>
<NO>2</NO>
<PG>97-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNICEF_x002f_WHO-2009" MODIFIED="2010-12-03 10:25:32 +0000" MODIFIED_BY="Lynn Hampson" NAME="UNICEF/WHO 2009" TYPE="OTHER">
<AU>WHO UNICEF</AU>
<TI>Baby-friendly Hospital Initiative, revised, updated and expanded for integrated care</TI>
<SO>World Health Organization (http://www.who.int/nutrition/publications/infantfeeding/9789241594950/en/index.htm)</SO>
<YR>(accessed 2009)</YR>
<IDENTIFIERS MODIFIED="2010-12-03 10:25:32 +0000" MODIFIED_BY="Lynn Hampson"/>
</REFERENCE>
<REFERENCE ID="REF-Vail-2015" MODIFIED="2016-07-24 12:01:23 +0100" MODIFIED_BY="Heather Maxwell" NAME="Vail 2015" TYPE="JOURNAL_ARTICLE">
<AU>Vail B, Prentice P, Dunger DB, Hughes IA, Acerini CL, Ong KK</AU>
<TI>Age at weaning and infant growth: primary analysis and systematic review</TI>
<SO>Journal of Pediatrics</SO>
<YR>2015</YR>
<VL>167</VL>
<NO>2</NO>
<PG>317-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Victora-2016" MODIFIED="2016-07-24 12:04:26 +0100" MODIFIED_BY="Heather Maxwell" NAME="Victora 2016" TYPE="JOURNAL_ARTICLE">
<AU>Victora CG, Bahl R, Barros AJ, França GVA, Horton S, Krasevec J, et al; Lancet Breastfeeding Series Group</AU>
<TI>Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect</TI>
<SO>Lancet</SO>
<YR>2016</YR>
<VL>387</VL>
<NO>10017</NO>
<PG>475-490</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wagner-2013" MODIFIED="2014-03-27 10:20:07 +0000" MODIFIED_BY="[Empty name]" NAME="Wagner 2013" TYPE="JOURNAL_ARTICLE">
<AU>Wagner EA, Chantry CJ, Dewey KG, Nommsen-Rivers LA</AU>
<TI>Breastfeeding concerns at 3 and 7 days postpartum and feeding status at 2 months</TI>
<SO>Pediatrics</SO>
<YR>2013</YR>
<VL>132</VL>
<NO>4</NO>
<PG>e865-e875</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wells-2012" MODIFIED="2014-04-04 14:28:31 +0100" MODIFIED_BY="[Empty name]" NAME="Wells 2012" TYPE="JOURNAL_ARTICLE">
<AU>Wells JCK, Jonsdottir OH, Hibberd PL, Fewtrell MS, Thorsdottir I, Eaton S, et al</AU>
<TI>Randomized controlled trial of 4 compared with 6 mo of exclusive breastfeeding in Iceland: differences in breast-milk intake by stable-isotope probe</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>96</VL>
<NO>1</NO>
<PG>73-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1999" MODIFIED="2010-08-29 21:27:14 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 1999" TYPE="JOURNAL_ARTICLE">
<AU>WHO</AU>
<TI>The World Health Organization multinational study of breast-feeding and lactational amenorrhea. III. Pregnancy during breast-feeding. World Health Organization Task Force on Methods for the Natural Regulation of Fertility</TI>
<SO>Fertility and Sterility</SO>
<YR>1999</YR>
<VL>72</VL>
<NO>3</NO>
<PG>431-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" MODIFIED="2010-12-03 10:26:06 +0000" MODIFIED_BY="Lynn Hampson" NAME="WHO 2003" TYPE="OTHER">
<AU>World Health Organization, UNICEF</AU>
<TI>Global strategy for infant and young child feeding</TI>
<SO>www.who.int/nutrition/publications/infantfeeding/9241562218/en/index.html</SO>
<YR>(accessed 24 August 2010)</YR>
<IDENTIFIERS MODIFIED="2010-11-10 21:56:46 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2007" MODIFIED="2014-11-05 10:51:31 +0000" MODIFIED_BY="[Empty name]" NAME="WHO 2007" TYPE="BOOK">
<AU>World Health Organization</AU>
<SO>Safe Preparation, Storage and Handling of Powdered Infant Formula: Guidelines</SO>
<YR>2007</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2008" MODIFIED="2010-12-03 10:26:28 +0000" MODIFIED_BY="Lynn Hampson" NAME="WHO 2008" TYPE="OTHER">
<AU>World Health Organization, UNICEF, USAID, AED, UCDAVIS, IFPRI</AU>
<TI>Indicators for assessing infant and young child feeding practices, Part 1: Definitions</TI>
<SO>www.who.int/nutrition/publications/infantfeeding/9789241596664/en/index.html</SO>
<YR>(accessed 24 August 2010)</YR>
<IDENTIFIERS MODIFIED="2010-11-10 21:52:46 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2014" MODIFIED="2016-06-02 09:45:31 +0100" MODIFIED_BY="Gen Becker" NAME="WHO 2014" TYPE="OTHER">
<AU>World Health Organization/UNICEF</AU>
<TI>Global nutrition targets 2025: breastfeeding policy brief</TI>
<SO>WHO/NMH/NHD/14.7 Geneva: World Health Organization;</SO>
<YR>2014</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Williams_x002f_WHO-1997" MODIFIED="2011-10-14 11:37:38 +0100" MODIFIED_BY="Denise Atherton" NAME="Williams/WHO 1997" TYPE="OTHER">
<AU>Williams AF</AU>
<TI>Hypoglycaemia of the newborn: review of the literature</TI>
<SO>World Health Organization (http://www.who.int/child_adolescent_health/documents/chd_97_1/en/)</SO>
<YR>(accessed 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilson-1998" MODIFIED="2010-05-07 00:39:54 +0100" MODIFIED_BY="[Empty name]" NAME="Wilson 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wilson AC, Forsyth JS, Greene SA, Irvine L, Hau C, Howie PW</AU>
<TI>Relation of infant diet to childhood health: seven year follow up of cohort of children in Dundee infant feeding study</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<NO>7124</NO>
<PG>21-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wong-2016" MODIFIED="2016-07-24 12:08:20 +0100" MODIFIED_BY="Heather Maxwell" NAME="Wong 2016" TYPE="JOURNAL_ARTICLE">
<AU>Wong GWK</AU>
<TI>Preventing food allergy in infancy &#8212; early consumption or avoidance?</TI>
<SO>New England Journal of Medicine</SO>
<YR>2016</YR>
<VL>374</VL>
<NO>18</NO>
<PG>1783-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-World-Health-Organization" MODIFIED="2016-08-30 13:00:42 +0100" MODIFIED_BY="[Empty name]" NAME="World Health Organization" TYPE="COMPUTER_PROGRAM">
<AU>World Health Organization</AU>
<TI>Software for assessing growth and development of the world&#8217;s children</TI>
<YR>2010</YR>
<EN>3.1</EN>
<PB>World Health Organization</PB>
<CY>Geneva, Switzerland</CY>
<MD>http://www.who.int/childgrowth/software/en/</MD>
<IDENTIFIERS MODIFIED="2016-08-30 13:00:42 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wright-2004" MODIFIED="2014-04-30 21:55:08 +0100" MODIFIED_BY="[Empty name]" NAME="Wright 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wright CM, Parkinson KN</AU>
<TI>Postnatal weight loss in term infants: what is "normal" and do growth charts allow for it?</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2004</YR>
<VL>89</VL>
<NO>3</NO>
<PG>F254-F257</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wright-2006" MODIFIED="2011-10-17 09:48:47 +0100" MODIFIED_BY="Denise Atherton" NAME="Wright 2006" TYPE="OTHER">
<AU>Wright N, Marinelli KA</AU>
<TI>Academy of Breastfeeding (ABM) Protocol Committee. Protocol Number 1, Guidelines for glucose monitoring and treatment of hypoglycaemia in breastfed neonates</TI>
<SO>www.bfmed.org/Resources/Protocols.aspx</SO>
<YR>(accessed 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yamauchi-1990" MODIFIED="2010-08-29 21:48:57 +0100" MODIFIED_BY="[Empty name]" NAME="Yamauchi 1990" TYPE="JOURNAL_ARTICLE">
<AU>Yamauchi Y, Yamanouchi I</AU>
<TI>Breast-feeding frequency during the first 24 hours after birth in full-term neonates</TI>
<SO>Pediatrics</SO>
<YR>1990</YR>
<VL>86</VL>
<NO>2</NO>
<PG>171-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yee-2007" MODIFIED="2010-08-29 21:55:37 +0100" MODIFIED_BY="[Empty name]" NAME="Yee 2007" TYPE="JOURNAL_ARTICLE">
<AU>Yee CF, Chin R</AU>
<TI>Parental perception and attitudes on infant feeding practices and baby milk formula in East Malaysia</TI>
<SO>International Journal of Consumer Studies</SO>
<YR>2007</YR>
<VL>31</VL>
<NO>4</NO>
<PG>363-70</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-07-25 16:15:53 +0100" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Becker-2011" MODIFIED="2016-07-24 12:12:49 +0100" MODIFIED_BY="Heather Maxwell" NAME="Becker 2011" TYPE="COCHRANE_REVIEW">
<AU>Becker GE, Remmington S, Remmington T</AU>
<TI>Early additional food and fluids for healthy breastfed full-term infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>12</NO>
<IDENTIFIERS MODIFIED="2014-03-17 13:20:38 +0000" MODIFIED_BY="Genevieve E Becker"><IDENTIFIER MODIFIED="2014-03-17 13:20:38 +0000" MODIFIED_BY="Genevieve E Becker" TYPE="DOI" VALUE="10.1002/14651858.CD006462.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Becker-2014" MODIFIED="2016-07-24 12:11:58 +0100" MODIFIED_BY="Heather Maxwell" NAME="Becker 2014" TYPE="COCHRANE_REVIEW">
<AU>Becker GE, Remmington T</AU>
<TI>Early additional food and fluids for healthy breastfed full-term infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2016-02-08 11:58:17 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-02-08 11:58:17 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006462.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Remmington-2007" MODIFIED="2016-07-25 16:15:53 +0100" MODIFIED_BY="Heather Maxwell" NAME="Remmington 2007" TYPE="COCHRANE_PROTOCOL">
<AU>Remmington S, Remmington T</AU>
<TI>Early additional food and fluids for healthy breastfed full-term infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-07-25 15:20:20 +0100" MODIFIED_BY="Heather Maxwell"><IDENTIFIER MODIFIED="2016-07-25 15:20:18 +0100" MODIFIED_BY="Heather Maxwell" TYPE="DOI" VALUE="10.1002/14651858.CD006462"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2014-04-04 14:28:48 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-08-30 12:58:08 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-08-30 12:58:08 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-08-29 18:38:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cohen-1994">
<CHAR_METHODS MODIFIED="2010-12-14 14:36:38 +0000" MODIFIED_BY="Denise Atherton">
<P>RCT. 3-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-08-07 21:38:33 +0100" MODIFIED_BY="[Empty name]">
<P>Low-income communities in San Pedro Sula, Honduras. Primiparous, breastfeeding mothers and their infants (n = 152) recruited from public maternity hospitals.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-29 18:38:01 +0100" MODIFIED_BY="[Empty name]">
<P>Trial from 4 to 6 months and longitudinal study of infants from birth to 12 months.</P>
<P>At 16 weeks, infants assigned to:</P>
<OL>
<LI>control (EBF to 26 weeks; no other liquids (water, milk or formula) or complementary food);</LI>
<LI>CFs (introduction of CFs at 16 weeks, with ad libitum breastfeeding); or</LI>
<LI>CFs and maintenance (introduction of CFs at 16 weeks with maintenance of pre-intervention breastfeeding frequency).</LI>
</OL>
<P>After 6 months, mothers continued to breastfeed and also fed their infants.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-29 18:38:04 +0100" MODIFIED_BY="[Empty name]">
<P>Infant weight measured weekly between 16 and 26 weeks and monthly from 7 to 12 months. Infant length measured at 16, 21 and 26 weeks and monthly from 4 to 12 months.</P>
<P>Infant motor development following 10 motor milestones.</P>
<P>Maternal height and weight measured at birth of infant and weight was re-measured according to the infant weight measurement schedule. Maternal supra-iliac and thigh skinfold thickness and circumference at the bust, below the bust, waist and hip were measured at 16, 21 and 26 weeks. Maternal % body fat measured at each time point.</P>
<P>Breast milk intake measured by test weighing for 48 hours at 4, 5 and 6 months. After this period, breast milk samples were collected for 24 hours and samples were pooled and frozen for later lipid and lactose analysis. For the CF groups, CF intake measured at 19, 24 and 26 weeks.</P>
<P>Infant morbidity was tabulated at 4 to 6 months and 6 to 12 months. Morbidity prevalence was calculated as % of days ill in each category of illness (diarrhoea, fever and upper-respiratory illness).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-29 18:38:10 +0100" MODIFIED_BY="[Empty name]">
<P>We combined 2 intervention arms with complementary foods into 1 for our analysis of infant weight gain. Original data are:</P>
<P>EBF arm n = 50; 1092 g (SD 356 g);</P>
<OL>
<LI>complementary food arm n = 47; 1052 g (SD 315 g);</LI>
<LI>complementary food and maintenance arm n = 44; 1004 g (SD 402 g).</LI>
</OL>
<P>The additional foods for the trial infants were reported as provided at reduced cost by the Gerber Products Company. Non-commercial funding for the study was provided by the Thrasher Research Fund, WHO, UNICEF Honduras, and Institute for Reproductive Health Washington DC under a funding agreement from USAID.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-29 18:38:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dewey-1999">
<CHAR_METHODS MODIFIED="2011-09-29 20:28:06 +0100" MODIFIED_BY="Denise Atherton">
<P>Prospective observational study followed by a randomised intervention trial (from 4 to 6 months). 2-arm. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-25 15:58:43 +0100" MODIFIED_BY="Heather Maxwell">
<P>222 (of which 128 were eligible for the intervention phase of the study) full-term (&#8807; to 37 weeks' gestation) low birthweight infants (weighing 1500 to 2500 g at birth) from 2 maternity hospitals in San Pedro Sula, Honduras whose mothers (aged &#8807; 15 years of age) were willing to exclusively breastfeed for 6 months and were not planning to work outside the home.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-29 18:38:23 +0100" MODIFIED_BY="[Empty name]">
<P>At 16 weeks of age, infants who were still exclusively breastfeeding were randomly assigned to 1 of 2 groups: (1) continued EBF to 6 months, or (2) complementary feeding (CFs) plus breastfeeding from 4 to 6 months, with mothers encouraged to maintain baseline (16 week) breastfeeding frequency.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-29 18:38:24 +0100" MODIFIED_BY="[Empty name]">
<P>Growth and morbidity from 16 to 26 weeks were assessed for all infants. Morbidity data collected by maternal recall of illness symptoms (weekly).</P>
<P>Blood samples collected at 2, 4, 6 months of age. Any infants identified as anaemic, i.e. Hb &lt; 100 g/L, were given iron supplements and re-tested 2 weeks later.</P>
<P>Daily diary of infants stool frequency and consistency were recorded by the mothers.</P>
<P>For a sub-sample (n = 63) measurements of breast milk intake and composition and total energy intake at 16 and 26 weeks were completed.</P>
<P>At 26 weeks, intake of CFs by infants in the complementary feeding plus breastfeeding group was also determined.</P>
<P>Infant motor development following 10 motor milestones.</P>
<P>Maternal height (at time of birth) and weight (weekly).</P>
<P>Maternal consumption of any vitamin and mineral supplements were recorded.</P>
<P>Duration of lactation amenorrhoea.</P>
<P>Assessment of attitudes of mothers to EBF.</P>
<P>After the intervention phase, infant growth was measured monthly until 12 months of age.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-16 13:08:47 +0100" MODIFIED_BY="Genevieve Becker">
<P>Support from UNICEF and Wellstart International under a grant from USAID; commercial support for the provision of jars of complementary food not stated.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-25 15:59:00 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Flaherman-2013">
<CHAR_METHODS MODIFIED="2016-07-25 15:59:00 +0100" MODIFIED_BY="Heather Maxwell">
<P>RCT, 2-arm, parallel design. 2 to 4 days in first week after birth with follow-up to 3 months. Designed to be a pilot to test feasibility.</P>
<P>USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-19 12:17:07 +0100" MODIFIED_BY="[Empty name]">
<P>40 exclusively breastfeeding healthy term infants <U>&gt;</U> 37 weeks' gestation, 24 to 48 hours old, who had lost <U>&gt;</U> 5% birthweight before 36 hours of age were randomly assigned to continue EBF n = 20 (control) or to receive formula supplementation n = 20 (intervention).</P>
<P>"Infants were excluded if [at time of enrolment] they had lost <U>&gt;</U> 10% of their birthweight, had received formula or water, required a higher level of care than a Level 1 nursery or had mothers who were, 18 years old, could not speak English or Spanish, or were making mature milk as assessed by a previously validated technique."</P>
<P>2 hospitals California, USA.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-04-04 14:18:11 +0100" MODIFIED_BY="[Empty name]">
<P>&#8220;Early limited formula (ELF) intervention (10 mL formula by syringe after each breastfeeding and discontinued when mature milk production began) or control (continued exclusive breastfeeding).&#8221;</P>
<P>Nutramigen infant formula (stated as &#8220;extensively hydrolyzed").</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:01:57 +0100" MODIFIED_BY="[Empty name]">
<P>Breastfeeding and formula use at 1 week and 1, 2, and 3 months (duration of breastfeeding).</P>
<P>Weight nadir in protocol, only weight loss reported (at age not stated).</P>
<P>Maternal breastfeeding self-efficacy and maternal satisfaction at 1 week.</P>
<P>Incidence of febrile illness.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-19 12:02:07 +0100" MODIFIED_BY="[Empty name]">
<P>Further details sought from trialist with some response.</P>
<P>Registered as ClinicalTrials.gov Identifier: NCT00952328.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-29 18:40:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jonsdottir-2012">
<CHAR_METHODS MODIFIED="2014-03-27 10:17:28 +0000" MODIFIED_BY="[Empty name]">
<P>RCT. 2-arm. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-04-04 14:19:33 +0100" MODIFIED_BY="[Empty name]">
<P>119 randomly assigned at 4 months. Full-term (&#8805; to 37 weeks' gestation).</P>
<P>61 were allocated to the CF group and 58 to the EBF group. Although 1 mother-infant pair was incorrectly instructed to group EBF and was therefore analysed in the EBF group, so N = 60 for CF; N = 59 for EBF.</P>
<P>At a screening visit all mothers stated willing to continue to exclusively breastfeed to 6 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-08-29 18:40:49 +0100" MODIFIED_BY="[Empty name]">
<P>At 4 months of age, infants who were still exclusively breastfeeding were randomly assigned to 1 of 2 groups: (1) continued EBF to 6 months, or (2) CF plus breastfeeding from 4 to 6 months.</P>
<P>EBF was defined as breastfeeding with no additional liquid or foods other than vitamins and medications.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-25 16:00:11 +0100" MODIFIED_BY="Heather Maxwell">
<P>For the CF group, mothers kept a diary to indicate the date that every new food item was added to the infant's diet from the time of enrolment into the study until 6 months of age. A 3-day weighted food record was obtained when the infant reached approximately 5 months and 1 week of age. Energy and nutrient information were calculated.</P>
<P>For both groups</P>
<P>Anthropometric assessment: included infant's weight, length and head circumference. Measured at birth, 6 weeks, and 3, 4, 5 and 6 months of age (converted to z scores using the WHO Infant Growth Standards).</P>
<P>Blood samples: obtained to determine iron status. Obtained at 6 months of age - blood for Hb, MCV, RDW, serum ferritin, and TIBC.</P>
<P>Breast-milk intake: determined by the deuterium dose-to-the-mother method.</P>
<P>Measures of developmental and behavioural status: assessed at both 18 months and 30 to 35 months with the Parent's Evaluation of Developmental Status (PEDS) questionnaire and the Brigance Screens-II.</P>
<P>The Jonsdottir trial retrospectively collected information on total duration of breastfeeding for all infants. However, we are unable to present these data as they were combined with data from an additional cohort of infants from a separate national prospective study.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-28 13:51:30 +0100" MODIFIED_BY="Genevieve Becker">
<P>EBF: the use of up to 10 feedings of formula or water during the first 6 months was allowed to avoid having to exclude infants who were otherwise exclusively breastfeeding.</P>
<P>Clinical Trial Registration: ISRCTN41946519.</P>
<P>Study was supported by the Primary Health Care organisations in the Reykavik Capital area, Akranes, and Sudurnes, and by the Directors of the participating health centres.</P>
<P>The study was supported by Mead Johnson and the Eimskip Fund for the University of Iceland. The sponsors of the study had no role in the study design, data collection, data analysis or interpretation, preparation of the report or the decision to submit for publication. None of the authors received honoraria, grants or other forms of payment to produce the manuscript.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-19 12:06:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindfors-1988">
<CHAR_METHODS MODIFIED="2016-07-19 12:05:34 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-RCT.</P>
<P>Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-19 12:05:38 +0100" MODIFIED_BY="[Empty name]">
<P>Term infants (37-42 gestational weeks') with no major initial neonatal problems born and a birthweight between -1 and -2 SDs between June 1981 and January 1983 in Danderyd Hospital, Sweden.</P>
<P>112 infants were assigned to the intervention group (infant formula) and 109 infants had data available for analysis at 18 months. 104 infants were assigned to the breastfeeding group and 98 infants had data available for analysis at 18 months.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-19 12:05:48 +0100" MODIFIED_BY="[Empty name]">
<P>Adapted cow milk formula (Milkotal®). This was first given when the infants were 6 hours old and the amounts given were increased every 4 hours until the infant was taking 60 mL per meal. The formula was gradually withdraw when "the mother's breastmilk production started".</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:06:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allergy symptoms (atopic eczema; wheezing; urticaria; GI allergy; multiple allergies).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-02 09:13:39 +0100" MODIFIED_BY="Gen Becker">
<P>Outcomes are based on paediatricians assessment but no diagnostic tests were performed. Follow-up assessments occurred at 3, 6 and 18 months but it is not stated if outcomes are incidence or prevalence. We were unable to contact authors to address any of our queries related to their study.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-19 12:17:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martin_x002d_Calama-1997">
<CHAR_METHODS MODIFIED="2010-12-14 14:32:15 +0000" MODIFIED_BY="Denise Atherton">
<P>RCT. 2-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-14 14:32:19 +0000" MODIFIED_BY="Denise Atherton">
<P>Full-term newborns weighing between 2599 g to 4000 g (n = 180). Vaginal deliveries only, who had no congenital abnormalities and who represented no risk factors for hypo- or hyperglycaemia. General Hospital, Teruel, Spain.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-19 12:07:32 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1 called "glucose water" group, received 5% glucose <I>ad libitum </I>from a bottle for the first 3 days of life in addition to breastfeeding. Group 2, the "non glucose water" group, was not given glucose water or any other type of alternative solution to human milk.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:17:23 +0100" MODIFIED_BY="[Empty name]">
<P>Weight change (6, 12, 24, 48 and 72 hours of life).</P>
<P>Serum glucose levels (6, 12, 24 and 48 hours of life).</P>
<P>Rectal temperature (every 6 hours for the first 72 hours of life). The maximum and minimum values during period of observation were used in the final analysis.</P>
<P>After discharge no contact for 5 months. Then telephone interview determined duration of EBF, duration until introduction of infant formula, and duration until complete weaning were recorded. Time points of 4, 8, 12, 16 and 20 weeks were used.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-19 12:07:42 +0100" MODIFIED_BY="[Empty name]">
<P>We have estimated from the graph in the published report the percentage of mothers breastfeeding at each time period (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>) and calculated the number breastfeeding at each time period from these estimates.</P>
<P>No information on funding sources in the published paper.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-08-29 18:38:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nicoll-1982">
<CHAR_METHODS MODIFIED="2010-12-14 14:36:57 +0000" MODIFIED_BY="Denise Atherton">
<P>RCT. 3-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-21 21:45:24 +0000" MODIFIED_BY="Tracey Remmington">
<P>Primiparous mothers intending to breastfeed their full-term infants. Intending to be in hospital (London, UK) for 5 days after delivery. 49 originally randomised.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-11-11 17:20:58 +0000" MODIFIED_BY="[Empty name]">
<P>3 groups: water supplement (n = 14); glucose supplement (n = 17); no supplement (n = 16).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-08-29 18:38:33 +0100" MODIFIED_BY="[Empty name]">
<P>Infant weight (days 1, 3 and 5).</P>
<P>Plasma bilirubin (day 6).</P>
<P>Volume of supplement taken per day per kilo of baby's birthweight (mL/kg/day).</P>
<P>Average weight gain per breastfeed (mg/kg of baby's birthweight).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-08-24 16:14:26 +0100" MODIFIED_BY="[Empty name]">
<P>Weight loss data for glucose and water supplement arms have been combined for our analysis 2.7. We converted the SEs presented in the original paper to SDs.</P>
<P>Original data are mean and SE:</P>
<OL>
<LI>% weight loss from baby's birthweight;</LI>
<LI>EBF 6.0 (0.5) day 3 and 4.3 (0.6) on day 5;</LI>
<LI>water supplement 5.9 (0.4) day 3 and 4.2 (0.6) on day 5;</LI>
<LI>glucose supplement 4.1 (0.4) day 3 and 4.0 (0.5) on day 5.</LI>
</OL>
<P>Plasma bilirubin data from the glucose and water supplement arms have been combined for our analysis 2.8.</P>
<P>Original data are mean and SE:</P>
<OL>
<LI>EBF 67.7 (6.7) umol/L;</LI>
<LI>water supplement 93.5 (13.8) umol/L;</LI>
<LI>glucose supplement 80.8 (8.8) umol/L.</LI>
</OL>
<P>The additional artifical feeds were "kindly supplied by Wyeth Laboratories".</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-19 12:09:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ojofeitimi-1982">
<CHAR_METHODS MODIFIED="2010-12-14 14:33:25 +0000" MODIFIED_BY="Denise Atherton">
<P>RCT. 2-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-19 12:09:44 +0100" MODIFIED_BY="[Empty name]">
<P>180 neonates delivered between October 1980 and January 1981 in 2 local maternity centres in Ile-Ife, Oyo State, Nigeria were randomised. Criteria for selection were that birthweight be above 2.50 kg, no sign of congenital malformation, that mothers experienced uncomplicated birth with membrane rupture less than 24 hours prior to delivery, and no manifest sign of physical exhaustion or sickness after delivery to prevent them from performing their maternal responsibilities to the neonates.</P>
<P>105 kept strictly to instructions (60 (57%) on colostrum regimen and 45 (43%) on glucose water).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-14 14:33:43 +0000" MODIFIED_BY="Denise Atherton">
<P>1 group received glucose water feedings and the other colostrum. The mothers were told to keep strictly to these feeding regimens for the entire 3-day stay at the maternity centre.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-11-11 17:21:50 +0000" MODIFIED_BY="[Empty name]">
<P>Stool specimens (2 daily) analysed for bacterial counts.</P>
<P>Bacterial counts in samples of colostrum and glucose water.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-06-16 13:23:40 +0100" MODIFIED_BY="Genevieve Becker">
<P>Did not report any data that were eligible for inclusion in the review.</P>
<P>no information on funding sources in the published paper</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-25 16:01:56 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Perkin-2016">
<CHAR_METHODS MODIFIED="2016-06-02 09:23:43 +0100" MODIFIED_BY="Gen Becker">
<P>RCT. 2-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-25 16:01:38 +0100" MODIFIED_BY="Heather Maxwell">
<P>n = 1303 eligible infants enrolled at 3 months from a general (not an "at risk" population). Intervention group 652 randomised and ITT analysis for 567; control group 651 randomised and ITT analysis for 595,</P>
<P>"recruited to the study from those who responded to a flyer mailed to parents of young infants throughout England and Wales&#8221;. Tested at enrolment for allergy sensitisation.</P>
<P>Inclusion criteria: Exclusively breastfeeding at enrolment, 37+ weeks' gestation, singleton birth, no major health concerns, not planning to move from the United Kingdom for the duration of the study.</P>
<P>Exclusion criteria:<B> "</B>Infants who had consumed anything other than breast milk or water since birth, were part of multiple births, were born prematurely, had any serious medical condition, or were participating in other medical research were not eligible for enrolment. A current household member with a food allergy was not an exclusion criterion.&#8221;</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-25 16:01:56 +0100" MODIFIED_BY="Heather Maxwell">
<P>To determine whether the early introduction of common dietary allergens from 3 months of age in exclusively breast-fed infants in the general population would prevent food allergies than those in infants who were exclusively breast-fed for approximately 6 months. &#8220;Between 13 and 17 weeks of age, enrolled infants were randomly assigned to either the SIG or the early introduction group (EIG).&#8221;</P>
<P>(Early Introduction Group/EIG): at 3 months infants were introduced to cow&#8217;s milk and then the following foods (cooked hen&#8217;s egg, peanut, sesame, whitefish) in a randomised sequence and then the last food introduced was wheat and no wheat before 4 months. Trial recommendation was 2 to 4 g of the food protein per week by 6 months.</P>
<P>Control/Comparison intervention (Standard Introduction Group/SIG): exclusively breast-fed to approximately 6 months of age. After 6 months of age, the consumption of allergenic foods was allowed according to parental discretion.</P>
<P>Both groups &#8220;Parents completed an on-line questionnaire monthly to 12 months and then every 3 months to 36 months. Parents reported any atopic symptoms in their children and any adverse events (serious and non-serious) through the online questionnaire."</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:12:08 +0100" MODIFIED_BY="[Empty name]">
<P>Duration of any breastfeeding.</P>
<P>Eczema (visible) at 12 months.</P>
<P>Prevalence of "food allergy" to 1 or more foods between 1-3 years of age.</P>
<P>Adverse events including gastrointestinal events, colic, respiratory effects, growth, hospitalisation for any reason, and morbidity for any reason and many other conditions and details are reported in the supplementary appendices available on-line (data not suitable for analysis and summary reported descriptively. Trialists replied that more publications were likely to arise from this large trial).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-19 12:17:34 +0100" MODIFIED_BY="[Empty name]">
<P>EBF definition allowed water.</P>
<P>Supported by grants from the Food Standards Agency and the Medical Research Council, by the NIHR Biomedical Research Centre, which is based at Guy&#8217;s and St. Thomas&#8217; NHS Foundation Trust and King&#8217;s College London, and by a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy&#8217;s and St. Thomas&#8217; NHS Foundation Trust and King&#8217;s College London. Also supported by an NIHR Clinician Scientist Award (NIHRCS/01/2008/009) to Dr Flohr. The clinical trials unit is supported in part by the National Peanut Board, Atlanta.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-19 12:13:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schutzman-1986">
<CHAR_METHODS MODIFIED="2010-12-14 14:34:03 +0000" MODIFIED_BY="Denise Atherton">
<P>RCT. 2-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-12-14 14:34:16 +0000" MODIFIED_BY="Denise Atherton">
<P>Healthy term neonates (n = 136) in the first 3 days after birth.</P>
<P>78 babies nursed exclusively on demand, and 58 babies received supplemental water in addition to on-demand nursing.</P>
<P>This study was performed in a maternity hospital in Philadelphia, Pennsylvania at which the patient population is highly motivated to breastfeed.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-09-25 23:54:01 +0100" MODIFIED_BY="[Empty name]">
<P>Exclusive on-demand breastfeeding versus on-demand nursing plus supplemental water. The choice of sterile water or 5 % glucose water was left to the mother.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-02-24 21:26:11 +0000" MODIFIED_BY="Tracey Remmington">
<P>Mean total amount of water ingested by the supplemented group prior to the arrival of true milk.</P>
<P>The time in hours when true milk first "came in" was recorded for each mother as it occurred.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-19 12:13:22 +0100" MODIFIED_BY="[Empty name]">
<P>Did not report any data that were eligible for inclusion in the review.</P>
<P>No information on funding sources in the published paper.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-07-25 16:02:32 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<CHAR_METHODS MODIFIED="2016-06-02 09:29:46 +0100" MODIFIED_BY="Gen Becker">
<P>RCT. 2-arm trial. Parallel design.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-19 12:13:50 +0100" MODIFIED_BY="[Empty name]">
<P>Total number randomised: 52 randomised per group, data available for 50 per group. Inclusion criteria:</P>
<P>&#8220;Infants were eligible for randomisation when their weight loss was equal to or greater than 5 per cent between 24th and 48th hour of life. Only healthy, singleton, appropriate for gestational age (AGA) term neonates, born after uncomplicated pregnancy and delivery, who had no severe congenital defects were enrolled. Mothers of the included infants were planning to breastfeed for a long time and all were Czech citizens. &#8230;All mothers involved in the study were planning and wishing to breastfeed over long term&#8221;.</P>
<P>Exclusion criteria: mothers with serious complications (hypertension, diabetes, systemic diseases, drug abuse) or using therapy that might affect breastfeeding (antidepressants) were excluded.</P>
<P>&#8220;The study was conducted at the Institute for the Care of Mother and Child in Prague. Patients were recruited from the 1st of April 2014 until the 29th of August 2014. Follow up was completed on the 27th of February 2015.&#8221;</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-19 12:21:40 +0100" MODIFIED_BY="[Empty name]">
<P>Experimental intervention: &#8220;Infants in the controlled limited formula group (CLF&#8212;intervention group) were given a set volume of 10ml of formula (HIPP NE, HIPP Inc., Germany) after each breastfeed until adequate milk production began&#8221;.</P>
<P>Control/Comparison intervention: &#8220;Infants in the standard approach group (SA&#8212;control group) were exclusively breastfed. Supplemental feeds were administered only in indicated cases. This included excessive weight loss (more than 10% of birthweight), irritability of the newborn, in terms of unsettling cry and hungry behaviour, and on mothers specific request. Infants in the control group, if requiring supplemental feeding, were given breastmilk from the breastmilk bank or formula according to the mothers&#8217; choice. All formula feeds were always given using the syringe-technique.&#8221;</P>
<P>All infants were weighed daily while in hospital.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-25 16:02:32 +0100" MODIFIED_BY="Heather Maxwell">
<OL>
<LI>Any breastfeeding at discharge (binary outcome)</LI>
<LI>EBF at discharge (binary outcome)</LI>
<LI>Any breastfeeding at 3 months (binary outcome)</LI>
<LI>EBF at 3 months of age (binary outcome)</LI>
<LI>Breastfeeding at 6 months of age (binary outcome)</LI>
<LI>EBF at 6 months of age (binary outcome)</LI>
<LI>Percentage of weight loss during hospitalisation (continuous outcome)</LI>
<LI>Phototherapy in hospital or home setting if required, absence or presence, and if present, duration (days)</LI>
</OL>
<P>&#8220;all participants have been regularly checked for hyperbilirubinaemia as according to standard hospital guidelines. Levels of bilirubin above 200 umol/l have been recorded, as per standard hospital guidelines levels of serum-bilirubin were measured and all cases requiring phototherapy noted.&#8221;</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-19 12:14:26 +0100" MODIFIED_BY="[Empty name]">
<P>Additional information provided by trialists.</P>
<P>Supplemental data provided with publication.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>B: breastfeeding</P>
<P>BMI: body mass index<BR/>CF: complementary foods</P>
<P>CF-M: complementary foods and maintenance<BR/>EBF: exclusive breastfeeding<BR/>GI: gastrointestinal</P>
<P>F: cow milk formula<BR/>Hb: haemoglobin<BR/>Hct: haematocrit<BR/>MCV: mean corpuscular volume<BR/>ITT: intention-to-treat<BR/>min: minutes<BR/>RCT: randomised controlled trial<BR/>RDW: red blood cell distribution width<BR/>SD: standard deviation<BR/>SE: standard error<BR/>SF: solid food<BR/>
<BR/>TIBC: total iron-binding capacity<BR/>USAID: United States Agency for International Development<BR/>WHO: World Health Organization</P>
<P>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-07-24 17:08:17 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:01:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bannert-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:01:37 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-02 09:35:24 +0100" MODIFIED_BY="Gen Becker" STUDY_ID="STD-Cameron-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-02 09:35:24 +0100" MODIFIED_BY="Gen Becker">
<P>Intervention is counselling to affect timing of introduction of complementary foods and not addition of foods/fluids.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-19 12:21:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Collins-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-19 12:21:24 +0100" MODIFIED_BY="[Empty name]">
<P>Preterm infants only (23 to 33 weeks).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:01:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Corchia-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:01:50 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:01:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cronenwett-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:01:57 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-14 14:36:25 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-De-Carvalho-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-14 14:36:25 +0000" MODIFIED_BY="Denise Atherton">
<P>Not randomised or quasi-randomised. Babies on 1 ward received water supplementation and those on another 2 wards did not. The admission of babies and mothers to the 3 wards was dependent upon availability, but not regarded as random allocation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-24 17:07:08 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-de-Jong-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-24 17:07:08 +0100" MODIFIED_BY="Heather Maxwell">
<P>Intervention did not have an exclusively breastfeeding arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-04 14:21:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Oliveira-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-04 14:21:47 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention was not the addition of foods/fluids. It was "to evaluate the efficacy of counselling about breastfeeding and complementary feeding in preventing the introduction of non-breast milk and complementary foods in the first 6 months&#8221;.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-24 17:07:26 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Du-Toit-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-24 17:07:26 +0100" MODIFIED_BY="Heather Maxwell">
<P>Intervention did not have an exclusively breastfeeding arm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-06-02 09:35:48 +0100" MODIFIED_BY="Gen Becker" STUDY_ID="STD-Flaherman-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-06-02 09:35:48 +0100" MODIFIED_BY="Gen Becker">
<P>Refers to infants needing treatment for a medical condition, not well infants.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-02-24 20:52:31 +0000" MODIFIED_BY="Genevieve E Becker" STUDY_ID="STD-French-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-02-24 20:52:31 +0000" MODIFIED_BY="Genevieve E Becker">
<P>Mix of breastfeeding and artificial feeding. No exclusively breastfeeding group. Evaluating guidance on infant feeding behaviours.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:02:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gray_x002d_Donald-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:02:08 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-24 17:08:17 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Howard-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-24 17:08:17 +0100" MODIFIED_BY="Heather Maxwell">
<P>Treatment group included preterm babies (36 to 42 weeks).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-25 08:54:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Juvonen-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-25 08:54:17 +0100" MODIFIED_BY="[Empty name]">
<P>Group was fed donor human milk not exclusive breastfeeding.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:02:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kearney-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:02:15 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-24 17:07:50 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kimani_x002d_Murage-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-24 17:07:50 +0100" MODIFIED_BY="Heather Maxwell">
<P>Intervention was counselling to affect timing of introduction of complementary foods and not addition of foods/fluids.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-04 14:22:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krebs-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-04 14:22:05 +0100" MODIFIED_BY="[Empty name]">
<P>Infants were assigned at 5 months to receive 1 of 3 types of complementary foods. Not comparing exclusively breastfeeding under 6 months.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 21:18:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ly-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 21:18:25 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-14 14:37:15 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Marinelli-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-14 14:37:15 +0000" MODIFIED_BY="Denise Atherton">
<P>Preterm infants only (34 weeks or less).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-12-14 14:37:18 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Mosley-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-12-14 14:37:18 +0000" MODIFIED_BY="Denise Atherton">
<P>Treatment group included preterm babies (32 to 37 weeks).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-04 14:22:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olaya-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-04 14:22:18 +0100" MODIFIED_BY="[Empty name]">
<P>Infants were assigned at 6 months to receive 1 of 2 types of complementary feeding. Not comparing exclusively breastfeeding under 6 months.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:02:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rosegger-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:02:29 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 20:02:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rosegger-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 20:02:36 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-19 12:22:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saarinen-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-19 12:22:32 +0100" MODIFIED_BY="[Empty name]">
<P>Unclear randomisation; may not have randomised control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 21:17:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sachdev-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 21:17:38 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-04 14:22:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schiess-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-04 14:22:28 +0100" MODIFIED_BY="[Empty name]">
<P>Observational study comparing 2 formula groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 21:18:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schmitz-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 21:18:08 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 21:18:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schubiger-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 21:18:11 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-05-07 21:18:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Simondon-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-05-07 21:18:15 +0100" MODIFIED_BY="[Empty name]">
<P>No exclusively breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-19 12:22:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ziegler-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-19 12:22:47 +0100" MODIFIED_BY="[Empty name]">
<P>Review of 3 studies of the research group comparing 2 types of cereal introduced at 4 months. No exclusive breastfeeding group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2016-05-14 19:00:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-07-25 16:08:26 +0100" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2016-07-25 16:08:05 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Flaherman-2014">
<CHAR_STUDY_NAME MODIFIED="2016-07-19 12:23:03 +0100" MODIFIED_BY="[Empty name]">
<P>Early limited formula for treating lactation concerns (ELF)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-07-24 17:16:20 +0100" MODIFIED_BY="Heather Maxwell">
<P>RCT, parallel assignment, single-blind (outcomes assessor).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-25 16:08:05 +0100" MODIFIED_BY="Heather Maxwell">
<P>Inclusion criteria</P>
<OL>
<LI>Full-term, healthy singleton infant (&#8805; 37 0/7 weeks gestational age) in "well newborn nursery"</LI>
<LI>Exclusively breastfeeding (has not received any feedings other than breast milk)</LI>
<LI>Infant is 18-72 hours old</LI>
<LI>Infant has weight loss of &#8805; 75th percentile on delivery mode specific nomogram documented at 12-72 hours of age</LI>
<LI>English-speaking mother</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Mothers or infants for whom breastfeeding is not recommended by the clinical team</LI>
<LI>Mothers who have already begun to produce mature breast milk</LI>
<LI>Any formula or water feeding prior to enrolment</LI>
<LI>Infants who have already lost &#8805; 10% of their birthweight</LI>
<LI>Family with no active telephone number (home or cellular)</LI>
<LI>Plan for infant adoption or foster care</LI>
<LI>Mothers &lt; 18 years of age</LI>
<LI>Infant receiving scoring for Narcotic Abstinence Syndrome</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-19 12:24:08 +0100" MODIFIED_BY="[Empty name]">
<P>Standard Care: continue exclusive breastfeeding unless otherwise directed by a healthcare provider.</P>
<P>Experimental: early Limited Formula-10 (mL) Nutramigen fed to baby by syringe after each breastfeeding and discontinued at the start of mature milk production.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:24:23 +0100" MODIFIED_BY="[Empty name]">
<P>Length of breastfeeding duration (follow-up to 12 months); Maternal State Trait Anxiety Inventory, Edinburg Postnatal Depression Scale, Breastfeeding Self-Efficacy Scale, Satisfaction with Quality of Care, Infant Satisfaction and Satiety Subscale (all 1 month), health care utilisation (1 month), formula use (6 months).</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-07-19 12:24:30 +0100" MODIFIED_BY="[Empty name]">
<P>December 2014. Estimated completion date June 2017.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-06-02 09:39:30 +0100" MODIFIED_BY="Gen Becker">
<P>Valerie Flaherman, MD, MPH <A HREF="mailto:flahermanv%40peds.ucsf.edu">flahermanv@peds.ucsf.edu</A> Michelle Rait, RN <A HREF="mailto:raitm%40peds.ucsf.edu">raitm@peds.ucsf.edu</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-07-19 12:24:50 +0100" MODIFIED_BY="[Empty name]">
<P>Sponsor and collaborators: University of California, San Francisco, Milton S. Hershey Medical Center, HRSA/Maternal and Child Health Bureau.</P>
<P>ClinicalTrials.gov Identifier NCT02313181.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2016-07-24 17:14:39 +0100" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Kair-2014">
<CHAR_STUDY_NAME MODIFIED="2016-07-19 12:25:11 +0100" MODIFIED_BY="[Empty name]">
<P>Rx milk study of donor milk supplementation to improve breastfeeding outcomes.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-07-24 17:10:55 +0100" MODIFIED_BY="Heather Maxwell">
<P>RCT, parallel assignment, open-label.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-24 17:14:39 +0100" MODIFIED_BY="Heather Maxwell">
<P>Inclusion criteria</P>
<OL>
<LI>Gestational age greater than or equal to 37 weeks</LI>
<LI>Weight loss greater than or equal to 5% (rounded to nearest whole %) of birthweight in the first 36 hours after birth</LI>
<LI>Chronological age of 24-48 hours old at the time of study enrolment</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Twins and higher level multiples</LI>
<LI>Infant has congenital or chromosomal anomalies that may affect feeding, diagnosed prior to study enrolment</LI>
<LI>Mother incarcerated</LI>
<LI>Mother's age &lt; 18 years</LI>
<LI>Mother reports mature milk production prior to study enrolment</LI>
<LI>Mother does not speak English</LI>
<LI>Infants offered &gt; 1 supplemental feeding of formula or donor milk</LI>
<LI>Weight loss greater than 10%</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-19 12:26:26 +0100" MODIFIED_BY="[Empty name]">
<P>Control: exclusive breastfeeding.</P>
<P>Intervention: "Infants in this arm will continue to breastfeed and will be given 10 ml of donor breast milk by syringe after each breastfeeding until their mother's milk "comes in." (until the onset of lactogenesis II)".</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-19 12:27:01 +0100" MODIFIED_BY="[Empty name]">
<P>Any formula use at 1 week of age, any formula intake within the last 24 hours, exclusive breastfeeding (at 1 month, 2, month, 3 month), any breastfeeding (at 1 week, 1 month, 2, month, 3 month).</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-07-19 12:26:51 +0100" MODIFIED_BY="[Empty name]">
<P>July 2014. Estimated completion date June 2016.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-06-02 09:39:33 +0100" MODIFIED_BY="Gen Becker">
<P>Laura R Kair, MD <A HREF="mailto:laura-kair%40uiowa.edu?subject=NCT02221167,%20201406730,%20Rx%20Milk%20Study%20of%20Donor%20Milk%20Supplementation%20to%20Improve%20Breastfeeding%20Outcomes">laura-kair@uiowa.edu</A> Gretchen Cress, RN <A HREF="mailto:gretchen-cress%40uiowa.edu?subject=NCT02221167,%20201406730,%20Rx%20Milk%20Study%20of%20Donor%20Milk%20Supplementation%20to%20Improve%20Breastfeeding%20Outcomes">gretchen-cress@uiowa.edu</A>
</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-07-19 12:27:06 +0100" MODIFIED_BY="[Empty name]">
<P>Sponsors: University of Iowa, Children's Miracle Network, The Gerber Foundation. Study Director: Valerie J Flaherman.</P>
<P>ClinicalTrials.gov Identifier NCT02221167.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-08-29 18:38:32 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-07-19 12:14:33 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-04 14:16:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>By week of birth (i.e. all infants born in the same week were randomly assigned to the same group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-11 20:57:16 +0000" MODIFIED_BY="Tracey Remmington" RESULT="NO" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>Assigned by week of birth (i.e. all infants born in the same week were assigned to the same group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-09 13:08:25 +0000" MODIFIED_BY="Genevieve E Becker" RESULT="YES" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>&#8220;The allocation sequence for randomisation was generated by an independent bio- statistician stratified on location; assignments were placed into sealed opaque envelopes by an independent administrative assistant."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-27 10:17:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>The randomisation method was prepared using Jerry Dallal's Tufts-based software, and the trial statistician prepared the provided a computer-generated randomisation code. Assignments were generated by using permuted blocks of 2 and 4, with the sequence presented in random order.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:06:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>Quasi-RCT &#8220;Following a predetermined protocol,the maternity wards changed their feeding routine the first day of every other month between breastfeeding and early feeding with an adapted cow milk formula&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-12-14 14:32:38 +0000" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>"Divided randomly into 2 groups."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-09-05 13:52:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>Described as "randomly allocated" to 1 of 3 groups (no supplement (n = 17); glucose supplement (n = 17), water supplement (n = 15)).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:09:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>"Randomly assigned at birth to two groups...."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:12:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Reply from trialists: "Done via ALEA randomisation software".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:13:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:14:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>&#8220;Using the sealed envelope technique and randomization with permuted blocks, we randomly assigned 104 mother-infant pairs to either controlled limited formula group (CLF) or standard approach group (SA). The randomization sequence was generated and the sealed envelopes in blocks of 8 were prepared by the hospitals&#8217; administration office staff.&#8220;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-07-19 12:14:38 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-25 22:22:32 +0000" MODIFIED_BY="Tracey Remmington" RESULT="NO" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>Participants were not informed of their assignment until they had completed the first (non-RCT) section of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-25 22:27:59 +0000" MODIFIED_BY="Tracey Remmington" RESULT="NO" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>Participants were not informed of their assignment until they had completed the first (non-RCT) section of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-02-24 20:58:39 +0000" MODIFIED_BY="Genevieve E Becker" RESULT="YES" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>"Immediately after enrolment, a study investigator opened the sequential envelope in the presence of a second investigator and revealed the randomisation arm.&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-04 14:20:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>Assignments were accessed by using a password-protected web-based application, after eligibility criteria were confirmed. Assignments were generated by 1 person (a nurse) who was not involved in any other aspect of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:06:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>No allocation concealment took place - hospital staff were aware of the allocation procedure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-11 22:00:38 +0000" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-01-15 22:23:35 +0000" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-11 22:09:17 +0000" MODIFIED_BY="Tracey Remmington" RESULT="UNKNOWN" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:12:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Reply from trialists: "There was no blinding in the study team and the participant's GP was notified of the allocation. The exception to this was the double blind placebo controlled food challenge that some participants underwent at the 3 year visit".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:13:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>Not discussed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:14:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>Reply from trialist:</P>
<P>&#8220;the group allocation was not stated on the day-to-day medical records of the infants, clinicians were not necessarily aware about group allocation, unless told by the mother&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-04-03 15:35:04 +0100" MODIFIED_BY="Genevieve E Becker" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>Outcome assessors</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-06-21 18:35:44 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-20 21:05:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:07:09 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:11:43 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>Unfeasible to blind participant or personnel.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:12:23 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-21 18:35:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:18:11 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:21:57 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:22:09 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:26:57 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:29:16 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-06-02 09:31:21 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>Due to the nature of intervention this was not possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-08-28 13:56:31 +0100" MODIFIED_BY="Genevieve Becker" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-09-29 02:59:05 +0100" MODIFIED_BY="Genevieve E Becker" RESULT="UNKNOWN" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-04-03 15:31:09 +0100" MODIFIED_BY="Genevieve E Becker" RESULT="UNKNOWN" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>Not stated for outcome assessors, although appears to be same researchers at all points.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-07-25 15:59:33 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>&#8220;A blinded research assistant assessed outcomes at 1 week and 1, 2, and 3 months.&#8221;</P>
<P>Unfeasible to blind participants or personnel.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-27 18:48:02 +0000" MODIFIED_BY="Genevieve E Becker" RESULT="YES" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>Nurses who collected data on complementary food intakes and anthropometric outcomes were not blinded to participant group status, but all mass spectrometric analyses and isotopic modelling were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-06-02 09:13:59 +0100" MODIFIED_BY="Gen Becker" RESULT="NO" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>Publised paper states that paediatricians at the child welfare clinics who did the follow-up "were unaware of the feeding regimen". As part of the study assessment included taking a full feeding history from birth they may have been told by the parents if the child had received the intervention formula.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-07-19 12:07:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-09-29 20:33:10 +0100" MODIFIED_BY="Genevieve E Becker" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-07-19 12:10:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-07-19 12:12:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Reply from trialists: "No blinding. Outcome was based upon objective measures of sensitisation (skin prick test results). Food allergy at one year and beyond was determined by the gold standard measure, the double blind, placebo controlled food challenge. This also has strict, set criteria that must be objectively met in order to be deemed positive".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-05-07 20:28:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>No information available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-08-28 13:56:31 +0100" MODIFIED_BY="Genevieve Becker" RESULT="YES" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>&#8220;A research nurse who was blinded to group allocation assessed outcomes during a personal interview at discharge and by a telephone-interview at 3 and 6 months of the infants&#8217; age.&#8221;</P>
<P>Reply from trialist: "those carrying out analysis of data were blinded as to group allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-08-29 18:38:27 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-29 18:38:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>152 women entered the intervention trial, 11 (7%) dropped out prior to 26 weeks (9, 1, and 1 in the EBF, CF, and CF-M groups, respectively; P &lt; 0.01). Reasons for leaving the study between 16 weeks and 26 weeks were reported: 2 had to return to work (both in EBF) and 5 were refused permission to continue participating (4 EBF and 1 CF-M). The other 4 (3 EBF and 1 CF) were excluded because they did not exclusively breastfeed (or introduced other milks in the CF group). Characteristics of non-participants who dropped out at commencement of the intervention trial were similar to those of participants.</P>
<P>141 participants completed the study (50 EBF, 47 CF, 44 CF-M). 20% of infants weighed less than 2500 g at birth. The groups were similar in infant birthweight and sex; maternal age, weight, BMI, education, and marital status; and household income. Mothers in the CF-M group were less likely to have received prenatal care than mothers in the 2 other groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-29 18:38:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>For RCT part of study n = 128 at 4 months (study commencement). By the end of study, 9 (8 in the EBF group) had dropped out with 119 completing study to 6 months. Mothers in the EBF group dropped out because: they moved away (n = 3), they went back to work (n = 2), they never intended to exclusively breastfeed (n = 1), they felt they were losing too much weight (n = 1). The 1 participant who dropped out of the CF group did so because she did not want to continue.</P>
<P>There were no significant differences between the 119 participants and the 9 dropouts in infant sex, gestational age, ponderal index, or weight and length gains from birth to 16 weeks, nor in maternal height, BMI, income or prenatal care.</P>
<P>However, dropouts had significantly lower birth weights, head circumferences, Apgar scores at 5 min, and maternal ages.</P>
<P>Of those who remained in the study through 6 months, 44% were male, and mean values were 2364 +/- 137 g for birthweight, 23.3 +/- 3.3 kg/m<SUP>2 </SUP>for maternal BMI, and 5.7 +/- 2.7 years for maternal education.</P>
<P>The sample sizes at 4 and 6 months for the blood indices analysed using frozen samples were smaller than those analysed immediately (Hb, Hct and MCV) because of a robbery (of the freezer with contents) at the Honduras facility near the end of data collection. This resulted in a loss of approximately 30% of the 4-month samples and approximately 30% of the 6-month samples. To determine whether these losses introduced bias, the authors evaluated whether the characteristics of those with lost samples at 4 or 6 months differed from those with complete data in either intervention group. There was little indication that the loss of samples introduced bias in interpreting the effect of the intervention. Nevertheless, data were analysed in 2 ways: considering only those with information available at both 4 and 6 months, and considering all samples available at 6 months.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-06-02 09:12:09 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>1-3 infants were missing data at various follow-up time points according to the published table with no information regarding which group, or if the same participants were missing data at multiple points, or different participants at each point. Information requested from trialist but was not available. Outcomes in trial protocol did not fully match outcomes reported in publication.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-28 13:52:23 +0100" MODIFIED_BY="Genevieve Becker" RESULT="YES" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>A total of 119 (n = 61 in CF group, n = 58 in EBF group) mother-infant pairs were recruited, of whom 100 completed the trial protocol.</P>
<P>CF group</P>
<P>10 pairs discontinued the intervention (n = 3 infant did not receive CF; n = 3 infant did not want CF; n = 1 mother stopped breastfeeding; n = 2 mother did not have time to finish study; n = 1 mother not contacted after randomisation).</P>
<P>EBF group</P>
<P>9 pairs discontinued the intervention (n = 7 infant received CF before 6 months; n = 1 mother wanted to leave study; n = 1 illness in family.</P>
<P>Also, after randomisation, 1 mother who was randomly assigned to the CF group was incorrectly instructed to the EBF group. The primary analysis was conducted with this mother included in the EBF group (n = 50 EBF, 50 CF) but reported outcomes for the baseline analyses with the participant in the CF group (n = 49 EBF, 51 CF).</P>
<P>The authors state that they were not able to test whether those who dropped out of the study were those with lower breast milk intakes - i.e. potentially a self-selected group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-08-28 18:05:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>F = 112 and B = 104 at start = 216. At 18 months F = 109 and B = 98 = 207. Loss F = 3 B = 6.</P>
<P>Followed-up at 5 years of age 183 of the 207 children. Loss 24 F = 95 (-14) B = 88 (-10).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-11-11 17:20:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>N = 180 (90 in each group). 3 children from the non glucose water group and 7 from the glucose water group were ineligible because of missing data or because it was impossible to assure correct transcription of data. Therefore 10 excluded = 5.5%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2010-11-11 17:21:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>4 mother/baby pairs defaulted from the 'no supplement' group because their babies were "too hungry" and were replaced by further randomised pairs. 2 infants were later excluded from the study because of: rhesus incompatibility (n = 1) and ABO incompatibility with positive haemolysins (n = 1). This reduced numbers in each group to: no supplement (n = 16); glucose supplement (n = 17); water supplement (n = 14).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-11-11 22:08:22 +0000" MODIFIED_BY="Tracey Remmington" RESULT="NO" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>Participation was voluntary, and those mothers who failed to adhere were excluded from the study.</P>
<P>Of the 180 mothers chosen for the study, 105 kept strictly to the instructions. 60/105 were on the colostrum regimen (57%) and 45 were on glucose water (43%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-07-19 12:12:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>&#8220;43 participants in the standard-introduction group and 69 participants in the early-introduction group withdrew voluntarily from the study. Reasons given were as follows: concerns about the blood tests (SIG 0, EIG 2), emigration (SIG 10, EIG 12), expenses (SIG 1, EIG 1), family health issues (SIG 3, EIG 0), family issues (SIG 2, EIG 4), no reason given (SIG 11, EIG 16), lost contact with family (SIG 15, EIG 28), too far to travel for study assessments (SIG 0, EIG 1) and unhappy participating in the study (SIG 1, EIG 5).&#8221;</P>
<P>&#8220;Only 31.9% (208/652) of all the enrolled early-introduction group participants were primary outcome evaluable and adhered to the protocol versus 80.5% (524/651) in the standard-introduction group.&#8221; With detailed explanation reported in NEJM appendix.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-05-07 20:28:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>No reference to dropouts reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-07-25 16:02:44 +0100" MODIFIED_BY="Heather Maxwell" RESULT="YES" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>2 dropped out from each group and reasons were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-08-29 18:38:32 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:17:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>Lack of definition of breastfeeding and particularly of EBF. The rates of EBF dropped from week 1 to 1 month then increased in the both groups in month 2 and dropped in month 3. This implies the definition of EBF was not in accordance with WHO guidelines. The control group of EBF may have received infant formula as only 53% of this group were exclusively breastfeeding by the end of week 1 and the amount of formula used in the control group in the first week was over double the amount used in the intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-29 18:38:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>In protocol states under secondary outcomes: "3. Occurrence of upper respiratory infections and diarrhoea episodes (dichotomous variables)".</P>
<P>But in Wells paper states "Finally, our study was designed to evaluate growth and energy intake and not other issues such as development of dietary preferences, mineral status, or effects on health such as diarrhoea and allergy".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:14:07 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>All outcomes mentioned in the methods are reported. No protocol or raw data available.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:12:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Protocol published and very extensive appendices on-line with additional data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:58:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>Data on all the outcomes mentioned in the 'Methods' section of the published papers were reported. We did not retrieve the protocol or raw data of the trial and thus did not identify whether outcomes other than those reported within the published papers were collected but not reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:31:21 +0100" MODIFIED_BY="Gen Becker" RESULT="UNKNOWN" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>Measured and recorded clinical outcomes that were not pre-determined as study outcomes in the registered protocol.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-08-28 13:50:18 +0100" MODIFIED_BY="Genevieve Becker" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:06:39 +0100" MODIFIED_BY="Gen Becker" RESULT="NO" STUDY_ID="STD-Cohen-1994">
<DESCRIPTION>
<P>No power calculation was done to determine the study's sample size. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:01:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dewey-1999">
<DESCRIPTION>
<P>No issues.</P>
<P>"The target sample size was 56 per group, which was based on detecting a difference between groups of &#8805;15% in weight or length gain between 4 and 6 mo by using SDs for these outcomes for the 28 low-birth-weight infants in our previous study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-08-28 13:50:18 +0100" MODIFIED_BY="Genevieve Becker" RESULT="NO" STUDY_ID="STD-Flaherman-2013">
<DESCRIPTION>
<P>Protocol as ClinicalTrials.gov Identifier NCT00952328 listed primary outcome as: Is infant receiving exclusively breast milk at 8 days of life, published paper refers to &#8220;1 week&#8221;. Protocol &#8220;Both groups will receive intensive lactation support&#8221; &#8211; published report does not mention &#8220;intensive&#8221; support.</P>
<P>Small sample size. Only 62% of those replying (6 out of 40 did not reply) at the start of the intervention had planned to exclusively breastfeed which may have affected their motivation to comply with the allocation. There were more multiparous women in the intervention group than the control group (70% vs 50%) and previous experience of breastfeeding is a well-established predictor of subsequent feeding.</P>
<P>Effect on weight was an outcome however, the study did not specifically weigh infants; used hospital routine weights, and only reported loss, not gain.</P>
<P>Inclusion criteria was weight loss of &#8805; 5% though this is well within the range of normality, and no infant in the study had a medical reason for supplementation. Unclear what was the support provided for breastfeeding, if mothers were instructed regarding how often to feed, to express milk if infant was not feeding well, etc. No information on birth practices that may have affected commencing breastfeeding. No definition of a &#8220;feed&#8221; thus the instruction to give the 10 mL of supplement &#8220;after each feed&#8221; could be 8 times, 12 times or more and thus variable quantities consumed. As supplement was given by syringe the infant was not able to refuse the supplement if already content with the amount of breast milk received.</P>
<P>Funding: supported by grants 5 K12 HD052 and 1K23HD059818-01A1 from the National Institute of Children Health and Human Development. One of the trialists has served as a paid consultant to 4 companies in the formula industry including the company producing the supplemental formula used in the intervention. Report does not state if formula was supplied by the company or purchased; some participants were provided with small amounts of the formula to continue supplementation for a short time after discharge from hospital ("about 12 ounces" from additional information from trialists).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:12:30 +0100" MODIFIED_BY="Gen Becker" RESULT="YES" STUDY_ID="STD-Jonsdottir-2012">
<DESCRIPTION>
<P>Stated that the study sponsors (Mead Johnson and the Eimskip Fund of the University of Iceland) had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication. None of the authors declared a conflict of interest.</P>
<P>"Our sample size of 50 mother-infant pairs who completed their participation in each group (n = 100) was based on primary outcome of the study, breast-milk intake. That sample size allowed for the detection of an effect size of 0.6 between the 2 groups with 5% significance level (2-sided comparison) and 80% power.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:07:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lindfors-1988">
<DESCRIPTION>
<P>No evidence that power calculation was undertaken to determine sample size.</P>
<P>&#8220;when the mother's breastmilk production started&#8221; &#8211; does this mean Lactogenesis II or colostrum?</P>
<P>&#8220;Both groups were breastfed as soon as the mother&#8217;s lactation started&#8221; &#8211; did breastfeeding group get any water/glucose water or other fluids? Published paper refers to the examination of feeding originally was started "in order to reduce the starvation period for these infants" which suggests either babies did not have access to colostrum or the value of colostrum was not recognised in the maternity unit.</P>
<P>High number of outcome assessors working independently. Diagnosis of allergy based on clinical criteria with no lab testing at 18 months.</P>
<P>A family history of allergy was higher in the breastfeeding group than in the early artifical formula group. "In the F-group 31 children (29%) had a single and 19 (17%) a double heredity. In the B-group 39 infants (40%) had a single and 18 (18%) a double family history of allergy."</P>
<P>Non-commercial funding was reported in the follow-up paper.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-25 16:00:50 +0100" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Martin_x002d_Calama-1997">
<DESCRIPTION>
<P>Some information on partial or EBF was obtained via telephone conversations (maternal recall of illness symptoms) and this is open to recall bias.</P>
<P>"Sample size for this study was calculated on the babies of the least exact quantitative variable (blood glucose), with a 95% conference level and an exactness of ± 1SD. Under these conditions, the minimum size required for the sample was 162. To cover the possibility of attrition, the sample was increased by 10% to 180 cases."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:22:01 +0100" MODIFIED_BY="Gen Becker" RESULT="NO" STUDY_ID="STD-Nicoll-1982">
<DESCRIPTION>
<P>No evidence that a power calculation was undertaken to determine sample size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:22:14 +0100" MODIFIED_BY="Gen Becker" RESULT="NO" STUDY_ID="STD-Ojofeitimi-1982">
<DESCRIPTION>
<P>No evidence that a power calculation was undertaken to determine sample size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-19 12:13:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perkin-2016">
<DESCRIPTION>
<P>Adherence to protocol was low in the intervention group (43%). Triallists also reported the per-protocol results/dose response analysis as well as the ITT. Reasons for low adherence require more exploration rather than assume per-protocol results are more true than ITT and not a reverse causality effect.</P>
<P>States no commercial funding.</P>
<P>Clarification from trialists: "The trial has 80% power to detect a 50% relative reduction in the absolute prevalence of food allergy by three years of age (from 8% in the SIG to 4% in the EIG) assuming a 15% drop out rate".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-06-02 09:29:24 +0100" MODIFIED_BY="Gen Becker" RESULT="NO" STUDY_ID="STD-Schutzman-1986">
<DESCRIPTION>
<P>No evidence that a power calculation was undertaken to determine sample size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-25 16:03:47 +0100" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-Stra_x0148__x00e1_k-2016">
<DESCRIPTION>
<P>No information on overall hospital maternity population and cannot assess for selection bias.</P>
<P>Publication implies that protocol was written and registered <I>after </I>the trial finished.</P>
<P>Unclear definitions. Definitions of EBF varied. Trialists replied:</P>
<P>"The definitions varied in the time of data collection and the length of time considered for exclusive breastfeeding. Data collection &#8220;during hospitalization&#8221; considered the whole time from study enrolment to discharge from hospital. Only newborns who have not received any supplement during the entire time of this period were classified as exclusively breastfed. Data collection &#8220;at the point of discharge&#8221; was performed at the time of discharge home and babies were considered as exclusively breastfed if no supplement was given for at least 24 hours with adequate weight gain.... Mothers were interviewed at the time point of 3 and 6 months of age of their infant...Infants were classified as exclusively breastfed if no supplement formula was given for at least 24 hours."</P>
<P>Review authors queried the definition of a "feed". It is common for infants in the first few days to go to the breast 10-12 or more times in 24 hours; if the infant went to the breast 12 times, did the infant get 12 supplements of 10 ml? Trialists replied: "Breastfeeding on demand is supported within our hospital and was enabled for all unless the mother wished otherwise, however newborns in the CLF group only received supplemental feed of 10 ml after breastfeeding every 3 hours, i.e. 8 times in 24 hours".</P>
<P>Review authors queried: what was the definition of &#8216;adequate milk production&#8217; and who decided that &#8216;adequate milk production&#8217; had started? Trialists replied: "Mothers were checked for expressing milk and adequate milk production each day by experienced specialised nurse, although this was not done quantitatively".</P>
<P>Review authors queried Why was weight loss of 5% used? Trialists replied: "As per the standard guideline of our hospital, weight loss of &gt;10% of birth weight is considered as excessive and measures to prevent risk of dehydration are taken including begin of supplemental formula feeds. Thus weight loss of <B>&#8805;</B>5% of birth weight at the age of 24-48 hours was considered most suitable as inclusion criterion to select newborns who may be at risk, yet who are still within &#8220;normal limits&#8221; for physiological weight loss that does not strictly require intervention".</P>
<P>Trialist replied that artificial formula filled syringes were not provided by manufacturer and prepared in the maternity unit. The published paper lists funded by PRVOUK32. The Charles University Research Development Schemes.</P>
<P>"For the given effect size (population proportions of 0.95 versus 0.75) and alpha (0.052-tailed) with power of 0.80, the estimated sample sizes are 49 in each group. This means that 80% of studies would be expected to yield a significant effect, rejecting the null hypothesis that the two population proportions are equal."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-07-25 16:15:06 +0100" MODIFIED_BY="Heather Maxwell">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-07-25 16:12:33 +0100" MODIFIED_BY="Heather Maxwell" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-06-22 10:11:21 +0100" MODIFIED_BY="[Empty name]">Non-exclusive breastfeeding (artificial milk) versus exclusive breastfeeding</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Non-exclusive breastfeeding (artificial milk) versus exclusive breastfeeding</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>healthy breastfeeding full-term infants<BR/>
<B>Setting: </B>hospital settings USA, Sweden and the Czech Republic<BR/>
<B>Intervention: </B>non-exclusive breastfeeding infants (artificial milk)<BR/>
<B>Comparison: </B>exclusive breastfeeding infants</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with exclusive breastfeeding infants</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with non-exclusive breastfeeding infants (artificial milk)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Any breastfeeding at discharge</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
<P>RR 1.02 (0.97 to 1.08)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>100<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2, 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>980 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
<P>1000 per 1000</P>
<P>(951 to 1000)</P>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Any breastfeeding at 3 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.21<BR/>(1.05 to 1.41)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>137<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2, 4, 5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>765 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>925 per 1000<BR/>(803 to 1000)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Infant morbidity - allergy symptoms - Infants with allergy symptoms at 18 months of age</P>
</TD>
<TD COLSPAN="2">
<P>Study population</P>
</TD>
<TD ROWSPAN="2">
<P>RR 0.56<BR/>(0.35 to 0.91)</P>
</TD>
<TD ROWSPAN="2">
<P>207<BR/>(1 RCT)</P>
</TD>
<TD ROWSPAN="2">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>5, 7</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>327 per 1000</P>
</TD>
<TD>
<P>183 per 1000<BR/>(114 to 297)</P>
</TD>
</TR>
<TR>
<TD>
<P>Weight change</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>This outcome was not reported.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Maternal self-confidence</P>
<P>Modified breastfeeding self-efficacy score at 1 week. Items rated on a scale from 1 (&#8220;Strongly Disagree&#8221;) to 5 (&#8220;Strongly Agree&#8221;), with positive scores associated with increased breastfeeding self-efficacy.</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal self-confidence was 3.9 units (SD 0.7) n = 20</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean maternal self-confidence in the artificial milk group was 0.1 units higher on a 5-point scale (95% CI 0.34 lower to 0.54 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>39<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2, 6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Modified breastfeeding self-efficacy score at 1 week. Items rated on a scale from 1 (&#8220;Strongly Disagree&#8221;) to 5 (&#8220;Strongly Agree&#8221;) with higher scores associated with more breastfeeding self-efficacy</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Control group had low adherence to the study protocol (-1).</P>
<P>
<SUP>2</SUP> We are unsure of the impact of the recruitment of only infants with greater than or equal to 5% weight loss as 5% is within normal expected range.</P>
<P>
<SUP>3</SUP> Wide confidence intervals crossing the line of no effect and small sample size (-1).</P>
<P>
<SUP>4</SUP> 1 trial had baseline imbalances in multiparity.</P>
<P>
<SUP>5</SUP> Evidence based on small sample size (-1).</P>
<P>
<SUP>6</SUP> Confidence intervals crossing the line of no difference and small sample size (-1).</P>
<P>
<SUP>7</SUP> 1 trial with quasi-random sequence generation, baseline imbalances for family history of allergy, 1 infant was changed from its allocated group due to family history of allergy, unclear if exclusive breastfeeding group received water or colostrum in the first 48 hours, high number of outcome assessors working independently and diagnosis of allergy was based on clinical criteria with no diagnostic testing</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2016-07-25 16:15:06 +0100" MODIFIED_BY="Heather Maxwell" NO="2" READONLY="YES">
<TITLE MODIFIED="2016-06-23 21:57:28 +0100" MODIFIED_BY="[Empty name]">Non-exclusive breastfeeding (water or glucose water) versus exclusive breastfeeding</TITLE>
<TABLE COLS="7" ROWS="17">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Non-exclusive breastfeeding (water or glucose water) versus exclusive breastfeeding</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>healthy breastfeeding full-term infants<BR/>
<B>Setting: </B>hospital setting in Spain and UK<BR/>
<B>Intervention: </B>non-exclusive breastfeeding infants (water or glucose water)<BR/>
<B>Comparison: </B>exclusive breastfeeding infants</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
<P>Risk with exclusive breastfeeding infants</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
<P>Risk with non-exclusive breastfeeding infants (water)</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Any breastfeeding at 12 weeks</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.68<BR/>(0.53 to 0.87)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>170<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Estimated from the graph the percentage of mothers breastfeeding at each time period (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>747 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>508 per 1000<BR/>(396 to 650)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Hypoglycaemia episodes at 12 hours of life (glycaemia &lt; 2.2 mmol/L)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>
<BR/>
</P>
<P>RR 0.07 (0.00 to 1.20)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>170<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1, 3, 4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Trialists used a cut-off point as serum glucose less than 2.2 mmol/L whereas some researchers define a lower cut-off level (1.7 mmol/L). Trialists report there was no case of serum glucose levels under 1.7 mmol/L in either of the 2 groups and no cases presented hypoglycaemic symptoms.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
<P>80 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
<P>6 per 1000<BR/>(0 to 97)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Hypoglycaemia episodes at 24 hours of life (glycaemia &lt; 2.2 mmol/L)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.57<BR/>(0.27 to 9.17)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>170<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1, 3, 4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Trialists used a cut-off point as serum glucose less than 2.2 mmol/L whereas some researchers define a lower cut-off level (1.7 mmol/L). Trialists report there was no case of serum glucose levels under 1.7 mmol/L in either of the 2 groups and no cases presented hypoglycaemic symptoms.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>23 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>36 per 1000<BR/>(6 to 211)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Weight change (loss) (g) at 48 hours</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean weight loss (g) at 48 hours was 197.8 g (SD 73.2)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Infants with additional fluids (water) were on average (MD) 32.5 g heavier (less weight lost) (CI 12.91 g heavier to 52.09 g heavier)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>170<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>This mean difference of 32.5 g is not clinically meaningful.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Weight change (loss) (g) at 72 hours</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean weight loss (g) at 72 hours was 141.9 g (SD 89.1)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Infants with additional fluids (water) were on average (MD) 3 g lighter (more weight lost) (CI 26.83 g lighter to 20.83 heavier)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>170<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1, 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Weight loss (%) day 3</P>
<P>(percentage of birthweight)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean weight loss (%) day 3 was 6% of birthweight</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Infants with additional fluids (water) lost on average (MD) 1.03% less of their birthweight (CI 2.24% less to 0.18% more weight lost)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>47<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1, 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>We combined the glucose and water supplement arms of the <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK> trial.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Weight loss (%) day 5</P>
<P>(percentage of birthweight)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean weight loss (%) day 5 was 4.3% of birthweight</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Infants with additional fluids (water) lost on average (MD) 0.2% less of their birthweight (CI 0.86% less to 0.46% more weight lost)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>47<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1, 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>We combined the glucose and water supplement arms of the <LINK REF="STD-Nicoll-1982" TYPE="STUDY">Nicoll 1982</LINK> trial.</P>
</TD>
</TR>
<TR>
<TD>
<P>Confidence in breastfeeding (maternal or of those influencing the mother)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>This outcome was not reported.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>MD: </B>mean difference; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> 1 trial with no information on sequence generation or allocation concealment (-1).</P>
<P>
<SUP>2</SUP> Evidence based on small sample size (-1).</P>
<P>
<SUP>3</SUP> Wide confidence intervals crossing the line of no effect and small sample size (-2).</P>
<P>
<SUP>4</SUP> Few events</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2016-07-25 16:14:53 +0100" MODIFIED_BY="Heather Maxwell" NO="3" READONLY="YES">
<TITLE MODIFIED="2016-06-23 20:22:00 +0100" MODIFIED_BY="[Empty name]">Non-exclusive breastfeeding (foods) versus exclusive breastfeeding</TITLE>
<TABLE COLS="7" ROWS="17">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Non-exclusive breastfeeding (foods) versus exclusive breastfeeding</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>healthy breastfeeding full-term infants<BR/>
<B>Setting:</B>home setting in Honduras, Iceland and the UK<BR/>
<B>Intervention: </B>non-exclusive breastfeeding infants (foods)<BR/>
<B>Comparison: </B>exclusive breastfeeding infants</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
<P>Risk with Exclusive breastfeeding infants</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
<P>Risk with non-exclusive breastfeeding infants (foods)</P>
</TH>
</TR>
<TR>
<TD>
<P>Duration of breastfeeding (at different time points)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>This outcome was not reported in a format that could be analysed.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Fever (% of days) - 4 to 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean fever (% of days) - 4 to 6 months was 8% days (SD 7.2)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Infants with additional foods had a fever on average 0.7% of days lower (CI 3.4% fewer to 2% more days)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>119<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1, 2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8220;Food allergy&#8221; to 1 or more foods between 1 to 3 years of age</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.80<BR/>(0.51 to 1.25)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1162<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>There was low adherence to the protocol in the intervention group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>71 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>56 per 1000<BR/>(36 to 88)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Visible eczema at 12-month visit stratified by visible eczema at enrolment</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.86<BR/>(0.51 to 1.44)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>284<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>There was low adherence to the protocol in the intervention group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>182 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>156 per 1000<BR/>(93 to 262)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Food protein enterocolitis syndrome positive response to challenge (number of children)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 2.00<BR/>(0.18 to 22.04)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1303<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>There was low adherence to the protocol in the intervention group</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000<BR/>(0 to 34)</P>
</TD>
</TR>
<TR>
<TD>
<P>Weight change (gain) (g) - 4 to 6 months</P>
</TD>
<TD>
<P>The mean weight change (gain) (g) at 4 to 6 months was 1054 g</P>
</TD>
<TD>
<P>Infants with additional foods gained on average (MD) 39.48 g less weight (CI 128.43 g less to 49.48 g more weight gain)</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>260<BR/>(2 RCTs)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1 2</SUP>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Weight change (z score)</P>
<P>as standard deviations of an overall population distribution of infant weight gain at 4 - 6 months</P>
</TD>
<TD>
<P>The mean weight change (z score) was 0.01 standard deviations less weight gained</P>
</TD>
<TD>
<P>The mean weight change for infants with additional foods was 0.01 standard deviations less weight gained (0.15 standard deviations less weight gained to 0.13 standard deviations more weight gained)</P>
</TD>
<TD>
<P>-</P>
</TD>
<TD>
<P>100<BR/>(1 RCT)</P>
</TD>
<TD>
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>3</SUP>
</P>
</TD>
<TD>
<P>The differences in weight change from 4 to 6 months are negligible between the groups</P>
</TD>
</TR>
<TR>
<TD>
<P>Confidence in breastfeeding (maternal or of those influencing the mother)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>This outcome was not reported in a format that could be analysed.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>MD: </B>mean difference; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Quasi-random sequence generation (by week of birth) (-1).</P>
<P>
<SUP>2</SUP> Wide confidence interval crossing the line of no effect and small sample size (-1).</P>
<P>
<SUP>3</SUP> Estimate based on small sample size (-1).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2014-11-17 18:36:56 +0000" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-11-17 18:36:56 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<TITLE MODIFIED="2010-09-02 21:54:25 +0100" MODIFIED_BY="[Empty name]">Martin-Calama 1997. Primary outcome: breastfeeding duration</TITLE>
<TABLE COLS="3" ROWS="6">
<TR>
<TD>
<P>% of mothers who continued either exclusive or partial breastfeeding</P>
</TD>
<TD>
<P>Exclusive breastfeeding on day 1-3 group (non-glucose water) (n = 87)</P>
</TD>
<TD>
<P>Glucose water on day 1-3 (n = 83)</P>
</TD>
</TR>
<TR>
<TD>
<P>At 4 weeks</P>
</TD>
<TD>
<P>93%</P>
</TD>
<TD>
<P>77%</P>
</TD>
</TR>
<TR>
<TD>
<P>At 8 weeks</P>
</TD>
<TD>
<P>81%</P>
</TD>
<TD>
<P>64%</P>
</TD>
</TR>
<TR>
<TD>
<P>At 12 weeks</P>
</TD>
<TD>
<P>75%</P>
</TD>
<TD>
<P>51%</P>
</TD>
</TR>
<TR>
<TD>
<P>At 16 weeks</P>
</TD>
<TD>
<P>67%</P>
</TD>
<TD>
<P>43%</P>
</TD>
</TR>
<TR>
<TD>
<P>At 20 weeks</P>
</TD>
<TD>
<P>57%</P>
</TD>
<TD>
<P>40%</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>These figures were estimated from a graph (Figure 2) on page 212 of the <LINK REF="STD-Martin_x002d_Calama-1997" TYPE="STUDY">Martin-Calama 1997</LINK> paper.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-08-28 14:00:30 +0100" MODIFIED_BY="Genevieve Becker">
<COMPARISON ID="CMP-001" MODIFIED="2016-07-25 13:55:07 +0100" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Non-exclusive breastfeeding infants (artificial milk) versus exclusive breastfeeding infants</NAME>
<DICH_OUTCOME CHI2="48.496909801284104" CI_END="1.3067675603307651" CI_START="1.1282790579617639" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2142481097143978" ESTIMABLE="YES" EVENTS_1="241" EVENTS_2="197" I2="87.62807769693991" I2_Q="76.96812722645372" ID="CMP-001.01" LOG_CI_END="0.11619834485435677" LOG_CI_START="0.05241652725749921" LOG_EFFECT_SIZE="0.084307436055928" METHOD="MH" MODIFIED="2016-07-25 13:55:07 +0100" MODIFIED_BY="Heather Maxwell" NO="1" P_CHI2="9.400575096130126E-9" P_Q="0.0016398002672957102" P_Z="2.2022726038282638E-7" Q="17.367237303404522" RANDOM="NO" SCALE="1.7" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="258" TOTAL_2="256" WEIGHT="500.0" Z="5.18139948105441">
<NAME>Breastfeeding duration</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0779169651380869" CI_START="0.9655773085368866" DF="0" EFFECT_SIZE="1.02020202020202" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="49" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.03258530725957012" LOG_CI_START="-0.015212948889384915" LOG_EFFECT_SIZE="0.00868617918509262" MODIFIED="2016-06-08 09:31:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.47624666311952935" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.7123522796726637">
<NAME>Any breastfeeding at discharge</NAME>
<DICH_DATA CI_END="1.0779169651380869" CI_START="0.9655773085368866" EFFECT_SIZE="1.02020202020202" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="49" LOG_CI_END="0.03258530725957012" LOG_CI_START="-0.015212948889384915" LOG_EFFECT_SIZE="0.00868617918509262" MODIFIED="2016-06-08 09:31:22 +0100" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.02807693226708008" STUDY_ID="STD-Stra_x0148__x00e1_k-2016" TOTAL_1="50" TOTAL_2="50" VAR="7.883141255302026E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2428147625601318" CI_START="0.9978847916631649" DF="0" EFFECT_SIZE="1.1136363636363635" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="44" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.09440640330543934" LOG_CI_START="-9.19596220786974E-4" LOG_EFFECT_SIZE="0.046743403542326194" MODIFIED="2016-06-08 09:31:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05458701162048143" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.00000000000001" Z="1.9221490026459334">
<NAME>Exclusive breastfeeding in 24 hours prior to discharge</NAME>
<DICH_DATA CI_END="1.2428147625601318" CI_START="0.9978847916631649" EFFECT_SIZE="1.1136363636363635" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="44" LOG_CI_END="0.09440640330543934" LOG_CI_START="-9.19596220786974E-4" LOG_EFFECT_SIZE="0.046743403542326194" MODIFIED="2016-06-08 09:31:28 +0100" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.05599496399301326" STUDY_ID="STD-Stra_x0148__x00e1_k-2016" TOTAL_1="50" TOTAL_2="50" VAR="0.0031354359925788514" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.6842120862468235" CI_START="1.0893699551470977" DF="0" EFFECT_SIZE="1.71" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.42881682753560985" LOG_CI_START="0.03717539324869777" LOG_EFFECT_SIZE="0.23299611039215382" MODIFIED="2016-07-25 13:54:56 +0100" MODIFIED_BY="Heather Maxwell" NO="3" P_CHI2="1.0" P_Z="0.01969798534127886" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="19" WEIGHT="100.00000000000001" Z="2.332051437499299">
<NAME>Exclusive breastfeeding at 1 week (previous 24 hours)</NAME>
<DICH_DATA CI_END="2.6842120862468235" CI_START="1.0893699551470977" EFFECT_SIZE="1.71" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" LOG_CI_END="0.42881682753560985" LOG_CI_START="0.03717539324869777" LOG_EFFECT_SIZE="0.23299611039215382" MODIFIED="2016-06-08 09:31:43 +0100" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.23005211715649812" STUDY_ID="STD-Flaherman-2013" TOTAL_1="20" TOTAL_2="19" VAR="0.05292397660818714" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.338893168801821" CI_END="1.7674393091024274" CI_START="1.1546740620853433" DF="1" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="42" I2="76.95264757403214" ID="CMP-001.01.04" LOG_CI_END="0.24734450978183528" LOG_CI_START="0.06245941018965111" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2016-07-25 13:55:07 +0100" MODIFIED_BY="Heather Maxwell" NO="4" P_CHI2="0.03725133400770986" P_Z="0.001022627358719051" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="69" WEIGHT="100.0" Z="3.284226401980484">
<NAME>Exclusive breastfeeding at 3 months (previous 24 hours)</NAME>
<DICH_DATA CI_END="3.8525441717451376" CI_START="1.3140666983467117" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="8" LOG_CI_END="0.5857476268674702" LOG_CI_START="0.11861740935525485" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2016-06-08 09:32:14 +0100" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="0.27439460209854477" STUDY_ID="STD-Flaherman-2013" TOTAL_1="19" TOTAL_2="19" VAR="0.07529239766081872" WEIGHT="19.047619047619047"/>
<DICH_DATA CI_END="1.5475504437063465" CI_START="0.9860431776548803" EFFECT_SIZE="1.2352941176470589" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="34" LOG_CI_END="0.18964481411623554" LOG_CI_START="-0.006104067404944806" LOG_EFFECT_SIZE="0.09177037335564536" MODIFIED="2016-06-08 09:32:32 +0100" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.11498386197813223" STUDY_ID="STD-Stra_x0148__x00e1_k-2016" TOTAL_1="50" TOTAL_2="50" VAR="0.013221288515406163" WEIGHT="80.95238095238095"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.35869062602811846" CI_END="1.4065246485162608" CI_START="1.0464756702524625" DF="1" EFFECT_SIZE="1.2132163138874548" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="52" I2="0.0" ID="CMP-001.01.05" LOG_CI_END="0.1481473473229771" LOG_CI_START="0.0197291357822738" LOG_EFFECT_SIZE="0.08393824155262544" MODIFIED="2016-06-08 09:32:52 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.549234563599372" P_Z="0.01040143904482882" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="68" WEIGHT="99.99999999999999" Z="2.5621900257756587">
<NAME>Any breastfeeding at 3 months</NAME>
<DICH_DATA CI_END="1.7803854289286907" CI_START="0.9664559911271574" EFFECT_SIZE="1.311740890688259" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="13" LOG_CI_END="0.25051403126215843" LOG_CI_START="-0.014817917368265718" LOG_EFFECT_SIZE="0.11784805694694639" MODIFIED="2016-06-08 09:32:43 +0100" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.15585730003983936" STUDY_ID="STD-Flaherman-2013" TOTAL_1="19" TOTAL_2="18" VAR="0.02429149797570851" WEIGHT="25.503355704697984"/>
<DICH_DATA CI_END="1.3957836481707302" CI_START="0.9967089157391057" EFFECT_SIZE="1.1794871794871795" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="39" LOG_CI_END="0.1448181061901958" LOG_CI_START="-0.0014316568800460893" LOG_EFFECT_SIZE="0.07169322465507488" MODIFIED="2016-06-08 09:32:52 +0100" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.08590783477546299" STUDY_ID="STD-Stra_x0148__x00e1_k-2016" TOTAL_1="50" TOTAL_2="50" VAR="0.007380156075808247" WEIGHT="74.496644295302"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.9149713578787095" CI_START="0.34510534920565894" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5619266055045872" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.03859250080778177" LOG_CI_START="-0.46204830900032523" LOG_EFFECT_SIZE="-0.25032040490405355" METHOD="MH" MODIFIED="2016-07-11 15:53:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.02049204778658688" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="109" TOTAL_2="98" WEIGHT="100.0" Z="2.317214541472749">
<NAME>Allergy symptoms</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive bf</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9149713578787095" CI_START="0.34510534920565894" DF="0" EFFECT_SIZE="0.5619266055045872" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="32" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-0.03859250080778177" LOG_CI_START="-0.46204830900032523" LOG_EFFECT_SIZE="-0.25032040490405355" MODIFIED="2016-06-08 09:59:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.02049204778658688" STUDIES="1" TAU2="0.0" TOTAL_1="109" TOTAL_2="98" WEIGHT="100.0" Z="2.317214541472749">
<NAME>Infants with allergy symptoms at 18 months of age</NAME>
<DICH_DATA CI_END="0.9149713578787094" CI_START="0.34510534920565894" EFFECT_SIZE="0.5619266055045872" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="32" LOG_CI_END="-0.038592500807781815" LOG_CI_START="-0.46204830900032523" LOG_EFFECT_SIZE="-0.25032040490405355" MODIFIED="2016-06-08 09:59:37 +0100" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.24874003787235668" STUDY_ID="STD-Lindfors-1988" TOTAL_1="109" TOTAL_2="98" VAR="0.06187160644074144" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.362075880786862" CI_START="0.8288130389239684" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.13420130264949368" LOG_CI_START="-0.08154342520479536" LOG_EFFECT_SIZE="0.02632893872234915" METHOD="MH" MODIFIED="2016-07-11 15:53:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.6323811516196689" Q="0.0" RANDOM="NO" SCALE="397.41" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="19" WEIGHT="100.0" Z="0.47837805503009867">
<NAME>Incidence of fever</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.362075880786862" CI_START="0.8288130389239684" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.13420130264949368" LOG_CI_START="-0.08154342520479536" LOG_EFFECT_SIZE="0.02632893872234915" MODIFIED="2016-06-08 09:39:24 +0100" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.126729521095236" STUDY_ID="STD-Flaherman-2013" TOTAL_1="19" TOTAL_2="19" VAR="0.01606037151702787" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.5395280904245776" CI_START="-0.33952809042457743" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2016-07-25 13:54:37 +0100" MODIFIED_BY="Heather Maxwell" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.6556516958302522" Q="0.0" RANDOM="NO" SCALE="0.67" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="20" UNITS="" WEIGHT="99.99999999999999" Z="0.4459246239863214">
<NAME>Maternal self-confidence - Modified breastfeeding self-efficacy score at 1 week</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5395280904245776" CI_START="-0.3395280904245775" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.9" MODIFIED="2016-07-11 13:17:41 +0100" MODIFIED_BY="[Empty name]" ORDER="38" SD_1="0.7" SD_2="0.7" SE="0.2242531464310156" STUDY_ID="STD-Flaherman-2013" TOTAL_1="19" TOTAL_2="20" WEIGHT="99.99999999999999">
<FOOTNOTE>Items rated on a scale from 1 (&#8220;Strongly Disagree&#8221;) to 5 (&#8220;Strongly Agree&#8221;), with higher scores associated with increased breastfeeding self-efficacy.</FOOTNOTE>
</CONT_DATA>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.99146782835324" CI_START="0.013903717501920699" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" METHOD="MH" MODIFIED="2016-07-11 15:53:22 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.497922686342418" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6777618841839292">
<NAME>Phototherapy in hospital or home</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.99146782835324" CI_START="0.013903717501920699" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9026265554350377" LOG_CI_START="-1.8568690648743624" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2016-06-08 09:55:13 +0100" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Stra_x0148__x00e1_k-2016" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-08-28 14:00:15 +0100" MODIFIED_BY="Genevieve Becker" NO="2">
<NAME>Non-exclusive breastfeeding infants (water) versus exclusive breastfeeding infants</NAME>
<DICH_OUTCOME CHI2="4.9396806584964805" CI_END="0.8147764024123838" CI_START="0.6677648451045087" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7376171352074966" ESTIMABLE="YES" EVENTS_1="228" EVENTS_2="324" I2="19.023105408245087" I2_Q="2.3318625121501073" ID="CMP-002.01" LOG_CI_END="-0.08896155754434819" LOG_CI_START="-0.17537644838287933" LOG_EFFECT_SIZE="-0.13216900296361375" METHOD="MH" MODIFIED="2016-07-11 13:18:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2935428807471784" P_Q="0.3932356642278326" P_Z="2.0296877125447837E-9" Q="4.095501463307425" RANDOM="NO" SCALE="26.17" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="415" TOTAL_2="435" WEIGHT="500.0" Z="5.9954131323335655">
<NAME>Breastfeeding duration</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.7834918850461507E-30" CI_END="0.9435812418764744" CI_START="0.726930568637848" DF="0" EFFECT_SIZE="0.8282016956715751" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="81" I2="100.0" ID="CMP-002.01.01" LOG_CI_END="-0.025220701349936238" LOG_CI_START="-0.13850706795449974" LOG_EFFECT_SIZE="-0.08186388465221801" MODIFIED="2016-06-08 10:07:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.004616402280717843" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.8326491591517797">
<NAME>Any breastfeeding at 4 weeks</NAME>
<DICH_DATA CI_END="0.9435812418764745" CI_START="0.726930568637848" EFFECT_SIZE="0.8282016956715752" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="81" LOG_CI_END="-0.025220701349936186" LOG_CI_START="-0.13850706795449974" LOG_EFFECT_SIZE="-0.08186388465221796" MODIFIED="2016-06-08 10:07:12 +0100" MODIFIED_BY="[Empty name]" ORDER="25" O_E="0.0" SE="0.0665449725200794" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.004428233367698122" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9617627981922661" CI_START="0.6548924829211875" DF="0" EFFECT_SIZE="0.793631669535284" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="70" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="-0.01693202581938147" LOG_CI_START="-0.18382999452246493" LOG_EFFECT_SIZE="-0.10038101017092319" MODIFIED="2016-06-08 10:07:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.018391221381436746" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.3576460060669806">
<NAME>Any breastfeeding at 8 weeks</NAME>
<DICH_DATA CI_END="0.9617627981922662" CI_START="0.6548924829211875" EFFECT_SIZE="0.793631669535284" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="70" LOG_CI_END="-0.016932025819381417" LOG_CI_START="-0.18382999452246493" LOG_EFFECT_SIZE="-0.10038101017092319" MODIFIED="2016-06-08 10:07:41 +0100" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.09803669297446042" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.009611193169368617" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8655021169790478" CI_START="0.5300124282935301" DF="0" EFFECT_SIZE="0.6772937905468026" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="65" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="-0.06273186552262043" LOG_CI_START="-0.2757139464822006" LOG_EFFECT_SIZE="-0.16922290600241047" MODIFIED="2016-06-08 10:08:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0018423082618384858" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="3.11454183966656">
<NAME>Any breastfeeding at 12 weeks</NAME>
<DICH_DATA CI_END="0.8655021169790478" CI_START="0.5300124282935301" EFFECT_SIZE="0.6772937905468026" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="65" LOG_CI_END="-0.06273186552262043" LOG_CI_START="-0.2757139464822006" LOG_EFFECT_SIZE="-0.16922290600241047" MODIFIED="2016-06-08 10:08:40 +0100" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.12510672863396133" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.015651693549491637" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8670790612622589" CI_START="0.48817174158408805" DF="0" EFFECT_SIZE="0.6506024096385542" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="58" I2="0.0" ID="CMP-002.01.04" LOG_CI_END="-0.0619413012498661" LOG_CI_START="-0.31142736385634473" LOG_EFFECT_SIZE="-0.1866843325531054" MODIFIED="2016-06-08 10:09:00 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.003355023522279259" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.933186443036867">
<NAME>Any breastfeeding at 16 weeks</NAME>
<DICH_DATA CI_END="0.8670790612622588" CI_START="0.48817174158408805" EFFECT_SIZE="0.6506024096385542" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="58" LOG_CI_END="-0.06194130124986615" LOG_CI_START="-0.31142736385634473" LOG_EFFECT_SIZE="-0.1866843325531054" MODIFIED="2016-06-08 10:09:00 +0100" MODIFIED_BY="[Empty name]" ORDER="28" O_E="0.0" SE="0.14654934815097284" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.021476711443475044" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9533015199436939" CI_START="0.5020418324815384" DF="0" EFFECT_SIZE="0.6918072289156626" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="50" I2="0.0" ID="CMP-002.01.05" LOG_CI_END="-0.020769714538284332" LOG_CI_START="-0.29926009389288916" LOG_EFFECT_SIZE="-0.16001490421558673" MODIFIED="2016-06-08 10:09:20 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.02430263601370292" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.2523108337098883">
<NAME>Any breastfeeding at 20 weeks</NAME>
<DICH_DATA CI_END="0.9533015199436939" CI_START="0.5020418324815384" EFFECT_SIZE="0.6918072289156626" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="50" LOG_CI_END="-0.020769714538284332" LOG_CI_START="-0.29926009389288916" LOG_EFFECT_SIZE="-0.16001490421558673" MODIFIED="2016-06-08 10:09:20 +0100" MODIFIED_BY="[Empty name]" ORDER="23" O_E="0.0" SE="0.16358662738250568" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.026760584658382755" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.009781597257484953" CI_START="-0.1902184027425179" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2016-06-15 20:09:17 +0100" MODIFIED_BY="Genevieve Becker" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.029820543244262233" Q="0.0" RANDOM="NO" SCALE="137.8473779095998" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="83" TOTAL_2="87" UNITS="" WEIGHT="100.0" Z="2.172465843951842">
<NAME>Maximum temperature (ºC)</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.009781597257484953" CI_START="-0.1902184027425179" DF="0" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" MODIFIED="2016-06-08 10:18:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.029820543244262233" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.172465843951842">
<NAME>At 72 hours</NAME>
<CONT_DATA CI_END="-0.009781597257484953" CI_START="-0.1902184027425179" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="37.3" MEAN_2="37.4" MODIFIED="2016-06-08 10:18:57 +0100" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="0.3" SD_2="0.3" SE="0.046030643141480004" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.02367681627634083" CI_START="-0.176323183723662" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2016-06-15 20:09:34 +0100" MODIFIED_BY="Genevieve Becker" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.010229309983942083" Q="0.0" RANDOM="NO" SCALE="132.284910007066" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="83" TOTAL_2="87" UNITS="" WEIGHT="100.0" Z="2.5679798573870065">
<NAME>Minimum temperature (ºC)</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.02367681627634083" CI_START="-0.176323183723662" DF="0" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2016-06-08 10:22:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.010229309983942083" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.5679798573870065">
<NAME>At 72 hours</NAME>
<CONT_DATA CI_END="-0.023676816276340842" CI_START="-0.176323183723662" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="36.5" MEAN_2="36.6" MODIFIED="2016-06-08 10:22:12 +0100" MODIFIED_BY="[Empty name]" ORDER="3" SD_1="0.2" SD_2="0.3" SE="0.03894111541114434" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="3.8225276938242208" CI_END="0.9480803726585941" CI_START="0.1598326959780142" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3892739934363243" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="17" I2="21.517900188221493" I2_Q="16.67406858116928" ID="CMP-002.04" LOG_CI_END="-0.023154844178236992" LOG_CI_START="-0.7963343750197579" LOG_EFFECT_SIZE="-0.4097446095989975" METHOD="MH" MODIFIED="2016-07-25 13:55:33 +0100" MODIFIED_BY="Heather Maxwell" NO="4" P_CHI2="0.2812769639449678" P_Q="0.30798233414293963" P_Z="0.03776868804724689" Q="3.6003197911113105" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="332" TOTAL_2="348" WEIGHT="400.0" Z="2.077356281792382">
<NAME>Episodes of hypoglycaemia (glycaemia &lt; 2.2 mmol/L)</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.10178952360009" CI_START="0.08363981820379571" DF="0" EFFECT_SIZE="0.41927710843373495" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.32258922295968107" LOG_CI_START="-1.077586919818667" LOG_EFFECT_SIZE="-0.377498848429493" MODIFIED="2016-06-08 10:26:53 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2905826294622763" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="1.056844384820056">
<NAME>At 6 hours of life</NAME>
<DICH_DATA CI_END="2.10178952360009" CI_START="0.08363981820379571" EFFECT_SIZE="0.41927710843373495" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.32258922295968107" LOG_CI_START="-1.077586919818667" LOG_EFFECT_SIZE="-0.377498848429493" MODIFIED="2016-06-08 10:26:53 +0100" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.8224703972516898" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.6764575543553524" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2038512106720702" CI_START="0.00405183209502938" DF="0" EFFECT_SIZE="0.06984126984126984" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.08057281385107627" LOG_CI_START="-2.3923485597858645" LOG_EFFECT_SIZE="-1.1558878729673943" MODIFIED="2016-06-08 10:27:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.06691496457678606" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="1.8322447493353329">
<NAME>At 12 hours of life</NAME>
<DICH_DATA CI_END="1.2038512106720702" CI_START="0.00405183209502938" EFFECT_SIZE="0.06984126984126984" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.08057281385107627" LOG_CI_START="-2.3923485597858645" LOG_EFFECT_SIZE="-1.1558878729673943" MODIFIED="2016-06-08 10:27:15 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.4526062560325614" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="2.110064935064935" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="9.173074374424328" CI_START="0.2694945109065933" DF="0" EFFECT_SIZE="1.572289156626506" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-002.04.03" LOG_CI_END="0.9625149147406871" LOG_CI_START="-0.5694500761442355" LOG_EFFECT_SIZE="0.19653241929822587" MODIFIED="2016-06-08 10:27:50 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6150493921567619" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="0.5028789377184697">
<NAME>At 24 hours of life</NAME>
<DICH_DATA CI_END="9.173074374424328" CI_START="0.2694945109065933" EFFECT_SIZE="1.572289156626506" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9625149147406871" LOG_CI_START="-0.5694500761442355" LOG_EFFECT_SIZE="0.19653241929822587" MODIFIED="2016-06-08 10:27:50 +0100" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="0.899883818994811" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="0.8097908876886857" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.2922047740194897" CI_START="0.03708113089251657" DF="0" EFFECT_SIZE="0.3493975903614458" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-002.04.04" LOG_CI_END="0.5174868403497301" LOG_CI_START="-1.430847029303966" LOG_EFFECT_SIZE="-0.45668009447711777" MODIFIED="2016-06-08 10:28:06 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.3581937814719931" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.00000000000001" Z="0.9188122750138245">
<NAME>At 48 hours of life</NAME>
<DICH_DATA CI_END="3.2922047740194897" CI_START="0.03708113089251657" EFFECT_SIZE="0.3493975903614458" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5174868403497301" LOG_CI_START="-1.430847029303966" LOG_EFFECT_SIZE="-0.45668009447711777" MODIFIED="2016-06-08 10:28:06 +0100" MODIFIED_BY="[Empty name]" ORDER="10" O_E="0.0" SE="1.1444609594427788" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" VAR="1.3097908876886857" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.8638965344236793" CI_END="0.4726987702585419" CI_START="0.2172641260930568" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.34498144817579934" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2016-07-25 13:55:46 +0100" MODIFIED_BY="Heather Maxwell" NO="5" P_CHI2="0.6011301991773739" P_Q="0.6011301991773739" P_Z="1.1958891677967648E-7" Q="1.8638965344236793" RANDOM="YES" SCALE="1.16" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="332" TOTAL_2="348" UNITS="" WEIGHT="400.0" Z="5.294123011136959">
<NAME>Mean capillary blood glucose levels of infants (mmol/L)</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours additional fluids</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5638700227572205" CI_START="0.016129977242779536" DF="0" EFFECT_SIZE="0.29000000000000004" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.01" MODIFIED="2016-06-08 10:35:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.03794957616167367" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.075398942148846">
<NAME>At 6 hours of life</NAME>
<CONT_DATA CI_END="0.5638700227572205" CI_START="0.016129977242779536" EFFECT_SIZE="0.29000000000000004" ESTIMABLE="YES" MEAN_1="3.68" MEAN_2="3.39" MODIFIED="2016-06-08 10:35:49 +0100" MODIFIED_BY="[Empty name]" ORDER="3" SD_1="0.93" SD_2="0.89" SE="0.1397321710589951" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7030336757710187" CI_START="0.2369663242289817" DF="0" EFFECT_SIZE="0.4700000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" MODIFIED="2016-06-08 10:41:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="7.717611838431741E-5" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="3.953004087010114">
<NAME>At 12 hours of life</NAME>
<CONT_DATA CI_END="0.7030336757710187" CI_START="0.2369663242289817" EFFECT_SIZE="0.4700000000000002" ESTIMABLE="YES" MEAN_1="3.73" MEAN_2="3.26" MODIFIED="2016-06-08 10:41:02 +0100" MODIFIED_BY="[Empty name]" ORDER="4" SD_1="0.77" SD_2="0.78" SE="0.1188969172949903" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5953240492456569" CI_START="0.08467595075434287" DF="0" EFFECT_SIZE="0.33999999999999986" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.03" MODIFIED="2016-06-08 10:41:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.009055053024904735" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.6099686132678444">
<NAME>At 24 hours of life</NAME>
<CONT_DATA CI_END="0.5953240492456569" CI_START="0.08467595075434287" EFFECT_SIZE="0.33999999999999986" ESTIMABLE="YES" MEAN_1="3.73" MEAN_2="3.39" MODIFIED="2016-06-08 10:41:36 +0100" MODIFIED_BY="[Empty name]" ORDER="5" SD_1="0.91" SD_2="0.78" SE="0.13026976580162722" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5051964915314741" CI_START="-0.02519649153147452" DF="0" EFFECT_SIZE="0.23999999999999977" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.04" MODIFIED="2016-06-08 10:42:21 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.07610508636370837" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="1.7737465287461587">
<NAME>At 48 hours of life</NAME>
<CONT_DATA CI_END="0.5051964915314741" CI_START="-0.02519649153147452" EFFECT_SIZE="0.23999999999999977" ESTIMABLE="YES" MEAN_1="3.78" MEAN_2="3.54" MODIFIED="2016-06-08 10:42:21 +0100" MODIFIED_BY="[Empty name]" ORDER="6" SD_1="0.92" SD_2="0.84" SE="0.1353068187085632" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.450479684268475" CI_END="-5.240948985759563" CI_START="-14.522066287938856" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.881507636849209" ESTIMABLE="YES" I2="46.312181637835856" I2_Q="46.312181637835856" ID="CMP-002.06" MODIFIED="2016-06-17 12:47:00 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.11391294762734216" P_Q="0.11391294762734216" P_Z="2.999478409477717E-5" Q="7.450479684268475" RANDOM="NO" SCALE="148.43948991806687" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="415" TOTAL_2="435" UNITS="" WEIGHT="500.0" Z="4.173505936970392">
<NAME>Weight change (loss) (g)</NAME>
<GROUP_LABEL_1>Favours additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.7615698853938131" CI_START="-13.238430114606187" DF="0" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.01" MODIFIED="2016-06-08 10:47:53 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.027861512602596037" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.199230838485792">
<NAME>At 6 hours of life</NAME>
<CONT_DATA CI_END="-0.7615698853938131" CI_START="-13.238430114606187" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="39.4" MEAN_2="46.4" MODIFIED="2016-06-08 10:47:53 +0100" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="22.2" SD_2="19.1" SE="3.1829309945560875" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.70745616923689" CI_START="-21.29254383076311" DF="0" EFFECT_SIZE="-11.5" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.02" MODIFIED="2016-06-08 10:49:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.021351590884640732" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.301708954460117">
<NAME>At 12 hours of life</NAME>
<CONT_DATA CI_END="-1.70745616923689" CI_START="-21.29254383076311" EFFECT_SIZE="-11.5" ESTIMABLE="YES" MEAN_1="74.9" MEAN_2="86.4" MODIFIED="2016-06-08 10:49:10 +0100" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="34.5" SD_2="30.4" SE="4.9962876399798395" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.43196187556674914" CI_START="-26.368038124433234" DF="0" EFFECT_SIZE="-13.399999999999991" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.03" MODIFIED="2016-06-08 10:50:11 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.042841714245650205" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="2.0252498597573747">
<NAME>At 24 hours of life</NAME>
<CONT_DATA CI_END="-0.43196187556674914" CI_START="-26.368038124433234" EFFECT_SIZE="-13.399999999999991" ESTIMABLE="YES" MEAN_1="127.2" MEAN_2="140.6" MODIFIED="2016-06-08 10:50:11 +0100" MODIFIED_BY="[Empty name]" ORDER="13" SD_1="43.8" SD_2="42.4" SE="6.61646756099779" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-12.90881091135125" CI_START="-52.09118908864875" DF="0" EFFECT_SIZE="-32.5" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.04" MODIFIED="2016-06-08 10:50:49 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.0011483739674710651" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="3.251401903647556">
<NAME>At 48 hours of life</NAME>
<CONT_DATA CI_END="-12.90881091135125" CI_START="-52.09118908864875" EFFECT_SIZE="-32.5" ESTIMABLE="YES" MEAN_1="165.3" MEAN_2="197.8" MODIFIED="2016-06-08 10:50:49 +0100" MODIFIED_BY="[Empty name]" ORDER="14" SD_1="56.4" SD_2="73.2" SE="9.995688310184038" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="26.82657061537782" CI_START="-20.82657061537782" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.06.05" MODIFIED="2016-06-08 10:51:29 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.8050794364212388" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0" Z="0.24677877687631825">
<NAME>At 72 hours of life</NAME>
<CONT_DATA CI_END="26.82657061537782" CI_START="-20.82657061537782" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="144.9" MEAN_2="141.9" MODIFIED="2016-06-08 10:51:29 +0100" MODIFIED_BY="[Empty name]" ORDER="15" SD_1="68.5" SD_2="89.1" SE="12.156636960331294" STUDY_ID="STD-Martin_x002d_Calama-1997" TOTAL_1="83" TOTAL_2="87" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3855977361776235" CI_END="0.19055817221459942" CI_START="-0.9688098047788138" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.38912581628210724" ESTIMABLE="YES" I2="27.828981392633615" I2_Q="27.828981392633615" ID="CMP-002.07" MODIFIED="2016-06-15 22:01:23 +0100" MODIFIED_BY="Genevieve Becker" NO="7" P_CHI2="0.23915014535151435" P_Q="0.23915014535151435" P_Z="0.1882849710944616" Q="1.3855977361776235" RANDOM="NO" SCALE="6.8436985965185215" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="66" TOTAL_2="28" UNITS="" WEIGHT="200.0" Z="1.3156695725640402">
<NAME>Weight loss (%)</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.18438094292598173" CI_START="-2.2443809429259822" DF="0" EFFECT_SIZE="-1.0300000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.01" MODIFIED="2016-06-08 10:55:02 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.096436554917173" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="14" WEIGHT="100.0" Z="1.6623802570651032">
<NAME>Day 3</NAME>
<CONT_DATA CI_END="0.18438094292598173" CI_START="-2.2443809429259822" EFFECT_SIZE="-1.0300000000000002" ESTIMABLE="YES" MEAN_1="4.97" MEAN_2="6.0" MODIFIED="2016-06-08 10:55:02 +0100" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="1.8" SD_2="2.0" SE="0.6195934989136861" STUDY_ID="STD-Nicoll-1982" TOTAL_1="33" TOTAL_2="14" WEIGHT="100.0">
<FOOTNOTE>Loss as percentage of baby's birthweight. Data for separate glucose and water arms have been combined.</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.45969616953060743" CI_START="-0.8596961695306078" DF="0" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-002.07.02" MODIFIED="2016-06-08 10:55:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.5523770045667635" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="14" WEIGHT="100.0" Z="0.5942020205861209">
<NAME>Day 5</NAME>
<CONT_DATA CI_END="0.45969616953060743" CI_START="-0.8596961695306078" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="4.1" MEAN_2="4.3" MODIFIED="2016-06-08 10:55:32 +0100" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="1.7" SD_2="0.6" SE="0.33658586317616385" STUDY_ID="STD-Nicoll-1982" TOTAL_1="33" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="39.03114261343201" CI_START="-1.3511426134320068" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="18.840000000000003" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2016-06-15 21:03:53 +0100" MODIFIED_BY="Genevieve Becker" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.0674283885238465" Q="0.0" RANDOM="NO" SCALE="223.41156060927827" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="31" TOTAL_2="16" UNITS="" WEIGHT="99.99999999999999" Z="1.828807917198805">
<NAME>Maximum serum bilirubin levels umol/L</NAME>
<GROUP_LABEL_1>Additional fluids</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours additional fluids</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="39.03114261343201" CI_START="-1.3511426134320068" DF="0" EFFECT_SIZE="18.840000000000003" ESTIMABLE="YES" I2="0.0" ID="CMP-002.08.01" MODIFIED="2016-06-08 10:57:55 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.0674283885238465" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="16" WEIGHT="99.99999999999999" Z="1.828807917198805">
<NAME>Day 6</NAME>
<CONT_DATA CI_END="39.03114261343201" CI_START="-1.3511426134320068" EFFECT_SIZE="18.840000000000003" ESTIMABLE="YES" MEAN_1="86.54" MEAN_2="67.7" MODIFIED="2016-06-08 10:57:55 +0100" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="43.57" SD_2="26.8" SE="10.301792672057836" STUDY_ID="STD-Nicoll-1982" TOTAL_1="31" TOTAL_2="16" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2016-08-28 14:00:30 +0100" MODIFIED_BY="Genevieve Becker" NO="3">
<NAME>Non-exclusive breastfeeding infants (foods) versus exclusive breastfeeding infants</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.9963891129938385" CI_START="-3.396389112993839" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2016-07-11 13:22:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.6108789001760746" Q="0.0" RANDOM="NO" SCALE="22.718733944303175" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="60" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="0.5088192881978801">
<NAME>Fever (% of days)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.9963891129938385" CI_START="-3.396389112993839" DF="0" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2016-06-08 11:08:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6108789001760746" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0" Z="0.5088192881978801">
<NAME>4 to 6 months</NAME>
<CONT_DATA CI_END="1.9963891129938385" CI_START="-3.396389112993839" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="7.3" MEAN_2="8.0" MODIFIED="2016-06-08 11:08:29 +0100" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="7.8" SD_2="7.2" SE="1.3757340105545877" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="10.722406258482094" CI_START="-4.522406258482098" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.099999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2016-06-15 21:10:07 +0100" MODIFIED_BY="Genevieve Becker" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.4253877581850004" Q="0.0" RANDOM="NO" SCALE="47.68198083957376" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="60" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="0.7971089634999459">
<NAME>Cough (% of days)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="10.722406258482094" CI_START="-4.522406258482098" DF="0" EFFECT_SIZE="3.099999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2016-06-08 11:10:23 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4253877581850004" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0" Z="0.7971089634999459">
<NAME>At 4 to 6 months</NAME>
<CONT_DATA CI_END="10.722406258482092" CI_START="-4.522406258482097" EFFECT_SIZE="3.099999999999998" ESTIMABLE="YES" MEAN_1="29.2" MEAN_2="26.1" MODIFIED="2016-06-08 11:10:23 +0100" MODIFIED_BY="[Empty name]" ORDER="17" SD_1="22.1" SD_2="20.3" SE="3.8890542472242666" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5426450258276342E-32" CI_END="10.607858281246907" CI_START="-3.407858281246909" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.599999999999999" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2016-06-08 12:26:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="0.3140063116584022" Q="0.0" RANDOM="NO" SCALE="29.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="60" TOTAL_2="59" UNITS="" WEIGHT="99.99999999999999" Z="1.0068511749482387">
<NAME>Congestion (% of days)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.5426450258276342E-32" CI_END="10.607858281246907" CI_START="-3.407858281246909" DF="0" EFFECT_SIZE="3.599999999999999" ESTIMABLE="YES" I2="100.0" ID="CMP-003.03.01" MODIFIED="2016-06-08 11:11:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.3140063116584022" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="99.99999999999999" Z="1.0068511749482387">
<NAME>At 4 to 6 months</NAME>
<CONT_DATA CI_END="10.607858281246909" CI_START="-3.4078582812469085" EFFECT_SIZE="3.5999999999999996" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="15.4" MODIFIED="2016-06-08 11:11:43 +0100" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="23.2" SD_2="15.0" SE="3.5755035993130484" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.530313621753223" CI_START="-1.130313621753225" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="4.199999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2016-06-08 12:26:29 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.12250452460488254" Q="0.0" RANDOM="NO" SCALE="32.16" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="60" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="1.5443460402543148">
<NAME>Nasal discharge (% of days)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.530313621753223" CI_START="-1.130313621753225" DF="0" EFFECT_SIZE="4.199999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-003.04.01" MODIFIED="2016-06-08 11:21:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.12250452460488254" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0" Z="1.5443460402543148">
<NAME>At 4 to 6 months</NAME>
<CONT_DATA CI_END="9.530313621753223" CI_START="-1.130313621753225" EFFECT_SIZE="4.199999999999999" ESTIMABLE="YES" MEAN_1="16.2" MEAN_2="12.0" MODIFIED="2016-06-08 11:21:11 +0100" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="17.1" SD_2="12.2" SE="2.7195977394472846" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="2.0352000254784466" CI_START="-1.8352000254784466" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2016-06-15 20:12:38 +0100" MODIFIED_BY="Genevieve Becker" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.9193284630231862" Q="0.0" RANDOM="NO" SCALE="23.11976273322393" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="60" TOTAL_2="59" UNITS="" WEIGHT="100.0" Z="0.10127965888464097">
<NAME>Hoarseness (% of days)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.0352000254784466" CI_START="-1.8352000254784466" DF="0" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" I2="0.0" ID="CMP-003.05.01" MODIFIED="2016-06-08 11:24:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9193284630231862" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0" Z="0.10127965888464097">
<NAME>At 4 to 6 months</NAME>
<CONT_DATA CI_END="2.0352000254784466" CI_START="-1.8352000254784466" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="2.6" MEAN_2="2.5" MODIFIED="2016-06-08 11:24:31 +0100" MODIFIED_BY="[Empty name]" ORDER="21" SD_1="6.3" SD_2="4.3" SE="0.9873650948400367" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.248012288685026" CI_START="0.5122126828865232" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7995296884185773" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="42" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.09621886169401844" LOG_CI_START="-0.29054967217872146" LOG_EFFECT_SIZE="-0.09716540524235151" METHOD="MH" MODIFIED="2016-06-15 20:13:26 +0100" MODIFIED_BY="Genevieve Becker" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.32473282915980417" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="567" TOTAL_2="595" WEIGHT="100.0" Z="0.9847786370382956">
<NAME>&#8220;Food allergy&#8221; to one or more foods between 1-3 years of age</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.248012288685026" CI_START="0.5122126828865232" EFFECT_SIZE="0.7995296884185773" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="42" LOG_CI_END="0.09621886169401844" LOG_CI_START="-0.29054967217872146" LOG_EFFECT_SIZE="-0.09716540524235151" MODIFIED="2016-06-08 12:11:59 +0100" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.2271897513319673" STUDY_ID="STD-Perkin-2016" TOTAL_1="567" TOTAL_2="595" VAR="0.05161518311028115" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4404586656610832" CI_START="0.5112481090790102" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8581560283687943" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="0.15850080060125613" LOG_CI_START="-0.2913682852791158" LOG_EFFECT_SIZE="-0.0664337423389298" METHOD="MH" MODIFIED="2016-07-19 12:37:19 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.5626772465176981" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="141" TOTAL_2="143" WEIGHT="100.0" Z="0.578869481941423">
<NAME>Visible eczema at 12-month visit stratified by visible eczema at enrolment</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4404586656610832" CI_START="0.5112481090790102" EFFECT_SIZE="0.8581560283687943" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="26" LOG_CI_END="0.15850080060125613" LOG_CI_START="-0.2913682852791158" LOG_EFFECT_SIZE="-0.0664337423389298" MODIFIED="2016-06-08 12:19:13 +0100" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.26425532793402035" STUDY_ID="STD-Perkin-2016" TOTAL_1="141" TOTAL_2="143" VAR="0.06983087834151665" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="22.036063063432643" CI_START="0.1820787231060591" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.003072196620584" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-003.08" LOG_CI_END="1.3431340065793749" LOG_CI_START="-0.7397408009239562" LOG_EFFECT_SIZE="0.30169660282770944" METHOD="MH" MODIFIED="2016-06-25 15:55:47 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.5701797043222708" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="651" TOTAL_2="652" WEIGHT="100.0" Z="0.5677868623406929">
<NAME>Food protein enterocolitis syndrome positive response to challenge (number of children)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive bf</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours early foods</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours exclusive bf</GRAPH_LABEL_2>
<DICH_DATA CI_END="22.036063063432643" CI_START="0.1820787231060591" EFFECT_SIZE="2.003072196620584" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3431340065793749" LOG_CI_START="-0.7397408009239562" LOG_EFFECT_SIZE="0.30169660282770944" MODIFIED="2016-06-02 14:50:19 +0100" MODIFIED_BY="Nancy  Medley" ORDER="632" O_E="0.0" SE="1.223490972324038" STUDY_ID="STD-Perkin-2016" TOTAL_1="651" TOTAL_2="652" VAR="1.4969301593584197" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.31173443754342767" CI_END="49.47747214582569" CI_START="-128.43325908657738" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-39.47789347037584" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.09" MODIFIED="2016-06-23 00:47:06 +0100" MODIFIED_BY="Genevieve Becker" NO="9" P_CHI2="0.5766179209626884" P_Q="1.0" P_Z="0.38439821596100276" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="151" TOTAL_2="109" UNITS="" WEIGHT="100.0" Z="0.8698210484714504">
<NAME>Weight change (gain) (g)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours early foods</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.31173443754342767" CI_END="49.47747214582569" CI_START="-128.43325908657738" DF="1" EFFECT_SIZE="-39.47789347037584" ESTIMABLE="YES" I2="0.0" ID="CMP-003.09.01" MODIFIED="2016-06-08 11:27:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5766179209626884" P_Z="0.38439821596100276" STUDIES="2" TAU2="0.0" TOTAL_1="151" TOTAL_2="109" WEIGHT="100.0" Z="0.8698210484714504">
<NAME>At 4 to 6 months</NAME>
<CONT_DATA CI_END="59.39971235602968" CI_START="-186.85971235602972" EFFECT_SIZE="-63.73000000000002" ESTIMABLE="YES" MEAN_1="1028.27" MEAN_2="1092.0" MODIFIED="2016-06-08 11:27:16 +0100" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="358.45" SD_2="356.0" SE="62.822436191308185" STUDY_ID="STD-Cohen-1994" TOTAL_1="91" TOTAL_2="50" WEIGHT="52.193758072887505"/>
<CONT_DATA CI_END="115.65594127900704" CI_START="-141.65594127900704" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="1004.0" MEAN_2="1017.0" MODIFIED="2016-06-08 11:27:37 +0100" MODIFIED_BY="[Empty name]" ORDER="23" SD_1="366.0" SD_2="350.0" SE="65.64199255385746" STUDY_ID="STD-Dewey-1999" TOTAL_1="60" TOTAL_2="59" WEIGHT="47.806241927112495"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.13469260718081966" CI_START="-0.15469260718081967" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.01" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.10" MODIFIED="2016-06-15 21:08:18 +0100" MODIFIED_BY="Genevieve Becker" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.8922504869341547" Q="0.0" RANDOM="NO" SCALE="2.595510903112159" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="50" TOTAL_2="50" UNITS="" WEIGHT="100.00000000000001" Z="0.13545709229571928">
<NAME>Weight change (z score)</NAME>
<GROUP_LABEL_1>Early foods</GROUP_LABEL_1>
<GROUP_LABEL_2>Exclusive breastfeeding</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours exclusive bf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours early foods</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.13469260718081966" CI_START="-0.15469260718081967" DF="0" EFFECT_SIZE="-0.01" ESTIMABLE="YES" I2="0.0" ID="CMP-003.10.01" MODIFIED="2016-06-10 11:50:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8922504869341547" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.00000000000001" Z="0.13545709229571928">
<NAME>4 to 6 months</NAME>
<CONT_DATA CI_END="0.13469260718081966" CI_START="-0.15469260718081967" EFFECT_SIZE="-0.01" ESTIMABLE="YES" MEAN_1="-0.02" MEAN_2="-0.01" MODIFIED="2016-06-10 11:50:14 +0100" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="0.31" SD_2="0.42" SE="0.073824115301167" STUDY_ID="STD-Jonsdottir-2012" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.00000000000001">
<FOOTNOTE>Data estimated from graph. Trialists changed weights to z scores using World HealthOrganization (WHO) standards.</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-08-29 18:38:33 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-08-24 16:18:53 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoIAAAQlCAYAAAAiOax5AACAAElEQVR42uydf0Sf+///38xMJhmT
YyYTSZIkMjNHZmQmx9eMyeQ4jjczSSaHI0kmMZkkGUmO5Ihjf2SSmMxkjpgkOWYkyWRGjpkkj+/7
/uxzvXa9rl6v60e92l6vut249Hq9ntf1fD6v6/l4PK57z+f1vJ7/MR//+c9/2NjYYm75Bm2C/WF/
bKfV/uAIvut3YgBIduOjLkCbY3/YHxS8EKRBAQo3GOK/2B/2B7Q9HKEdaUiAQg2G+C9gf4AYBIQg
ADdiwP6wP8AGACEIwI0YsD/sD7ABQAgCcCMG7A/7A2wAEIIA3IgB+8P+ABsAhCAAN2LA/rA/wAYg
t0JweXmZq1kA0E7ciAH7w/6IkdgARArBDx8+2P/7f//Pzp07Z0VFRXb37l3b2trKmpH2y6XBHNa4
cmWUR83nOI8/St7Bdip0Jz7t71HLVvbnz5/twYMHdv78edfm8t9Pnz7RvtyIv2nZX758sYqKiu9i
n1F186f7P3/PGFmI9o6PnmAheOPGDfvzzz9tb2/Pbfp88+bNb2YM39u48lkI5jJfnPhk3ojb29tt
eHg45b+//fabu9lybbG/b1X27u6u3blzJ+M+38I+kwjBQhHW2B98UyF49uzZWL95hhBcg1B/37x5
Y6WlpVZfX3/AYN6/f2/Nzc2ut1H5VlZW2vPnzzMa14sXL9w+Z86csZqaGpufn4/9X97Y2JiVlZW5
Y5XHzMxMKn1nZ8daW1tdHVT+wsJC5H+LmX5TIHv48KEVFxfbpUuXbHJy8sAxvb29VlJS4v4D7ujo
SEuLc/xhzzFOOw0ODoYeH1b3TGWMj4/bxYsX3f5tbW2uV8CfHrSLbGX8+++/dvny5bTjvXaTHWRq
G91QlIfatLGx0TY2NmK3YxI7y/cbx4ULF5xd+W/KYb32Sdoljv/EaYtgeVF+cNj2QQh+n7LV5uvr
6xn3SWqfUfeLKNuJSvfHw0wxMoldh8XjJPc97A++uxD0egQ9pqam7Mcff0zU0yQRIAfc3Nw8sE9t
ba1NTEyk/iMcGhpyN4VM+fmdaXZ21srLy2OLJDmd56jKwy9mu7u73XmJ6elpq6qqOpQQfPr0qfX1
9bnz0PD59evX09JHRkZccFC6Ap6CUH9/f+zjj3KOcdrp9u3bWY+Pqnum/Ovq6lx+OkZCQv/9h9lF
WBkaPhoYGEgrQ9dL+QbPR/vJjjybUr4SKnHbMYmdFVoPgkSb378y5ZOkXaL8J05bBMuL8oPDtg9C
8PuUPTc3F7t+UfYZdb+Isp2o9LB4nzTGhMXjJPc97A++uxBcXV11/7V5/xnps35LIjD8/ynFMRj9
B5VpXzmKd8NJYpRRddCNy/9faVg+Yenq0VAg81hcXExLlzAKluO/iUUdf5RzPGo7RdU9U/7+niE9
C6RevbDywsqQzel4L11/r1y5ksrDX9fq6uq066jP6pmM245J7KzQhOAff/zhhFtYPknaJcp/4rRF
sLwoPzhs+yAEv2/ZcfaJss+o+0WU7USlxxWCh7Hrw973sD/47kJQ/9Xovx/vP5cnT5645z2SCIyo
fTQ0JOdvaWlxDpbNGfXfv9fT1NPTk0gIRvUAHUc+ul7B9OCQg9/5o44/St2O2k5Rdc90bFAc+M8v
U3lRZagnWj1TQv9NyzYz5ZepXlFlH9bOCulG/PHjR7t3757r1UuST1K7zXZzS2IHYX5w2PZBCOa3
EIxjn1H3izgxOCw9rhA8aoxJct/D/uC7C0E9r+G/oeuznmvIlcDQc2TqURgdHXVDCBoeCnMIOY+G
n5qamqyzszOvhWCc4BF2A0wi5o5bCEbVPa6gCEuPKkPtrmdphJ4N84ackrZD3CAdx84K5Uasm+v9
+/dDZ/wftl3C/OcwbRHHDw7TPgjB/BWCce0z6n4RZTtJ7DEsRh41xiS972F/8F2FYFD0SQjqAdlc
CQw9tLu9vZ36vra2FsshlpaWciaS9FqDwwwNB+t69erVtOGClZWVtHSJF/+5Bok6/nsKwai6ZzpW
beShV0KorcPKi1OGHr7Wcz4aFg6ra3DYxv8AelQ7JrGzQrgRq6dFz1jqPA+TT1S7hPlP0rZI6gdJ
2gchmJ9CMIl9Rt0vomwnKj2uEDyMXefivof9wXcRgnqQW/+16D82BXvdhDXrKhsSjno2wnOSKIfQ
jd2bLSWnbGhoyOoQ+g9KMwZFkskQUXVQ97yGm8TLly+zThbxP6SuWXAamvSna7jy8ePHqQeRNdEm
+ICx96CyNn3XbLO4x+dSCCZtp6i6ZzpW6ToP7f/777+nPVKQqbw4ZWiSgmb7BSeqBOuqGdBePno9
hf8dZlHtmMTO8v1G/Pr1azekrveBHjafqHYJ85+otshUXpQfHLZ9EIL5JwST2mfU/SLKdqLS/Z/D
YuRh7Pqw9z3sD767ENQrOyQG9d+ONonA4Gs8gjdqb984DvHq1Sv34LmCuQK8HgLP5hAaDtKzFN50
fO9mcFSRpPPRu6uUp/LXA8SZ9vNuOipfTq/yg3nrGUo9NKxXbWgmWTC9q6vL/Teo6yMB4s2UjHt8
roRg0naKU/fgsQp0P/zwg3u4/9GjR2kvis1Wt6gy1HugtOAQUrZXO2jTbL53797FbsckdpbvN2JN
sAk+33eYl5SHtUuY/0S1RbbywvzgsO2DEMw/IZjUPqPuF3FiaFi6/3NUjExq14e972F/8N2FIABB
4WTciAH7w/4AGwCEIBAUuBED9of9ATYACEE4PuKsOU0gJAgD9gfYHyAEAQiEBGHA/gD7A4QgAIGQ
IAzYH2B/gBAEIBAShAH7A+wPEIIABEKCMGB/gP0BQhCAQEgQBuwPsD9ACAIQCPMpCC8vL+dFO+RL
PbA/OE12jA0gBDEkwIny8EYcVadc1jn4yiB/3lr9Q6so1NXV5aTcsOPD6nGSbQUhePz1PY3+xP0b
IQgAJ/hGnMs6h+XlX9/5uMsKpiEEEYLfqr4n0Z8QgqdcCGodyOC6wlqAu6amJvW9t7fXrdmo9RY7
OjoOGIbWBdVas/X19Wn/yWidUOUzPz+f1ZC8tRy1+LcWudcC4P59x8bG3OLd3pqjuXQMgJNwI/b/
vre359YK15rBly5dssnJyQPHRflzNp/LtFas/2+2tDjlxqm3v46ZyhocHMwaKzLFqTjxJ6oNdE6q
84ULF2xoaOjAWrJhdTpJ9pfp2oa1t+4xWrtX172ystIWFhYS3ReC5UXZT9g96bT7E0IQIWgPHjyw
gYGBtN+ePn3qjExowW4Zsgxrd3fXGZQW6vYbRltbm0v3Fqn3G/vs7KxbeDuTIalcBU8dq01lKTj4
921ubk4FAeWpvAEQgpl/l+/29fU5f9ra2rLr16+npcfx5zCfC+uJC0uLKjeq3nF6BG/fvh1a72Cc
ihN/wsrV+XR2dqbqfO3atQPXI6xOJ8n+gtc2qr27u7ttamrKfZ6enraqqqpE94VgeVH2E3ZPwp8Q
gqdeCK6urrpeQRmM95/ElStXUoar5xO8NI+gsPP/tyb0n5rn5GGGVF1d7f4z9P+XePHixdC8MURA
CGb/XT0kfp9aXFxMSz+MP8e9OYWlRZUbVe84QjCq3sH0OPEnrNyrV6/ahw8fstb5OOJXvtpf8Dyj
2lvCL5h+lPtClP2E3ZPwJ4TgqReC4scff3T/XYiJiQn3H4z/P6lgN7W6uMMMQ/9x6XcZa09PT1ZD
8ufjLy9uIAZACNqBng8/ulkE05P6cy5uXFHlRtU7jhBMUu9cxJ/gg/7BOh9H/CqUyUpJ2/uo7RJl
P2H3JPwJIYgQtP2ueT2nIfT8xNzcXKhTxjEMPcOhfJuamtzwSRwnixO8MURACMa/ccX55+sogipu
WlS5UfU+DiF41PgTdbM9zULwMO19lHaJYz/Z7kn4E0IQIfh/6GFWPVegYWE/Eobb29uHNoylpaWs
xq28g0MA/v+yEYKAEEx2I9Zwpd+nVlZWDvhcUn/OxY0rqtyoeh+HEEwaf9bW1tJ+a2hocM9febx9
+xYhGLO9Kyoqsg4NH+a+kMR+gvck/AkhiBD8P/SgqWYX+R84FXpw13voVJu+axZXmGHo+Q/N0hJh
D8cqL82q8/IeHh52AQIhCAjBw92I9WjH48ePUw+J37hx44DPJfVn/2+axalnnrybTNwbV1S5UfUO
ElaPuEIwKv74Jxisr6+7R2bCJovofBCC8dpbk0U0XCtevnx5YLJI0vtClP2E3ZPwJ4QgQvD/+Pjx
o/uvy/8frkdXV5ebhq50BUNvplY2w1AXvB749abLew6YaX/vNQHaNDPs3bt3CEFACB7hRvzkyRP3
cL1eLaHZhcH0pP7s/03/KOo4r4cm7o0rqtw49Q7+45qtHnGFYFT88QSD4piEiOJYMB/dbFVf/ROt
Oh/3iEYhvdA8rL31yrK7d++666t7hSYzHOW+EGU/Yfck/AkhiBAEgIK+EUN+IHGjNzBgf0D8A4Qg
AIGQIHzCUW+LJh9473JTL1bYJATsD4h/gBAEIBAShE8IeruC3temoTmtLPLo0SMnCLE/IP4BQhCA
QEgQBuwPsD9ACAIQCAnCgP0B9gcIQQACIUEYsD/A/gAhCEAgJAgD9gfYHyAEAQiEBGHA/gD7A4Qg
AIHw25e9vLxMw2J/hy77NNrPafUZNARCEAAnKhAhmGRf/2oY3Aywv6RlB+0nH+0j13UqhHNGCAJC
EAAheCznRBzB/sJ+Pw1CsBDOGSEICEGAU3Ij1soWDx8+dOuOas3bycnJtH3fv3/v1iLVAvdaZ7Wy
stKeP3+eytO/Re3vHbOxseHWgNU+t27dSlsrNup4rfPqreFbU1Nj8/PzaefT29vr1kfVOrMdHR0Y
XR7bXyb70d/BwUErKytLre2rdZv9x2jt39LSUvdCbg9vfWHZTWNjo7OxqLKDdiMf0Mu9h4aGDqzb
G1anTGSrz2HOOcqus10T7A8QggAEwsiynz59an19fU4Qbm1t2fXr19P2ra2ttYmJCZeuTTdJ3XCy
5Rtn/6tXr9qHDx9c+l9//WU///xz7OP9N8nZ2VkrLy9PpY2MjNjY2Fhq2TaJ2v7+fgwvj+0vU+/Y
7du3U8JJba0296e3tbW5Nt7c3HS/DQwMODvxbEZ2oH804gpB2YyW9/N84Nq1aweEYFidgiStT1T+
UXad6Zpgf4AQBCAQxipbPQg7Ozup7+qdi6qnei2SnFNwf38PoG5edXV1sY+XKJyamsq4n/JRfn78
QhH7Kwwh6O/NC+6TKb26ujrNhvVZaznHFYLePybZfCCqTkGS1icq/yi7znQ89gcIQQACYayygz0b
uuEE99WwU3d3t7W0tLibXPAmGSTp/sE6hB2vXkB9182xp6fnQD7BoTe/iMT+CvMZwSj7ydTGwV7E
sDyDkzeCPhBnaPko9YnKP8quC+XejIZACALgRAUgBIP7jo+PW1VVlY2Ojtrc3Jwbegq7SSbdP3gj
jjreE4rT09PW1NTkhvTCbsBw8oVglA3HEVq5FIJJ6xOVf5RdIwThm7UhDQlQuEEwW/kaFvMPY62s
rKTtqwfot7e3U9/X1tZCb2px9l9dXU19V9mXL1+OfbyfpaWltDRNHvEfC6dDCKrdg0Ox/n8ugscE
baqhocE9G+jx9u3bIwnBpPWJyj/KrhGC8E2FII0JUJgBMFsdNDHj8ePHqQflb9y4kbavZjJ6s3Yl
EnXT9KdrVqSeT/JufFH76/PNmzft48ePrkxNVPFPFok6Xr2Fmjksgg/V6yF9b+KLNn3XjE3IXyEY
tJ/DCEG1s2bdeu0+PDxsFRUVqXT/BKP19XU3Kz1ssohs5ihCMKo+Sc85yq4RgvDNhaDXoGxsbPG2
fA/CT548cQ+z6/UUmqHo3/fVq1fuwXTdTCXCNFHDn67Zi+rt8Ho8ovbXZ5WhsnSMRKH/Qfeo4zUs
rOcGvddseKLQo6ury/UqKm/d8PN5FiVC8KD9HEYICu91Ldo0Q/fdu3epNO8fBtmMBJlsJpiP/hmS
TeoVSrLPsB68ONcyrD5JzznKrhGC8F2EIOBogG0ANnAS7e/Lly9pjysAMQgQgjgaYBuADZxQ+1Nv
uCYfee/pU2+efxISEIMAIYijAbYB2MAJtT/NTtf7NDXsqpVFHj165AQhEIMAIYijAbYB2AD2B9gA
IARxNMA2ABvA/gAbQAgCjgbYBmAD2B9gAwhBwNEA2wBsAPsDbAAhCDgaYBuADWB/gA0gBAFHA2wD
sAHsD7ABhCDgaIBt5KyO2DdCELA/QAgCjganVAgCQhCwP0AIAo4GObQNrbvqrcNaU1Nj8/Pzaem9
vb1uDVatmdrR0ZGW9v79e7fuaVFRkcujsrLSnj9/nlam1gYuLS11L+wVOzs7bu1VHaP9FxYW0vYf
HBy0srKy1FrCWic20zno89jYWNZ9vbprfVa9JHhoaOjU+0c+CsEo+/PW7JW9NDY2pq1LHWdd4iT2
F2XvUXUF7k8IQcDRoOBswy+gZmdnrby8PJU2MjLixJa39Nbk5KT19/en0mtra21iYsKla5PY0k3X
X2ZbW5tL29zcdL91d3fb1NSU+6xlvaqqqtL2v337dupmr3qpftlu8hKh2fZVvbVMmMre2tqya9eu
IQTzUAiG2d/AwICzKc++ZI8ScUmEYBL7i7L3sLoC9yeEIOBoUJC2IeHm3RiD1NXVuZuin6ibn3pL
/GX6e3CEbrzBPMP2D97Y4+579epV+/DhQ+r74uIiQjAPhWCY/VVXV7sePA991rrASYRgEvuLsvew
ugL3J4Qg4GhQkLahng2l6SbY09OTlqYeEKX5N7/QExp6Uy9LS0uLu3FnE27+PJPUMUwIhu2rdWP9
6AaPEPxPQdlf0NaC9pPEXuLYX5S9h9UVuD8hBAFHg4K1DYk5DZM1NTW54dSwG7Gf8fFx18MyOjpq
c3NzbvgtX4RgsByEYP5OFslmf5lsJYkNJLW/KHsPqytwf0IIAo4GBW8bS0tLafvpgfjt7e2s+2si
hj99bW0t8kZcUVEROjScKyHY0NDgng30ePv2LUIwz2cNZ7K/4NCwv6c3mOdR7S/K3sPqCtyfEIKA
o0FB2oZ69DQbUgQnXOhh/b6+vtTD+vqumZsemrHrzRJeWVlx4ivqRqxhZA2xiZcvXx6YLJIrIRic
LKJ6IwT/U3D2p1nknv0NDw87Iefhn7yxvr7uJg8dxf6i7D2srsD9CSEIOBoUpG1oqEvP9nmvYPFu
dB5dXV2u5089MbrRerMvxatXr9zD9DpON0k9SB91I/7y5YvdvXvXHaNyNYnjOISgePz4sXsVyKVL
l9yM0OBzg9hA/tuf9/oYbZox/O7du1SaJ8Z0rASijj2K/UXZe1RdgfsTQhBwNMA28hQJgMuXL2MD
2B9gA4AQxNEA2zjp6DUjeqjfeyecepZO+8P9CEEgBgFCEEcDbONUoFnMWk1CQ3xaWeTRo0dOEGID
2B9gA4AQxNEA2wBsAPsDbAAQgjgaYBuADWB/gA0AQhBHA2wDsAHsD7ABQAjiaIBtADaA/QE2AAhB
HA2wDcAGsD/ABmhDLgGOBtgGYAPYH2ADCEHA0QDbAGwA+wNsACEIOBpgG4ANYH+ADSAEAUcDbAOw
AewPsAGEIOBogG0ANoD9ATaAEAQcDbANQAjSANgfFwEhCDgaYBuAEATsDxCCgKMBtgEIQcD+ACEI
OBpgH3Cy2x7bA2wAIQg4GmAjcErbHLsDbAAhCDga5JGdsJ2e7STFpuXl5VPnryflnLk/IQQBRwPA
P7j2aXz+/NkePHhg58+ft3Pnztndu3ft06dPWfPRPrls50KwiTjnjP8BQhBwNAD8o+CufXt7uw0P
D9ve3p7bfvvtNycGv1UbFoJNnBS7xf8QgoCjAeAfXPs0Lly44ASgx+7ubtYesExD3vr75s0bKy0t
tfr6+gNlvX//3pqbm62oqMjOnj1rlZWV9vz581g2kSlv0dvbayUlJa4Xs6Oj48Ax4+PjdvHiRZfe
1tZmX758SdtHYldpqlNjY6NtbGxkLTPTOb948cKdy5kzZ6ympsbm5+fxP0AIAo4GgH8U/rXf2dlx
IihuPvousSUxubm5eWCf2tpam5iYSPU4Dg0NpeUfJQSDeY+MjNjY2Jj7TaJ1cnLS+vv7046pq6tz
4k77SDSq19NjYGDA1cGrj/JrbW2NfT5CInBmZsZ9np2dtfLycvwPEIKAowHgH4V/7f/44w/r7u5O
JAT9PWpxylJPWlwhGMxbIs/fgyn8QkzHLCwspL7rGcjLly+nvldXVzux6xe+6j1Mcj4SslNTU/gf
IAQBRwPAP07Otf/48aPdu3fP9bQlEYJR+2ioVeKypaXFCTF/epQQDKLeuOBwbVBYBoWijskkQjOl
xzkf9QJ6PY89PT34HyAEAUcDwD8K+9pL/N2/f9+2trYS5RMlnPS8XlVVlY2Ojtrc3Jwbbj2KEMwk
5OKIx0yfMx0TRwh64nZ6etqampqss7MT/wOEIOBoAPhHYV579QTqFTJra2uJ84kSTsXFxba9vZ36
rjKOIgQ1OcOfX6ZjlpaWUt/1KhzVwX98cGjYPzkmrhD0UFmFYtf4H0IQcDQA/INrn8br16/txx9/
tA8fPsTKRzNt9QydJ6aihFNZWVlqlvDKyoo1NDQcSQhqskdfX19qsoe+a+av/xh9V8+m0n///Xe7
c+dO2vGDg4Op4/XqnIqKitAyg+esHk7NHBaaNJKplxH/A4QgwRYA8I+8v/aaSJFkNRTN0FUPmteL
FiUEX7165SZzSCxJQGmSxVGEoOjq6nK9fKqDXk3jze71jpHw/OGHH9ykjkePHh14Qbb3+hhtmjH8
7t270DKD56xhYT3rqGFqnZcnCvE/QAgCjgaAf3DtOU+uDSAEcTQAwD+49pwn1wYQgjgaAOAfXPtv
wklZFxgbAIQgjgaAfwDXHrABQAjiaAD4B3DtARtACAKOBoB/ANcesAGEIOBoAPgHcO0BG0AIAo4G
gH8A1x6wAYQg4GgA+Acc77VfXl7mguJ/gBAEHA0A/yj0ax93lQ8/uXhFC+81xP8AIYjTA+AfkEdC
8Fu2I7aA/wFCEEcDwD8gj4Sg/7PWz9U6ulpPt6amxubn51P7ZFqTuLe310pKStz6vR0dHWll7O3t
2cOHD936wJcuXbLJyclQW3j//r1bQ7ioqMjVobKy0q0fHFW3bHhrCyu/xsZG29jYSDvnsbExKysr
S60dPDMzk3a8zk11v3Dhgg0NDR2oe1T+uSwL/0MIAjc6APwDjl0I+kXK7OyslZeXZ81rZGTECRwJ
vt3dXSf0+vv7U+lPnz61vr4+l761tWXXr18PtYXa2lqbmJhw+2uTICotLY1VtyADAwPueC8v1bW1
tTXtXCQ6PfGmfJW/h86rs7MzVfdr166l1T1O/rkqC/8DWpAbHQD+Ad9ECEp4TU1Nxcqrrq7OiRc/
fnFWX19vOzs7qe+Li4uJbUE9aHHqFqS6ujqtbH2+ePFi2rn4e/CC53f16lX78OFD1rrHyT9XZeF/
QAtyowPAP+CbCEH1tOm7RF5PT09oXurVCg4Z+4Wbv9dLSDRG2cKbN2+su7vbWlpanNiKW7cwAZmp
Ppnq4f8tODEmWPck+R+1LPwPaEFudAD4B3wTIeiJsenpaWtqanJDltn2yySGsgmjOLYwPj5uVVVV
Njo6anNzc7a5uRm7bknLjhJnUSI2Sf5HLQv/A1qQGx0A/gHfTAh6LC0the6nCRvb29tZy9aQp3/4
dGVlJdQWNFnCn9/a2lrsugVR3YJDt/6etyhx1tDQ4J7X83j79m1aepL8j1oW/ge0IDc6APwDvokQ
VI+cZueK4KQGzY7Vs26eANKECW8yiDZ91+xZD038ePz4cWoSxI0bN0JtQbNqvVnCEo0SSHHrFkR1
GRwcTNVteHjYKioqYouz4AQOnVdwskjc/I9aFv4HtCA3OgD8A76JENTQq57N815z4gkvoRnB6vXy
93x1dXW5njz9ppmxGs718+TJEzeJQq+Y0czaMFt49eqVm2yiciX6NDEkbt0y4b3eRZtm9L579y62
OBMSsaq3Xn2jugef5Yubfy7Kwv8QgsCNDgD/AK79d+LLly92+fLlgiwLG0AIAsEWAP/g2kMC1Iup
SSneOxLV+xc2OSWfy8IGEIJAsAXAP7j2kADNWtZ7EDVEq9U+Hj165ERaIZaFDSAEgWALgH9w7QEb
AIQg4GgA+AfXHrABQAgCjgaAf3DtARsAhCDgaAD4B9cesAFACAKOBoB/cO0BGwCEIOBoAPgH1x6w
AUAIAo4GgH+cqGtfSG1yGuznOM8R/0MIAoEKAP/g2gM2AAhBwNEA8A+u/cG1cMfGxqysrCy1ju/M
zExonuPj425FDK2z29bW5pZF86drXeDS0lL3omSP3t5et56ujuno6HC//fvvv245Nf/xYmdnx2pq
ajKeg7fGb1FRkTU2NtrGxkbo+fp/0/rEOj+dp/Kfn58/sH+cOmU7n7BrEFZ20nNM2l6AEARudAD4
B9c+qxBsbm5OiQ2JComLsDzr6urc/loWTYKovb09LV3iUGmbm5vut5GRESdevGXUJicnrb+/36U9
ePDABgYG0sp4+vSpyzdYV+03NDTk8tGmfFtbW2MLQb9omp2dtfLy8oznGFWnsPPJdg3Cyk56jknb
CxCCwI0OAP/g2mcVgv4ep6g2U9rCwkLq++fPn10PWlh+Eo4SNX48IbS6uuqO99L198qVK6k8/HWp
rq52PXMe+qyeybhCUD10U1NTkdctqk5h55PtGoSVnfQck7YXIASBGx0A/sG1zyoEk7SZ0oIiyN8j
lelYpet3/6ZhTY8ff/zR9bCJiYkJ1+OVKT//MXHL9v+mnjivR7Onpyf02oXVKep8MtUjrOxcniP+
hxAEbnQA+AccqxBMKlQyiRs/09PTVllZ6T7r+bm5ubmM+WUaAk16Lnp2T+U1NTVZZ2fnoeoUdT7Z
rl+2snN9jvgfQhC40QHgH3BsQnBpaSn1/dOnT1ZcXBx6rITU9vZ2aF01+UHP4WkINltdlE9w2PTc
uXNZy15bW8t6LjqHKNvMVqeo84nKN1j2Uc4RIYgQBG50APgHfFMhqJmsW1tbboj4999/tzt37oQe
qwkQfX19qQkQ+q48/GiyxaVLl9ImXQTz03GDg4OpfIaHh62ioiKV7p+Qsb6+7oZz/cdXVVW52bsi
apJFWJ2izifTNQgrO8k5IgQRgsCNDgD/gO8qBJ8/f24//PCDmwDx6NEj1ysYdWxXV5frOVTvlgSa
N5vW4+PHjy5NAjOsLt6rVbRpNu27d+9SaZ7A0tCtxJOEl/94Dc1qMob32hVPmGUjW52izifTNQgr
O8k5IgQRgsCNDgD/gO927WlPbAAQgoCjAeAfCEHA/wAhCDgaAP5xmq69f+IC4H+AEAQcDQD/4NoD
NgAIQRwNAPAPrj1gA4AQxNEAAP/g2gM2AAhBHA0A/wCuPWADgBDE0QDwD+DaAzYACEEcDQD/AK49
YAOAEMTRAPAP4NoDNgAIQRwNAP8Arj1gA4AQxNEA8A/g2gM2QBtyCXA0APwDuPaADSAEAUcDwD+A
aw/YAEIQcDQA/AO49oANIAQBRwPAP4BrD9gAQhBwNAD8A7j+QNsjBAFnA8A/gDagzQEhCDgcAP5B
O/yH7RRtgBAEbnQA+Adgf9gfIASBQAOAfwD2B4AQBAINAP4B2B8AQhAINAD4B2B/AAhBINAA4B+A
/QEgBIFAA4B/APYHgBAEAg0A/gHYHwBCEAg0APgHYH8ACEEg0ADgH4D9ASAEgUADgH8A9geAECTQ
cBEA8A/A/gAQggQaAMA/APsDQAgSaAAA/wDsDwAhSKABwD8AsD8AhCCBBgD/AMD+ABCCBBoA/AMA
+wNACBJoAPAPAOwPACFIoAHAPwCwPwCEIIEGAP8AwP4AIQgEGgD8AwD7A4QgEGgACsw/2Ni+5waA
EASEIAAQXwAAIQgEagAgvgAAQhAI1ABAfAEAhCAQqAGA+AIACEEgUAMA8QUAEIJAoAYA4gsAIASB
QA0AxBcAQAgCgRoAiC8AgBAEAjUAEF8AACFIoAYAIL4AAEKQQA0AQHwBAIQggRoA4LBxhTVzAQDP
RwgCAEKQOAOAEASEIACcVjEIAAhBQAgCAEIQABCCgBAEAIQgACAEASEIAAhBAEAIAkIQAIgvAIAQ
BAI1ABBfAAAhCARqgJPhZ2ynZwMAhCBCEADwMdocACEIBCwA/AtoewCEIBCsAPAtwAYAEIJAoALA
twAbAEAIAoEKAN8CbAAAIQgEKgB8C7ABAIQgEKgA8C3ABgAQgkCgAsC3ABsAQAgCgQoA3wJsoGDO
n+10v0idKEigAsC3svDlyxerqKjImDY5OWlXrlyxc+fOWUNDgy0tLRFbiK+cOxRcm2MFOCsAvpWB
3d1du3PnTsZ9/v77b7t69aqtra3Z3t6eTUxMWFVVFbGF+Mp5Q8G1PZaAwwLgWxlobGy09fX1jPu0
tLTYkydPEpXz5s0bKy0ttfr6+tTvvb29VlJSYufPn7eOjo60Y3Z2dqy1tdWKioqssrLSFhYW0tJ/
++03d5zSVdeNjY3Q8iRYHz58aMXFxXbp0iXXo+k/txcvXtjZs2ftzJkzVlNTY/Pz88RXzhlOgQ1g
DTgtAL6Vgbm5uaz7lJWV2fLycqJy2tranBjb3Nx0v42MjNjY2Jj7Tb2PEmb9/f2pY7q7u21qasp9
np6eTutxHBgYsKGhIXesNuUl0RhW3tOnT62vr8/9trW1ZdevX087N4nAmZkZ93l2dtbKy8uJr5wz
IAQBpwU43b6VaR+JJokl9dSpR+7u3bv26dOn0Dz8PXairq7OiTI/fvEl4RdM96iurnY9hh76fPHi
xdDy1DPoP2ZxcTHt3NR76AlPbIBzBoQg4LQA+FaWffTbgwcPbHt7O9Ujp+HipGIyOKNPw7L+9Gz4
98u0f7by/Kje/v0kbPVdArWnpwcb4JwBIQg4LQC+lWkfPWfn712TqNLs4SR5ZBJzYcItKi0tsMcQ
gpn203OFGoZuamqyzs5ObIBzBoQg4LQACMEgt27dSvsuIagh4iR5aEKGehSzodfWZBsa1rHBoWG/
EM1UnmY5+49ZWVnJev56Fc5piTsIQUAIAk4LgG8l2kfP0mnzJmsMDg66dwkmyUMTPrzJG9r0XbN/
PTRZRMO14uXLlwcmi6hM79jh4eG09x1mKk+vuHn8+HFqssiNGzfS9lP+mjksNGkkrEeS+Mo5A0IQ
cFqAUysEhYSYJlioJ665udn++eefxHl0dXW5YWYvD2+Gr9DLrDUJRYJMk0M0ucOP9/oYbZox/O7d
u8jy9MobTSrRK2v0XKN/Pw0LqxwNWatMTxRiA6fnnDXhSXao3m3Z1b1799w/DbTp96vLcR2PEMSo
AQDfAoRgGnqvpSYKeT3Nf/zxh/tnhTZFCAJGDYBvATZwws/55s2b7tlRD73fMvg8bDCfk/ai9Gx1
V++oHtHw5+tdm7BziprE5f8t6lyirm2c4xGCBCoAwLcAIZjxdwmI4AQl/RaWz0l6UXpY3VWengNW
mh7bUD6rq6uR55RECEadS9S1jToeIUigAgB8C7CBrOecaYJQ2KShk/ai9Ki6S4hJbEl8tbe3xzqn
JEIw6lyi6hd1PEKQQAUA+BZgA1nPOepF5XHyKeQXpUfV3RNjEqcfP35MfI2ihGDUuSS9tsHjEYIE
KgDAtwAbCB0ajvNbWD6F/KL0qLqL27dvux7AbyEEg+mHubYIQQIVAOBbgA3EOmcJpc+fP6e+61k4
/7st4+RTyC9Kj6q73tepZ/RGR0fThobDzilMCK6traX9FnUuUfVLci0QggQqAMC34ITagDdsmPSc
NSPV/5JzCZ6w4dST9qL0sLprssi1a9fSRJn37tCwc8o2cWV9fd29s9GfHnUuUdc26niEIIEKAPAt
OEVCMLhFnbPEjsSDeuG0aRhUL5lOeu0K+UXp2equOvtfH6PPSo86J39dPCGqukjgqi7Bcwo7l6hr
G+d4hCCBCgDwLWJKhmuRTTyd1A2we4QgQRsA30IIYgP0CAJCEAhUAPiWn7DVCKJWEUi60kJUuvLU
A+plZWWp4S3vOaM4xydZbQAbOFlCkHsKIAQJVABwCN8KW40gahWBpCstRKUrTz0L5L1IN/jAey5X
G8AGOGdACAJOC3DqfStsNYKoVQSSrrQQlZ4pz+NabQAb4JwBIQg4LcCp962w1QiOY6WFsPQ4L6HN
1WoD2ADnDAhBwGkB8C3LvhpBUiEYtRpAVHqUEMzlagPYAOcMCEHAaQHwLR/B1QjiriLgEbUaQFR6
lBDM5WoD2ADnDAhBwGkBTr1vha1GEHcVAY+o1QCi0qOEYC5XG8AGOGdACAJOC3DqfStsNYK4qwj4
iVoNICw9SgjGyT/uagPYAOcMCEHAaQHwLcAGOGdACAJOC4BvATbAOQNCEHBaAHwLsAHOGRCCgNMC
4FuADXDOgBAEnBYA3wJsgHMGhCDgtAD4FmADnDMgBAGnBcC3ABvgvKEg2h5LwGEB8C3ABjh3OKVt
jhXgrAD4FmADp/j82U7PltEGCAMEKgB8C7ABgFPqA1wCAhUAvgXYAABCEAhUAPgWYAMACEEgUAHg
W4ANACAEgUAFgG8BNgCAEAQCFQC+BdgAAEIQCFQA+BZgAwAIQSBQAeBfQNsDIASBYAWAjwFtDoAQ
BAIWQKH5GdvpXmEBACEICEEAIL4AAEIQCNQAQHwBAIQgEKgBgPgCAAhBIFADAPEFABCCQKAGAOIL
ACAEgUANAMQXAEAIAoEaAIgvAIAQBAI1ABBfAAAhCARqACC+AABCEAjUAEB8AQCEIBCoAYD4AgAI
QSBQAwDxBQAQgkCgBgDiCwAgBIFADQDEFwBACBKoAQCILwCAECRQAwAQXwAAIUigBgAgvgAAQpBA
DQBAfAEAhCCBGgCA+AIACEECNQAA8QUAEIIEagAA4gsAIAQJ1AAAxBcAQAgSqAGA+AIACEEgUAMA
8QUAEIJAoAYA4gsAIASBQA0AxBcAQAgCgRoAiC8AgBAEAjUAEF8AACEIBGoAIL4AAEIQCNQAQHwB
AIQgEKgBgPgCAAhBIFADAPEFABCCQKAGAOILACAEgUANAMQXAEAIAoEaAIgvAIAQBAI1ABBfAAAh
CARqACC+AABCEAjUAEB8AQCEIIEaAID4AgAIQQI1AADxBQAQggRqAADiCxyy/dlOz4YQJFADABBf
gLanzRGCOCsAAPGFdofT3vZYAg4LAMQXoM3hlNoA1oDTAgDxBWhzQAgCTgsAxBegzQEhCDgtABBf
gDYHhCDgtABAfAHaHBCCgNMCAPEFaHNACAJOCwDEF6DNvy3Ly8s0IEIQpwUAIL7AcbT55OSkXbly
xc6dO2cNDQ22tLSUV3VXvXJp06fV/hGCBGoAAOILbZ7G33//bVevXrW1tTXb29uziYkJq6qqOtH2
ihBECBKoAYD4ArT5/2hpabEnT54kymdsbMzKysrszJkzdvbsWZuZmUnbp7e310pKSuz8+fPW0dGR
+l29jh8/fnSfJTyVl4So+PDhg0vPVF5w3Vz9ffPmjZWWllp9ff2B83v//r01NzdbUVGRq19lZaU9
f/4847V48eKF20fnUlNTY/Pz8whBIFADAPEFTkebS9AleQZP+UhkbWxsuO8SgRJSHiMjI04oqndx
d3fXDTv39/e7tPv379tff/3lPv/5559uyFf7e99bW1tj1V3f29raXBmbm5sH9qmtrXU9m0rXNjQ0
5ERjpvz8QnZ2dtbKy8sRgkCgBgDiC5yONpcQkgBSr5l60O7evWufPn0KzccTgZnyrqurc+LLjyeu
xsfH7cGDB+7zr7/+6nojtYmff/7Zica4QjCsDplQj1+mfSUQp6amTp0NEAEI1ABAfAHa3P0ucba9
ve0EnHroPHEWN59gD1twONcTYaurq663TmgYVpNSLl++7L5LiGq4OK4QjNpHQ8fd3d3uXKqrq9NF
kO+zRLC+S8D29PQgBIFADQDEFzg9bV5cXGw7Ozup7xKDYbN0o0SYv+ctExcuXLCtra2UANTQ9MrK
Sup7LoSgeh414WV0dNTm5ubc8HE2IeiJxunpaWtqarLOzk6EIBCoAYD4AqejzW/dupX2XUJQQ8SH
FYLq6VPvYjbu3Lljv/zyS6rX0RseTtILGVUHiVt/HbyJKVHXQj2UJ9k3EIIEagAA4gttnoaej9Pm
TawYHBx07xI8rBAcGBiwvr6+VH763tjYmEpX/hcvXrTh4WH3/dmzZ054aoJJNpSuZwK9nsuoOqiX
0ZslrN5GnU82IaieQ80cFsGJLwhBIFADAPEFTnybS5xp0oSGhDUj+J9//jm0EBRdXV2uV87Lz5vZ
K16/fp322pjFxUX3PaxMzTpWXt6QdVQdXr165SaoSNRJ6EnoZhOCGhbWM4Teq3A8UYgQBAI1ABBf
gDYHhCDgtABAfAHaHBCCgNMCAPEFaHNACAJOCwDEF6DNASEIOC0AEF+ANgeEIOC0AEB8AdocEIKA
0wIA8QVoc0AIAk4LAMQXoM0BIQg4LQAQX4A2L1CWl5cRgoDTAgDxBWjz4yrrex8flp+3ukkh+hJC
EKcFACC+0OYIwRzmjRAEAjUAEF+goNu8t7fXSkpK7Pz589bR0ZH6/d69e/by5cvUd63De+vWLfd5
Z2fHWltbraioyCorK21hYSGz4IhYF3hvb88ePnzo1ia+dOmSTU5OHjgmW/3iHp+NK1eu2MePH93n
tbW1tDWQP3z44NL99dVf/+b9prWay8rKUusVz8zMIASBQA0AxBfI/zYfGRmxsbExJ6h2d3edkOrv
73dpm5ub1tDQ4NK+fPli5eXltrq66tK6u7ttamrKfZ6enraqqqpDCcGnT59aX1+fK2Nra8uuX7+e
lh5WvzjHh3H//n3766+/3Oc///zTDfuqPO+7hG7U+ej77du3bWNjw32XCJQYRAgCgRoAiC+Q921e
V1fnRJQfCT6/EJPYkvhqb29P/S7hFzzuMEKwvr7e9S56LC4upqVH1S/q+DDGx8ftwYMH7vOvv/5q
LS0tbhM///yzE51xhKAnAvPdvxCCBGoAAOILbZ6Geq+CQ54a4gyKxYsXL6aGUb3jYgmOCCEYzEei
L5geVr+o48NQ72Ztba37XFNTY0tLS3b58mX3XcPdGi6OIwQLxb8QggRqAADiC22eRlD0ZUJDn+oB
/BZCMJgeVb+o46O4cOGCG1L2BKCe9VtZWUl9RwgCgRoAiC9wYttcPWHb29tZjxseHnbP6I2OjqYN
DVdUVBxqaNiblOFx9erVtKFdiTB/elT9oo6P4s6dO/bLL7+khoS94WHvO0IQCNQAQHyBE9vmAwMD
qckW2vS9sbHRpWmyyLVr19JE2T///OM+a7LI7Oys+6yZxdkmi/hn0a6vr1tzc3Na+sTEhD1+/Dg1
2ePGjRtp6WH1i3N8FJrxq2FvCV7x7NkzNxNa4jfT+ShNzwR64hMhCARqACC+QEG3eVdXl3v9imbN
SqhJAIq7d++mvT5Gn5UuNItY6RJ61dXVbpJGprK8WbQa4lUvol5BE6zLkydPnBjTK2I0OSWYnq1+
cY8PO/fXr1+nvTbGm2ziCd7g8Zo0o3p4L5ZGCAKBGgCIL0Cb5zGaEQwIQZwWAID4QpufQjSMDQhB
nBYAgPhCmwM2gBDEaQGA+AK0OSAEAacFAOIL0OaAEAScFgCIL0CbA0IQcFoAIL4AbQ4IQcBpAYD4
ArQ5IAQBpwUA4gvQ5oAQBJwWAIgvQJtzjRCCgEECAPEFaHOuEUIQMEgAIL5AYbW5fn/z5o2VlpZa
fX196vfe3l63du/58+eto6Mj7Zj379+7NX+LiorcOsKVlZX2/PnzVLrWE/bWF66pqbH5+fm043/7
7TeXr45vbGy0jY2NtPqMjY1ZWVmZO175aL3iuHlHXYPx8XG3LrHKb2trc2smZxRKEWsIJ63HUc45
qj0QggRqAADiCxxaCEoQ7e3t2ebmpvttZGTECRP9tru7a5OTk9bf3586pra21iYmJly6tqGhISck
PfxCZnZ21srLy1NpAwMDbn/vWJXV2tqaVh+JTE8oKR/lFyfvONegrq7O5a2yJa7a29sPJQST1OOo
5xzVHghBAjUAAPEFDi0E/b1TQmJJosNPlOBST5aHROHU1FTG/aqrq21nZyf1XZ/VQxdWH3/dw/KO
cw0WFhZS3z9//myXL18+lBBMUo+jnvNh2gMhSKAGACC+QCwhGES9Ufrdv/mFntBwcnd3t7W0tDih
489HPWRe71tPT09WwegvL64AC8s7zjUICqpsZeeyHkc95zjtgRAkUAMAEF8gJ0IwSmToObuqqiob
HR21ubk5N6QczEdCcXp62pqamqyzszOjADqMAAvL+zDX4LBCMEk9jnrOhxF9CEECNQAA8QUOJQQ1
+WF7eztrXsXFxWnpa2trWfNfWlpKS1PewWHSc+fOJRJg2fKOcw10jMenT5/cucQRZ0nOMdP1PMo5
R7UHQpBADQBAfIGcCUFNbujr60tNbtB3zXT10OxWb5bwysqKNTQ0pOWj3kLNqhXBiQ/Ka3BwMJX3
8PCwVVRUxBZFYXnHuQY6j62tLVf277//bnfu3MlYjn8yyPr6upvMcdh6HPWco9oDIUigBgAgvkDO
hKDo6upyvWXquZII8mYUi1evXrnJChI/EkSaNOHPR0Omem7QexWKJ5g8vFepaNPs2Xfv3sUWRVF5
h9m20iRgf/jhBzfZ49GjR65XMNOxnrhTORJtKidJPYIc5Zyj2gMhSKAGACC+AG3+P3799VfsHiGI
0wIAEF/gNLa5ZjJj9whBnBYAgPgCtHka/gkaCEHAaQGA+AK0OSAEAacFAOIL0OaAEAScFgCIL0Cb
A0IQcFoAIL4AbQ4IQcBpAYD4ArQ5IAQBpwUA4gvQ5oAQBJwWAIgvQJvnZT2wcYQgTgsAQHyBU9rm
2DhCECMGACC+QESb6/fx8XG7ePGiWwe3ra3Nvnz5kpaudXW1Nm99fX3q997eXispKXHHdHR0uN/+
/fdfu3z5ctrxYmdnx2pqajLWw1uDt6ioyBobG21jYyO0zv7ftL6vtx6w8p+fn0/bT+v51tbWHshj
d3fX1VP1RQgCgRoAiC9wqoVgXV2dE2B7e3tO4LW3t6elSxwqbXNz0/02MjJiY2Nj7jeJqsnJSevv
73dpDx48sIGBgbQynj596vIN1kP7DQ0NuXy0Kd/W1tbYQlAicGZmxn2enZ218vLyA/vduHEjTSAK
1f2///3vqbYBIgCBGgCIL0Cbu98XFhZS3z9//ux6y/zp/l46IeEo4ebHE2Grq6vueC9df69cuZLK
w1+P6upq11vooc/qmYwrBNVLOTU1FXq+09PT1tTUlJamns23b98iBIFADQDEF0AIBkWdetrCjlO6
fvdvGp71+PHHH12vm5iYmLDm5uaM+fmPiVu2/zf1Ano9mj09PVn3KysrcwJVLC4upg1xIwSBQA0A
xBc41UIwqRjLJOD8qBeusrLSfdaze3Nzcxnz85eTUaxECEGh5xe9Xr/Ozs6M+z1+/NgNWQsNPT97
9gwhiEsQqAGA+AK0uX5fWlpKff/06ZMVFxeHHidxt729HVqeeuH0bKCGhbPVQ/kEh4bPnTuXtey1
tbWs56FzyCYit7a23GSUDx8+uAkuwcksCEEgUAMA8QVOrRDUbF2JJQ0R//7773bnzp3Q4zTJo6+v
LzXJQ9+Vhx9NHrl06VJqEkmm/HTc4OBgKp/h4WGrqKhIpfsng6yvr7shZv/xVVVVbuaw0H5hPZnq
Cfzpp5/cxBdsACFIoAYA4gvQ5v/3+/Pnz+2HH35wky8ePXrkegWjjuvq6nI9h+rBk0DzZhR7fPz4
0aVJYIbVw3t9jDaJNb3yxcMTdxqKlkCU6PMfr2FhTThRuvbzRGGmcjQhRr8tLy9jAwhBAjUAEF+A
Nj9NtiChquFqbAAhSKAGAOIL8YU2P0W2oGFn9WAGZxYjBIFADQDEFzjVbe6fnHFS0USRmzdvntpJ
IghBAjUAAPGFNuciYAMIQZwWAID4QpsDQhBwWgAgvgBtDghBwGkBgPgCtDkgBAGnBQDiC9DmgBAE
nBYAiC9Am59MTuOLpRGCOC0AAPGFNqdelpvX5hSaHyEEcVoAAOILbQ45uh4IQcBpAYD4AgXf5t56
v3rxcmNjo21sbKQdNzY25pZn89b01RrAfnp7e926wxcuXLChoaGs6wlnyz+XZfnR2sPeWsU1NTU2
Pz+fKse/Zbs+/t+0OsnDhw9d2ZcuXbLJyUmXrrWRa2trDxy7u7trly9ftn///RchCARqACC+QH62
+cDAgBNUEjraRkZGrLW1Ne245ubmlHiTMJO48pBw6+zsdMdubW3ZtWvX0sqKk3+uygriF5Kzs7NW
Xl6e9XpECcGnT59aX19fquzr16+n0m/cuJESmf66/ve//81bGyACEKgBgPgCtLlVV1fbzs5O6rs+
X7x4Me04fw9eMK+rV6/ahw8fUt8XFxfT0uPkn6uygpSWltrU1FSs6xElBOvr69POw1/29PS0NTU1
pR2r/d++fYsQBAI1ABBfIH/bXMOmQfy9cFECKTjpQj1m/vQk+R+1rCDqBVR6XV2d9fT0HEkI+uuc
qWwNZ6+urqZEooRgPtsAEYBADQDEF6DNDwicpOIsSiAlyf+oZWXizZs3qR47DSvnSggG0x8/fmwP
HjxwnzX0/ezZM4QgEKgBgPgC+d3mmkQRHLr197xFCaSGhgb3zJyHhkP96UnyP2pZYSwtLYWWFfy+
trZ2YFjafx4rKytp6aqXJsNo6LqkpMS+fPmCEAQCNQAQXyC/21yTOQYHB1OTOYaHh62ioiK2OAtO
4NCs4OBkkbj5H7WsIFVVVW7msAhOPJFo0/OInrjzTyxZX193k1b8eU9MTLheP69sTRAJlq2ewJ9+
+sna2try3gaIAARqACC+AG3u8F7vok1iRq9EiSvOhASSesH0WhXNCg4+yxc3/1yU5UfDwpqs4r2K
xhOFor+/3x3rHe8JRe0roap9g2U/efLETXRR+So7mL6wsOB+y9dVSxCCBGoAAOILbX6saEhU7887
aWXFYXNz000aKQQbIALgtABAfAHa/Mioh0yTMTRkqpcoq/fPPymjUMtKiurU1dV1YHYyQhAI1ABA
fIET2+Zzc3PuVSkaYtVqH48ePXIirdDLSoqeObx582ZeThJBCOK0AADEF9qci4ANIARxWgAA4gtt
DghBwGkBgPgCtDkgBAGnBQDiC9DmgBAEnBYAiC9AmwNCEHBaACC+AG0OCEHAaQGA+AK0+Qk+v+99
PEIQCNQAQHwB2hwhiBAEAjUAEF/g27S5fh8bG3NLo3lr8mrdXT/eWsF6aXJjY6NtbGy4369cuWIf
P350n9fW1lxef//9t/v+4cMHl56N3t5et2av8u3o6Ej9fu/ePXv58mXqu9b8vXXrlvu8s7Pj1ipW
PSorK93avhlFTsSaxVoF5OHDh1ZcXOzWLJ6cnDxwTLb6xT0eIQgEagAgvkBBCMHm5uaUuJMIlBj0
GBgYsKGhISd+tI2MjDgxJu7fv29//fWX+/znn3+6FT+U7n339guifSQ+vaXiJKT6+/tdmtbrbWho
cGlapaO8vNxWV1ddWnd3t01NTbnPWmquqqrqUELw6dOn1tfX58rY2tqy69evp6WH1S/O8QhBIFAD
APEFCkYIeiIw077V1dWuJ85Dn7XmrxgfH7cHDx64z7/++qu1tLS4Tfz8889OQGWirq7OiSg/Enx+
ISaxJfHV3t6e+l3CL3jcYYSglqnzn9Pi4mJaelT9oo5HCAKBGgCIL1AwQjDsNw0XB/F6DNVTV1tb
6z7X1NTY0tKSXb582X3X0K2GizOh41WGfwuWIzEmwekNPfvLPaoQDOYj0RdMD6tf1PEIQSBQAwDx
BU6EEMwkvvzpFy5ccMOjngDUs4YrKyup75nIJC6D3L592/UAfgshGEf8ZhLCheZTCEECNQAA8YU2
TyQE1dMXHBrWs4Aed+7csV9++SU1JOwND3vfM6E8t7e3s6YPDw+7Z/RGR0fThoYrKioONTTsTWTx
uHr1ato5SbgGzzmsflHHIwSBQA0AxBc4EUJQk0UGBwdTk0Uk0iTIPJSmIVz9Lp49e+Zm9UrIZUN5
epMttOm7ZiMLTRa5du1amij7559/3GdNFpmdnXWfNbM422QR/8zn9fV1NxnGnz4xMWGPHz9OTfa4
cePGgXPOVr84xyMEgUANAMQXOBFCUHivj9GmmcDv3r1Lpb1+/TrttTHexAlPvGWjq6vLvX5FvYsS
ahKA4u7du2mvj9FnpQvNIla6hJ4msaisTHX2Zj5riFeiVa+gCZ7TkydPnIDVK2I0OSWYnq1+cY9H
CAKBGgCIL0CbA0IQcFoAIL4AbQ4IQcBpAYD4ArQ5IAQBpwUA4gvQ5oAQBJwWAIgvQJsDQhBwWgAg
vgBtDghBGgynBQDiC9DmgBCkwQAAiC9AmwNCEKcFACC+AG0OCEGcFgCA+AK0OSAEcVoAAOIL0OaA
EMRpAQCIL0CbA0IQpwUAIL4AbQ4IQZwWAID4QpsDNoAQxGkBgPhCfKHNASEIOC0AEF+ANgeEIOC0
AEB8AdocEIKA0wIA8QVoc0AIAk4LAMQXoM0BIQg4LQAQX+Bktvns7Kzdvn2bi4QQBAI1ABBf4LS1
eV1dna2urnKREIJAoAYA4gucpjZ//fq13bx5M+23Fy9e2NmzZ+3MmTNWU1Nj8/Pzaem9vb1WUlJi
58+ft46OjgN5hqVjewhBIFADAPEF8qTN29vbbXx8PO03icCZmRn3WcPG5eXlqbSRkREbGxuzvb09
293dtcnJSevv74+dDghBIFADAPEF8qTNGxoabGVlJe230tJSm5qayri/hpEl8vz4hWJUOiAEgUAN
AMQXyJM2LyoqOiDc1Auo/SXqenp60tLUW6g0/6Yh5LjpgBAEAjUAEF8gT9o8m0h78+aNTU9PW1NT
k3V2dkbuHzcdEIJAoAYA4gvkSZtn6hH0s7S0lHasJo9sb29n3T8qHRCCQKAGAOIL5Emb6xnBxcXF
tN+qqqrczGGhSSMa7vUYGBiwvr4+Jx616XtjY2PsdEAIAoEaAIgvkCdtrlnDmunrR8PC1dXVbphX
ItAThR5dXV1WXFxs586ds+bmZtvc3Iydju0hBIFADQDEF8iTNl9YWKDHDiEIBGoAIL7AaW1zzQ5e
Xl7mIiEEgUANAMQXOG1trucAf/rpJy4SQhAI1ABAfAHaHBCCgNMCAPEFaHNACAJOCwDEF6DNASEI
OC0AEF+ANgeEIOC0AEB8AdocEIKA0wIA8QVo82/It3zbzUl5sw5CEKcFACC+0OYH+PjRrKPDrLTU
TKvJVVebTU4Gj8+v8zl3LhfX5HBlfY9rocVd1DZ1dQhBnBYAgPgCOWrzf/81q683Gxsz29nZ/+3v
v82uXDEbH89fIfgt65MP5y4RODOTOxsgAhCoAYD4ArS5dXebDQwc/F1iUALRL4YGB83KyszOnDko
TN6/N2tuNisq2k+rrDR7/jz9+Ddv9nsdvXyjjpEwbW3dT1fawsLXvPybR2+vWUmJ2fnz+z2cQTEX
LN9/rNfjpnOrqTGbn89elv+4bHUMyzMbv/22X3flpVX/NjbCzxchSKAGACC+wJHavKrKbH09zvFm
t29/FScSgRI5HrW1ZhMTZnt7+9vQ0L7o8h/f1raftrkZ7xiJ1Kmp/c/T0/t19efnZ2Rkv1dT+ezu
7g9t9/eHl+/Pwy9sZ2fNysuzl+X/HlbHsDyDSIzr/L1rofORwMxWB4QggRoAgPgCR25zv5iLEoKe
CIwrTtQTFnZ81DESVRJF2erjR8/OBfcNirmw+kuAeoIuqiz/97A6huUZRM9lekPzQp8vXkQI4rQA
AMQXOMY21zBkXCEY9ZuGXtVD1tKyL2z86dlMLuyYMJEazE/7BodQg0I0LA/12Om7BGVPT3whGFbH
sDzDBHCmvBGCOC0AAPEFct7mGp7d2jr4u4ZXg8/4hQkpTSxR79joqNnc3P7wa5QQjDomiRDMJKQO
I2Q1vNvUZNbZeXQhGJZnmOjLVA5CEKcFACC+QM7bXD1VerYuyB9/mF27Fl9IFRebbW9//b62Fi1k
oo6pqIg/NKzJGP68DiMEPZaWwuset45heQZR/YNDw/7X1iAEcVoAAOIL5LzNP33aH5IdHjb7/Hlf
1Pz1l9mFC2avXsUXUppN7PUgrqyYNTREC8GoYzRkrOFV8fJl+kQMDWnrmT9PPGmyRV/f18kW+q6Z
t3Hrr7w1y1cEJ8IEy4pbx7A8g6i+mpXt1V/tIZGJEMRpAQCIL3Csba5Zw/fv77+6REOser2KRE02
0ZTpN4lGTc6Q2JEA0iSJKCEYdcyXL2Z37359yfXi4tc0zQhWj5m/16yra7+XUb/ptTTe7OA49dcQ
rsrwXo3jCbhMZcWtY1iemfBeH6NNM4bfvUMI4rQAAMQXoM0hxzaANeC0AEB8gVPe5sFZtmyFsyEE
CdQAAMQXoM0BIYjTAgAQX4A2B4QgTgsAQHwB2hwQgjgtAADxBWhzQAjitAAAxBfanIuADSAEcVoA
AOILbQ4IQcBpAYD4ArQ5pFheRggCTgsAxBegzY9YVmEe71+lJBdl5+qSNzc328vgUi8IQZwWAID4
AgjB3B2fm2Xccn89V1dXrV7r/iEEcVoAAOIL5LrNe3vNSkr217jt6Pj6+7176WsOa63cW7f2P+/s
7K+HW1RkVllptrCQWQxFrfG7t2f28OH+GsGXLplNTh48Jlv94h7vR+egdX+1/m9Njdn8/Nc6BVfu
OGrdk5xHtnp53Lx5016/fo0QxGkBAIgvkLs2HxkxGxvbFzW7u/tipr9/P21z06yhYT/tyxez8nL1
Tu2ndXebTU3tf56eNquqOpwQfPrUrK9vv4ytLbPr19PTw+oX5/ggElszM/ufZ2f3zylbXY9a9yTn
EVYvMTo6au3t7QhBnBYAgPgCuWvzurp9ceLHL0IkYCR4JFr8OkTCL3jcYYSgRjzVu+ixuJieHlW/
qOODlJZ+FbBh9cpF3ZOcR1i9xMrKyv9EeQNCEKcFACC+QO7aXD1RwWFRDU8GxeLFi2YfP6Yfl72s
+GIqmI/EUjA9rH5RxwdRb5vSdU49PUcTglFlJzmPsHrt571n5zWmjBDEaQEAiC+QqzYPir5M3L69
3wP4LYRgMD2qflHHZ+LNm/3h7KYms87O3AnBsHOPc52z1etreWcRgjgtAADxBXLX5pqYsL2d/bjh
4f1n20ZH04eGKyoONzS8tpb+29Wr6cOrKyvp6VH1izo+jKWl8Loete5JziOsXmJ3d5ceQZwWAID4
Arlt84GBrxMetOl7Y+N+miaLXLuWLmb++Wf/syaLaDhTaGZxtski/kkQ6+t6J156+sSE2ePHXydc
3LiRnh5WvzjHB1E9NUNXqF7+TjbNgN7Y+Crujlr3JOcRVi/x9u1bnhHEaQEAiC+Q+zbv6tp/BYpe
qCyxIwEo7t5Nf32MPitdaBax0iVYqqv3J0pkEkCeqNHQqHoRJXaCVXnyZP8ZRL1aRZNTgunZ6hf3
eD8aflV9VR/VyxNfQhNiVIb3Yumj1j3JeYTVSzx79uzArOGkfowQJFADABBfaHMoQK5fv/4/sfgm
ZzaANeC0AEB8gVPe5sFZrGz5uenVMXWaTpxDGyACEKgBgPgCtDkUAD/99BNrDeO0AADEF6DNASGI
0wIAEF+ANgeEIE4LAEB8AdocEII4LQAA8QVoc0AI4rQAAMQXoM0BIYjTAgAQX4A2B4QgTgsAQHyh
zQEbQAjitABAfOEi0OaAEAScFgCIL0CbA0IQcFoAIL4AbQ4IQcBpAYD4ArQ5IAQBpwUA4gvQ5oAQ
BJwWAIgvQJsDQhBwWgAgvgBtDghBwGkBgPgCtDkgBAGnBQDiC9DmgBAEnBYAiC9QCG3++fNne/Dg
gZ0/f97OnTtnd+/etU+fPnHBTqC/IAQxPAAA4gttnkZ7e7sNDw/b3t6e23777TcnBuFk2wARgEAN
AMQXoM3twoULTgB67O7uup7BsHzGxsasrKzMzpw5Y2fPnrWZmZm0fXp7e62kpMT1MnZ0dKR+v3Ll
in38+NF9Xltbc3n9/fff7vuHDx9cejYkUJVfUVGRNTY22sbGRuI6FRcXu/MdGho6cD2i8s9lWQhB
IFADAPEF8rLNd3Z2rLS0NDSf5ubmlFCSCJIY8hgZGXFCSeJSonJyctL6+/td2v379+2vv/5yn//8
808nOLW/9721tTVjmQMDA05Qeb2WOsa/b1SdVJ/Ozk537NbWll27di3tesTJP1dlIQSBQA0AxBfI
2zb/448/rLu7OzQff29ZMO+6urq0HkZRXl7u/o6Pj7vnEcWvv/5qLS0tbhM///yzE42ZqK6udgLV
L1YvXrwYu05Xr151PY4ei4uLaelx8s9VWQhBIFADAPEF8rLNNWx7794915OXJB//b+od03f/piFU
sbq6arW1te5zTU2NLS0t2eXLl933yspKN1ycCe94P/5euKg6BYe6JVT96UnyP2pZCEEgUAMA8QXy
rs0l/jR0q+HMpPlEiSo/em5OZXgCUM/arayspL5nwi/KDiPOgscHxVmS/I9aFkIQCNQAQHyBvGpz
9QRqyDZbj1wSIaievu3t7azH37lzx3755ZfUkLA3POx9z4TyDA7d+nveourU0NCQJnDfvn17oM5x
8z9qWQhBIFADAPEF8qbNX79+bT/++GPac21HEYKaeNHX15eaeKHvmoXrMTg46J6/0ytrxLNnz9xM
XU2yyIby0HFenjq2oqIidp2CEzhUn2Cd4+Z/1LIQgkCgBgDiC+RNm2tINvhMX5h9RAkh0dXV5V6f
ol41zbDd3NxME57+18Z4kyn++eef0Pp7r3fRphm97969S1Snx48fu1faXLp0yc0KDj7LFzf/XJSF
EAQCNQAQX4A2/058+fIl9JnEQi0LIYjTAgAQX4A2D6Ch6Onp6dS7DdX7p+HbQi8LIYjTAgAQX4A2
j2Bubs7q6+vdEK1mLT969Cj0FTmFUhZCEKcFACC+AG0OCEGcFgCA+AK0OSAEcVoAAOIL0OaAEMRp
AQCIL0CbA0IQpwUAIL7Q5oANIARxWgAgvhBfaPN9lpeXuTgIQSBQAwDxBU5jm8dZ9SKJvWBbCEEg
UAMA8QUKpM1zbQvYFkIQcCYAIL5AAbR5pvWF9ffNmzdWWlrqXowcPPb9+/du/eCioiI7e/asVVZW
2vPnzzOW8+LFC7fPmTNnrKamxubn52kIhCAQqAGA+AL50ubB3/W9ra3NLZG2ubl5YJ/a2lqbmJhw
6dqGhoacaMyUn0TgzMyM+zw7O2vl5eU0BEIQCNQAQHyBfBaCGxsbiexFPX6Z9pVAnJqa4uIjBIFA
DQDEFygUIRi1j4aOu7u7raWlxaqrq9MFhu+zegH1va6uznp6emgEhCAQqAGA+AKFLATHx8etqqrK
RkdHbW5uzg0fZxOCnmicnp62pqYm6+zspCEQgkCgBgDiCxSqECwuLrbt7e3U97W1tVAh6LG0tITd
IQSBQA0AxBfIpzbX7F89E7izsxNLCJaVlaVmCa+srFhDQ0NWIaieQ80cFpo0oskjgBAEAjUAEF8g
T9q8v7/fvVTae7F0lBB89eqVm/0rUSehp8kg2YSghoX1DKEmk2h/TxQCQhAI1ABAfAHaHBCCgNMC
APEFaHNACAJOCwDEF6DNASEIOC0AEF+ANgeEIA0GAEB8AdocEII4LQAA8QVoc0AI4rQAAMQXoM0B
IYjTAgAQX4A2B4QgTgsAQHwB2hwQgjgtAADxBWhzQAjitAAAxBfanIuADSAEcVoAAOILbQ4IQcBp
AYD4ArQ5IAQBpwUA4gvQ5oAQBJwWAIgvQJsDQhBwWgAgvgBtDghBwGkBgPgCtDkgBAGnBQDiC9Dm
gBAEnBYAiC9AmwNCEHBaACC+QKG2+ezsrN2+fZuLhBAEAjUAEF/gtLV5XV2dra6ucpEQgkCgBgDi
C5ymNn/9+rXdvHkz7bcXL17Y2bNn7cyZM1ZTU2Pz8/Np6b29vVZSUmLnz5+3jo6OA3mGpWN7CEEg
UAMA8QXypM3b29ttfHw87TeJwJmZGfdZw8bl5eWptJGRERsbG7O9vT3b3d21yclJ6+/vj50OCEEg
UAMA8QXypM0bGhpsZWUl7bfS0lKbmprKuL+GkSXy/PiFYlQ6IASBQA0AxBfIkzYvKio6INzUC6j9
Jep6enrS0tRbqDT/piHkuOmAEAQCNQAQXyBP2jybSHvz5o1NT09bU1OTdXZ2Ru4fNx0QgkCgBgDi
C+RJm2fqEfSztLSUdqwmj2xvb2fdPyodEIJAoAYA4gvkSZvrGcHFxcW036qqqtzMYaFJIxru9RgY
GLC+vj4nHrXpe2NjY+x0QAgCgRoAiC+QJ22uWcOa6etHw8LV1dVumFci0BOFHl1dXVZcXGznzp2z
5uZm29zcjJ2O7SEEgUANAMQXyJM2X1hYoMcOIQgEagAgvsBpbXPNDl5eXuYiIQSBQA0AxBc4bW2u
5wB/+uknLhJCEAjUAEB8AdocEIKA0wIA8QVoc0AIAk4LAMQXoM0BIQg4LQAQX4A2B4Qg4LQAQHwB
2hwQgoDTAgDxBWjzb8i3fNvNSXmzDkIQpwUAIL7Q5gf4+NGso8OstNRMq8lVV5tNTgaPz6/zOXcu
F9fkcGV9j2uhxV3UNnV1CEGcFgCA+AI5avN//zWrrzcbGzPb2dn/7e+/za5cMRsfz18h+C3rkw/n
LhE4M5M7GyACEKgBgPgCtLl1d5sNDBz8XWJQAtEvhgYHzcrKzM6cOShM3r83a242KyraT6usNHv+
PP34N2/2ex29fKOOkTBtbd1PV9rCwte8/JtHb69ZSYnZ+fP7PZxBMRcs33+s1+Omc6upMZufz16W
/7hsdQzLMxu//bZfd+WlVf82NsLPFyFIoAYAIL7Akdq8qspsfT3O8Wa3b38VJxKBEjketbVmExNm
e3v729DQvujyH9/Wtp+2uRnvGInUqan9z9PT+3X15+dnZGS/V1P57O7uD23394eX78/DL2xnZ83K
y7OX5f8eVsewPINIjOv8vWuh85HAzFYHhCCBGgCA+AJHbnO/mIsSgp4IjCtO1BMWdnzUMRJVEkXZ
6uNHz84F9w2KubD6S4B6gi6qLP/3sDqG5RlEz2V6Q/NCny9eRAjitAAAxBc4xjbXMGRcIRj1m4Ze
1UPW0rIvbPzp2Uwu7JgwkRrMT/sGh1CDQjQsD/XY6bsEZU9PfCEYVsewPMMEcKa8EYI4LQAA8QVy
3uYant3aOvi7hleDz/iFCSlNLFHv2Oio2dzc/vBrlBCMOiaJEMwkpA4jZDW829Rk1tl5dCEYlmeY
6MtUDkIQpwUAIL5AzttcPVV6ti7IH3+YXbsWX0gVF5ttb3/9vrYWLWSijqmoiD80rMkY/rwOIwQ9
lpbC6x63jmF5BlH9g0PD/tfWIARxWgAA4gvkvM0/fdofkh0eNvv8eV/U/PWX2YULZq9exRdSmk3s
9SCurJg1NEQLwahjNGSs4VXx8mX6RAwNaeuZP088abJFX9/XyRb6rpm3ceuvvDXLVwQnwgTLilvH
sDyDqL6ale3VX+0hkYkQxGkBAIgvcKxtrlnD9+/vv7pEQ6x6vYpETTbRlOk3iUZNzpDYkQDSJIko
IRh1zJcvZnfvfn3J9eLi1zTNCFaPmb/XrKtrv5dRv+m1NN7s4Dj11xCuyvBejeMJuExlxa1jWJ6Z
8F4fo00zht+9QwjitAAAxBegzSHHNoA14LQAQHyBU97mwVm2bIWzIQQJ1AAAxBegzQEhiNMCABBf
gDYHhCBOCwBAfAHaHBCCOC0AAPEFaHNACOK0AADEF9qci4ANIARxWgAA4gttDghBwGkBgPgCtPkp
ZXkZIQg4LQAQX4A2/871+j7l+lckyUXdc3Uezc3N9jK4rAtCEKcFACC+AG2eXwL0OC7p6uqq1WuN
P4Qg4LQAcBxxJbgB9xRvjduiIrPGRrONjXSxMzZmVlb2dc3cmZn043t799f4vXDBbGjooECKyj+X
ZfnR2r7KQ3nV1JjNz38tJ7hKR9RaxHt7Zg8f7pd96ZLZ5GR4j6DqWVKyf94dHfHq5XHz5k17/fo1
QhCnpZkAACEIx3tPGRjYF1QSOtpGRsxaW9MFTnPzV/EmYSYR4yHh1tm5f+zWltm1a+miKE7+uSor
iF9Izs6alZdnF25RQvDpU7O+vq9lX7+eXQjqHFVX7bu7uy8a+/vj1UuMjo5ae3s7QhCnpZkA4HjF
IHBPqa4229n5+l2fL15MFzj+Hryg6Ll61ezDh6/fFxfT0+Pkn6uygpSWmk1NZbseyYSgRmv95xEs
2/+5rm5fBPrxi72weomVlRVraGhACOK0NBMAIATheO8pGp4M4u+FixJIwUkXEkD+9CT5H7WsIOpt
U7qEWU/P0YSgv86Zyg7uGxx+9l+HsHrt571n5zWmjBDEaQEAEIJwnPeUoMBJKs6iBFKS/I9aVibe
vDGbnjZratofVs6VEAyreybxG7deX8s7ixDEaWkmAEAIwvHeUzRZITh06+95ixJIGsHUM3Meb9+m
pyfJ/6hlhbG0FF5W8Pva2sFhaf95rKxkz0/nvL19uHqJ3d1degQBIQgAxBc4/jbXZI7Bwa+TOYaH
zSoq4ouz4AQOzQoOThaJm/9RywpSVbU/Q1cEJ55oBrOeR/TEnX8Cx/r6/qQVf94TE2aPH38t+8aN
7HXXOXsTS7Tpu+oap177AvctzwgCgRoAiC/wbdrce72LNs3offcuvjgTEkh6VYpeq6IZs8Fn+eLm
n4uy/Gj4VZNVvFfReOJLaBavjvWO9wSZ9pVQ1b7Bsp882Z/oovJVdljdu7r2XzWj/CUqNzfj1Us8
e/bswKzhXPgsQpBADQAZ/Izt9GzcU46fL1/MLl+2E1fWt+T69ev/E4tvjtUGUBg4LQA+ho/R5qf8
3IMzW9m+/6ZXx9RpOvEx2wDRj4AFgH8Bbc95H5m5uf137GkIVKt9PHq0/xLlQi/re/HTTz+x1jBw
owLAtwAb4JwBIUiDAQC+BdgA5wwIQQIVAOBbgA1wzoAQxGkBAN8CbIBzBoQgTgsA+BZgA5wzIARx
WgDAtwAb4JwBIYjTAsDJ9q3l5eW8yue488QGOGdACOK0APBNfOvLly9W4V8M1cfk5KRduXLFzp07
59YCXdKK8Vl48eKFnT17NvbLYdOCdEQdz4Wtq5WAXOUTlmfcWPYtYx5CEBCCgNMC4FsH2N3dtTt3
7mTc5++//7arV6/a2tqa7e3t2cTEhFVp9fgsSATOeKvY51gI5io+HEecOWyeCEHOGRCCgNMCfFff
amxstPX19Yz7tLS02BOtOh+zjOAat5mX+PpPYiGYbf3c3t5eKykpsfPnz1tHR0fq93v37qWtVKCe
ylu3bsVah/f9+/fW3NxsRUVFTthWVlba8+fP0+qiNVFLS0utvr4+8rx3dnastbXV5ae8FhYWsp5z
tvPxzkH1OXPmjNXU1Nj8/DzxlXMGhCBOCwBH8605rWGVZZ+ysrJEz78F88iVEMyUPjIyYmNjY66n
Ur2aGsLu7+93aZubm24YW2ka9i4vL7fV1dVY5dTW1rqeTx2rbWhoyIk+fz3a2tpcmsqJOu/u7m6b
mppyn6enp9N6VP37hZ2P8Pe2zs7OunMivnLOgBDEaQEgJ76VaR+JD4kO9WSpR+vu3bv26dOnvBCC
eg5RosmPXxxJWD19+tSJqfb29iPFGfXC+Y/f2NiIfd4SfsF6Ztov6nwkRj1BSXzlnAEhiNMCwLEL
Qf324MED297ediJF4krDxfkgBCVSg8OyfsHmiauLFy/ax48fE10LDf2qJ0/nWl1dHVnPsPNWPeOc
U9T5SJDrN51TT08P8ZVzBoQgTgsAxysEi4uL3TNuHhKDYbNucyEEsz3HF8wrKPoycfv2bdcjl0QI
jo+Pu2NGR0fdsLmGf7+FEIxzPhKoGl5uamqyzs5O4ivnDAhBnBYAjk8IaoKFHwlBDREfVghq9nGu
egQ1YUI9ldkYHh52z9xJ0CUZGpb49ecbVuc4563X8sQZGo46Hz96hU/SeIkQBIQg4LQA+FaiffRM
mjZv4sTg4KCbhBE3D/8EB81M1mzcwwpBCVA9m+f1UA4MDFhfX1+qbvquGdBCvXjXrl1LE1n//PNP
xnyCaIKMN0t4ZWXFnW9UPYN5BieLaFhXaCZztskiYecj/n979x+Z1/n/D/zLzERVjaqpqglVEREV
aqYmqsTHVP+Y8VFvNW8zampiakxURUSoqIqKUlEfFROmPmImylRN1Fuoqqq3KlERFTOipiLi+nqd
z/vczn1y/+yPNW0eD267z33Ouc45d65z+tx13dc5sV6MHA7xnTZqaXR99W8KgqCTFnjpIBgi/MVA
hegSjiCXB6pWysgDS3R7RstYBJkXDYIx6CP2odg1PTQ0lLXg5fuWj+KNQS3F28fE+5hfr5yi27dv
Z4M0Yr8jfEUQbraf5TKLy8So5difKC9+b7iwsFC3rHrHE6JbONaP7zLKykOh66tjRhB00gLOLdQB
x4wg6KQFnFuoA+o9gqCTFnBuIQii3guCTlpwbqEOOGYEQZy04NxCHXDMCII4acG5hTrgmBEEcdKC
cwt1wDEjCOKkBecW6oBjRhDESQvOLdQBx4wgiJMWnFvv3rHH0zniKR2HDh1SBxwzgiBOWnBubadj
Lz4LWR1wzAiCOGlhW51bjx8/zp5p29HRkYWigwcPphs3blTm5y1m8Xzbnp6edOvWrZbmheHh4bRr
1660Y8eONDg4WDXvdZW7sbGRvv322+x5vXv37k3T09N1jz0+L75yP/zwQ1Z2fCf9/f1paWmpap14
5m88e7mvr8/11TEjCOKkhbf33Ort7U3Xr1/PAlS8JiYmspCTK7aYzc3Npc7OzpbmTU5OpqmpqazM
9fX1LJCNjY299nIvXryYRkdHs/krKyvpyJEjDa8r5Xnj4+PZd5B/H7G9U6dOVS1/5syZbN7y8rLr
q2NGEMRJC+/WuRUtcbkIhTMzMzWXazQvfnMXYamoGOheV7nRSre2tlaZXlhYaCsIdnd3V60f73fv
3l21fLGF0PXVMSMI4qSFt/rciq7Oc+fOpZMnT2ZBqLhstMjFdASw8+fPV63XaF606pW7XosB83WV
G/OLIjS2EwSLZdUq822+RgmCCII4acG5VeXatWupq6srXb16Nd28eTPr7iwvG0FxdnY2DQwMpLNn
z7Y0r1agqhVAX3W55SDY7LpSntdsfUHQMSMI4qSFd+bcikEVq6urlenFxcW6y967d6/leTHIo1hu
I6+y3E8++aSqa/fBgwdtBcEov9w1/MEHHwiCW/iY2vn7IgjiQgXOrYL9+/dXRglHaDp8+HDVstFa
GKN4QwzgKLaYNZoXgy7yQRvxiukYgfu6y42BLyMjI5XBIkePHm17sMilS5cq5V++fDkdOHBAENzi
QbDeCHD/piAIulABDc6t27dvZ4MtImxFAItBGsVlo4s2fjcYXbKxTB7Qms0LQ0NDWYtjtKjFLWqK
o2xfV7nhwoUL2QCPuMVMjPptt8Uov31MvGLE8KNHj96pIFgvPL2rL1z7BEFBEJxbzi11QIsggiAu
VODcQh1414Kgeo8g6EIFOLdQB9R7BEEnLeDcQh1Q7xEEnbSAcwtBEPVeEHTSgnMLdcAxIwjipAXn
FuqAY0YQxEkLzi3UAceMIIiTFpxbW9b9+/f9EV1fHTOCoJMW+DvPrRe9OW8769Vbtvi++LxfXF8d
M4Kgkxb4m4Pg37Htesu6Nri+OmYEQSct8BrOreHh4ey5vPFs3cHBwfoX0VIZsV488/fDDz9MExMT
DVv2lpaWsuf2dnR0pP/6r/9KCwsLTbdR79m4vb29m45hfX097du3Lz179swf2/XVvykIgk5aoJVz
a3JyMk1NTaWNjY0sTE1PT6exsbGmIS3WOXv2bLbeyspK+vTTTxsGuk8++SQ9ffo0W/7nn39OX331
VctBsPz+6NGj6datW1XHEfvzzTff+EO7vvo3BUHQSQu0em4dOnQoC2dFnZ2dTcNYHuxy0cLXKMQV
WwBje7HdFw2Cs7OzaWBgoGqf+/r60t27d/2hXV/9m4Ig6KQFWj233n///U1dr++9917TMFYevBHh
rpUQV9zuiwbBsH///vTw4cNKCI0giOurY0YQdNICbZxbxdDX9CJaeF8Mci8SBItB8kWC4MjISDp9
+nT2Pn57eOXKFX9k11fHjCDopAXaObd6enrS6upq20Hw8OHD2W8Dc9Et2yjE5a13YW1tLRvY8TJB
MLYdA0+iezoGujx//twf2fXVMSMIOmmBds6t8fHxNDo6mrXoxSum+/v7m4ax8mCRWKdRiDt27Fj6
448/suVje+0OFonQFyOPI0TmoiXwxIkT6cyZM/7Arq+OGUHQSQu8yLk1NDSU3QYmumuPHz+elpeX
mwazEN2z0Rq3d+/ebPRxo+7emB/LxjIRCiPUtRMEYyRzrFvcxvz8fLaMp464vjpmBEEnLfAGz63o
mi129/4dIrDGoBFcXx0zgqCTFvgbz63du3dnt3HJ7z/4ww8/ZF3Ff5fYbrRknj9/3h/X9dUxIwg6
aYG/89y6efNmdsuW6KqNJ4t8//33WSD8u8RvBqOL2SAR11fHjCDopAWcW6gDjhlB0EkLOLdQB9R7
BEEnLeDcQhBEvRcEnbTg3HJuqQOCIIIgTlpwbqEOOGYEQZy04NxCHXDMCII4acG5hTrgmBEEcdKC
cwt1wDEjCOKkBecW6oBjRhDESQvOLdQBx4wgiJMWnFuoA44ZQRAnLTi3UAccM4IgTlpwbqEOOGYE
QZy04PzC396xs9X+9mqCExacY84xf3PfAdv0b64WOFmB/5xnXtvnhXqv3guCgiDg+uL6Atv7GuAr
cKEGXF8AQRAXasD1BRAEcaEGXF8AQRAXasD1BRAEcaEGXF8AQRAXasD1BRAEcaEGXF8AQRAXasD1
BRAEcaEGXF8AQRAXasD1BRAEcaEGXF8AQRAXasD1BRAEcaEGXF8AQRAXasD1BRAEcaEGXF8AQdCF
2pcAuL4AgqALNYDrCyAIulADuL4AgqALNYDrCyAIvqMXai8vL6/X9QIEQUALDwCCICAIAiAIAoIg
AIIgIAgCIAgCgiAAgiAgCAIgCAKCIACCICAIAiAIAoIgAIIgIAgCIAgCgiAAgiDw6gKgZ8gCIAiC
ICgIAiAIwnYNgwAgCIIgCACCIAiCACAIgiAIgH83fAXw7oVBABAEQRAEAEGQ7RmIvLbPCwBBECoh
EH9zAARBBAL87QEQBBEEUAcAEAQRAlAHAARBEAJQBwAEQRACUAcABEEQAlAHAARBEAJQBwAEQRAC
Xpf79+/7AwqCAIIgvOoQ8Ndff6XTp0+nHTt2pA8++CB9+eWX6c8//9xS+x779SpDzssEorm5ufT5
559XffbDDz+knTt3po6Ojuz7e/r0qSAIIAjC1g8B3333Xbp8+XLa2NjIXhFqIsy8ywHmZco7dOhQ
evjwYWX6woULaWJiovL9jYyMpP7+fkEQQBCErR8CPvzwwyzA5NbX1xu2wEU5U1NTaf/+/em9995L
77//fvr111+rlhkeHk67du3KWhkHBwcrn3/88cfpjz/+yN4vLi5mZf3rX//KpqMVLebX2l75ubnx
3zt37qQ9e/akvr6+Tcf3+PHjdPz48ayFLvbv4MGD6caNGzW/i19++SVbJo6lp6cn3bp1q+6x//77
7+nYsWNVn3V2dmatqkVRniAIIAjCWxcC1tbWsoDVqJwIWUtLS9l0hMBi8JmcnMyCYoTLCJXT09Np
bGwsm/ePf/wj/fzzz9n7n376KQucsXw+ferUqZb2PabPnDmTbWN5eXnTMr29ven69euVVrposSse
U3HZYpCNbt8IdvVE6+m1a9fqzl9dXc1C8MmTJwVBAEEQ3r4Q8D//8z/p3LlzDcvJQ2CtsqPrtNjC
GPJwFSEqfo8Yvv766yww5aHpq6++ykJjq0Gw0T7UEi1+tZaNgDgzM9PSd3P48OH04MGDmvP++7//
O2sBjdfdu3cFQQBBEN6uEBDdthFooiWvnXLKLWzl7tw8hMVv66K1LkQ37L1799K+ffuy6ei+je7i
VoNgs2Wi6zgCbQTN7u7uqvnF99EKGNMRYM+fP9/w+4mu5nLILYvfWMaxCYIAgiC8NSEgwl903a6s
rLRdTvGzYstbLfGbxNhGHgDjt4bRypZPv4ogGC2PXV1d6erVq+nmzZtZ93G9IJiHxtnZ2TQwMJDO
nj1bdz+aHVv+PfqNIIAgCG9NCIiWwOiyrdci104Ii9aw+K1cPV988UX65z//WekSzruHG/2urt0g
GLdyKe5DPjCl2XcRLZSNvqdaLYLRtVwMz/Eby927dwuCAIIgbP0QECNhP/vss5bvfdcshI2Pj6fR
0dHKQI2YLt5O5dKlS1lQilvWhCtXrmQBKwaYNApg8ZvACFmt7EO0MuajhKO1MX7bVy8IRsthjBwO
5YEvZVHOwsJC1WfRFRxdyvnx/vjjj9lLEAQQBGHLh4Doki3/pq9RYGjl93lDQ0NZq1yMCo4RxvnI
3jx4Fm8bE8Eqpv/973/X3WaMOo6y8tvaNNuH27dvZwNUItRF0IvBIPWCYHQLx28I81vh5KGwlhg1
nI9yzkVXcIxgjn2LgSIRDN+2OgCAIMg2DYK0bn5+fsveLFodABAEQQh4zWJ08dv67GN1AEAQRBDk
JcTvCE+cOKEOAAiCIASgDgAIgiAEoA4ACIIgBKAOAAiCIASgDgAIgiAEoA4ACIIgBGzytt6SRR0A
EARBCHhJ+VNDWhFPK/ntt9/equ/n+fPn6cCBA+oAgCAIQsDL7N/Dhw9TX1/fW/P9xGPovvjiizf+
NxAEAQRBBMFNn8fzdvfs2VMVroaHh9OuXbuy5+cODg5uWufatWtp9+7d2fx41m60eBXFM3djXkdH
R/ZYtqWlpbrbrPWc43jmbzz7N54B3NPTk27dulVV/rFjx7LnFrdz/I32ud6ziGt91mzfyuL4nzx5
IggCCIKw9YJghKKNjY20vLycfTY5OZmmpqayz6I1a3p6Oo2NjVWtE49ai3AXy0Ro/O677yrzx8fH
08TERDYvXlHeqVOnGm6zvH8RtOIpHmFubi51dnZWzb969WrVNls5/kb73E4QbLZvZTdv3twSQUwQ
BBAEEQQ3fV5srQsRmCIsFRXDTqwzPz9fmf7rr7/Svn37KtPd3d1pbW2tMh3voyWu0TbL+xethTMz
M3WP58GDB+nw4cNtHX+jfW4nCDbbt60axARBAEEQQbDp59HiVe6ujW7Q4jrloBjr5IrL1prfLGiF
aGnLW/HOnz+/afnYfnTxtnP8jfa5nSDYbN8EQQBBEN7aIFgryLUSHmu9f5GglYvfEc7OzqaBgYF0
9uzZhtt8keN/0SDYyr4JggCCILyVQTAGQKyurjYs6969e5XpP//8M+3cubNq/XLXcPH2MK0GwVxs
qzw/frvYbotgo31uFAQXFxfr7l+tfRMEAQRBeGuDYAz2GB0drQz2iOkY+VpcJ6ZXVlay+T/++GN2
e5Ti+pcuXaqsf/ny5ap76NXaZowujt8N5gGyq6srG50bYmBGufXv7t27bf9GsNE+1xsMEqN9476F
xfnN9k0QBBAE4a0NgmFoaChrMYuWvAhC+ejefJ0bN26kjz76KBs48f3332ctbEX57WPiFSOGHz16
1HCbMSo5tpW3HEbXaww6iW7qCFp58MpduXJl06jhRkGn2T4X183DXWw7Amxsuzi/2b4JggCCILwV
QfBtDRRHjhzJAlnR119/LQQJggCCILzLQTBuHRMjdsvOnTsnBAmCAIIgvM4Q0M5zgV+HEydOtP2s
4Te9z4IggCAIQgDqAIAgCEIA6gCAIAhCAOoAgCAIQgDqAIAgCEIA6gCAIAhCAOoAgCAIb3kI+Lv2
Q+jxnQAIgrBNQ4DQ4zsBEAShSQiIz69du5Z2796dPRf4zJkz6fnz51Xz41Fu8Xzevr6+yufDw8Np
165d2TqDg4PZZ8+ePUv79u2rWj+sra2lnp6emvuRP5O4o6Mj9ff3p6WlpYb7XPwsnvGbPxM4yr91
61bVcvF8497e3k1lrK+vZ/sZ+6sOACAIsq2DYDyuLQLYxsZGFvC+++67qvkRDmPe8vJy9tnk5GSa
mprKPotQNT09ncbGxrJ5p0+fTuPj41XbuHjxYlZueT9iuYmJiayceEW5p06dajkIRgj89ddfs/dz
c3Ops7Nz03JHjx6tCogh9v2bb75RBwAQBBEE5+fnK9N//fVX1lpWnF9spQsRHCO4FeUh7OHDh9n6
+fz478cff1wpo7gf3d3dWWthLt5Hy2SrQTBaKWdmZhoe7+zsbBoYGKiaFy2bd+/eVQcAEAQRBMuh
LlraGq0X8+Pz4iu6Z3OfffZZ1uoWrl+/no4fP16zvOI6rW67+Fm0AuYtmufPn6+73P79+7OAGhYW
Fqq6uNUBAARBtnUQbDeM1QpwRdEKd/Dgwex9/Hbv5s2bNcsrbqfW/GZBMMTvF/NWv7Nnz9ZcbmRk
JOuyDtH1fOXKFXUAAEEQISA+v3fvXmX6zz//TDt37my4XoS71dXVhtuLVrj4bWB0C9fbjyin3DX8
wQcf1N324uJi3eOIY6gXIldWVrLBKE+fPs0GuJQHswiCAAiCbNsgGKN1IyxFF/GPP/6Yvvjii4br
xSCP0dHRyiCPmI4yimLwyN69eyuDSGqVF+tdunSpUs7ly5fTgQMHKvOLg0GePHmSdTEX1+/q6spG
DodYrlFLZrQEnjhxIhv4og4AIAgiBPzn8xs3bqSPPvooG3zx/fffZ62CzdYbGhrKWg6jBS8CWj6i
OPfHH39k8yJgNtqP/PYx8YqwFrd8yeXhLrqiIyBG6CuuH93CMeAk5sdyeSistZ0YEBOf3b9/Xx0A
QBBECNhO4SCCanRXqwMACIIIAdsoHES3c7RglkcWqwMACIJs6xBQHJzxroqBIseOHdu2g0QEQQBB
EEHQl6AO+BIABEGEANQBAARBhADUAQAEQYQA1AEABEGEANQBAEEQhIB303a8sbQ6ACAIIgjar/Rq
bpvztgUrQRBAEEQQ5BV9H4IggCAIb30IyJ/3Gzde7u/vT0tLS1XrTU1NZY9ny5/pG88ALhoeHs6e
O/zhhx+miYmJus8Trlf+q9xWUTx7OH9WcU9PT7p161ZlO8VXve+n+Fk8neTbb7/Ntr137940PT2d
zY9nI/f29m5ad319Pe3bty89e/ZMEAQQBGFrhoDx8fEsUEXQidfk5GQ6depU1XrHjx+vhLcIZhGu
chHczp49m627srKSPv3006pttVL+q9pWWTFIzs3Npc7OzrrfR7MgePHixTQ6OlrZ9pEjRyrzjx49
WgmZxX395ptv3pr/GQBAEGQbBsHu7u60trZWmY73u3fvrlqv2IJXLuuTTz5JT58+rUwvLCxUzW+l
/Fe1rbI9e/akmZmZlr6PZkGwr6+v6jiK256dnU0DAwNV68byd+/eFQQBBEHYuiEguk3Liq1wzQJS
edBFtJgV57dT/stuqyxaAWP+oUOH0vnz518qCBb3uda2ozv74cOHlZAYQfBtqQMACIJs0yBYDjjt
hrNmAamd8l92W7XcuXOn0mIX3cqvKgiW54+MjKTTp09n76Pr+8qVK4IggCAIWzsExCCKctdtseWt
WUA6fPhw9pu5XHSHFue3U/7LbquRe/fuNdxWeXpxcXFTt3TxOB48eFA1P/YrBsNE1/WuXbvS8+fP
BUEAQRC2dgiIwRyXLl2qDOa4fPlyOnDgQMvhrDyAI0YFlweLtFr+y26rrKurKxs5HMoDTyK0xe8R
83BXHFjy5MmTbNBKsezr169nrX75tmOASHnb0RJ44sSJdObMmbeqDgAgCLJNg2DIb+8SrwgzcUuU
VsNZiIAUrWBxW5UYFVz+LV+r5b+KbRVFt3AMVslvRZOHwjA2Npatm6+fB8VYNoJqLFve9oULF7KB
LrH92HZ5/vz8fPbZVn1qiSAIIAgiCL5W0SUa989717bViuXl5WzQyHavAwCCIGyTEBAtZDEYI7pM
4ybK0fpXHJTxtm6rXbFPQ0NDm0YnC4IAgiC8syHg5s2b2a1Soos1nvbx/fffZyHtbd9Wu+I3h8eO
HduSg0QEQQBBEEHQl6AO+BIABEGEANQBAARBhADUAQAEQYQA1AEABEGEANQBAEEQhICtaavetFkd
ABAE4a0KAXNzc+nzzz9/q46h/ESRlwk5MzMz2yIkCYIAgiCC4CaHDh1KDx8+fKuP50VDTjxXuNkz
iwVBAEEQ3skQ8Pvvv2c3Qi4vOzU1lT0uLX9ObzyLtyh/fnDcSDmC1NLSUvb5xx9/nP7444/s/eLi
YlbWv/71r2z66dOn2fyyVtfJjyH+W3zln126dKnhPtcyMDCQ/v3vfwuCAAiCbL8Q8N1336Vr165t
Wvb48eOVcBeBKoJVbnx8PE1MTGSPVYvX5ORkOnXqVDbvH//4R/r555+z9z/99FPWhRvz8+l8uaJW
1ykeQ60WwejerrfPtYyMjGTHsV1CkiAIIAgiCFY5fPhwevDgwaZl80BVa/3u7u60trZWmY738Rzg
EKHy9OnT2fuvv/46nTx5MnuFr776Kk1PT2/ah1bXaRYEG+1zWbQ4FltCBUEABEG2XQiIrt1o1Wu2
bPGz6Hoty1vf4reGvb292fuenp507969tG/fvmz64MGDWddvWavrNAuCrR7zs2fPsmcWR7ezIAiA
IMi2DQG1Ql2zUFWry7U4/8MPP0wrKyuVMBe/24tWx3y6llbWeVVBMFoZ865oQRAAQZBtGwJepEUw
Wu3KXcPF27l88cUX6Z///Gelezfv6s2na2llnVcVBMuDTcoDTwRBAFwx2RYhIH4juLCw0FaoisEi
MUI3Hyxy+fLldODAgcr8mBe/GYzPw5UrV7LAGSOR62llneI+xLz4TWAeSNsJgts1JAmCAIIggmCV
GDWcj9BtNQiG/PYx8YpRvY8eParMi1vSFG8BE0EzpuM2LfW0sk5xH8bGxrJWyLwlUhB0jACCILQZ
Aubn57P7ALJ96wAAgiDbOATEk0U8u1cQBEAQZBuGgLj58okTJ3xJgiAAgiBCAOoAgCAIQgDqAIAg
CEIA6gCAIAhCAOoAgCAIQgDqAIAgCELAG+C2N+oAgCAI71AIaGdfi884FpAcJ4AgCNsoBLyK4xIE
ARAE2ZYh4PHjx+n48eOpo6Mjvf/+++ngwYPpxo0blfm//PJL9vl7772Xenp60q1bt1qaF/LnEUfZ
8Ri7paWlyry1tbXsGcUxL7YZj7qrta+N9i+WK75yw8PDadeuXdm2BwcHq/ZpY2Mjffvtt2nnzp1p
7969aXp6WhAEQBBke4aA3t7edP369SwgxWtiYiLt2bOnMj/CVzx5JMzNzaXOzs6W5o2Pj2dl5eVO
Tk5mwS937ty5NDMzk72fnZ1NXV1dNfe12f6Vjyu2MzU1lS27vr6eBb2xsbHK/IsXL6bR0dFs/srK
Sjpy5IggCIAgiBCQixa+XISuPLCVNZrX3d2dtfrl4v3u3bsr0xH8Ioy9yL4W96+8bDw3uVxuMaD2
9fVV7dfCwoIgCIAgyPYNAXfu3Mla6E6ePJkFuOKy0dIX0xGwzp8/X7Veo3nFsJaLFsRa75vta6P9
Ky8b5Za7jIv7Ut5uhEZBEABBkG0ZAq5du5a1zl29ejXdvHkzLS8v1wxi0X07MDCQzp4929K8WkGv
WG6rQbDZ/pX3tVYArRdGt1tAEgQBBEEEwSoxaGJ1dbUyvbi4WHfZe/futTwvBo+Uu4aLt3o5cOBA
S13DzfavvD+x3eLyZZ988knVfj148EAQBEAQZHuGgP3791dG4UYoOnz4cNWy0RoXo4NDDAwptqg1
mheDRS5dulQZ5HH58uUs/OWiqze6lsNvv/1Wd7BIs/2L0cQxGjkPd7HdfDBIvGI6RiznYuDJyMhI
ZbDI0aNHBUEABEG2Zwi4fft2NpgiQlyEsRj8UVw2un7jd3nR5RrL5MGv2byQ3z4mXjFi+NGjR5V5
z58/T19++WW2XpQRgzZq7Wuz/YsRwdHSWGxtHBoayloS47O49Ux0JxdduHAhG7gSt5iJUcaCIACC
IEIA6gAAgiBCAOoAgCAIQgDqAIAgCEIA6gCAIAhCAOoAgCAIQgDqAIAgCEIA6gCAIAhCAOoAgCAI
QkAL7t+/748kCAIIgrAdQ0DxySDNxNNC4rF0f8fxvmw5b3p9QRBAEIQtHwLa2b+HDx+mvr6+t+J7
EwQBBEHYskErPo9nBu/Zs6cqXA0PD2fP4o3nBA8ODm5a59q1a9nzemP+mTNnsmcHF+XPGe7o6Ej9
/f1paWmp7jZjuvgK8dzieL5wPMe4p6cn3bp1q6r8Y8eOpd9//72l4433U1NTaf/+/ZXnIv/666+V
+Wtra9mzkGNfDx48mObn5+uW02g7Gxsb6dtvv82ec7x37940PT29aZ1G32sr6wuCAIIgvNIgGEEu
Qsjy8nL22eTkZBac4rP19fUskIyNjVWtc+jQoSzcxTIRbr777rvK/PHx8TQxMZHNi1eUF0Gr0TbL
+1cMa3Nzc6mzs7Nq/tWrV6u22SwIRndyHkaj3Cg/d+7cuTQzM5O9n52dTV1dXS8UBC9evJhGR0ez
41pZWUlHjhypmt/se222viAIIAjCKw+Cxda6ECEvwkhRMYjFOsVWs7/++ivt27evMt3d3Z21suXi
fbQeNtpmef+itTAPZ7U8ePAgHT58uOUg2Gh7EfzKx/siQTBaN4vHvbCwUDW/2ffabH1BEEAQhFce
BMuitazcXRtdqsV1yoGm2MJWXLbW/GaBKkQrYN7yeP78+U3Lx/aje7XVINhofnHfXmU5sY/l+Y2+
12brC4IAgiC89iBYK8i1Eh4bBat2AlUufkcYXbUDAwPp7NmzDbe5FYNgeX6z77XZ+oIggCAIrz0I
xuCM1dXVhmXdu3evMv3nn39mAxyK65e7hou3h2k1COZiW+X58Ru7V9UieODAgRfqGl5cXKz67JNP
Pqk67ui+Ls5v9r02W18QBBAE4bUHwRjskQ9aiFdMx8jf4joxHQMaYv6PP/6Yvvjii6r1L126VFn/
8uXLWdhqtM0YsRu/48uDUPxuL0YOh/LgjnD37t22fiPYaH4MFomu6BD3J6w3WKQ4gOXJkyfZAJTi
/OvXr6eRkZHKYI+jR49WzW/2vTZbXxAEEAThtQfBMDQ0lLXyRUteBJ58dG++zo0bN9JHH32UDer4
/vvvs1bBovz2MfGKEcOPHj1quM0YPRvbylsOo1s4Bp3kt3vJQ2HuypUrbY0abjQ/bn3z5ZdfZtuJ
bcYgjVrL5YE09imCbexTuewLFy5kA2PiFjExSrg8v9H32sr6giCAIAhvNARshUARt1aJsIggCCAI
wjYKgvHbuRhNjCAIIAjC3xwC2nku8Otw4sSJps8aRhAEEARBCEAdABAEEQJQBwAQBBECUAcAEAQR
AlAHABAEEQJQBwAQBBECtrL79++/1uXVAQBcMdkWIWArh4N6Twdp9/Y15eW3ayASBAEEQQTBbRde
BSDfA4AgiBDQ5PN4PzU1lfbv3195xm88X7eReKZwPDs3njl87dq1tp7x+/jx4+x5ux0dHdm2Dh48
mD3DuN6+5f8tvpqVU2v5+O+zZ8/Svn37sucMF62traWenp7K9PDwcPbc33hm8uDgoCAIIAjCuxsE
I1AtLS1l0xECI1jVc/HixTQyMpI2NjbS8vJy6uvraysI9qs2L4QAABSbSURBVPb2puvXr2frx2ti
YiILlI2CYK1y2ymnOH369Ok0Pj6+6Zgi/IXJycksGEeZ6+vraXp6Oo2NjQmCAIIgvJtBMA+BrYSH
eN5vsUVtfn6+rSBYS7REthsE2ymnOP3w4cOsVTCCXoj/fvzxx5XvII4vn5fr7OwUBAEEQXg3g2A7
4aHcWhihqd3y7ty5k86dO5dOnjyZuru7Wwp/tcpttZzy9GeffZa1+oVoVYwW0eLxlbuWiwFTEAQQ
BEEQfMHy4jeFXV1d6erVq+nmzZtZ9/KLBMF2yilPz87OZr8pDPHbwFg/9zaHPkEQQBCE1xoEP/30
0/Tnn39Wph88eNCwvMXFxarPYpDJ6upq3fmtBsF2yqk1HYNj4reB0S1cFMGwWK4gCCAIgiD4Hz//
/HM2aji6hFdWVtLRo0erli+OOn7y5EnW7VqcHwEsH90bIfLw4cMthb8YHRy/44sRvq2UU16+fEwx
AGTv3r2bBoLEQJLR0dHKIJSY7u/vFwQBBEEQBEOMrI0Ruh999FEWxorL56OOo4v1wIED6Zdffqma
f/v27WzwRSwTXbszMzMtBcEIbHGT6PxG0c3KKS9fPqY//vgjmxdhtmxoaChrcYz5EWSj21kQBBAE
QQgQNtQBAEEQhABhQx0AEARhm4eAdp8DjCAIIAiCEIA6ACAIghCAOgAgCIIQgDoAIAiCEIA6ACAI
ghCAOgAgCMJWDQH379/3pQuCAIIgbMcQUL6NzOvcvoDjewIQBGELhYDy9oQQQRBAEIQtFgLi+b/5
84B7enrSrVu30qNHj1Jvb++mZdfX19O+ffvSs2fPsvKmpqbS/v37s3WjjHi2cL6t4iv/7NKlSzWX
zw0PD6ddu3alHTt2pMHBwab7WevYGi2nDrisAQiCCAEFxUA2NzeXOjs7s/dHjx7dFKIi+H3zzTeV
8o4fP56Wlpay6Sgjyqq3vZj+/PPP6y4/OTmZlb+xsZEFzunp6TQ2NtZ0P8vbarScOuCyBiAIIgQU
7NmzJ83MzGz6fHZ2Ng0MDFR91tfXl+7evVspLw91tbZRKwg2Wv7QoUNZCCwqhrh6+1kup9Fy6oDL
GoAgiBBQEK1mMS+C2Pnz56vmRTfuw4cPs/cLCwtZEGxUXrMg2Gj5aMkrdylH924r+1ksp9Fy6oDL
GoAgiBBQcufOnUoL4NmzZyufj4yMpNOnT2fvT506la5cufLagmAx9LW7n+Wy6y2nDrisAQiCCAF1
3Lt3r2q5lZWV1NHRkZ4+fZoN4nj+/PlrC4IxsGN1dbWlYynvZ71jKy+nDvguAARBhICCrq6ubKRt
KA/gCNESeOLEiXTmzJm2gl0EyPhN4NraWkvLj4+Pp9HR0ex3gvGK6f7+/pb2s1hOs+NRBwAQBBEC
/iO6Ubu7uyu3dMlDVG5+fj5bt/ykkGbBLkb8xk2l8xtLN1s+DA0NpZ07d2brxIjk5eXllvazWE6z
41EHABAEEQJaFGEsBo0gCAIIgrCNQkB00UYrndG3giCAIAjbLATE7/yOHTtWNUgEQRBAEAQhAHUA
QBAEIQB1AEAQBCEAdQBAEAQhAHUAQBAEIQB1AEAQBCEAdQBAEAQhAHUAQBAEIQB1AEAQBCEAdQBA
EAQhAHUAQBAEIQB1AEAQBCEAdQBAEAQhAHUAQBAEQQB/ewBBEAQC/M0BBEGoHwy8ts8LAEEQnNRC
EQCCIAiCACAIgiAIAIIgCIIAIAiCIAiAIAgIggAIgoAgCIAgCAiCAAiCgCAIgCAICIIACIKAIAiA
IAgIggAIgoAgCIAgCAiCAAiCgCAIgCAICIIACIKAIAiAIAgIggAIgoAgCIAgCAiCAAiCgCAIgCAI
CIIACIKAIAiAIAgIggAIgiAIAoAgCIIgAAiCIAgCgCAIgiAA+BcDBEEABEFAEARAEAQEQQAEQUAQ
BEAQBLZ4ACy/AEAQBEEQAARB2C5hEAAEQRAEAUAQBEEQAARBEAQB8O+GrwDevTAIAIIgCIIAIAiy
PQOR1/Z5ASAIQiUE4m8OgCCIQIC/PQCCIIIA6gAAgiBCAOoAgCAIQgDqAIAgCEIA6gCAIAhCAOoA
gCAIQgDqAIAgCEJAuH///lv/XbV7DG/LMQuCAIIggmBNz58/TwcOHHjh+bkPPvjglQaSFw0vLxN6
WjmGl1n+TQUyQRBAEEQQ3GR9fT198cUXdZdpNv91ho03EV7a3ebrXl4QBBAE4bWFgP7+/vTkyZO6
yzSbX9xG+Rm38d87d+6kPXv2pL6+vk378vjx43T8+PHU0dGR3n///XTw4MF048aNmvv9yy+/ZMu8
9957qaenJ926daul4433U1NTaf/+/dm6Ucavv/7a8jGEH374Ie3YsSPbz/g+lpaW6i7fzjEJggCC
ILzREHDz5s2GyzSb32g7MX3mzJm0sbGRlpeXNy3T29ubrl+/ns2P18TERBYaa5VXDHBzc3Ops7Oz
5SAYwSwPb1FGlNXqMYyPj2f7le/j5ORkOnXqVN3l2zkmQRBAEIQtEQJaafF7kSCYB7BWy4lWu1rL
RpiamZlp+3jb3YfyvO7u7rS2tlaZjve7d+9u63upd0yCIIAgCO90EGy2THQdnzt3Lp08eTILXeUQ
l4tWwJg+dOhQOn/+fFtBsJ1jKc8rhrhcsUWxVlmtHpMgCCAIwrYNgteuXUtdXV3p6tWrWRd0dB83
Ck0RsGZnZ9PAwEA6e/bs3xIEa3UjNyq/3WMSBAEEQdiWQXDnzp1pdXW1Mr24uNhSaLp3717LYe5l
g2AMTCl3DRdvGVNe/kWPSRAEEAThrQ6CMVI2fo+XB6dmISxG8uYjah88eJAOHz5cNzRFK1uMHA7t
DPhoNwiWjyEGi1y6dKky+OPy5ctV91QsL9/OMQmCAIIgvDNBcGxsLGsty1vMmoWw27dvZ6N/I9RF
0IvBIPVCU3QLx+/t8lvA5KHwVQfB8jGE/PYx8YoRw48ePaq7fDvHJAgCCIIgBKAOAAiCIASgDgAI
giAEoA4ACIIgBKAOAAiCIASgDgAIgiAEoA4ACIIgBKAOAAiCIASgDgAIgiAEoA4ACIIIAf/vtYaD
ly3nda4vAPkeAARBhIAtXP6bXl8dAEAQZNuFgPIzcKemptL+/fsrz/P99ddfK/PX1tay5+x2dHSk
gwcPpvn5+brlNNrOxsZG+vbbb9POnTvT3r170/T09KZ1hoeH065du7Jn+w4ODlbNa2X9Fz1GQRAA
QZBtGwSPHz+elpaWsukISBGUcufOnUszMzPZ+9nZ2dTV1fVCQfDixYtpdHQ0C3QrKyvpyJEjVfMn
JyezsBbz19fXs6A3NjbW8vovc4yCIACCINs2COYBqdb8CH4Rvlopp9H8vr6+rHUxt7CwUDX/0KFD
m7bT2dnZ8vovc4yCIACCINs2CDaa36jl7GXKidBXnh/TxVd047a6/svsmyAIgCCIIPg3BsHy/GLo
q6XZ+oKgIAggCMIrDoIHDhx4oa7hxcXFqs8++eSTqq7dBw8eVM3v6elJq6urdY+l2fqCoCAIIAjC
Kw6CMVhkbm4ue//bb7/VHSxSHIn75MmTbHBGcf7169fTyMhIZbDH0aNHq+aPj49XBoPEK6b7+/tb
Xl8QFAQBBEF4xUHw+fPn6csvv8yCXnd3dzZIo9Zy+Ujc6OKNVsRffvllU9kXLlxIu3fvzm4RE6OE
y/OHhoay28N88MEHWZBcXl5ua31BUBAEEARBCEAdABAEEQJQBwAQBBECUAcAEAQRAlAHABAEEQJQ
BwAQBBECUAcABEEQAlAHAARBEAJQBwAEQRACXpH79++/0LxXsbw6AIAgiBDwBsWTQ+rtZ3ney5SF
7wNAEEQIeIv2q919FnR8PwCCILQZAn744Yfsub579uxJ165da+vZvI8fP86eBdzR0ZE9X/jgwYPp
xo0bVctOTU2l/fv3Z88ejmXiWcT5vOKrWHateY22Va+sZ8+epX379mXPSS5aW1tLPT09lenh4eHs
ucU7duxIg4ODgiCAIAjvfgi4ePFiGhkZSRsbG2l5eTn19fW1FQR7e3vT9evXs/XjNTExkQXK4rIR
3paWlrLpCIER4uqV32jbrWyrVlmnT59O4+Pjm447wl+YnJzMwmqUub6+nqanp9PY2JggCCAIwrsd
Ag4dOlTVWjY/P99WEKwlWv6Ky+YhsJWw12zbzbZVq6yHDx9mrYIR9EL89+OPP67sV3wH+bxcZ2en
IAggCMK7HQKKrXN5SGo3CN65cyedO3cunTx5MnV3d7e1frtBsJ1tFac/++yzrNUvRKtitFIWv4Ny
13IxYAqCAIIgbIsg2EoYK34Wvyns6upKV69eTTdv3sy6l19XEGx3W8Xp2dnZ7DeFIX4bGOvn3sXQ
JwgCCILQNAR8+umn6c8//6xMP3jwoGG4WlxcrPosBpmsrq7Wnf8qg2C72ypPx4CV+G1gdAsXRTAs
lisIAuCKybYIAT///HM2aji6hFdWVtLRo0erli2O8n3y5EnWpVqcH+EqH7kbIfLw4cNtBcEYARy/
1YtRvM3mNdtWo7JCDADZu3fvpoEgMZBkdHS0Mgglpvv7+wVBAEEQ3v0QEKNmY/TtRx99lAWt4rL5
KN/oPj1w4ED65Zdfqubfvn07G1gRy0S37czMTFtBMEJZ3Ag6vxl0o3nNttWorPDHH39k8yLwlg0N
DWUtjjE/wm50OwuCAIIgbLsQIDCoAwCCIAiCCIIAgiBspxDQ7jN+EQQBBEEQAlAHAARBEAJQBwAE
QRACUAcABEEQAlAHAARBEAJQBwAEQXgXQ8D9+/d96YIggCAI2zEElG9B8zq3L+D4ngAEQdhCIaC8
PSFEEAQQBGGLhYB4dnD+LOGenp5069at9OjRo9Tb27tp2fX19bRv37707NmzrLypqam0f//+bN0o
I55LnG+r+Mo/u3TpUs3lc8PDw2nXrl1px44daXBwsOl+1jq2RsupAy5rAIIgQkBBMZDNzc2lzs7O
7P3Ro0c3hagIft98802lvOPHj6elpaVsOsqIsuptL6Y///zzustPTk5m5W9sbGSBc3p6Oo2NjTXd
z/K2Gi2nDrisAQiCCAEFe/bsSTMzM5s+n52dTQMDA1Wf9fX1pbt371bKy0NdrW3UCoKNlj906FAW
AouKIa7efpbLabScOuCyBiAIIgQURKtZzIsgdv78+ap50Y378OHD7P3CwkIWBBuV1ywINlo+WvLK
XcrRvdvKfhbLabScOuCyBiAIIgSU3Llzp9ICePbs2crnIyMj6fTp09n7U6dOpStXrry2IFgMfe3u
Z7nsesupAy5rAIIgQkAd9+7dq1puZWUldXR0pKdPn2aDOJ4/f/7agmAM7FhdXW3pWMr7We/Yysup
A74LAEEQIaCgq6srG2kbygM4QrQEnjhxIp05c6atYBcBMn4TuLa21tLy4+PjaXR0NPudYLxiur+/
v6X9LJbT7HjUAQAEQYSA/4hu1O7u7sotXfIQlZufn8/WLT8ppFmwixG/cVPp/MbSzZYPQ0NDaefO
ndk6MSJ5eXm5pf0sltPseNQBAARBhIAWRRiLQSMIggCCIGyjEBBdtNFKZ/StIAggCMI2CwHxO79j
x45VDRJBEAQQBEEIQB0AEARBCEAdABAEQQhAHQAQBEEIQB0AEARBCEAdABAEYbuFgPKNqBEEAQRB
2EIhYG5uLn3++eevZbv5k0Xe9YDUahnxxJTffvtNEAQQBGFrhIBDhw6lhw8fbtvw8XfuY3zPfX19
giCAIAhvPgT8/vvv2U2jy8tevXo17d69O3344Yfpp59+SuPj49lzgOP5vb/++mvV8sPDw2nXrl1p
x44daXBwsKqc4is8fvw4axWLm1VHWQcPHkw3btxouO/N1omyp6amskfh5c8YLu5jK+s/evQo9fb2
btr2+vp62rdvX3r27Fn23OJYP7bR09OTbt26VfP7bbRciO87vndBEEAQhDcaAr777rt07dq1Tct+
9dVXWQj63//93ywAfvPNN9l0BKwIObnJyckshMXj6GL+9PR0Ghsbq7vdCFvXr1/Plo/XxMRE2rNn
T8N9b7ZObCOC3tLSUjZd3sdW1g9Hjx7dFNri2OLYQzFgRnd6Z2dnzeNstFyIkB3fuyAIIAjCGw0B
hw8fTg8ePNi0bB6q8unV1dWaZUW3coSronoBqZ5oOWtXcZ3y/ray3fL6YXZ2Ng0MDFQtF924d+/e
zd5HeJyZmWn6/TZaLsT3Hd+7IAggCMIbDQHRXVoOcuVlG01H61e5C7hWyCq6c+dOOnfuXDp58mTq
7u5uKaA0WqfW+uXPWl0/upfz30suLCxU/Z4vWvdi2Qi/58+fr7u9RsuF+L6jG10QBBAE4Y2GgFqt
ce0EwWateeV1oxu6q6sr6x69efNmWl5erixT6zeFzdZpJQi2s/7IyEg6ffp09v7UqVPpypUrmwJl
3nJ49uzZhsGz1nLFAC0IAgiC8EZDwMu2CMZgiGK3cbPtxu8Ni8svLi42DSjN1mkWBNtZf2VlJftO
nj59mg2Aef78ec19unfvXtN9qLVciN9SahEEEAThjYeA+K1adIG+aBCM0cSjo6OVgRgx3d/fXxU0
4/d7a2tr2XR0veYjdvPfyjULKM3WaRYE210/WgJPnDiRzpw5U/V5tCrGiOBQHpBSLKPRciF+c+g3
ggCCILzxEBCjV2Pk74sGwTA0NJS1usXNo2P0bnS95mIEcXye31j69u3b2WCSCEcRmGJQRbOA0myd
ZkGw3fXn5+ezz8pPRYnu3vh9YX6LmjzslctotFyI7majhgEEQXjjISBCT7EFj5QF2WhFfF2OHDmS
hUVBEEAQhDceAmJ0q2cC/5/o3o4WzlqjfV+F6JqO73ur1QEABEG2aRCM37HFb+L4v980xpM/6g0S
eVnxPXvWMIAgCEIA6gCAIAhCAOoAgCAIQgDqAIAgCEIA6gCAIAhCAOoAgCAIQgDqAIAgCEIA6gCA
IAhCAOoAgCAIQgDqAIAgCEIA6gCAIIgKLQSoA+oAgCCIEIA6AIAgiBCAOgCAIIgggL89AIIgAgH+
5gCCILy7wcBr+7wAaN//B+qj6aVJI9QnAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-08-29 18:38:33 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///9BjlLGAAAdMklEQVR42u1da2wc13U+fMxrd0VyhmQtSo1hSmpaQP2ROpViyaJi
L60kapM4CRogcJyXgcpOnCYoEjSJC7hOf8SWEzl1DTuJbEDxK21gw6idh2VLWsdeKQ+qUFE0SgOH
lBQ54tIVOUNKJGd3Z7nsfc1rH+Ryubvclc+nx+zce849Z2bP3Htn9n5zABCIuqENdDwJiDrBasdz
gKgfMLwQGF4IDC8EAsMLgeGFwPBCIDC8EGuGTjwFtYWFpyDwpB7Dq8XGg7o2v1CTVhZxcETg3AuB
4YVAYHghMLwQGF4tA7Phiog6hVecQI6kSlat1bFtLGNbjy3jYRnFeGnpRQPDqO69VyKRmJA2N9Wx
7SBeleqb7N9Xp+geacF+zsberhGDo3E2B9CvyQq5nOM9qkw2IxGFPsJ1onLUoYWKfMhWpSQTtyVF
TdI6KeZQSVWP866B/DMjStRkCopN6lTapCgD1moPEXJivNXuvbLttRPvVoUPcfaHlnMp1+4zdi/Y
sqIx2zLVAa8tRx32FSNKxPeB2dVYSwB9mqyS40rKstoH0vxmjKNGzL02SQCXo9noHPmcH4+RTVxN
0SfBvc9n5V5amDr2uYHxS8NMuiuWOXITqRt1aF38pfFAJ3D1TOawzhSmuwFu1M7ZfhnANjmVp61a
WYW2Ck8f6/LagY5xmI1mp+dIL8P6md7neTm4dv/+OLP9MrU9zf1ibdFPPdp/z7uKupJRr/Z8YHYv
jHLpOTMbmQcYjmWPzAIcz2Ic1Tu86NwrNw2QngTzerJ/zqCb3KgxRXYy18JYmmynjKEdZwxtF9NQ
nOTWDKkbAJNsnK1GLjDgSDCksVaocG5swPbLALQzvFWJacJZY2jIawdGDbAnQbvebepjwvZZ1+7C
VmI7y22LFtgnK0MtTaY9H8ZgNOf5QGEZA1za1thBSpm+rUR8aw7jqAxqxRSKJ8A2LpHea2pTLr8j
QffpPznLNnSPfBSF7B8JqJ6PP951kQ2H5PqXHE+Sbnihu5dwp9S8o9h30BOSD5dQmdq0sMB9EMpK
JmCX+kRtr5sM6AS0IaAYcBoCLZmDC7mdCZi62mk7N8D9cWHhb46Lej1OhqZ8ifx/K0xeCkSvCXRu
c8IscbMvzd0XuUy+VHJTQL7w3VxSPBY4wQsFTjBlv+wJLks1D3tCx32VW+Gif3N4nNheDNodMrnt
2WCTQrst4CZ1eijksQPmp8StpfwaHVHnJrRbicOPYzfVgIth+jEyWz52xO71i9KboY+Og1tgs1oo
riaNF8jlovaDHgU4qTHJE7ZJY5/0ZYc0T7JzS0pjZTZvxN4EvWQCpTpwNOI3x9uhODZpZ7yoVAtt
//I0KbSZbSXl6pC2dNLWLzf3qywiqQ8abPlVyONu0P6dfcj/dvQmfgQ/Iod8GpedNKSvndljwszu
gUCbJ7NqG51zZeTsVKH0uj0yG8lsOU2C51yfQiWnu9d/n978d8uf9TvB6flB8oUnemT9Mu9zMwq1
MdUjHYh6QqId5sc65kPneihlWyYzqXUGt/0nrg5p6zrS1iv2JRJk8lXsAUSvbIcfQsyo/bylyG3M
QGyPMjwDsEvGOKrz3KtWE7iKH4LYdrVWzI8/1VtLr50PPm3g3Kv03KsDtOYJr/EKD+/L/9mx8Oqj
1VrZPzX381p63Z36emAv3Vbv/qCOWKzRLDxwMvAdEzUFLoYOLIa2cFZar1OLAFyQg8DwQmB4IRAY
XohGAqf2eOdYx9sbDK8mHQ/WZFhBGi0C514IBIYXAsMLgeGFQLRGeJlr3zQSy1o3vIw4XakVL0uv
3bg64u1Sunfzjf3gMjp3r4hGG7MxjJonvLIjfUvWL81hXRV+w/smfcfyciug0Z7XsbdrmvAyHSvn
fR0mZ6o6GuXBpjRZPepyWM2IrJkeGxcYPdf2+bjdmpx09URZv6YoXDSuK/tsW5XsANOWysd5x3NK
2Q6GIms24+NGuDNmVKafUppi+/xbWfByZc6/hf4I88mzZcuSlgRDRhptOTR8teo9sQX1HyUYPEv/
PqzMrvtWFrrl6e4c/OZU+7oncmcHE7TmvnVzXaRm8MIb351jz5LbmYwuzUW1DAymzu+N54WebsG6
L/wc8rHLs+0LrOELf/hcZ8/5v/rhAnzlCMRIHZenTRM899NDkI/Mde0ZhX975buXDrQxe/OQ+NM2
+FYs0rYgXCC2IszWG9QWweAb5w/ezaSFrWhk/vIzOTj6uOMfX61Wq7atRTTUfLVqw3uvgzLIHi3Q
GYVR8tVkz0hpgBc1sHa6NeoYqxFsXIJbmExmDM74zFmuR7mwDzH+rkt3nTImd5wxhsjeQxJYD3ny
HLdsBeg07dEXif3toHEWkcY5urefuZhx5cK2gH26yKWFrW/mbJvSaB3spspeJI1dXml+lFwhJ1JG
EVOVVF3z6YM7E0txWKGgOESvdfpyuzOJABW3HB2X0mjNP15Y7L5YQKNNOsvTaHmBsDVyQw4Suxi3
1oOFvznWh0ZbWb/5i0Qi0XFa7FGmaptLSNzY/tRlT07UQLAAOCe2qIwzYLth8oUic8dDdFz/uYMx
n4pdCtJo6SfHZTgK3SLub5/rk7C1fX4iOozPMZroIqEsVVBPib37T8MWCUDa5JDivDRK128kR2gN
5bBKQUUuo26BTWphGWfT5kL8XXeMdTxuLQ0YNorJZBDca7C7AGkEDDHccd6uvNlRXLkvhGyxJxrw
dv4GCmFLM4xx0hlruOykWcIrN0r+G/2KuOA/8V4lfR7gd5nYEYDo7Ffpd66wCdT5Xlbjg8uczexz
pgrKpnqkD5AQmnli4Lkic1M9+9I+kVtirwb4j6sATtrS3DSxcqNyi2DmdiuUt2vZd067cvdmJCfM
/R3VbL6cS9h62ZZ7iOhVz2McNcncqwlgDiS317I9J5aqA432yph7vRV5jkZmrpbNPfj14OQLw+ut
Hl51BS6GRhptI04tAnBBDgLDC4HhhUBgeCEaCZza451jHW9vMLzwgq01cjg4InDuhcDwQiAwvBAY
XggMr0ph1kgGcWWEF01qpvaXoLjGl2Sn2vKXS5YH+bDl1Dcu7d0q+LRCVS9FfknKXatosohGi79i
V9Z7JRITGl+8WcQiXYJW2jXzrZLlQT5sOfUddT48M10qGd7wsUuraLPwWKw09sEVDo6Glff6K50x
WE2N5ZONe/lcnShLBQtuntf40F8zDYMxUpOaRPO0ElmXjMoyyVL1JGO09qkKz1arCMKqYLRCUJfb
EQRaiNtMcyQqR0aYX66OGcoX6+px5izHZkminmkjwdy18V3/FMhRy9RFjtxkRFZ7eH7bJGPuHgq1
56giG62QS0qK1geShDTaSudehs+q5flkf6il3DWMiyyfa6+Uupfv8zyvIncrTKXUHwK8x3Ronlbo
GBflj2jn5rn4ronnewFmj2Sm/wZYjtcepjsbyZp8eHF1uZ1OecJd6d4/QTPFbpvOTtE8ZDAOc1zn
aiWjPum25elZ2Rc9TkeWZpPKpdRtfnnH09Sqm6O2Y5yqHxU5ct/zUpaH+tPHSLv2j7o/G2rvsXGN
fxJyT8YyL38EQL4H46iS8CKTr3fc7+2dZQzWZ3k+WQqeljVzxngn30+LPK8cOWP0WS9PK80Jy/HC
2ICQOWl0ZYjSEGijvDHOj5UcxkUFX5fbUceMk+5wZFA7qgQaJRSOGdDJdd41BqMv+G0JPQl2e7zD
616ngW+MqX4598z1ne75OXLtIbCuZ4c+RHzMXnsxHWrvnYbIVSvkfuDYWw8CvP4PGEdlEFwMTWmi
/ZcyARZpKJ+sKKCc0cLsrOBxTM3BaW1nIsBbDRJTqYDT//Wv7ggKjNywALOMcxbWLbYDHtN15N15
qlNMqi3MKyty3NJtMaM2kKNW/BvZ46axLZUE19cRck5Ptn3dJCfmejMx/M0xV55Ge7HwTqu9iEzq
FYRzzDqMY7qxrfe1kPQJT2SECXTnrw3Pq7fPpyJ38tvIsK7fuullqBWToO12KhIrwbWlCDFn202u
3lHIqD1RmKOWYXebHHDuuFnQXr/rkZCT5t6kOW3NNuymKpx76R2Fjx02wzWhAmUT6Mf54Phr2Kx4
5X2whYwc+f9leVr9b6dzc2ov378JThHpW6e29oa+Qc022r7PJ3u+LrVzyjOsMztpx5sZUh2yub+Q
a0uhOvCaR23spHzwQdgsF5Qz34vy48IiZ/IKyKf61ZDeHJxWgnI0p+0nAU7fj3FU2dxLTr9aIHAy
q4TZqVOO+wqS3N5gntc2OUPmStHbvGS0d7BksK/Y14iMwd+UP0Skd6wLZqslMtGPSHMzbCd62/pA
1dTNivuaN4PZsbqVedG3UJ1p0lavnC565DHVI93rEbMfoJzcNiV7rqC8wHcX0b9cH8i6rh24ZIX0
fqa+byoot06Xhz9B7llwal/J3Kti6NliouCymWTjVb8UrnpNMDdekuKJ+p5Cp+uCgXOv0nOvlYdX
zFnsjF4sKpazy+hJVb+maNmml7oSnNng+2vqgcXeEI0WwyuHNNq6ARdDI422EacWAbggB4HhhcDw
QiAwvBCNBE7t8c6xjrc3GF4tNh4003BT5m1zmI0WgXMvBIYXAoHhhcDwQmB41QHmGtsx18gfDK/y
oKTbSGrFpFtDebCobEODDlbYMaKun2Xsb1hRNtoHDQyjOvReicSEfBv/VFRVXms2+sWisp0NOlhu
x5x/Yxn7O1eUjXbHPPZ2dRkcjeljXn91lOVsdaL7XNJtD+PPmppylF/unPMa3/UOukPkBCNV5H7l
bFszynmxuqK8lmR0W/NBOcq/vT5NoW0bMmPQJvfJah+p/hJrx5bf9/kkuOza+FFFsW3mj6iP9+zd
Z3vZaGXD9ZPbo+XCjqPtM9xstFPCxx51n8iWndIiPBut6wuzt10+hXFUl7mX7nMjDo/PMO7rfe6j
3Px4dI5I/EvqI0JWyai6S7rtfP6g3Ol3Bwno0brmiYyceZh+7Qup6Xvfn2L6O7KT/DeG2ZczO4jI
XDRrkhaHd2SPzJLq+w5O9gJ0Rw+/cw8wdi21djh11Bhg/oh6yD+9o9u1ffObnp/6dObha1i5sNOj
PDzvyhkS93Fx/BPd3NEDFyJXe77Mefbe/BDGUe3Di0y+/sJ//n8X46HePmacEwU8j6z2UZeFq43B
qMfNuf1aGFOCjeXGKGWVyNysMV0tw1m86nbQOD0oPQSfuZ7mkTXsFwHkv+vbShRul0D7GIB0T/Lm
tFdHfHF5saKeNPiZXa4px/b81CT4DF9pLew4LL+t8PEM9/Esy2tLca8x6Xi+7PLs2ZiNthyqXwxN
GRLJPemSHNsiFi74bNZCBm4B29aVCZNiaVT05yh1VeSRFQxWWn0iA46ebSN75sY8dF0sVD+RCfNi
qY+un+Ayc0PkW9+lANM2lI22P5fbmXDthWm0+JtjzbLRDuWL7/HD89z2EOnWs0Z3PhV8CMDZtiEZ
Xu6RWLsWXzwDLI9s9MOMwarN8moSKdLsxE/InmGnIh8uUi9kcnzKhGJmrrCzJZzrVvjoIuV617V4
8Sx49nBmXxYdftr2FWKQnOCeRYdu+V/6L/qv6e9sCBY4j6a/M8aCULtLevRyGysnY+Fj9sHjbXBh
9vI3UmdhPN2hPhLL54Iy4l/u5KMGf5N1+8y37yeye//ngcjJBVBf+TNLzkN0tkNvd0C9/MDfPr7g
1gXURb3YI3ZIQ799xHb9zOU6Dr2co+XCzvW3XY6yfWqa++i2Rv7/ivP+g6ygfWYu4MujEOi90m31
Hm6aB4tlyr2QSq9q7iU7YwVlUzklvMTHyijPcRvnDSV90ptqZeQsCZpjXQOPAcv+Oj1/OcJlwgum
rBtkwZ09to7J3mUwBm1sj9x1iXJc5fQY5bMqw8d4XTTsD68X4Flmn895fp7kOWhJubDzNZbflssR
H53w28Ei2nutQl+IvZyE3VTN514V49Cd8011yOaGyzWNh5Hd43XIRntlzL3qHV5dH3u8Y6bJrm77
4Bdr2VzsYnB+geGF2WjrCFwMjTTaRpxaBOCCHASGFwLDC4HA8EI0Eji1xzvHOt7eYHhdGePBmlhF
Gi0C514IDC8EAsMLgeGFwPBqEphVVa1UxQxW4fLTWqHBKyYqTmHgC6rpskIiD+RKWgur6F46IFIe
mXdlyU4pR0VZYVXBe+3xwUTN1to3AktwbKvIZRtSCeSqJeXX8U+JcB7dYhRW5Wzs7Zon6kXu2BHG
m3VEPtnvycNGkueUtYdpzllgvNso57iKPLTgy4NLv+3fK9sscy1nvCryoSTn83o5ZEndIWCpZRXO
kKX5cPn1RXPVeuWsvR5FtEssjIRy3VKMaIL726fJwzrNyU25vNI8ZqNtok41n5ruBrhRO2dzbi1l
pu6b+HHm/awcrnpG2cbkrp7JHOa8221viDy0nrzoRhJg/2Kuh+bFzbLcsvnUsc99YPwYzZlrZRWe
ea1Xnvg00JcPZKfnePrbI5lpnhOJ5qr1yhl59tmUaJfGr7DF/aXYdmGStzlnZv+LeD8cY1ze/izG
UfOEF08amxsbsOn/MEo7mZOG9q6zrFzkjgXGkBjiy4xVAzT+FbryHpwzUsbPLcvzylLWa0YCkzPQ
MmMG/R3QngSR/pbmw+W82NzrwXKKawOr5l1b3F82lTA03ibNm0sGbSmTpFze13MYR2VQPRGtKlCG
2h1s8+476P7uO2B/xwIM3gVu+eB52N+ep592Dw4O/p7Ryt5NPp3LB+U5Ocxrhvy/v3OB6nrNE5Xz
bOrZ+Q3YTwqmvtfZ+Tam4vTuf/VtjFnWfi8Eyn3f+F/X1h0eEY186mTGze9K7URp4tuHDvzhAPPX
Q3ptmGJrYrWuRLTVwefNDoUrHJY7FoIM2jaf7erJ87mYmzG2KLdsIIesyWTfBpMxvt+V7xJpIWmu
Wr+8hIcFvjnuI4uNINO8ub1zE9qtUMj8RTTBc6/OLSkS5JIGW34VruhluWOBvQ3gEBE57sDRETcP
rZA/bpg38aiSNzkKGT23FOaWVYkWf7+KcgqobG7SzvCYWZi6WeTDpblq/fKkdwPIY/b+It+6QeMv
xsj/dpTOD7Wk8SNyG3Eal500XXhNzw+SLzHRK9sFN/rtLHcsnWF3y599VXBcFZt3OEI+NjdAezh5
PVjp2FEywmUKc8tO9UgHOKN26kMKlZ3hWXCl9ZQDK45a3hUsV9a7yjL7VJzrdkbt565Fbxug957R
PcrwDMAuGeOo7JjdZNSWeueODT332nChd/WtTG1sJI22mbqJFuQ51jt3bAhGdnb1jcSk4ApVDK9g
eDXdtKGR0VWbHxcLIjS/JqctD00JnJXWGEijbYqpPQLDC4HA8EJgeCHegsCpfY2BNFqk0a7JeNDC
A8XCiqSRRovAuRcCwwuBwPBCYHghMLzWDGYDNFanh2jm8HIiyr4un6hRmPV1w5JZbkvh7jIaeqwq
vTLZaGM2hlErhFeXkroPvla2eukcsaXwm9Ia5nVWVXoChVXndeztWiG88mOGcekhmiNWjvBvjDJp
RxgF1hbkVs0BR3PLaVfSrbrycZsxZ2nW2xHGfhV02HiPKhuUA6v08I5n8wmpKj3oj2icw9uvsVS5
hixpSTCUTRhHLRBenYNHHbqcUJ/OvsR/V7j6Z5nJbQC2MufmsZX+CJ6S3HKKjnFPvn9C6iU6akZh
4ZASdFjIj8fmALapKbHmLvuT6vQg84cY9+tyNDM9CzAbccw9AD/GdKGtEF5v/PMHo1qK5YgV/Fln
O2gqiQc/R+xP7oHPK245xajhyZ83zpDgdEZhjH7fZ7wF8DwvrjpmnOX7ua3V6cFZ4yK3mp5kTNxv
5mybOLYVw6scmmytvTm488Ulc8SaG9JqOpCjluWK9eRFslh3UyYvruRUpxfIRtuX251JwMgNOUjs
CvMDLPzNsUnfkKOYYMwcK5Ej9oQ/dzY6evYHGbaulMOeJ5if5uzXUpxlPy9uu1mdHvS7Et0w+QLZ
bJ+fiA7jc4wWGRzTg47ZLZEt58/SfobzZ6VNjuoGmXxtl1fu6gn5a2ATrTsNW0SGv+PBUcveDNck
+RzvdHV6MA9v5zTa3BGbMtg0wxhfJBtcdtIK4WXdF1ufO0+2PEcsnRXdqNwSA/gdyxF7/wAt+r/j
N3vlrp6Q79iXu4vUvVdJn+cVUvD5lp8XV/51dXowqtnn2IeZJwaeo9M0W+4holc9j3HUGnOv1WB5
Aq7Ii2t+/AWpGr0yqDQb7Vtx7tXgN+TUExeWPgldi50/ffVR+mn/VKatGr0y+PNnHgiO8G3lr+SW
xeLKxLXAyUBiXm1HeDwFmI22AacWAbggB4HhhcDwQiAwvBCNBE7t8c6xjrc3GF5rPR6sTH6hBc4A
0mgROPdCYHghEBheCAwvBIbXWwO4AhXDqw4w9sosYW05zm4ZKi0Cw6sCpObvypp635I5cCkSeKow
vFaO9doQaFqa82h1RfLz2sa79zIJRxUZaZMRWekBsCVFS+KJw/CqBOoY+W8syzm7+dQlntf2Rcrb
6HiaSTw2fpjnIXrPS9kIGUa/GMu8/CSeuDLA1arhqRUb9ZQM4zk+a9ANJTHSgmfZgvr4fdtdNiQX
j8FFO7DUfuXUvivwR6Hm5Dk2AVgmR/eukUfN9fF4fNHbg+3uonmzO0bXlFuLXQN9eOJwcKwEmc3k
v81SKOJClF1KpeUfNrTJlMUmzb0ZmcUTh+FVCSbsJCTt3wGc8Ji0GQdei/gSc3CaU2kXpVG63ES1
jRc+iSeuDK4gIlotcODy5PmnrQdJ1HQuiHzwuZ62C5PzIls7DD715A+sDro3O3znd06fBb29/YkD
h/wWVpyqfWXyi61wFpGIVjfg1B6n9ogGAVer1hr5OstjeL2VgXMNvHNEYHghMLwQCAwvBIYXAsML
gcDwQmB4ITC8ECuCtcb6zdUAhhcCey8EhhcCUQBc79Vkc68rAfji8Qac2yrDc7WXexM0gIMjAude
CAwvBAKn9oi1uM/BqX097h11ttErnyZ7Omy7IlV/Oq1XZ9ufjusVe8CrfK/LGcXwqnl08ZPM/lYc
Xe4Xo4u9ylVDN6zV2PbVLajUA6vgSMsaxblXEz3MqP6RgKXX7LqoqTXsverckVUzrlahahU+cFu5
bb1iD/SKDxjDq14dkkX/WhXfObljI9muVBU8zSptF7VTlQeldDC86jngiZnJCsfIKlT1VdterQel
dXDu1Rxjo7XKoW3147K++tlcsQ6GVxNFYvU/h9fqh/Ra/yCPj1VrHyrBpwSVnd7AU6eVqoaNrqIB
fSXOl3ruVULHwvBC1PFKw8ERUUdgeCEwvBAYXggEhhcCwwtxRSDwoxByXBA1gl4ivPAJGKI2sHBw
RODcC4HhhUBgeCEwvBBXFjqXnvm33j0l+t704VXYp+Vb+IhyreR7QfK9xVaPLhwcERheiCs+vKwK
a4vkLMsvXaMfnqySxq2WOB7P93IuNfOprxURbbnXEbTaXLUJj0dvwVO/8sHRssSV5F0ZFvsjaoJX
HJe0Cq4kIeZLN7Qbc40Hj8bdWE19PNwWhPxv9lO/4t6r1JsILD1cE9x332rhESzDL75oeHzp/t9i
Z3xfm/N4qJ2Q8WY/9VUOjrol/hT0u3pRn1zUN+tr2l/rJW3r4W1zHY9VcOaLHWzeU1/DlwDogZdU
LX+6dKspZmJLzHub5XgqYNg27anvrO15oFfPMq8msAIvKVv7+NJDPrXs8TSrq9U+99LZe1T0ap5c
BG4KGnb2raKBw1rmqUWzHo+1modGDT/1nSs8ML18z+rX8LgLS+qWV8lrGjo4FlgLOkM/CZ+a/nhK
+tnMpz7wEgD/6i7kbudb6Wfhwt8cW8n3wt8c9eUeZjXpcehlvgxEc39v0GKrKDC8Wgktt0CndHjl
W/gryLWw74tX2vXQeUVcJOh7kwIX5CAwvBAYXggEhhcCwwuB4YVALI3ggwl8AxOifuGF719C4OCI
wPBCIDC8EBheCAwvBALDC4HhhUAgEMvj/wHUYCBIvplgsAAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-08-29 18:38:33 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVsAAAKfCAIAAABPPPyFAAAjUElEQVR42u3dv44cx9nF4QEMGA42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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS>

<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;11 trials in total included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 new trials (3 reports), plus 1 previously ongoing study (now with 4 associated reports) included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;8 trials included in the previous version&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;16 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;16 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;12 additional records identified through other sources&lt;/p&gt;&lt;p&gt;2 trial reports listed as ongoing in previous version&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;0 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;6 new trials excluded, with reasons, plus one previously ongoing study now excluded&lt;/p&gt;&lt;p&gt;(see: &lt;a link_type=&quot;SECTION&quot; href=&quot;CHARACTERISTICS_OF_EXCLUDED_STUDIES&quot; protected=&quot;true&quot;&gt;Characteristics of excluded studies&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;2 new ongoing trials&lt;/p&gt;&lt;p&gt;(see: &lt;a link_type=&quot;SECTION&quot; href=&quot;CHARACTERISTICS_OF_ONGOING_STUDIES&quot; protected=&quot;true&quot;&gt;Characteristics of ongoing studies&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_EE5D21D682E26AA201CF22BBD5EB6D97_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="EE5D21D682E26AA201CF22BBD5EB6D97"><ADDRESS><ORGANISATION>BEST Services</ORGANISATION><ADDRESS_1>2 Kylemore Park</ADDRESS_1><ADDRESS_2>Taylor's Hill</ADDRESS_2><CITY>Galway</CITY><COUNTRY CODE="IE">Ireland</COUNTRY><PHONE_1>+353 91527511</PHONE_1></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>